We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that $T2$ expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, $T1$, or with $T2$.
FosB
c-Jun
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$$T2$, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
TRADD
0
Two lines of evidence support the notion that $T1$ and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with $T2$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
RbAP46
RbAP46
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T1$$T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sCAM
endothelin-1
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, $T2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Rb
cyclin E
0
Through their interaction with the ErbB family of receptors ($T1$, $T2$ and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.
ErbB2
ErbB3
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
The molar ratio of serum retinol-binding protein (RBP) to $T1$ ($T2$) is not useful to assess vitamin A status during infection in hospitalised children.
transthyretin
TTR
0
Insulin receptor substrate 1 ($T1$) is a major substrate of the $T2$ and has been implicated in insulin signaling.
IRS-1
insulin receptor
1
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing $T1$$T2$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Two potentially oncogenic cyclins, $T1$ and $T2$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
cyclin A
cyclin D1
0
Furthermore, the 60-kilodalton subunit of $T1$ is related to the yeast splicing protein $T2$.
SF3a
PRP9
0
Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor $T1$$T2$ and hTAFII28: three subunits of the human transcription factor TFIID.
TFIID
hTAFII20
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and $T1$ were both potent agonists for $T2$ and CC CKR1.
RANTES
CC CKR3
1
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of $T1$ and c-Jun are necessary and sufficient for stable association with $T2$.
c-Fos
TBP
1
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
decorin
elastin
0
Here we report the crystal structure of human dimeric $T1$ in complex with two high affinity $T2$s(BRIAec).
BMP-2
BMP receptor IA extracellular domain
1
Association of CDK4 with both $T1$ and HSP90 may also imply a mechanistic link between the functions of CDC37 and $T2$.
CDC37
HSP90
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$ G protein-coupled receptor and the $T2$.
CCKB
insulin receptor
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, $T1$, and a ubiquitin-like protein $T2$.
p53
UBL1
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T1$ respectively), and is the homologue of Drosophila (d)$T2$.
hTFIID beta
TAFII30 beta
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
IGF-1R
0
CD5 associates with the T-cell receptor zeta chain ($T1$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
TcR zeta
CD3
0
We studied the human IL-6 ($T1$)/$T2$ binding interface by a combination of molecular modelling and site-directed mutagenesis.
hIL-6
hIL-6R
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$, and $T2$) that translocate to membrane and bind to cytochrome b558.
p67-phox
p21rac
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the $T1$$T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
p53
p53
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, $T1$, and $T2$.
K5
K6
0
A protein, sorting nexin-1 ($T1$), was identified in a human cell line that bound to a region of the $T2$ (EGFR) containing the lysosomal targeting code.
SNX1
epidermal growth factor receptor
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex ($T1$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
SNAPc
PTF
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and $T1$$T2$ receptor ( LTbetaR ) and HVEM / TR2 receptors .
HVEM
lymphotoxin beta
0
We previously have shown that PTF purified from human HeLa cells is a multisubunit complex of four polypeptides designated $T1$$T2$ purified from human HeLa cells is a multisubunit complex of four polypeptides designated PTF alpha, -beta, -gamma, and -delta.
PTF alpha
PTF
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing $T1$$T2$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric ($T1$$T2$ is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
IL-6
sIL-6R
0
$T1$ also interacts weakly with the p55 tumor necrosis factor receptor ($T2$) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.
RIP
TNFR1
1
In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, $T1$, or $T2$.
CDK6
CDK2
0
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and $T1$$T2$ through communication with RPB5 and TFIIB.
TFIIB
TFIIB
0
Here we show that a complex of $T1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, $T2$ and MIP-1beta (refs 7, 8).
gp120
macrophage inflammatory protein (MIP)-1alpha
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind $T1$ ($T2$), were substituted with those from human TrkA.
nerve growth factor
NGF
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing $T1$$T2$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, cyclin E-$T2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Rb
Cdk2
0
We propose that $T1$ binding proteins play a key role in the modulation of $T2$ aggregation and normally prevent amyloid formation in biological fluids and in the brain.
A beta
A beta
0
We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, $T1$, and $T2$, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.
IL-6
IL-10
0
Other NH2-terminal residues directly modulate the affinity of $T1$ dimers for the $T2$ tethering site.
RII beta
AKAP75
1
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with $T2$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
TBP
Oct2
1
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, regulated on activation, normal T expressed and secreted (RANTES), and $T1$ ($T2$), but the receptors involved have not been defined.
monocyte chemoattractant protein-3
MCP-3
0
$T1$ contains this primary site as well as a region that restricts interaction with $T2$.
FGF-7
FGFR1
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
0
Our analyses demonstrate that the XPB, XPD, p44, and $T1$$T2$, XPD, p44, and p62 proteins interact with each other.
p62
XPB
0
Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and $T1$$T2$/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation.
TPO
Grb2
0
$T1$ and $T2$ display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.
cdc25A
cdc25B
0
A domain is conserved between $T1$ and the $T2$/Blimp-1 differentiation factor.
RIZ
PRDI-BF1
0
Intriguingly, $T1$-alpha-actinin binding is directly antagonized by Ca2+/$T2$.
NR1
calmodulin
0
$T1$ interacts with the "effector domain" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of $T2$, a known RAS effector.
RIN1
RAF1
0
Peptide growth factors, as well as the immediate early gene products $T1$, $T2$, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.
c-Jun
v-Fos
0
Deletion analysis indicates that TBP and $T1$ bind to distinct domains of $T2$.
hTAFII18
hTAFII28
1
Three of these clones encode DNA binding proteins (NF-IL6 beta, $T1$$T2$, HMG I/Y, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.
HMG I/Y
NF-IL6 beta
0
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras/$T1$$T2$, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras/mitogen-activated protein kinase signal transduction pathway.
mitogen-activated protein kinase
JAK2
0
The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger $T1$$T2$ MAb to trigger CD30 signaling.
CD30
CD30
0
The binding epitopes of $T1$ for BMPR-IA (type I) and BMPR-II or $T2$ (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMP-2
ActR-II
1
Interleukin-2 (IL-2) signaling requires the dimerization of the $T1$$T2$) signaling requires the dimerization of the IL-2 receptor beta.
IL-2 receptor beta
IL-2
0
In addition, we show that in extracts depleted of $T1$ and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by $T2$ or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TFIID
0
The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator $T1$/$T2$.
Swi
Snf
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the $T1$$T2$) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds IL-13.
IL-2 receptor
IL-4R
0
HFE binds to the $T1$$T2$ (TfR), a receptor by which cells acquire iron-loaded transferrin.
transferrin
transferrin receptor
0
We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the $T1$$T2$ release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (CaR).
calcium-sensing receptor
gastrin
0
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
MCP-4
0
Specific cleavage of laminin-5 (Ln-5) by matrix metalloprotease-2 ($T1$$T2$ (MMP2) was shown to induce migration of breast epithelial cells.
MMP2
matrix metalloprotease-2
0
$T1$: a protein kinase stimulated by UV light and $T2$ that binds and phosphorylates the c-Jun activation domain.
JNK1
Ha-Ras
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T1$, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
Conversely, a $T1$ mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit $T2$ activation.
FADD
NF-kappa B
0
After a brief historical incursion regarding $T1$ of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with $T2$, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
RAS
isorenin
0
In patients with a complete response to IFN-alpha, the levels of $T1$ were higher at 24 weeks following $T2$ treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-gamma
IFN-alpha
0
The $T1$ POU domain, which is highly homologous to the $T2$ POU domain, likewise mediates interaction with TBP.
Oct1
Oct2
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$ containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cdk2
0
Deletion analysis indicates that $T1$ and hTAFII18 bind to distinct domains of $T2$.
TBP
hTAFII28
1
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$ has a deep hydrophobic cleft on which the $T2$ peptide binds as an amphipathic alpha helix.
MDM2
p53
1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$ related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin
0
Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely serum response factor ($T1$), which binds to the $T2$ promoter.
SRF
c-fos
0
Here we show that $T1$ directly interacts with $T2$ and FADD, signal transducers that activate NF-kappa B and induce apoptosis, respectively.
TRADD
TRAF2
1
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, $T1$) of the $T2$.
EBP
EPOR
0
We previously have shown that PTF purified from human HeLa cells is a multisubunit complex of four polypeptides designated $T1$$T2$ alpha, -beta, -gamma, and -delta.
PTF alpha
PTF
0
Of these 400, interferon regulatory factor 4 (IRF4), $T1$, TBP-associated factor, eukaryotic elongation factor and $T2$ were up-regulated more than 3.5 fold.
cyclin B2
pim 2
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
dTAFII40
0
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTFIID
0
The gamma chain of the interleukin-2 (IL-2) receptor is shared with the functional $T1$$T2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
IL-4
IL-4 receptor
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$$T2$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
p85
gastrin
0
The amount of CDK4 and CDK6 associated with $T1$ does not change in a cell cycle-dependent fashion; in contrast, the amount of $T2$ associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
p27
CDK2
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ (hsp90), $T2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
heat shock protein 90
p23
0
We show here that $T1$ associates with $T2$ in somatic mammalian cells and in meiotic frog oocytes.
Cdc25 phosphatase
raf1
1
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the $T1$ IL-7R, and not with expression of the $T2$ IL-7R.
p76
p90
0
hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and $T1$$T2$, but it interacts more strongly with hTAFII28 and hTAFII30.
hTAFII30
TBP
0
These cells contain a temperature-sensitive mutation in the $T1$$T2$-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.
TATA-binding protein-associated factor
TATA-binding protein
0
The binding of $T1$ to $T2$ induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.
p56lck
CD5
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
The interaction between interleukin-6 ($T1$) and IL-6 receptor ($T2$) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
IL-6R
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ (sIL-6R) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
IL-6 receptor
IL-6
0
A region of the beta subunit of the $T1$ different from box 1 interacts with $T2$ and is sufficient to activate the Jak-Stat pathway and induce an antiviral state.
interferon alpha receptor
Jak1
1
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T1$$T2$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3
0
These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein $T1$$T2$-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.
CCG1
TATA-binding protein
0
Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type $T1$$T2$ protein that binds AKAP75 approximately 4% as avidly as wild-type RII beta.
RII beta
RII beta
0
Analysis of $T1$ in vivo in a diabetic mouse model of delayed wound healing showed that $T2$ significantly enhanced repair of a full-thickness skin excision.
PDGF-CC
PDGF-CC
0
We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of $T1$, $T2$, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.
IL-1beta
IL-6
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
keratinocyte growth factor receptor
KGFR
0
The novel fold of the TNF receptor structure is likely to be representative of the nerve growth factor ($T1$$T2$ (NGF)/TNF receptor family as a whole.
NGF
nerve growth factor
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta($T1$$T2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
IGF-1R beta
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
Residues in human $T1$ (hLIF) crucial for binding to both the human LIF receptor (R) and $T2$ were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.
leukemia inhibitory factor
gp130
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Further investigation indicated that the $T1$/$T2$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/HLH462.
ITF-2b
MyoD
1
Eotaxin-3 competed the binding of (125)$T1$ to $T2$-expressing L1.2 cells with an IC(50) of 13 nM.
I-eotaxin
CCR3
1
We find that p53, p21(CIP1) and $T1$$T2$) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
p15
CIP1
0
Two potentially oncogenic cyclins, cyclin A and $T1$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an $T2$ (SPF) as well as a candidate proto-oncogene.
cyclin D1
S-phase-promoting factor
0
The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger $T1$$T2$ binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger CD30 signaling.
CD30
CD30L
0
Jak1 and Jak3 associated with $T1$ and gamma c, respectively; IL-2 induced $T2$-IL-2R beta and increased Jak3-gamma c associations.
IL-2R beta
Jak3
0
Analysis of $T1$, p21(CIP1), p15(INK4b), p16(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p53
p57
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural $T1$ ligands, macrophage inflammatory protein (MIP)-1alpha and $T2$ (refs 7, 8).
CCR-5
MIP-1beta
0
Jak1 and $T1$ associated with IL-2R beta and gamma c, respectively; $T2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
Jak3
IL-2
0
The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator $T1$$T2$ protein, a component of the transcriptional regulator Swi/Snf.
Swi
Snf2
0
$T1$ also interacted with Bcl-X-L and $T2$ and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-2
Mcl-1
1
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind $T1$$T2$ and its biological potency but did not result in the ability to bind FGFR1.
FGFR1
KGFR
0
The crystal structure of the p53 core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of $T1$ in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of $T2$.
p53
p53
0
$T1$ expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to $T2$.
rIL-10R
hIL-10
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by $T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
PS1
0
We show that the physical interaction between YY1 and p300, a coactivator for $T1$$T2$ and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.
CREB
YY1
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to $T1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with $T2$.
TBP
TBP
0
The pleiotropic biological activities of $T1$ (IL-1) are mediated by its type I receptor ($T2$).
interleukin-1
IL-1RI
1
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 $T1$$T2$ is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
IL-6R
sIL-6R
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, $T1$-Cdk4, and cyclin D2-$T2$ complexes.
cyclin D1
Cdk4
0
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase p53/$T1$$T2$) and Src-family kinase p53/56Lyn (Lyn) contribute to signaling via the B-cell antigen receptor complex.
56Lyn
Syk
0
Surprisingly, the N-terminal third of GAP-43 alone bound CaM more strongly than did intact $T1$, suggesting that the protein's C-terminus may play a role in modulating the interaction with $T2$.
GAP-43
CaM
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to $T1$, $T2$, and FGFR4 but interacts poorly with KGFR.
FGFR1
FGFR2
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EBP
0
One was $T1$, and the second was the human homolog of Xenopus $T2$.
CDC2-HS
CDK2
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha ($T1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and $T2$ can be used in the differential diagnosis of serous effusion.
TNFalpha
C4
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , $T1$ ( herpes virus entry mediator ( HVEM ) - L ) and $T2$ ligand ( FasL / CD95L ) .
LIGHT
Fas
0
We have characterized the physical and functional interactions between $T1$ and $T2$, a leucine zipper transcription factor implicated in inflammatory responses.
PU.1
NF-IL6 beta
1
By using several different experimental systems we show that $T1$ efficiently associates with $T2$ and Oct2.
TBP
Oct1
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex ($T1$) containing substoichiometric levels of $T2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
SNAPc
TBP
0
The death-inducing receptor $T1$ is activated when cross-linked by the type II membrane protein Fas ligand ($T2$).
Fas
FasL
1
The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP ($T1$$T2$ p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
GAP-334
GTPase-activating protein
0
Here we report the three-dimensional structure of IL-1beta bound to the extracellular domain of $T1$ ($T2$) at 2.5 A resolution.
IL1R
s-IL1R
0
Using a yeast interaction assay, we find that $T1$ binds the RAP74 subunit of $T2$ and that SRF's transcriptional activation domain is the region involved in this binding.
SRF
TFIIF
0
Enhanced degradation of EGF receptors by a sorting nexin, $T1$$T2$, SNX1.
SNX1
nexin
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated $T1$ proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T2$ for binding to Rb.
Rb
RbAP46
0
The interactions between GRB2 and these two proteins require ligand activation of the $T1$ and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both $T2$ and Shc.
insulin receptor
IRS-1
0
Crystal structure of the hereditary haemochromatosis protein $T1$ complexed with $T2$.
HFE
transferrin receptor
1
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
Grb2
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/$T2$, and the Torpedo 87K protein.
utrophin
dystrophin related protein
0
The correlation of SRF-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for $T1$$T2$-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.
SRF
SRF
0
Coexpression of the alpha and betaL subunits of the human $T1$ is required for the induction of an antiviral state by human $T2$.
interferon alpha (IFNalpha) receptor
IFNalpha
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
NGF-receptor
0
A gp120 fragment retaining the CD4-binding site and overlapping epitopes was able to interact with $T1$$T2$-binding site and overlapping epitopes was able to interact with CCR-5 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
CCR-5
CD4
0
Insulin receptor substrate 1 (IRS-1) is a major substrate of the insulin receptor and has been implicated in $T1$$T2$ and has been implicated in insulin signaling.
insulin
insulin receptor
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and $T1$$T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
calreticulin
HLA-E
0
These results demonstrate that $T1$ and $T2$ utilize different ligand binding proteins, but share common signal transducer, gp130, in TF-1 cells.
IL-11
IL-6
0
CD30 and its counter-receptor $T1$ ($T2$) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
CD30L
0
A domain is conserved between RIZ and the $T1$/$T2$ differentiation factor.
PRDI-BF1
Blimp-1
0
Jak1 and $T1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-$T2$ and increased Jak3-gamma c associations.
Jak3
IL-2R beta
0
Two lines of evidence support the notion that $T1$ and simian virus 40 T antigen have homologous $T2$-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
RbAP46
Rb
1
Physical and functional interactions between the transcriptional inhibitors $T1$ and $T2$.
Id3
ITF-2b
1
We have previously demonstrated such changes by affinity cross-linking studies, and have shown that unstimulated human T cells express a single $T1$ of 90 kDa, whereas activated T cells express an additional 76-kDa $T2$ binding protein.
IL-7R
IL-7
0
We propose that c-Fos and $T1$ proteins function as transcriptional activators, in part by recruiting $T2$ to form complexes to initiate RNA synthesis.
c-Jun
TBP
1
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$ promoter by the myogenic transcription factor $T2$.
creatine kinase
MyoD
0
Both $T1$ and $T2$ have been implicated in a highly conserved mechanism that regulates p21ras signalling by receptor tyrosine kinases.
GRB2
sem-5
0
The objective of this study was to measure the concentrations of $T1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors $T2$ and C4 can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
C3
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or $T1$$T2$ or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TFIIIB
TFIID
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / $T1$$T2$ ( LTbetaR ) and HVEM / TR2 receptors .
TR2
lymphotoxin beta receptor
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$$T2$, and the Torpedo 87K protein.
dystrophin
dystrophin related protein
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
collagenase
0
These proteins, $T1$ ($T2$) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.
14-3-3 zeta
PLA2
0
Differential expression of $T1$ and perforin by NK cells in cancer patients and correlation of impaired $T2$ expression withprogression of cancer.
granulysin
granulysin
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and $T1$, and that $T2$ immune complexes exhibit appreciable histone H1 kinase activity.
p33cdk2
cyclin D1
0
Molecular cloning and expression of the 32-kDa subunit of human $T1$ reveals interactions with VP16 and $T2$ that mediate transcriptional activation.
TFIID
TFIIB
0
Tumor necrosis factor (TNF) can induce apoptosis and activate $T1$ through signaling cascades emanating from $T2$ (TNFR1).
NF-kappa B
TNF receptor 1
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/$T2$).
LIGHT
CD95L
0
These results suggest that the RAD52-dependent processes, cell cycle control, p53-mediated pathway(s), and ubiquitination interact through human $T1$$T2$-dependent processes, cell cycle control, p53-mediated pathway(s), and ubiquitination interact through human UBE2I.
UBE2I
RAD52
0
A potential interaction of $T1$ and $T2$ NGF receptors revealed by affinity crosslinking and immunoprecipitation.
p75
trkA
0
The $T1$-induced phosphorylation of $T2$ was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.
gastrin
IRS-1
1
We studied the capacity of these mutants to form an $T1$/$T2$ complex and their ability to transduce the signal.
IL-6
IL-6R
1
A double point mutation in the activation domain of $T1$ impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both TAFII40 and $T2$.
p53
TAFII60
1
The results showed that IL-11 and $T1$ can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ($T2$) expression in TF-1 cells.
IL-6
junB
1
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$$T2$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
erythropoietin (EPO) receptor
0
Our results indicate that the trkA and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity $T1$$T2$ receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
NGF
p75
0
The $T1$ tumour-suppressor protein controls the expression of a gene encoding the $T2$ cyclin-dependent protein kinase (CDK) regulator.
p53
p21
0
Two distinct and independent sites on $T1$ trigger $T2$ dimer formation and signalling.
IL-6
gp 130
1
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
neurotrophin-3
TrkC
1
IL-10 also activated Stat5 in Ba/F3 cells that stably expressed the murine $T1$$T2$.
IL-10
IL-10 receptor
0
The results of his3 activation indicated that $T1$, N + C-SH2 and C-SH2 interact with both IR beta and $T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
p85
IGF-1R
0
Both $T1$ and sem-5 have been implicated in a highly conserved mechanism that regulates $T2$ signalling by receptor tyrosine kinases.
GRB2
p21ras
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both $T1$ and $T2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
NR1
NR2B
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of $T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
TcR zeta
CD5
0
Associations of UBE2I with RAD52, $T1$, $T2$, and RAD51 proteins in a yeast two-hybrid system.
UBL1
p53
0
Specific cleavage of $T1$ (Ln-5) by matrix metalloprotease-2 ($T2$) was shown to induce migration of breast epithelial cells.
laminin-5
MMP2
1
cDNA clones encoding a human IL-10R ($T1$) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds $T2$ specifically.
hIL-10R
hIL-10
1
As a result of this physical interaction, binding of h-TR beta 1 to its hormone response elements either as homodimer or as a heterodimer with the $T1$ was inhibited by $T2$ in a concentration-dependent manner.
retinoic X receptor
p53
0
Interferon-gamma and several other cytokines that are known to activate $T1$ were also found to stimulate Raf-1 kinase activity toward $T2$ in mammalian cells.
JAK2 kinase
MEK-1
0
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras/$T1$$T2$, a central component of the ras/mitogen-activated protein kinase signal transduction pathway.
mitogen-activated protein kinase
Raf-1
0
cDNA clones encoding a human $T1$ (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds $T2$ specifically.
IL-10R
hIL-10
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
cyclin A
Cdk4
0
We show that the carboxy terminal "tail" of $T1$ associates directly with the amino terminal "head" of type II epidermal keratins, including $T2$, K2, K5, and K6.
DPI
K1
1
In addition, we show that the conserved motif Y699 MTP present in $T1$ is the binding site for the $T2$ SH2 domain in vitro.
c-Cbl
Vav
1
Our finding that $T1$ directly interacts with RNA polymerase II subunit 5 (RPB5), a common subunit of RNA polymerases, implies that $T2$ directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
HBx
HBx
0
Our analyses demonstrate that the XPB, XPD, $T1$$T2$, XPD, p44, and p62 proteins interact with each other.
p44
XPB
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for $T1$$T2$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
MCP-3
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits $T1$$T2$ stimulation, the Grb2/c-Cbl complex recruits Shc, probably via Grb2.
Shc
SCF
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ receptor alpha chain ($T2$ R alpha) has been designed and characterized.
IFN-gamma
IFN-gamma
0
RESULTS: $T1$, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-$T2$ and AAV-GCH.
TH
AADC
0
While the circulating $T1$ of renal origin is acutely activated to contribute to the accomplishment of short term homeostatic reactions, tissue $T2$, in paracrine or autocrine ways, exerts local-regional adaptive actions of long duration.
RAS
RAS
0
In this context, we examined the possibility that $T1$ and $T2$ interact with other general transcription factors.
HBx
RPB5
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
sE-selectin
0
In this article, we demonstrate that $T1$ associates with a complex containing $T2$- and beta-catenin in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.
PTPmu
cadherins, alpha
0
Our finding that HBx directly interacts with $T1$ ($T2$), a common subunit of RNA polymerases, implies that HBx directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
RNA polymerase II subunit 5
RPB5
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( $T1$$T2$ ( LTbetaR ) and HVEM / TR2 receptors .
LTbetaR
lymphotoxin beta receptor
0
Our results indicate that the trkA and $T1$$T2$ and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
p75
trkA
0
RESULTS: TH, AADC and $T1$ were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-$T2$.
GCH
GCH
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with $T1$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and $T2$ (refs 7, 8).
CCR-5
MIP-1beta
0
In addition, p27 associates with three different CDKs: $T1$, CDK4, and $T2$.
CDK2
CDK6
0
Analysis of p53, p21($T1$$T2$(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
CIP1
p21
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ and EPO mimetic peptide.
EPO mimetic peptide
EPO
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human Cdc2, Cdk2, and $T1$, but not with $T2$.
Cdk3
Cdk4
0
CD9 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of CD44 and $T1$$T2$ and syndecan, but not of cadherins.
syndecan
CD44
0
We next tested whether IL-11 induced signaling can be inhibited by anti-gp130 antibodies which blocked $T1$$T2$ antibodies which blocked IL-6-mediated functions.
IL-6
gp130
0
Associations of $T1$ with RAD52, UBL1, p53, and $T2$ proteins in a yeast two-hybrid system.
UBE2I
RAD51
1
USF specifically interacts with Fra1 but not with other closely related family members, $T1$$T2$ specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
c-Fos
USF
0
Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity $T1$s($T2$).
BMP receptor IA extracellular domain
BRIAec
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that $T1$$T2$ immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
c-Cbl
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .
LTbetaR
LIGHT
0
Here, a direct interaction between the activation domain of p53 and two subunits of the $T1$ complex, TAFII40 and $T2$, is reported.
TFIID
TAFII60
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T1$ binding: MCP-2, MCP-3, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-1
1
In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of $T1$$T2$ from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.
CD3
CD26
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor $T1$, via a pathway that appeared to involve $T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
TNFR-associated factor 2
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and $T1$ subunits of the $T2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
NR2B
NMDA receptor
0
Here we show that beta:beta activin binds to the $T1$ ($T2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
activin type II receptor kinase
ActRII
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
CD26
dipeptidyl peptidase IV
0
In contrast, physical interaction is not necessary for $T1$ to repress Sp1- and $T2$-mediated transcription.
YY1
CREB
0
In vitro, purified G beta gamma subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of $T1$ ($T2$).
Raf-1
Raf/330
0
The erythropoietin-like domain of $T1$ (TPO1-153) has been fused to the $T2$ coat protein of M13 bacteriophage.
TPO
gIII
0
When the ligand binds, $T1$ initiates a signaling cascade that results in the activation of the transcription regulator nuclear factor kappa B ($T2$).
IL-1RI
NF-kappa B
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
bicoid
0
IL-2, $T1$, $T2$ (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-4
IL-7
0
CD30 and its counter-receptor $T1$$T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
CD30
0
Despite binding to only one IFN-gamma R alpha, $T1$$T2$ R alpha, IFN-gamma SC1 is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.
IFN-gamma SC1
IFN-gamma
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$ and Grb2/c-Cbl are present in different complexes.
c-Cbl
Sos1
0
Collectively, the novel function of PS1 via $T1$$T2$ via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.
QM
PS1
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
hGITRL
0
Measurement of $T1$ I3A,I5A interaction with the human $T2$, Ht 31, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.
RII alpha
thyroid AKAP
1
A $T1$ (pp120) associated with $T2$ and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
120-kDa phosphoprotein
CD5
1
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T1$$T2$ pathway by gastrin.
gastrin
mitogen-activated protein kinase
0
Expressions of TH, $T1$ and $T2$ were detected by Western blot analysis.
AADC
GCH
0
Presenilin 1 suppresses the function of c-Jun homodimers via interaction with $T1$$T2$ homodimers via interaction with QM/Jif-1.
QM
c-Jun
0
Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to $T1$, $T2$ and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.
laminin 1
type IV collagen
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to $T1$, FGFR2, and FGFR4 but interacts poorly with $T2$.
FGFR1
KGFR
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, $T1$, and $T2$.
NCC-4
CCL16
0
$T1$, $T2$, and complement factors C3 and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
TNFalpha
alpha1AT
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for $T1$$T2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
CCR5
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 $T1$$T2$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
IL-6R
IL-6
0
Association between $T1$ and $T2$/cdc2 was detected in the HeLa cells.
cdc25A
cyclin B1
1
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
IL-10 receptor
0
$T1$ (neuromodulin, $T2$, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
GAP-43
B-50
0
We found that deletion of the carboxyl-terminal 28 amino acids of $T1$ disrupted $T2$-NF-IL6 beta physical interaction.
PU.1
PU.1
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/$T1$$T2$ but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Fos
c-Jun
0
14-3-3 zeta negatively regulates raf-1 activity by interactions with the $T1$$T2$ activity by interactions with the Raf-1 cysteine-rich domain.
Raf-1
raf-1
0
These results indicate that there is an additional mechanism by which $T1$ suppresses cell growth, namely that $T2$ directly represses transcription of the rRNA genes.
Rb
Rb
0
These proteins, 14-3-3 zeta (PLA2) and $T1$ ($T2$), are members of the 14-3-3 family of proteins.
14-3-3 beta
HS1
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
dTBP
0
In vivo complexes of Raf-1 and G beta gamma were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged $T1$$T2$ were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged G beta 2.
G beta 2
G beta gamma
0
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and $T1$$T2$ subunits hTAF80, hTAF31 and hTAF20/15.
hTAF20/15
TFIID
0
Thus, these two TNFR1-TRADD signaling cascades appear to bifurcate at $T1$$T2$-TRADD signaling cascades appear to bifurcate at TRADD.
TRADD
TNFR1
0
CD30 and its counter-receptor $T1$ (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
TNFalpha
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$$T2$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
UBE2I
RAD52
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$$T2$, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
RIP
0
However, in cell lines with defined combinations of ErbBs, $T1$ only activates those with $T2$ and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.
neuregulin-2beta
ErbB3
1
Interactions of $T1$, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and $T2$.
p60
hsp70
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$$T2$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
KGFR
keratinocyte growth factor
0
The HFE-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of $T1$$T2$ complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.
HFE
TfR
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
A physical interaction between CDC37 and $T1$ suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on $T2$.
CDK4
CDK4
0
alpha-Actinin-2, a member of the spectrin/$T1$ family of $T2$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95.
dystrophin
actin
0
We show that hTAFII28 interacts with $T1$ both in vitro and intracellularly; in contrast to its Drosophila homologue, $T2$ also interacts directly with TBP.
hTAFII18
hTAFII28
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, $T1$ $T2$ and RANTES were both potent agonists for CC CKR3 and CC CKR1.
(MIP)-1 alpha
MIP
0
Interaction of p85 subunit of PI 3-kinase with insulin and $T1$$T2$ with insulin and IGF-1 receptors analysed by using the two-hybrid system.
IGF-1
PI 3-kinase
0
$T1$ transcriptional activation mediated by coactivators $T2$ and TAFII60.
p53
TAFII40
1
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
sVCAM-1
0
In contrast, the other three monoclonal antibodies, which were effective at blocking $T1$ activity but did not block initial binding of $T2$ to its receptor, had epitopes predominantly on helix or 3.
TPO
TPO
0
These findings strongly suggest that CD26 may be closely associated with the $T1$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with $T2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD45
CD45
0
LexA protein fused to the Drosophila protein $T1$ (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed $T2$-Abeta interaction was specific.
bicoid
Abeta
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the $T1$ (bHLH) protein MyoD and the pocket proteins pRb, $T2$ and pRb2/p130.
myogenic basic helix-loop-helix
p107
0
The same domain of $T1$ that binds $T2$ also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other RAS effectors.
RIN1
RAS
1
Our finding that HBx directly interacts with $T1$ (RPB5), a common subunit of RNA polymerases, implies that $T2$ directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
RNA polymerase II subunit 5
HBx
0
Crosslinking of iodinated acidic FGF ($T1$) and basic FGF ($T2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
aFGF
bFGF
0
Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated beta-galactosidase ($T1$$T2$ (SA-beta-gal).
SA-beta-gal
senescence-associated beta-galactosidase
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human Cdc2, $T1$, and Cdk3, but not with $T2$.
Cdk2
Cdk4
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds $T1$$T2$) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds IL-13.
IL-13
IL-4R
0
Enhanced degradation of $T1$ receptors by a sorting nexin, $T2$.
EGF
SNX1
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor
IFN-gamma
0
Ligation of the extracellular domain of the cell surface receptor Fas/$T1$ ($T2$) elicits a characteristic programmed death response in susceptible cells.
APO-1
CD95
0
This suggests that one domain of IFN-gamma is sufficient to recruit IFN-gamma R alpha and $T1$$T2$ into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma R beta
0
$T1$ induced transient calcium mobilization specifically in $T2$ (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.
Eotaxin-3
CC chemokine receptor 3
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of $T1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) $T2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$, $T2$, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
fibromodulin
0
We recently reported that Ras interaction with the Raf-1 cysteine-rich domain ($T1$, residues 139-184) may be required for $T2$ activation.
Raf-CRD
Raf-1
0
Associations of $T1$ with RAD52, $T2$, p53, and RAD51 proteins in a yeast two-hybrid system.
UBE2I
UBL1
1
We have shown previously that Phe93 in the extracellular domain of the $T1$$T2$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
erythropoietin (EPO) receptor
0
A neutralizing polyclonal antibody to LEC was developed to demonstrate that the unusually high concentration of $T1$$T2$ was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of LEC and not as a result of an irrelevant protein contamination.
LEC
LEC
0
The same domain of RIN1 that binds $T1$ also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other $T2$ effectors.
RAS
RAS
0
The three-dimensional structure of the complex between human $T1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human $T2$ p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
H-Ras
GTPase-activating protein
0
We have cloned cDNAs encoding three novel TAFIIs [$T1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes $T2$, hTAFII20 and hTAFII18.
TATA-binding protein
hTAFII28
0
The binding of p56lck to CD5 induced a 10- to 15-fold increase in $T1$$T2$ to CD5 induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.
p56lck
p56lck
0
The $T1$ protein binds to $T2$, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.
retinoblastoma
RIZ
1
Levels of p16(INK4a) and p57($T1$) rise in HUCs during progressive passages, whereas only $T2$ increases in HPEC cultures.
KIP2
p16
0
A GT155 mutant that was not glycosylated (AGGT155) did not associate with calnexin or $T1$$T2$ mutant that was not glycosylated (AGGT155) did not associate with calnexin or CAP-60.
CAP-60
GT155
0
This protein, designated $T1$ (VRP), specifically binds to the extracellular domain of $T2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF-related protein
Flt4
1
In contrast, in the absence of p21ras, coexpression of JAK2 and $T1$$T2$ and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.
Raf-1
JAK2
0
Coexpression of $T1$ with $T2$ in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.
CD5
p56lck
0
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T1$ IIIb-expressing cells responded only to $T2$.
FGFR3
FGF-1
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$$T2$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FD5
Fas
0
A $T1$ fragment retaining the $T2$-binding site and overlapping epitopes was able to interact with CCR-5 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
gp120
CD4
1
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ receptor ($T2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
sIL-6R
1
Here we report that (1) there is an accumulation of $T1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) $T2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
An $T1$ complex containing mainly $T2$ and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F4
0
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to $T1$ ($T2$) binding.
erythropoietin
EPO
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ($T1$)-associated factors] from the human (h) HeLa cell TFIID complexes $T2$, hTAFII20 and hTAFII18.
TBP
hTAFII28
0
In contrast, in the absence of p21ras, coexpression of $T1$$T2$, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.
JAK2
p21ras
0
A cellular protein that competes with $T1$ for binding to the $T2$ gene product.
SV40 T antigen
retinoblastoma
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds $T1$$T2$ receptor, but neither of these proteins binds IL-13.
IL-13
IL-2
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IR
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronidase
elastin
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with $T1$ and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by $T2$ and/or ErbB4 receptors.
ErbB3
ErbB3
0
The 72-kDa spleen tyrosine kinase ($T1$) and Src-family kinase p53/56Lyn ($T2$) contribute to signaling via the B-cell antigen receptor complex.
Syk
Lyn
0
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases $T1$$T2$, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
Jak1
IL-2
0
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of $T1$ and a protein of approximately 60 kDa designated CAP-60 ($T2$ of 60 kDa).
GT155
calnexin-associated protein
1
These findings imply that $T1$ and $T2$ share similar early signaling events with the possibility of using the same signal transducer, gp130.
IL-11
IL-6
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the $T1$$T2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
phosphatidylinositol 3-kinase
insulin receptor
0
Taken together, these data suggest that JAK2 and p21ras cooperate to activate $T1$$T2$ cooperate to activate Raf-1.
Raf-1
p21ras
0
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 IL-7R, and not with expression of the $T1$ $T2$.
p90
IL-7R
0
$T1$ exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and $T2$ on several mesenchymal cell types.
PDGF-CC
PDGF-BB
0
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and $T1$ ligands, namely: $T2$ and TPO, induce c-Cbl tyrosine phosphorylation.
c-Kit
SCF
0
$T1$ interacts with $T2$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3a
U2 snRNP
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T2$) oligomers in the absence of ligand.
BR-II
BR-Ib
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila $T1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor $T2$.
TAFII40
TFIIB
0
Peptide growth factors, as well as the immediate early gene products $T1$, v-Fos, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with $T2$ products.
c-Jun
E2A
0
hTAFII20 is the homologue of $T1$$T2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).
p22
hTAFII20
0
Interleukin-2 (IL-2) signaling requires the dimerization of the $T1$$T2$ (IL-2) signaling requires the dimerization of the IL-2 receptor beta.
IL-2 receptor beta
Interleukin-2
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector $T1$$T2$ DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.
p21
MyoD
0
We found $T1$ mRNA in several peripheral tissues, and detected $T2$ protein on cultured vascular endothelial cells.
hGITRL
hGITRL
0
Aggregated $T1$ ($T2$) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.
amyloid beta-protein
A beta
0
CD5 associates with the $T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
T-cell receptor zeta chain (TcR zeta)/CD3
TcR zeta
0
This $T1$ sequence shows preferential binding to the $T2$ domain in vitro.
RIN1
ABL-SH3
1
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
ER
0
RESULTS: TH, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-$T1$, AAV-$T2$ and AAV-GCH.
TH
AADC
0
Molecular cloning and expression of the 32-kDa subunit of human $T1$ reveals interactions with $T2$ and TFIIB that mediate transcriptional activation.
TFIID
VP16
0
The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of $T1$ to phosphotyrosines on both IRS-1 and $T2$.
GRB2
Shc
1
The cytokine, designated interleukin-15 (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with $T1$$T2$ (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2.
IL-2
interleukin-15
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I ($T1$$T2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
GCH
AADC
0
Functional participation of the IL-2 receptor gamma chain in $T1$$T2$ receptor gamma chain in IL-7 receptor complexes.
IL-7 receptor
IL-2
0
In addition, we show that in extracts depleted of $T1$ and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a $T2$ complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, $T1$, and $T2$ but interacts poorly with KGFR.
FGFR2
FGFR4
0
Bcl-2 also interacted with $T1$ and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with $T2$ family proteins as Bcl-2.
Bcl-X-L
Bcl-2
0
The conformers that are committed to the native state remained in the supernatant and were assayed after 1 h. At 25 degrees C, the rate profiles indicate the release and commitment to folding of $T1$ to its native state occurs far earlier (t1/2 < 1 min) than for $T2$ (t1/2 = 5 min).
GS
rhodanese
0
Interaction of p85 subunit of PI 3-kinase with insulin and $T1$$T2$ subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.
IGF-1
p85
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, $T1$$T2$-forming enzymes, starting with isorenin, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
tonin
angiotensin
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of $T1$$T2$ function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-1
0
The Fos/Jun and $T1$$T2$/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
ATF
Fos
0
After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including $T1$, the cadherins associated with $T2$ are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PTPmu.
PTPmu
PTPmu
0
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that $T1$$T2$ and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
IRS-1
0
Analysis of p53, p21(CIP1), $T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p15
p53
0
$T1$ is a novel cytokine with a variety of biofunctions which overlap with those of $T2$.
IL-11
IL-6
0
Mutational analysis of $T1$ indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding $T2$ and hsp70.
p60
hsp90
1
Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and $T1$$T2$ and hsp70.
hsp70
hsp90
0
$T1$ and Jak3 associated with $T2$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
Jak1
IL-2R beta
1
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
MDM2
MDM2
0
Moreover, $T1$ was found to be phosphorylated on tyrosine residues in vivo and, like $T2$, was readily phosphorylated by pp60c-src in vitro.
cyclin D1
cyclin A
0
$T1$ is a multisubunit protein complex comprised of the TATA-binding protein ($T2$) and multiple TBP-associated factors (TAFs).
TFIID
TBP
0
A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein ($T1$) has been used here to form complexes between the $T2$ tyrosine kinase and hsp90.
hsp90
pp60src
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with $T1$$T2$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Grb2
Gastrin
0
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an $T1$$T2$ transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
Abeta
B42
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T1$, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sE-selectin
sVCAM-1
0
A bacterially expressed 318-amino acid fragment, $T1$ (418-736), containing the amphipathic helix region, was able to bind $T2$ alpha.
Ht 31
RII
0
$T1$ and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor ($T2$).
Flt1
VEGF
1
Activin A, a member of the $T1$$T2$, a member of the TGFbeta superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.
TGFbeta
Activin A
0
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
CTF
1
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for $T1$$T2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-beta
TNF-R2
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the $T1$$T2$ adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma SC1
0
In resting human epithelial and fibroblastic cells, $T1$ is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 ($T2$).
c-Jun
GSK-3
1
This activation with p85 and $T1$$T2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R beta
IGF-1R
0
Mutational analysis of $T1$ indicates that the N terminus is required for $T2$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.
p60
hsp70
1
$T1$- and tapasin-dependent $T2$ surface expression correlates with the binding of an MHC class I leader peptide.
TAP
HLA-E
0
Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in $T1$$T2$ binding, and mutants deficient in FLT-1 binding did not affect KDR binding.
FLT-1
FLT-1
0
These results reveal differences not only in subunit composition, but also in the organization of $T1$ and $T2$ complexes.
dTFIID
hTFIID
0
After T cell activation, the phosphorylation of Rb results in the release of $T1$, which is correlated temporally with the activation of $T2$-mediated transcription.
Elf-1
Elf-1
0
PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular $T1$$T2$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).
endothelial growth factor
PDGF-C
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ ($T2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6 receptor
sIL-6R
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
MCP-3
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
p75
p75
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
PI 3-kinase
p85
0
$T1$ protein interacts with $T2$ protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.
CSA
CSB
1
LexA protein fused to the Drosophila protein bicoid ($T1$-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed $T2$-Abeta interaction was specific.
LexA
Abeta
0
CD5 associates with the T-cell receptor zeta chain ($T1$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
TcR zeta
TcR zeta
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
Two previously unidentified human $T1$ genes have been isolated, cdc25A and $T2$.
cdc25
cdc25B
0
The cloning of a complementary DNA encoding a human $T1$ TAF, TAFII55, that has no known homolog in Drosophila $T2$ is now described.
TFIID
TFIID
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
elastin
0
We report here the identification of one such human cellular $T1$-associated protein of relative molecular mass 46,000 (46K) ($T2$).
Rb
RbAP46
0
MyoD prevents $T1$/$T2$ containing E2F complexes formation in terminally differentiated myocytes.
cyclinA
cdk2
1
The genes for $T1$/eotaxin-2 (SCYA24) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
MPIF-2
SCYA26
0
Our analyses demonstrate that the XPB, XPD, p44, and $T1$$T2$, p44, and p62 proteins interact with each other.
p62
XPD
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T1$), p23, and immunophilins and, on the other, enhance recovery of early $T2$ complexes containing hsp70 and Hip (p48).
hsp90
PR
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
ER
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, $T1$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the $T2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
FADD
p60
1
One of these proteins, $T1$, appears transiently during assembly and is not a component of functionally mature $T2$ complexes.
p60
PR
0
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor ($T1$$T2$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
SPF
cyclin A
0
The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor($T1$$T2$ gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(EGF)-like domain gives rise to two isoforms (alpha and beta).
EGF
neuregulin-2
0
GAP-43 ($T1$, $T2$, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
neuromodulin
B-50
0
Moreover, a partial recombinant $T1$ complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the $T2$ activation domain.
TFIID
VP16
0
We report here the identification of one such human cellular $T1$ of relative molecular mass 46,000 (46K) ($T2$).
Rb-associated protein
RbAP46
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
PI 3-kinase
gastrin
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed $T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
Estrogen Receptor
0
We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-$T1$$T2$ was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.
CD26
CD26
0
Two potentially oncogenic cyclins, $T1$ and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor ($T2$) as well as a candidate proto-oncogene.
cyclin A
SPF
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NIK
hGITRL
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T1$ complexes containing $T2$ and Hip (p48).
PR
hsp70
0
CD5 associates with the $T1$ (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
T-cell receptor zeta chain
CD3
0
These results demonstrate that $T1$ and IL-6 utilize different ligand binding proteins, but share common signal transducer, $T2$, in TF-1 cells.
IL-11
gp130
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ (sIL-6R) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6 receptor
gp130
0
In all cells tested, IL-10 activated $T1$ and $T2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
Stat1
Stat3
0
FGF-7 recognizes one FGFR isoform known as the $T1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
FGFR2 IIIb
FGFR4
0
The binding of hTAFII28 and $T1$ requires distinct domains of $T2$.
hTAFII30
hTAFII18
1
Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than $T1$$T2$, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6D
sIL-6R
0
This suggests that one domain of IFN-gamma is sufficient to recruit IFN-gamma R alpha and $T1$$T2$ R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma R beta
IFN-gamma
0
Concentrations of $T1$ (GFAp) and $T2$ (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
glial fibrillary acidic protein
light subunit neurofilament protein
0
This transcriptional activity is inhibited by association with the $T1$ ($T2$) or its relatives p107 and p103.
retinoblastoma tumor suppressor protein
pRB
0
Here we show that $T1$ and c-Cbl form inducible molecular complexes in $T2$-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
Vav
TCR
0
Association of CDK4 with both CDC37 and $T1$ may also imply a mechanistic link between the functions of $T2$ and HSP90.
HSP90
CDC37
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein ($T1$) and the gamma chain (gammac) of the $T2$ receptor, but neither of these proteins binds IL-13.
IL-4R
IL-2
0
Activation of interferon-gamma inducing factor mediated by $T1$$T2$.
interleukin-1beta
interleukin-1beta converting enzyme
0
Here we show that TRADD directly interacts with $T1$ and FADD, signal transducers that activate $T2$ and induce apoptosis, respectively.
TRAF2
NF-kappa B
1
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma
0
The apparent affinity of the interaction between gp120 and $T1$ was dramatically lower in the absence of soluble $T2$.
CCR-5
CD4
0
Thymocyte activation induces the association of $T1$ and pp120 with $T2$.
phosphatidylinositol 3-kinase
CD5
1
USF specifically interacts with Fra1 but not with other closely related family members, $T1$, $T2$, FosB, or with c-Jun.
c-Fos
Fra2
0
hPRL does not bind to the hGH receptor, but hGH binds to both the $T1$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGHR
hGH
0
In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific $T1$$T2$, hTAFII18 is a TFIID beta-specific hTAFII.
hTAFII
hTAFII28
0
Gastrin stimulates tyrosine phosphorylation of $T1$$T2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
insulin receptor substrate 1
insulin receptor
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$ associates with the transporter associated with antigen processing ($T2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
TAP
1
The HFE-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of $T1$$T2$ and sheds light upon the function of HFE in regulating iron homeostasis.
HFE
TfR
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, $T1$, $T2$, and CCL16.
HCC-4
NCC-4
0
When transfected into COS cells the cloned cDNA directed the expression of a GM-CSF-R showing a single class of affinity (KD = 2(-8) nM) and specificity for human $T1$ but not $T2$.
GM-CSF
interleukin-3
0
Our finding that $T1$ directly interacts with $T2$ (RPB5), a common subunit of RNA polymerases, implies that HBx directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
HBx
RNA polymerase II subunit 5
1
The protein product of $T1$ proto-oncogene is known to interact with several proteins, including Grb2, $T2$ and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.
c-cbl
Crk
1
Here , we demonstrate that TR6 specifically binds two cellular ligands , $T1$ ( herpes virus entry mediator ( HVEM ) - L ) and $T2$ ( FasL / CD95L ) .
LIGHT
Fas ligand
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T1$ or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO-binding protein
EBP
0
$T1$ phosphorylates $T2$ on serine 41.
PKC
GAP-43
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component ($T2$) identical in sequence to the PTF gamma reported here.
TBP
SNAPc43
0
These findings indicate that the Fos/$T1$ and $T2$/CREB families of transcription factors are not as distinct as was previously thought.
Jun
ATF
0
CREB is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates $T1$$T2$ (PKA), but precisely how phosphorylation stimulates CREB function is unknown.
CREB
protein kinase A
0
Here, a direct interaction between the activation domain of p53 and two subunits of the $T1$ complex, $T2$ and TAFII60, is reported.
TFIID
TAFII40
0
Unlabeled $T1$ and $T2$ were equally effective at displacing the binding of labeled TNF-alpha to TNF-R expressing cells.
TNF-alpha
TNF-beta
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, $T1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor $T2$.
hTAFII32
TFIIB
1
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell $T1$ complexes hTAFII28, $T2$ and hTAFII18.
TFIID
hTAFII20
0
Bcl-2 also interacted with Bcl-X-L and $T1$ and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as $T2$.
Mcl-1
Bcl-2
0
In vitro binding studies demonstrated that the intracellular segment of $T1$ binds directly to the intracellular domain of $T2$, but not to alpha- or beta-catenin.
PTPmu
E-cadherin
1
Abolition of the $T1$ binding site in $T2$ created antagonists of LIF action.
gp130
hLIF
1
However, the various $T1$/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of $T2$ or p107 binding is mediated by the E2F subunit.
E2F
pRB
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous $T1$-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to $T2$.
Rb
Rb
0
Following gastrin stimulation, we observed a time- and dose-dependent association of $T1$ with the p85 regulatory subunit of $T2$ (PI 3-kinase).
IRS-1
phosphatidylinositol 3-kinase
1
An E2F complex containing mainly E2F4 and $T1$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
pRb2
cyclinA
0
Here, a direct interaction between the activation domain of $T1$ and two subunits of the TFIID complex, TAFII40 and $T2$, is reported.
p53
TAFII60
1
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$, $T2$, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
cd44
0
Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3(-) $T1$$T2$ and granulysin expression by CD3(-) CD16(+) cells in healthy controls.
CD16
perforin
0
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the $T1$ ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IGF-1 receptor
IGF-1R
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human $T1$, Cdk2, and $T2$, but not with Cdk4.
Cdc2
Cdk3
0
Here , we demonstrate that $T1$ specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T2$ ligand ( FasL / CD95L ) .
TR6
Fas
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of $T1$, hsp70, and three additional proteins, p54, p50, and $T2$.
hsp90
p23
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether $T1$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and $T2$ can be used in the differential diagnosis of serous effusion.
TNFalpha
C4
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ ($T2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPOR
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, $T1$ and $T2$ (refs 7, 8).
macrophage inflammatory protein (MIP)-1alpha
MIP-1beta
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), $T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
endothelin-1
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated $T1$$T2$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
c-Kit
c-Cbl
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO-binding protein
1
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the BMP type II receptor ($T1$$T2$) and the BMP type II receptor (BR-II).
BR-II
BR-Ib
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including Sp1, YY1, $T2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
USF
0
hTAFII18 also interacts with TBP, but it interacts more strongly with $T1$$T2$, but it interacts more strongly with hTAFII28 and hTAFII30.
hTAFII28
TBP
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T1$) and calreticulin, and that $T2$ expression is TAP-dependent and tapasin-dependent.
TAP
HLA-E
0
To further examine the function of the bHLHZip protein, $T1$, we screened for cellular proteins which could directly interact with $T2$ using the yeast two-hybrid system.
USF
USF
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-$T1$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T2$.
Sos
gastrin
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor receptor
FGFR2 IIIb
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of $T1$$T2$ but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
QM
c-Jun
0
We have previously reported that tyrosine phosphorylation of $T1$ and its association with the Grb2-$T2$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
Shc
Sos
1
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: $T1$ and $T2$, induce c-Cbl tyrosine phosphorylation.
SCF
TPO
0
The increased binding affinity of $T1$ appears to be due to its ability to cross-link two $T2$ molecules on the biosensor surface.
IL-6D
sIL-6R
1
This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (pRB) or its relatives p107 and $T1$$T2$ and p103.
p103
p107
0
The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that $T1$ is a negative regulator of the $T2$.
c-Cbl
epidermal growth factor receptor
1
In vitro binding studies demonstrated that the intracellular segment of PTPmu binds directly to the intracellular domain of $T1$, but not to alpha- or $T2$.
E-cadherin
beta-catenin
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of $T1$ or $T2$ binding is mediated by the E2F subunit.
pRB
p107
0
$T1$-related protein: a ligand and specific activator of the tyrosine kinase receptor $T2$.
Vascular endothelial growth factor
Flt4
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, $T1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator $T2$ (VP16) as well as with the general transcription factor TFIIB.
hTAFII32
viral protein 16
1
hPRL does not bind to the hGH receptor, but $T1$ binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hPRLR
1
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
IL-7
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO-binding protein
0
Expressions of $T1$, AADC and $T2$ were detected by Western blot analysis.
TH
GCH
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble $T1$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and $T2$ (refs 7, 8).
CD4
MIP-1beta
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPO
0
$T1$, a novel death domain-containing protein, interacts with the death domain of $T2$ and initiates apoptosis.
FADD
Fas
1
Associations of UBE2I with $T1$, UBL1, p53, and $T2$ proteins in a yeast two-hybrid system.
RAD52
RAD51
0
$T1$ suppresses the function of c-Jun homodimers via interaction with QM/$T2$.
Presenilin 1
Jif-1
1
A bZip protein, $T1$, was found to efficiently interact with $T2$.
Fra1
USF
1
The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that $T1$ is a negative regulator of the $T2$ receptor.
c-Cbl
epidermal growth factor
0
We screened for proteins that bind to $T1$ from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the $T2$/Jif-1 gene.
PS1
QM
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T1$-LPR and $T2$-FD8.
Fas
Fas
0
One clone encodes a novel type 1 protein phosphatase catalytic subunit ($T1$), which differs from the originally defined $T2$ by an amino-terminal 11-amino-acid insert.
PP-1 alpha 2
PP-1 alpha
0
Although Fos/$T1$$T2$/Jun and ATF/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
Jun
Fos
0
The cytokine-activated tyrosine kinase $T1$ activates Raf-1 in a $T2$-dependent manner.
JAK2
p21ras
0
Furthermore, this mutational analysis implicates KDR, but not FLT-1, in $T1$$T2$, in VEGF induction of endothelial cell proliferation.
VEGF
FLT-1
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the $T1$ and p76 $T2$ have different extracellular domains.
p90
IL-7R
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve $T1$ ($T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
TNFR-associated factor 2
TRAF2
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the $T1$$T2$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the p76 IL-7R.
p90
IL-7R
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of $T1$ and site III of viral $T2$, which is necessary for receptor activation.
gp130
IL-6
1
Thus, the C-terminal domain in IGF-1R appears to exert a negative control on binding of $T1$ thereby providing a possible regulatory mechanism for direct activation of the $T2$ pathway.
p85
PI 3-kinase
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that $T1$ is associated with both $T2$ and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.
cyclin D1
p34cdc2
1
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T1$$T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sE-selectin
soluble cell adhesion molecules
0
Interactions between brain-derived neurotrophic factor and the $T1$$T2$ receptor.
TRKB receptor
TRKB
0
Here, we show that $T1$ interacts strongly with $T2$, another death domain protein that was shown previously to associate with Fas antigen.
TRADD
RIP
1
Moreover, a transcriptional activation signal was transduced by $T1$ in the presence of type I receptors after stimulation by $T2$/BMP-7.
BMPR-II
OP-1
1
It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, erythropoietin and $T1$$T2$ and interleukin-2 (beta-chain) and also to the prolactin receptor.
interleukin-2
erythropoietin
0
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and $T1$$T2$ is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and TFIIB.
TFIIB
HBx
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
NGF
0
The interactions of hsp70 and hsp90 in intermediate $T1$$T2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
hsp90
0
Identification of vascular endothelial growth factor determinants for binding $T1$ and $T2$ receptors.
KDR
FLT-1
0
Gastrin stimulates tyrosine phosphorylation of $T1$$T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
insulin receptor
insulin
0
Furthermore, a partial TFIID complex containing Drosophila $T1$ (dTBP), human TAFII250, $T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TATA binding protein
dTAFII60
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the $T1$$T2$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
p90
p90
0
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor $T1$$T2$ glycoproteins with the chemokine receptor CCR-5.
CCR-5
gp120
0
Immunoprecipitation of $T1$ from 32P-labeled 293/$T2$ cells demonstrated that the receptor is phosphorylated.
TNF-R2
TNF-R2
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$ immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
c-Cbl
0
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
IGF-I
0
$T1$ interaction with $T2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
CD5
p56lck
1
Interaction of the p85 subunit of $T1$ with the $T2$ receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
insulin
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with $T1$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T2$ for binding to Rb.
RbAP46
RbAP46
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human $T1$ and the extracellular ("soluble") portions of the IL-6 receptor ($T2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
sIL-6R
0
SF3a interacts with $T1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of $T2$ into the spliceosome.
U2 snRNP
U2 snRNP
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with $T1$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to $T2$.
RbAP46
Rb
0
Interaction between cell cycle regulator, $T1$, and $T2$ mediates repression of HIV-1 gene transcription.
E2F-1
NF-kappaB
1
Functional participation of the $T1$$T2$ chain in IL-7 receptor complexes.
IL-2
IL-2 receptor gamma
0
Associations of UBE2I with RAD52, $T1$, p53, and $T2$ proteins in a yeast two-hybrid system.
UBL1
RAD51
0
Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that $T1$ interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of $T2$, but not with that of PS-2.
delta-catenin
PS1
1
$T1$ binds to the transferrin receptor ($T2$), a receptor by which cells acquire iron-loaded transferrin.
HFE
TfR
1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, $T1$$T2$, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
FLICE
MORT
0
$T1$ was derived by linking the two peptide chains of the $T2$ dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.
IFN-gamma SC1
IFN-gamma
0
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-$T1$ MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30
CD30
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), $T1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T2$ (p48).
p23
Hip
0
LexA protein fused to the Drosophila protein bicoid (LexA-$T1$) failed to interact with the $T2$ fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
B42
0
In addition, we identified domains within $T1$ and $T2$ that mediate their interactions with each other.
YY1
Sp1
1
Activation of lacZ upon interaction of p85 with IR beta($T1$$T2$ with IR beta(delta C-43) was 4-fold less as compared to IR beta.
delta C-43
p85
0
Cotransfection of $T1$ and $T2$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITRL
hGITR
0
Residues in $T1$ from both the A- and C-helices are involved in binding the $T2$ co-receptor.
hLIF
gp130
1
The SH2/SH3-containing protein Vav also contains a guanine nucleotide exchange factor domain, and $T1$ has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the $T2$.
Vav
TCR
0
Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa $T1$-rapamycin-binding domain within $T2$.
FKBP12
FRAP
1
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T2$ (FasL/CD95L).
TR6
Fas ligand
1
The molar concentration of $T1$ required to induce maximum cell migration is 20- to 200-fold greater than that required for RANTES or $T2$, respectively.
LEC
I309
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and $T2$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
alpha 1-syntrophin
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, K5, and $T1$$T2$, K2, K5, and K6.
K6
K1
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
TATA binding protein
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTFIID beta
0
Antibodies to $T1$ did not affect the proportion of keratinocytes that adhered to $T2$, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.
CD9
laminin 1
0
$T1$-TRAF2 and $T2$-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
TRADD
TRADD
0
GAP-43 (neuromodulin, B-50, $T1$$T2$, B-50, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
F1
neuromodulin
0
The death domain of $T1$ (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein $T2$.
tumor necrosis factor (TNF) receptor-1
TRADD
1
Using the cytoplasmic domain of $T1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
Fas
FD8
0
We show that the carboxy terminal "tail" of $T1$ associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, K5, and $T2$.
DPI
K6
1
We have exploited the availability of the cloned XPB, XPD, $T1$, $T2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p62
p44
0
In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of $T1$$T2$ binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.
Rb
Rb
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPOR
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$$T2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cdk2
MyoD
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
gp130
0
In addition, selected mutant proteins were expressed as full-length $T1$ on the surface of COS cells and analyzed for 125I-$T2$ binding in receptor binding assays.
EPOR
EPO
0
Thus, our data show that both $T1$ and calreticulin interact with $T2$ in a glycosylation-dependent manner.
calnexin
Glut 1
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T2$-LPR and Fas-FD8.
FD5
Fas
0
CONCLUSION: The triple transduction of TH, $T1$ and $T2$ genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.
AADC
GCH
0
$T1$ negatively regulates raf-1 activity by interactions with the $T2$ cysteine-rich domain.
14-3-3 zeta
Raf-1
1
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of $T1$ to Raf/330; however, the $T2$-binding proteins, Ras and 14-3-3, had no effect.
G beta gamma
Raf-1
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
procollagen I
0
Using immunoprecipitation techniques, we have determined the rates at which $T1$ and glutamine synthetase ($T2$) are released from groEL in a form committed to refold to active enzyme.
rhodanese
GS
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$$T2$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
TAFII55
0
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
MCP-2
0
Expression of exogenous $T1$ led to a decrease in $T2$-dependent transcription in F9 cells.
USF
AP1
0
Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of FGFR3, suggesting that the 66-kDa protein may play an important role in $T1$$T2$, suggesting that the 66-kDa protein may play an important role in FGFR3-specific signaling.
FGFR3
FGFR3
0
hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast $T1$$T2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.
TAFIISPT3
hTAFII
0
RESULTS: TH, AADC and $T1$ were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-$T2$, AAV-AADC and AAV-GCH.
GCH
TH
0
$T1$ and its counter-receptor CD30 ligand ($T2$) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30L
1
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
interleukin-1 beta-converting enzyme
Fas
0
The binding of IL-1alpha or $T1$ to IL1R is an early step in $T2$ signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL-1beta
IL-1
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding $T2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPO
1
The retinoblastoma-susceptibility gene product binds directly to the human $T1$-associated factor $T2$.
TATA-binding protein
TAFII250
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-$T1$) chimerae, we found that estrogen directed $T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
MyoD
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as $T1$$T2$ and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Grb2
TCR
0
Recombinant $T1$ induces the tyrosine-phosphorylation of ErbB2, ErbB3 and $T2$ in cell lines expressing all of these ErbB-family receptors.
neuregulin-2beta
ErbB4
1
Thus , TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death .
LIGHT
TR6
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$ complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
A receptor specific for human $T1$ was identified, which suggests that cell surface LT may have functions that are distinct from those of secreted $T2$.
LT-beta
LT-alpha
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ ($T2$ R alpha) has been designed and characterized.
IFN-gamma receptor alpha chain
IFN-gamma
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing $T2$-mediated HT29 cell death .
TR6
LIGHT
0
METHODS: The genes for dopamine synthetic enzymes, $T1$ ($T2$), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
tyrosine hydroxylase
TH
0
Concentrations of $T1$ ($T2$) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
glial fibrillary acidic protein
GFAp
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
decorin
procollagen I
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T1$$T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID beta
0
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the $T1$ ($T2$).
BMP type II receptor
BR-II
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to $T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGFR1
FGFR2 IIIb
0
Binding of $T1$/BMP-7 to $T2$ was also observed in nontransfected cell lines.
OP-1
BMPR-II
1
This activation with p85 and IGF-1R beta was 4-fold less as compared to $T1$$T2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IR beta
IGF-1R
0
Here we demonstrate that DP is also a family of polypeptides with at least two members ($T1$ and $T2$).
hDP-1
hDP-2
0
The data thus demonstrate specific binding of platelet $T1$ to HSP27 and suggest that $T2$ may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.
FXIII
HSP27
0
An expression plasmid encoding the human 75-kDa $T1$ (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing $T2$.
tumor necrosis factor (TNF) type 2 receptor
TNF-R2
0
This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein ($T1$) or its relatives $T2$ and p103.
pRB
p107
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
TAFII250
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, cyclin E-Cdk2, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
Cdk2
Cdk4
0
The ability of $T1$ and c-Jun proteins to interact directly with the $T2$ (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
c-Fos
TATA box-binding protein
1
Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not Ras, to the $T1$$T2$, to the Raf-CRD.
Raf-CRD
Ras
0
We demonstrate that $T1$ binds to $T2$ in vitro under conditions where the latter is tyrosine-phosphorylated.
Grb7
SHPTP2
1
PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of $T1$$T2$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).
neuropilin-1
PDGF-C
0
A 51-residue region from the conserved C-terminal region of TBP, previously shown to be the binding site for the viral activator protein $T1$, interacts with c-Fos and $T2$ proteins.
E1A
c-Jun
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
Sos1
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
FADD
FD8
0
RIN1 interacts with the "effector domain" of RAS and employs some $T1$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known $T2$ effector.
RAS
RAS
0
By using the growth factor dependent M-07e cell line, we found that both $T1$ and c-Kit ligands, namely: $T2$ and TPO, induce c-Cbl tyrosine phosphorylation.
c-Mpl
SCF
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein $T2$.
UBE2I
UBL1
1
CIP1 encodes a novel 21 kd protein that is found in $T1$, cyclin D1, cyclin E, and $T2$ immunoprecipitates.
cyclin A
Cdk2
0
The cytokine, designated interleukin-15 (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with $T1$$T2$), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2.
IL-2
IL-15
0
The present study has shown that cell surface $T1$ binds to the $T2$ mediating its mitogenic activity.
calreticulin
B beta chain of fibrinogen
1
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/$T1$$T2$ differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-X-S
0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as $T1$$T2$, EBP) of the EPOR.
EPO
EPO binding protein
0
These data demonstrate that Stat3 but not $T1$ or Stat5 is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat1
IL-10 receptor
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
However, MIP-1 beta was also an agonist for CC CKR3 but not $T1$; MCP-3 was an agonist for CC CKR1 but not $T2$.
CC CKR1
CC CKR3
0
In competition experiments, the carboxyl terminus of $T1$ (beta ARK) blocked the binding of G beta gamma to $T2$; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
beta-adrenergic receptor kinase
Raf/330
0
Although the individual amino acids in $T1$ involved in binding to $T2$ (NGF) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
nerve growth factor
1
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, $T1$, USF, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
YY1
E1A
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both $T1$$T2$ substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
RPB5
HBx
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein $T1$$T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
UBL1
UBC9
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of $T2$ (IRS-1), the major cytoplasmic substrate of the insulin receptor.
gastrin
insulin receptor substrate 1
1
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring $T1$ ($T2$) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.
lacZ
beta-galactosidase
0
Vav/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which $T1$$T2$, in which c-Cbl is hyperphosphorylated on tyrosine residues.
c-Cbl
CTLA-4
0
FADD contains a death domain homologous to the death domains of $T1$ and $T2$.
Fas
TNFR-1
0
We have previously reported that tyrosine phosphorylation of $T1$ and its association with the $T2$-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
Shc
Grb2
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that $T1$$T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and $T1$$T2$ and TFIIB that mediate transcriptional activation.
TFIIB
VP16
0
In contrast, p27 complexes containing CDK2 are incapable of phosphorylating $T1$$T2$ complexes containing CDK2 are incapable of phosphorylating histone H1.
histone H1
p27
0
Each of these molecules binds to the $T1$ ($T2$).
type I IL-1 receptor
IL1R
0
The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the $T1$$T2$ multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.
hsp90
hsp70
0
The deduced amino acid sequences of human alpha 1- and $T1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human $T2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 2-syntrophin
beta 2-syntrophin
0
$T1$ contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Fas and $T2$ intracellular domains.
RIP
TNFR1
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$$T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cdk2
MyoD
0
The genes for $T1$/$T2$ (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
eotaxin-2
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R beta
IGF-1R beta
0
$T1$ ($T2$) signaling requires the dimerization of the IL-2 receptor beta.
Interleukin-2
IL-2
0
These antibodies also immunoprecipitated the cloned IL-7R as a 90-kDa species from both 125-I-surface-labeled resting and activated T cells, but were unable to precipitate the 76-kDa $T1$$T2$ as a 90-kDa species from both 125-I-surface-labeled resting and activated T cells, but were unable to precipitate the 76-kDa IL-7R.
IL-7R
IL-7R
0
The products of the $T1$ and RBP2 genes are ubiquitously expressed, large (200 kDa for $T2$ and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP1
RBP1
0
Three of these clones encode DNA binding proteins (NF-IL6 beta, HMG I/Y, and $T1$$T2$, HMG I/Y, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.
SSRP
NF-IL6 beta
0
Computer-aided analysis of secondary structure, performed on four $T1$-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and $T2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
RII
Ht 31
0
Moreover, similar $T1$ sequences are required for binding $T2$ and SV40 large T antigen.
p110RB
PP-1 alpha 2
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T2$ (p48).
heat shock protein 90
Hip
0
The interactions between GRB2 and these two proteins require ligand activation of the $T1$ and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and $T2$.
insulin receptor
Shc
0
In addition, JAK2 phosphorylated Raf-1 at sites different from those phosphorylated by $T1$$T2$ phosphorylated Raf-1 at sites different from those phosphorylated by pp60v-src.
pp60v-src
JAK2
0
The human pituitary hormones, growth hormone (hGH) and prolactin ($T1$$T2$) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hPRL
hGH
0
Association of $T1$ with both $T2$ and HSP90 may also imply a mechanistic link between the functions of CDC37 and HSP90.
CDK4
CDC37
1
These results suggest that HIV-1 attachment to CD4 creates a high-affinity binding site for $T1$$T2$ creates a high-affinity binding site for CCR-5, leading to membrane fusion and virus entry.
CCR-5
CD4
0
$T1$, alpha1AT, and complement factors C3 and $T2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
TNFalpha
C4
0
Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of $T1$$T2$ (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.
A beta
Transthyretin
0
LexA protein fused to the Drosophila protein bicoid (LexA-$T1$) failed to interact with the B42 fragment fused to Abeta, indicating that the observed $T2$-Abeta interaction was specific.
bicoid
Abeta
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$ receptor in binding $T2$.
TRKB
BDNF
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
sICAM-1
0
In contrast, cancer patients exhibited significantly decreased levels of $T1$ expression ( P<0.005), despite having equally high levels of $T2$ expression in comparison with healthy controls.
granulysin
perforin
0
Interactions of $T1$, a mediator of $T2$ assembly, with heat shock proteins hsp90 and hsp70.
p60
progesterone receptor
0
As a result of this physical interaction, binding of $T1$ to its hormone response elements either as homodimer or as a heterodimer with the $T2$ was inhibited by p53 in a concentration-dependent manner.
h-TR beta 1
retinoic X receptor
1
Antibodies to $T1$ detect similar levels of p23 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that $T2$ is a conserved protein of broad tissue distribution.
p23
p23
0
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with $T1$$T2$ is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and TFIIB.
RPB5
HBx
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT ($T2$) and Fas ligand (FasL/CD95L).
TR6
herpes virus entry mediator (HVEM)-L
1
Physical interaction of mammalian $T1$ with CDK4 .CDC37 was originally identified as a Start gene in budding yeast and has been shown to be required for association of $T2$ with cyclins.
CDC37
CDC28
0
TRADD-TRAF2 and $T1$-$T2$ interactions define two distinct TNF receptor 1 signal transduction pathways.
TRADD
FADD
1
These data imply that c-Cbl is a molecular adapter that regulates the function of $T1$$T2$ is a molecular adapter that regulates the function of Vav in thymocytes and peripheral T cells.
Vav
c-Cbl
0
Ligation of the extracellular domain of the cell surface receptor Fas/APO-1 ($T1$$T2$/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells.
CD95
Fas
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$.
insulin
insulin receptor
0
Moreover, a transcriptional activation signal was transduced by $T1$ in the presence of type I receptors after stimulation by OP-1/$T2$.
BMPR-II
BMP-7
1
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$/c-Cbl are present in different complexes.
c-Cbl
Grb2
0
The ability of $T1$ and c-Jun proteins to interact directly with the TATA box-binding protein ($T2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
c-Fos
TBP
1
This Syk-$T1$ interaction may be dependent on the stage of B-cell differentiation, since Syk-$T2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Lyn
0
Interferon-gamma and several other cytokines that are known to activate $T1$ kinase were also found to stimulate Raf-1 kinase activity toward $T2$ in mammalian cells.
JAK2
MEK-1
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T1$$T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sE-selectin
endothelin-1
0
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and $T1$ co-localized on the cell surface, but not inside cells, suggesting that $T2$ did not transport ADA to the surface.
ADA
CD26
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or $T1$$T2$-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TFIIIB
TBP
0
$T1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate $T2$ kinase activity toward MEK-1 in mammalian cells.
Interferon-gamma
Raf-1
0
In physiological buffers and CSF, $T1$ exclusively decreased the level of $T2$ pentamers.
TTR
A beta
0
Thus , TR6 may play a regulatory role for suppressing in $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death .
FasL
TR6
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and $T1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of $T2$ and c-Jun are necessary and sufficient for stable association with TBP.
c-Jun
c-Fos
0
The native and reconstituted $T1$-$T2$ complexes have similar thermal stability and, like steroid receptor heterocomplexes, they are stabilized by molybdate.
pp60src
hsp90
1
Our finding that HBx directly interacts with RNA polymerase II subunit 5 ($T1$), a common subunit of RNA polymerases, implies that $T2$ directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
RPB5
HBx
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors $T1$ and Bcl-X-S. $T2$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bax
Bcl-X-L
0
In addition, $T1$ phosphorylated $T2$ at sites different from those phosphorylated by pp60v-src.
JAK2
Raf-1
1
Under these conditions, a ternary complex of $T1$, $T2$, and Raf-1 was observed.
p21ras
JAK2
1
A physical interaction between CDC37 and $T1$ suggests that $T2$ may regulate the mammalian cell cycle through a direct effect on CDK4.
CDK4
CDC37
0
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, $T1$$T2$, hTAF31 and hTAF20/15.
hTAF31
hTAF80
0
The interaction between $T1$ (IL-6) and IL-6 receptor (IL-6R) is the initial and most specific step in the $T2$ signaling pathway.
interleukin-6
IL-6
0
This is the first report to demonstrate that two of cytosolic components of cytochrome b558, $T1$ binding to $T2$ each other.
p47-phox
p67-phox
1
The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein $T1$ ligand ($T2$).
Fas
FasL
1
The interaction between interleukin-6 (IL-6) and $T1$ receptor (IL-6R) is the initial and most specific step in the $T2$ signaling pathway.
IL-6
IL-6
0
In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the $T1$$T2$, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.
Raf-1
p21ras
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$ and TAFII60 did not.
TAFII60
TAFII40
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and $T1$$T2$ and TFIIB.
TFIIB
RPB5
0
We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of $T1$ and $T2$ binding.
CD4
gp120
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and Fas ligand ($T2$/CD95L).
herpes virus entry mediator (HVEM)-L
FasL
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing $T1$$T2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Monoclonal antibodies to the beta chain of the $T1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that $T2$ uses components of the IL-2 receptor.
IL-2
IL-15
0
Cloning and functional analysis of $T1$: a novel $T2$-binding protein with anti-cell death activity.
BAG-1
Bcl-2
1
The hsp90-p60-$T1$$T2$-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.
hsp70
p60
0
Collectively, the novel function of $T1$ via QM/Jif-1 influences $T2$-mediated transcription and apoptosis.
PS1
c-jun
0
Cleavage of $T1$ by MMP2 and the resulting activation of the $T2$ cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
Ln-5
Ln-5
0
Interactions of the Bcl-2 protein with itself and other members of the $T1$$T2$ protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-2
Bcl-2
0
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins $T1$$T2$ assembly, with heat shock proteins hsp90 and hsp70.
hsp90
progesterone receptor
0
Finally, anti-IL-6R antibody inhibited the ability of $T1$$T2$ antibody inhibited the ability of IL-6, but not IL-11, to transduce early signals in TF-1 cells.
IL-6
IL-6R
0
The correlation of SRF-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for $T1$$T2$ binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.
SRF
RAP74
0
Cross-family dimerization of transcription factors $T1$/Jun and $T2$/CREB alters DNA binding specificity.
Fos
ATF
0
Although GRB2 associates with IRS-1 and $T1$$T2$ and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
Shc
IRS-1
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and $T1$, and that $T2$ expression is TAP-dependent and tapasin-dependent.
calreticulin
HLA-E
0
Using SHPTP2 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that $T1$ interacts with another signaling protein, $T2$.
SHPTP2
Grb7
1
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPO
0
Binding of $T1$/$T2$ to BMPR-II was also observed in nontransfected cell lines.
OP-1
BMP-7
0
Therefore, we suggested that this fragment is implicated in the neurotoxicity of $T1$ and in the protective effects of $T2$ in Alzheimer's disease.
Abeta
apolipoprotein E
0
The protein encoded by the $T1$ ($T2$) functions as a tumour suppressor and negative growth regulator.
retinoblastoma susceptibility gene
Rb
0
$T1$ and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by $T2$ (VEGF).
Flt1
vascular endothelial growth factor
1
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
p53
0
We demonstrate here that both the site 2 and site 3 $T1$ variants complexed with IL-6R alpha bind a single $T2$ molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130.
IL-6
gp130
1
Mutational analysis of $T1$ indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and $T2$.
p60
hsp70
1
We have exploited the availability of the cloned $T1$, XPD, p62, p44, and $T2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPB
p34
0
$T1$ was first characterized as a receptor for MIP-1alpha, MIP-1beta, and $T2$, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
CCR5
RANTES
1
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport $T2$ to the surface.
CD26
ADA
0
A $T1$ ($T2$) associated with CD5 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
120-kDa phosphoprotein
pp120
0
Interleukin-13 (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with $T1$$T2$) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.
IL-4
IL-13
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain ($T1$) for IL-4 signaling, it could not replace the function of $T2$ in allowing enhanced IL-2 binding activity.
gammac
gammac
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with $T1$$T2$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Lyn
0
The hGH and hPRL receptors (hGHR and $T1$$T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRLR
hGHR
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, $T1$ ($T2$)/fetal liver kinase 1 (Flk-1) and FLT-1.
kinase insert domain-containing receptor
KDR
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the $T1$-$T2$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
Grb2
Sos
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
Rb
cyclin D2
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$ and the $T2$.
CCKB G protein-coupled receptor
insulin receptor
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-FD5, a mutant of $T2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
Recombinant hTAFII250 binds directly to $T1$ both in vitro and in yeast, and participates in the formation of the $T2$ complex.
TBP
TFIID
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine $T1$$T2$ ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
glucocorticoid-induced TNFR-related (mGITR) protein
GITR
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T1$$T2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
alpha-1-antitrypsin
TNFalpha
0
The binding of $T1$ or $T2$ to IL1R is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL-1alpha
IL-1beta
0
PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular $T1$ (25%) and $T2$-chain (23%).
endothelial growth factor
PDGF A
0
Characterization of an interaction between $T1$ and the $T2$ by using the two-hybrid system.
insulin receptor substrate 1
insulin receptor
1
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with $T1$$T2$ through communication with RPB5 and TFIIB.
RPB5
TFIIB
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing $T1$ (an alternatively spliced form of $T2$ that lacks a well-conserved 63-amino acid region).
Bcl-X-S
Bcl-X
0
This suggests that one domain of $T1$ is sufficient to recruit $T2$ and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma R alpha
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds $T2$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FADD
Fas
1
We found that the human $T1$ (h-TR beta 1) physically interacted with $T2$ via its DNA binding domain.
TR subtype beta 1
p53
1
A mutant form of human interferon-gamma ($T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma SC1
interferon-gamma
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EBP
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
TR2
lymphotoxin beta receptor
0
BMP-2 binding significantly increased hetero- and homo-oligomerization (except for the $T1$ homo-oligomer, which binds ligand poorly in the absence of $T2$).
BR-II
BR-I
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, cyclin E-Cdk2, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
Rb
cyclin D1
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T2$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
cyclin A
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, $T1$, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-1
eotaxin
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$, cd44, fibromodulin, and $T2$) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
decorin
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for $T1$/$T2$ heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
1
Although the individual amino acids in $T1$ involved in binding to nerve growth factor ($T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
NGF
1
The mitogenic effects of the $T1$ are mediated through cell surface $T2$.
B beta chain of fibrinogen
calreticulin
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
gp91-phox
NADPH oxidase
0
Although numerous studies revealed predominant localization of PS1 to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of $T1$$T2$ to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of PS1 to the cell surface.
PS1
PS1
0
A potential interaction of $T1$ and trkA $T2$ receptors revealed by affinity crosslinking and immunoprecipitation.
p75
NGF
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-II
0
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-2
0
Determination of $T1$, complement factors C3 and $T2$, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
TNFalpha
C4
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
NGF
p75
0
However, in cell lines with defined combinations of ErbBs, $T1$ only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or $T2$ receptors.
neuregulin-2beta
ErbB4
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$ complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ receptor (KGFR), whereas FGF-2 binds well to $T2$, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor
FGFR1
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
trk
0
Here we show that a complex of $T1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with $T2$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
gp120
CCR-5
1
We find that p53, p21($T1$$T2$(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
CIP1
p21
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained $T2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
TrkA
neurotrophin-3
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTFIID
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as $T1$$T2$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.
LMC
Liver-expressed chemokine
0
Many of the same signaling molecules, including $T1$ (PKC), $T2$ (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
protein kinase C
tyrosine kinase, phosphatidylinositol 3-kinase
0
The data thus demonstrate specific binding of platelet $T1$ to HSP27 and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet $T2$.
FXIII
FXIII
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
NF-kappaB
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with $T1$, tonin, D and G cathepsin and ending with the conversion enzyme and $T2$.
isorenin
chymase
0
In vitro protein-RNA interaction studies with pre-mRNAs containing either a constitutive or regulated splicing enhancer revealed that U2AF35 directly mediates interactions between $T1$$T2$ directly mediates interactions between U2AF65 and proteins bound to the enhancers.
U2AF65
U2AF35
0
The region of $T1$ most important for binding to the $T2$ is composed of residues from the amino terminus of the D-helix, carboxyl terminus of the B-helix, and C-D loop.
hLIF
hLIF-R
1
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ($T1$, neu/ErbB-2, $T2$, and ErbB-4) and tumor recurrence.
ErbB-1
ErbB-3
0
Tumor necrosis factor (TNF) and lymphotoxin-alpha ($T1$$T2$ (LT-alpha) are members of a family of secreted and cell surface cytokines that participate in the regulation of immune and inflammatory responses.
LT-alpha
lymphotoxin-alpha
0
The ability of c-Fos and $T1$ proteins to interact directly with the TATA box-binding protein ($T2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
c-Jun
TBP
1
The interleukin-1beta ($T1$$T2$ (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
IL-1beta
interleukin-1beta (IL-1beta) converting enzyme
0
$T1$ is a lymphoid-specific $T2$ transcription factor that regulates inducible gene expression during T cell activation.
Elf-1
Ets
0
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of $T1$$T2$ is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.
Vav
c-Cbl
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a $T1$$T2$, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TFIIIB
0
Transcription factor TFIID consists of TATA binding protein (TBP) and at least eight $T1$$T2$ consists of TATA binding protein (TBP) and at least eight TBP-associated factors (TAFs).
TBP
TFIID
0
By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of $T1$$T2$ from the cytoplasm to the nucleus and to thereby suppress the binding of c-Jun homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).
c-Jun
QM
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-II
0
We found that in addition to $T1$, MIP-1alpha, and $T2$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
RANTES
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
0
Association of $T1$ with both CDC37 and HSP90 may also imply a mechanistic link between the functions of CDC37 and $T2$.
CDK4
HSP90
0
The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic $T1$$T2$ complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
Ras
RasGAP
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM / TR2 and $T2$ , thereby suppressing LIGHT-mediated HT29 cell death .
LIGHT
LTbetaR
1
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor ($T1$)/fetal liver kinase 1 (Flk-1) and $T2$.
KDR
FLT-1
0
This activation with p85 and $T1$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T2$ beta (delta C-43).
IGF-1R beta
IGF-1R
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/$T1$$T2$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Sos1
Ras
0
pRB, $T1$, p19(INK4d) and p27($T2$) decrease in both cell types.
cyclin D
KIP1
0
The death-inducing receptor $T1$ is activated when cross-linked by the type II membrane protein $T2$ (FasL).
Fas
Fas ligand
1
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ($T1$)-associated factors] from the human (h) HeLa cell $T2$ complexes hTAFII28, hTAFII20 and hTAFII18.
TBP
TFIID
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$$T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
p53
p21
0
In transfected COS-1 cells, osteogenic protein (OP)-1/$T1$, and less efficiently $T2$, bound to BMPR-II.
BMP-7
BMP-4
0
Reconstitution of the multiprotein complex of $T1$, hsp90, and $T2$ in a cell-free system.
pp60src
p50
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$ ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
trkA
0
Interaction of $T1$ and N+C-SH2 with IR beta (delta C-43) or $T2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
p85
IGF-1R beta
1
The ability of c-Fos and $T1$ proteins to interact directly with the $T2$ (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
c-Jun
TATA box-binding protein
1
Although $T1$ is thought to interact with the $T2$, the nature of the interaction has not been defined.
IRS-1
insulin receptor
1
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the $T1$, $T2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
microtubule-associated protein 2
P150
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$$T2$ were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.
IL-10
IL-10 receptor
0
When human soluble $T1$ (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each $T2$ monomer were found to be essential for efficient secretion.
FasL
FasL
0
These findings imply that IL-11 and $T1$ share similar early signaling events with the possibility of using the same signal transducer, $T2$.
IL-6
gp130
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the $T1$$T2$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
p90
IL-7R
0
However, the various $T1$/DP complexes display strong differences in the ability to bind to either $T2$ or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.
E2F
pRB
0
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including $T1$, -2, -4, and -6, while $T2$-expressing cells responded only to FGF-1.
FGF-1
FGFR3 IIIb
0
$T1$ (IRS-1) is a major substrate of the insulin receptor and has been implicated in $T2$ signaling.
Insulin receptor substrate 1
insulin
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-$T1$ immunoprecipitates suggesting that Grb2/$T2$ and Grb2/c-Cbl are present in different complexes.
c-Cbl
Sos1
0
We further showed that $T1$ was comodulated on the T cell surface with $T2$, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.
CD26
CD45
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with $T1$, consistent with the previous report of a PTF-related complex ($T2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
PTF
SNAPc
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, $T1$$T2$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MCP-3
MCP-3
0
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and $T1$$T2$ assembly, with heat shock proteins hsp90 and hsp70.
hsp70
progesterone receptor
0
PI 3-kinase activity and the regulatory $T1$ subunit of PI 3-kinase associated with $T2$ in pervanadate-stimulated, but not in unstimulated thymocytes.
p85
CD5
0
Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and $T1$$T2$ (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.
pim 2
interferon regulatory factor 4
0
P60 can bind either hsp70 or $T1$$T2$ or hsp90 independently and in an ATP-independent manner.
hsp90
hsp70
0
In these cells the adaptor protein $T1$ constitutively binds a substantial fraction of $T2$ through the N-terminal SH3 domain.
Grb2
c-Cbl
1
We report here that $T1$ also interacts with tyrosine-phosphorylated IRS-1 in response to $T2$.
Grb2
gastrin
0
$T1$ (neuromodulin, B-50, $T2$), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
GAP-43
F1
0
Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves $T1$$T2$ induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.
p21
MyoD
0
The high affinity interleukin-6 (IL-6) signaling complex consists of $T1$$T2$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein gp130.
IL-6
interleukin-6
0
The cell surface form of $T1$ is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta ($T2$), a type II transmembrane protein that is another member of the TNF ligand family.
LT-alpha
LT-beta
1
$T1$, cyclin D, p19(INK4d) and $T2$(KIP1) decrease in both cell types.
pRB
p27
0
Interestingly, both $T1$ and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby $T2$ could provide the core for a large signalling complex.
GRB2
IRS-1
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$ or CD4.
CD4
CD3
0
We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the $T1$ component of the $T2$ factor.
TATA box binding protein
TFIID
0
Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/$T1$$T2$/56Lyn and a 120-kDa phosphoprotein.
56Lyn
p53
0
We demonstrate here that both the site 2 and site 3 $T1$ variants complexed with IL-6R alpha bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
IL-6
gp130
0
Moreover, a transcriptional activation signal was transduced by BMPR-II in the presence of type I receptors after stimulation by $T1$/$T2$.
OP-1
BMP-7
0
$T1$ induced transient calcium mobilization specifically in CC chemokine receptor 3 ($T2$)-expressing L1.2 cells with an EC(50) of 3 nM.
Eotaxin-3
CCR3
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
elastin
collagenase
0
The molecular adapter $T1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and $T2$, which interact with guanine nucleotide exchange factors specific for the Ras family.
c-Cbl
Crk-L
1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/$T1$, RIP, FLICE/MACH, and TRAFs) associated with both of the $T2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MORT
p60
1
The retinoblastoma-susceptibility gene product binds directly to the human $T1$$T2$-associated factor TAFII250.
TATA-binding protein-associated factor
TATA-binding protein
0
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor ($T2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6D
sIL-6R
0
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to $T1$$T2$ (RBP) to transthyretin (TTR) to determine vitamin A (VA) status during infection.
transthyretin
retinol-binding protein
0
alpha-Actinin-2, a member of the spectrin/$T1$$T2$, a member of the spectrin/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95.
dystrophin
alpha-Actinin-2
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p75 neurotrophin receptor
NGF
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including $T1$$T2$ family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-X-L
Bcl-2
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R
IGF-1R
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase ($T1$) blocked the binding of $T2$ to Raf/330; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
beta ARK
G beta gamma
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
alpha-Actinin-2, a member of the spectrin/dystrophin family of $T1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule $T2$.
actin
PSD-95
0
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring $T1$ (beta-galactosidase) and LEU2 ($T2$) genes under the control of LexA-dependent operators.
lacZ
leucine utilization
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID alpha
hTFIID
0
We report chemotaxis and competitive binding studies that show LEC binds to and activates $T1$ and $T2$ transfected HEK-293 cells.
CCR1
CCR8
0
p23 is also present in immunoaffinity-purified $T1$ complexes along with hsp70 and another protein, $T2$.
hsp90
p60
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of $T1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor $T2$ (upstream binding factor) in vitro.
Rb
UBF
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding $T2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, $T1$, p53, and a ubiquitin-like protein $T2$.
RAD51
UBL1
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T1$, MCP-3, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-2
MCP-4
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$) receptor are important for binding EPO and EPO mimetic peptide.
EPO
EPO
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as $T1$ and $T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
p16
p21
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that $T1$$T2$ in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
HBx
RPB5
0
Like antibodies to the $T1$ subunit, anti-$T2$ inhibited suspension-induced terminal differentiation.
beta 1 integrin
CD9
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) $T1$ specifically inhibits the activity of the RNA polymerase I transcription factor $T2$ (upstream binding factor) in vitro.
Rb
UBF
1
$T1$ was first characterized as a receptor for $T2$, MIP-1beta, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
CCR5
MIP-1alpha
1
COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and $T1$$T2$ cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.
IL-13
IL-13R
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of $T1$$T2$/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
QM
c-Jun
0
Association of CDK4 with both $T1$ and HSP90 may also imply a mechanistic link between the functions of $T2$ and HSP90.
CDC37
CDC37
0
In summary, FGFR3 signaling pathway utilizes two $T1$-containing complexes; $T2$.
GRB2
Shc
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related ($T1$$T2$ ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
mGITR
GITR
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to $T1$ homodimers and $T2$/beta heterodimers.
PDGF receptor-alpha
PDGF receptor-alpha
0
When the ligand binds, $T1$ initiates a signaling cascade that results in the activation of the transcription regulator $T2$ (NF-kappa B).
IL-1RI
nuclear factor kappa B
0
The gamma chain of the interleukin-2 ($T1$) receptor is shared with the functional $T2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
IL-2
IL-4
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and $T1$ competed for binding with IL-2, indicating that $T2$ uses components of the IL-2 receptor.
IL-15
IL-15
0
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and $T1$ (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and $T2$.
IL-9
Jak3
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of $T2$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.
gastrin
insulin
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human $T1$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral $T2$, which is necessary for receptor activation.
gp130
IL-6
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T1$ binding: $T2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-2
1
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor alpha chain
IFN-gamma
0
pRB, cyclin D, p19($T1$) and $T2$(KIP1) decrease in both cell types.
INK4d
p27
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, $T1$ (KDR)/fetal liver kinase 1 (Flk-1) and $T2$.
kinase insert domain-containing receptor
FLT-1
0
The SH2/SH3-containing protein $T1$ also contains a guanine nucleotide exchange factor domain, and Vav has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the $T2$.
Vav
TCR
0
TR6 ( $T1$$T2$ ( decoy receptor 3 ( DcR3 ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
decoy receptor 3
TR6
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T1$ ($T2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII30
hTFIID alpha
0
GAP-43 (neuromodulin, B-50, $T1$), a protein kinase C ($T2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
F1
PKC
1
The hGITRL gene mapped to chromosome 1q23, near the gene for the TNF homolog $T1$/$T2$ [5].
Fas
CD95 ligand
0
HFE binds to the $T1$ receptor (TfR), a receptor by which cells acquire iron-loaded $T2$.
transferrin
transferrin
0
In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, $T1$$T2$, CDK6, or CDK2.
CDK6
CDK4
0
Moreover, similar p110RB sequences are required for binding $T1$ and $T2$.
PP-1 alpha 2
SV40 large T antigen
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T1$, YY1, USF, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
Sp1
E1A
0
The protein $T1$, a key mediator of mitogenesis and differentiation, associates with $T2$ (refs 1-3).
Raf-1
p21ras
1
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ($T2$).
p60
p48
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
LIGHT
LIGHT
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human $T1$, Cdk2, and Cdk3, but not with $T2$.
Cdc2
Cdk4
0
However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not $T1$$T2$ but not CC CKR3.
CC CKR3
CC CKR1
0
Of these 400, interferon regulatory factor 4 (IRF4), $T1$$T2$), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.
cyclin B2
IRF4
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of $T1$$T2$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.
IL-6D
IL-6
0
The genes for MPIF-2/$T1$ (SCYA24) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
eotaxin-2
eotaxin-3
0
$T1$ encodes a novel 21 kd protein that is found in cyclin A, $T2$, cyclin E, and Cdk2 immunoprecipitates.
CIP1
cyclin D1
0
Association of $T1$ with both CDC37 and HSP90 may also imply a mechanistic link between the functions of $T2$ and HSP90.
CDK4
CDC37
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the $T1$ $T2$.
p76
IL-7R
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronidase
procollagen I
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
IR
0
RIN1 interacts with the "effector domain" of $T1$ and employs some $T2$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.
RAS
RAS
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and $T1$$T2$, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein.
Cockayne syndrome group B (CSB) protein
TFIIH
0
Overexpression of a phosphorylation-defective form of $T1$ inhibited $T2$-dependent transcription during T cell activation.
Rb
Elf-1
0
An E2F complex containing mainly E2F4 and pRb2/$T1$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
p130
cyclinA
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
TFIID
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins $T1$, $T2$ and pRb2/p130.
pRb
p107
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes $T1$, $T2$ and hTAFII18.
hTAFII28
hTAFII20
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$ ($T2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin receptor
IR
0
Mouse $T1$ does not bind to $T2$, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.
IL-10
hIL-10R
0
Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes $T1$$T2$ signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.
Raf-1
Ras
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$$T2$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-2
FGF-7
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T1$/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
1
This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent $T1$$T2$ assembly to facilitate formation of subsequent PR complexes lacking p60.
PR
PR
0
Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to $T1$$T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
neurotrophin-3
NGF
0
Jak1 and $T1$ associated with $T2$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
Jak3
IL-2R beta
1
Recombinant $T1$ induces the tyrosine-phosphorylation of $T2$, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.
neuregulin-2beta
ErbB2
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$) protein MyoD and the pocket proteins $T2$, p107 and pRb2/p130.
bHLH
pRb
0
We suggest that activation of the cell cycle by the Ras/Raf1 pathways might be mediated in part by $T1$$T2$/Raf1 pathways might be mediated in part by Cdc25.
Cdc25
Ras
0
$T1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase ($T2$) on the surface of T cells and T cell lines.
CD26
ADA
1
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the $T1$ protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor ($T2$) as well as a candidate proto-oncogene.
Rb
SPF
0
A model is presented whereby the trimeric complex of IL-6R, gp130, and $T1$$T2$, gp130, and IL-6M forms before the functional hexamer.
IL-6M
IL-6R
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
MyoD
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM / TR2 and LTbetaR , thereby suppressing $T2$-mediated HT29 cell death .
LIGHT
LIGHT
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
sE-selectin
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the $T2$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p140trk
0
Secreted $T1$ is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface $T2$-LT-beta complex.
LT-alpha
LT-alpha
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable $T1$$T2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric ($T2$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-II
0
The 2.8 A crystal structure of a complex between the extracellular portions of HFE and TfR shows two $T1$ molecules which grasp each side of a twofold symmetric $T2$ dimer.
HFE
TfR
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins $T1$, p107 and $T2$/p130.
pRb
pRb2
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral $T1$, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
E1A
Tat
0
We have previously identified a nuclear protein of M(r)265K, $T1$, that binds specifically to the PKA-phosphorylated form of $T2$.
CBP
CREB
1
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / $T1$ and LTbetaR , thereby suppressing $T2$-mediated HT29 cell death .
TR2
LIGHT
0
The beta:beta activin homodimer and alpha:$T1$$T2$ homodimer and alpha:beta inhibin heterodimer are mutual antagonists which share a common beta subunit.
beta inhibin
beta activin
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T1$-$T2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin E
Cdk2
1
Here we report that (1) there is an accumulation of $T1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of $T2$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
$T1$ binds independently to two transmembrane receptors, the $T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p75
0
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTFIID alpha
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha ($T1$) in pleural and peritoneal effusions of different causes and to verify whether $T2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
TNFalpha
TNFalpha
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
sVCAM-1
0
CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/$T1$$T2$ (also known as the MIP-1 alpha/RANTES receptor).
RANTES
CC CKR1
0
$T1$ also was shown to coprecipitate with $T2$ in immunoprecipitation studies and to colocalize with HSP27 in immunofluorescence studies of intact glass-activated platelets.
FXIII
HSP27
1
Analysis of p53, p21(CIP1), p15(INK4b), $T1$(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
KIP2
0
$T1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and $T2$.
Bcl-2
Bcl-X-S
1
TRAP is highly similar to an identified murine $T1$ both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/$T2$.
CD40 ligand
lymphotoxin
0
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', $T1$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an $T2$ (SPF) as well as a candidate proto-oncogene.
cyclin A
S-phase-promoting factor
0
We screened proteins for interaction with $T1$, and cloned the full-length cDNA of human $T2$, which encoded 1225 amino acids.
presenilin (PS) 1
delta-catenin
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing $T2$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
PR
heat shock protein 90
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T1$ ($T2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII30
hTFIID
0
Since $T1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-$T2$ complex.
hsp90
hsp70
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto $T1$$T2$ binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
HLA-E
HLA-E
0
These data demonstrate that Stat3 but not Stat1 or $T1$$T2$ or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
Stat1
0
The tyrosine kinases Flt4, Flt1, and $T1$$T2$, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
Flk1
Flt4
0
The core domain contains the sequence-specific DNA binding activity and the in vitro $T1$ protein binding activity of $T2$.
53BP2
p53
1
In order to characterize the signaling pathway through which $T1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3 IIIc
0
In addition, we show that in extracts depleted of $T1$ and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or $T2$, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TFIIIB
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, $T1$, and $T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
dTAFII60
dTAFII40
0
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin ($T1$$T2$ (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
EPO
erythropoietin receptor
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing $T1$$T2$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Moreover, mutation of $T1$ residues 143-145 impairs binding of 14-3-3, but not Ras, to the $T2$.
Raf-1
Raf-CRD
1
Interactions of $T1$, a mediator of progesterone receptor assembly, with heat shock proteins $T2$ and hsp70.
p60
hsp90
1
Fusion proteins were created by linking the Abeta fragment to a LexA DNA-binding domain (bait) and also to a $T1$$T2$ fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey).
B42
Abeta
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
p140trk (trkA) tyrosine kinase receptor
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide ($T1$$T2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EMP1
EPO-mimetic peptide
0
We have identified a new TNF-related ligand, designated human $T1$ ligand ($T2$), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
GITR
hGITRL
1
Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely $T1$ (SRF), which binds to the $T2$ promoter.
serum response factor
c-fos
0
When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to $T1$, $T2$ rapidly associated with the IL-1RI complex and was phosphorylated.
IL-1
IRAK
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and $T1$$T2$ in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
TFIIB
RPB5
0
The $T1$ is localized to specific subcellular environments through the binding of the regulatory subunit ($T2$) dimer to RII-anchoring proteins.
type II cAMP-dependent protein kinase
RII
0
TR6 ( decoy receptor 3 ( $T1$$T2$ ( decoy receptor 3 ( DcR3 ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
DcR3
TR6
0
The binding of $T1$ and hTAFII30 requires distinct domains of $T2$.
hTAFII28
hTAFII18
1
Raf-1 is a serine/threonine protein kinase positioned downstream of $T1$$T2$ is a serine/threonine protein kinase positioned downstream of Ras in the mitogen-activated protein kinase cascade.
Ras
Raf-1
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric ($T2$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) $T1$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF ($T2$) in vitro.
Rb
upstream binding factor
1
hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and $T1$, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hPRLR
hGH
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T1$$T2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3 IIIc
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
delta C-4
IGF-1R beta
0
Characterization of $T1$ (Apo-1, CD95)-$T2$ ligand interaction.
Fas
Fas
0
The $T1$$T2$ (IL-1beta) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
interleukin-1beta (IL-1beta) converting enzyme
interleukin-1beta
0
The $T1$ POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with $T2$.
Oct1
TBP
1
This largest TAF may therefore play a central role in $T1$ assembly by interacting with both $T2$ and other TAFs, as well as serving to link the control of transcription to the cell cycle.
TFIID
TBP
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding $T1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
After a brief historical incursion regarding $T1$ of renal origin, we present the main extrarenal $T2$-forming enzymes, starting with isorenin, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
RAS
angiotensin
0
Expression of $T1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to $T2$.
FGFR3 IIIc
FGF-1
0
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
sVCAM-1
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, $T1$$T2$, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
FLICE
TRADD
0
We have identified a new TNF-related ligand, designated human $T1$$T2$ (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
GITR
GITR ligand
0
The $T1$ enzymes pp54 and $T2$/44 are regulated by tyrosine as well as serine/threonine phosphorylation.
MAP kinase
pp42
0
As expected, overexpression of either Id3/$T1$ or $T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
HLH462
ITF-2b
0
Interferon-gamma and $T1$ were diminished in the sera of $T2$-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
IGIF
ICE
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the $T1$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/$T2$.
myogenic basic helix-loop-helix
p130
0
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the $T1$/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase ($T2$) receptors leading to myeloid cell proliferation.
Grb2
c-Kit
0
Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a $T1$$T2$ and a 120-kDa phosphoprotein.
120-kDa phosphoprotein
56Lyn
0
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the $T1$$T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IGF-1
IGF-1 receptor
0
The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse $T1$ ($T2$).
IL-10R
mIL-10R
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the $T1$$T2$ resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.
IL-6D
IL-6D
0
Interestingly, both GRB2 and $T1$ can simultaneously bind distinct tyrosine phosphorylated regions on the same $T2$ molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.
phosphatidylinositol-3 (PI-3) kinase
IRS-1
1
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and $T1$ ligands, namely: SCF and $T2$, induce c-Cbl tyrosine phosphorylation.
c-Kit
TPO
0
At least two of the subunits of $T1$ ($T2$ and XPD proteins) are implicated in the disease xeroderma pigmentosum (XP).
TFIIH
XPB
0
This regulation results from a direct interaction between $T1$ and $T2$.
p21
PCNA
1
CD30 and its counter-receptor $T1$ ligand (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30
TNFalpha
0
In contrast, p27 complexes containing CDK2 are incapable of phosphorylating $T1$$T2$ are incapable of phosphorylating histone H1.
histone H1
CDK2
0
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and $T1$, induce $T2$ tyrosine phosphorylation.
TPO
c-Cbl
1
A direct interaction between $T1$ subunits and the $T2$.
G-protein beta gamma
Raf-1 protein kinase
1
HBx and RPB5 specifically bound to $T1$ ($T2$) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
transcription factor IIB
TFIIB
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
Fas
Fas
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain ($T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma
IFN-gamma
0
$T1$ interacts with CCR5 and SDF-1 with $T2$ receptors.
RANTES
CXCR4
0
We show that the carboxy terminal "tail" of $T1$ associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, $T2$, and K6.
DPI
K5
1
Using the human $T1$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast $T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
RAD52
UBC9
0
Although $T1$ is thought to interact with the $T2$ receptor, the nature of the interaction has not been defined.
IRS-1
insulin
0
In agreement, mAb to the previously cloned $T1$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the p76 $T2$.
IL-7R
IL-7R
0
A mutant form of human interferon-gamma ($T1$) that binds one $T2$ receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma SC1
IFN-gamma
0
Specific cleavage of $T1$ ($T2$) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.
laminin-5
Ln-5
0
PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than $T1$ and $T2$ on several mesenchymal cell types.
PDGF-AB
PDGF-BB
0
The POU domains of the Oct1 and $T1$ transcription factors mediate specific interaction with $T2$.
Oct2
TBP
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and $T1$ but interacts poorly with $T2$.
FGFR4
KGFR
0
Crosslinking of iodinated acidic FGF ($T1$) and $T2$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
aFGF
basic FGF
0
Characterization of $T1$ (Apo-1, $T2$)-Fas ligand interaction.
Fas
CD95
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator $T1$ (VP16) as well as with the general transcription factor $T2$.
viral protein 16
TFIIB
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including $T2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
Sp1
0
alpha-Actinin-2, a member of the spectrin/dystrophin family of $T1$$T2$, a member of the spectrin/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95.
actin
alpha-Actinin-2
0
However, MIP-1 beta was also an agonist for CC CKR3 but not $T1$; MCP-3 was an agonist for $T2$ but not CC CKR3.
CC CKR1
CC CKR1
0
A mutant form of human interferon-gamma ($T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma SC1
IFN-gamma
0
Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/$T1$$T2$/Jif-1.
Jif-1
QM
0
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein $T1$, regulated on activation, normal T expressed and secreted (RANTES), and $T2$ (MCP-3), but the receptors involved have not been defined.
(MIP)-1 alpha
monocyte chemoattractant protein-3
0
Activation of $T1$ results in rapid, site-specific dephosphorylation of $T2$ at one or more of these three sites and is coincident with increased AP-1-binding activity.
protein kinase C
c-Jun
1
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 $T1$ $T2$)2 complex.
IL-6R
gp130
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes $T1$, hTAFII20 and $T2$.
hTAFII28
hTAFII18
0
We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the $T1$:CBP interaction and report here that $T2$ can activate transcription through a region in its carboxy terminus.
phosphoCREB
CBP
0
The high affinity interleukin-6 ($T1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T2$ and the affinity converter/signal transducing protein gp130.
IL-6
IL-6 receptor
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
tumour necrosis factors (TNF) alpha
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the $T1$ ($T2$)2 complex to couple with the soluble portion of gp130.
IL-6D
sIL-6R
1
The cell surface form of LT-alpha is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta ($T1$$T2$ (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.
LT-beta
lymphotoxin-beta
0
The structure also reveals the final six C-terminal amino acid residues of $T1$ SC1 (residues 253-258) that have not been observed in any other reported $T2$ structures.
IFN-gamma
IFN-gamma
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T1$ and Fas-$T2$.
LPR
FD8
0
We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and $T1$$T2$ and EPO binding.
EPO
EMP1
0
An E2F complex containing mainly E2F4 and pRb2/$T1$ ($T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
p130
E2F
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and $T1$ competed for binding with IL-2, indicating that IL-15 uses components of the $T2$.
IL-15
IL-2 receptor
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural $T1$ ligands, $T2$ and MIP-1beta (refs 7, 8).
CCR-5
macrophage inflammatory protein (MIP)-1alpha
0
Coexpression of the alpha and betaL subunits of the human interferon alpha ($T1$$T2$ is required for the induction of an antiviral state by human IFNalpha.
IFNalpha
interferon alpha (IFNalpha) receptor
0
cDNA clones encoding a human IL-10R ($T1$$T2$ (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds hIL-10 specifically.
hIL-10R
IL-10R
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T1$$T2$ and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
gastrin
Shc
0
CCR5 was first characterized as a receptor for $T1$, $T2$, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
MIP-1alpha
MIP-1beta
0
The structure also reveals the final six C-terminal amino acid residues of $T1$$T2$ (residues 253-258) that have not been observed in any other reported IFN-gamma structures.
IFN-gamma
IFN-gamma SC1
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
p21CIP1
Cdk4
0
Gastrin stimulates tyrosine phosphorylation of $T1$ and its association with Grb2 and the $T2$.
insulin receptor substrate 1
phosphatidylinositol 3-kinase
1
A protein ligand for the ECK receptor protein-tyrosine kinase has been isolated by using the extracellular domain ($T1$$T2$ has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.
ECK
ECK receptor protein-tyrosine kinase
0
However, $T1$ was also an agonist for $T2$ but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not CC CKR3.
MIP-1 beta
CC CKR3
1
In vitro and in nonproliferating cells, $T1$ associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, $T2$, or CDK2.
p27
CDK6
1
Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding KDR/$T1$, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with $T2$ binding.
Flk-1
FLT-1
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
HLA-E
TAP
0
The findings suggest a model whereby Bax and $T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-X-S
Bax
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$ (TAP) and $T2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.
transporter associated with antigen processing
calreticulin
0
The human pituitary hormones, growth hormone (hGH) and prolactin ($T1$$T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hPRL
prolactin
0
$T1$ protein fused to the Drosophila protein bicoid (LexA-$T2$) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
bicoid
0
Our finding that $T1$ directly interacts with RNA polymerase II subunit 5 ($T2$), a common subunit of RNA polymerases, implies that HBx directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J.
HBx
RPB5
1
A potential interaction of p75 and trkA $T1$$T2$ NGF receptors revealed by affinity crosslinking and immunoprecipitation.
NGF
trkA
0
Thus, $T1$ functions as a bridge between $T2$ and the enhancer complex to recruit U2AF65 to the adjacent intron.
U2AF35
U2AF65
0
The cross-reactivity of $T1$ is apparently due to a chemical plasticity evident in the amphipathic $T2$ cytokine-binding sites.
gp130
gp130
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$ (IL-10) receptor, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10
IL-10
0
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, $T1$$T2$ but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
FosB
Fra1
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$ complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$$T2$(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
p15
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, $T1$$T2$, K2, K5, and K6.
K5
K1
0
Three of these clones encode DNA binding proteins (NF-IL6 beta, $T1$, and $T2$), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.
HMG I/Y
SSRP
0
These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the cdc2 protein kinase, but also activate the $T1$ tyrosine phosphatase, of which $T2$ is the physiological substrate.
cdc25
cdc2
0
The $T1$ gene mapped to chromosome 1q23, near the gene for the TNF homolog Fas/$T2$ [5].
hGITRL
CD95 ligand
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$$T2$ (IRS-1), the major cytoplasmic substrate of the insulin receptor.
insulin
insulin receptor substrate 1
0
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the $T1$$T2$ (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).
insulin-like growth factor-I
insulin-like growth factor-I receptor
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, $T1$, and $T2$) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibromodulin
decorin
0
Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor $T1$$T2$, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.
TFIID
hTAFII18
0
Crystal structure of the $T1$-$T2$ ectodomain complex.
BMP-2
BRIA
1
The specificity of intehraction between $T1$ and $T2$ was confirmed by an in vitro binding assay using recombinant proteins.
G alpha i2
nucleobindin
1
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor ($T2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPOR
1
Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate $T1$ kinase activity toward $T2$ in mammalian cells.
Raf-1
MEK-1
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ alpha chain ($T2$) has been designed and characterized.
IFN-gamma receptor
IFN-gamma R alpha
0
CD5 associates with the $T1$ (TcR zeta)/$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
CD3
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T1$ complexes containing hsp70 and $T2$ (p48).
PR
Hip
0
An E2F complex containing mainly $T1$ and pRb2/p130 ($T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F4
E2F
0
Here we show that a complex of $T1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble $T2$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
gp120
CD4
1
Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric $T1$$T2$.receptor complex.
IL-6.receptor
IL-6
0
Two distinct ligand binding domains of TRKB were isolated from proteolytic digests of the receptor by affinity separation on immobilized $T1$$T2$ were isolated from proteolytic digests of the receptor by affinity separation on immobilized BDNF.
BDNF
TRKB
0
$T1$ produced in E. coli bound and activated the $T2$ protein in extracts from human G1 cells, and antibodies against cyclin E immunoprecipitated a histone H1 kinase from HeLa cells.
Cyclin E
CDC2
1
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/$T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Fos
PS1
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T1$, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
LexA protein fused to the Drosophila protein $T1$ (LexA-$T2$) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
bicoid
0
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-$T1$ MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30
CD30L
0
We found that in addition to $T1$, $T2$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MIP-1alpha
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for $T1$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three $T2$ molecules.
TNF-alpha
TNF-R2
0
Both GRB2 and $T1$ have been implicated in a highly conserved mechanism that regulates $T2$ signalling by receptor tyrosine kinases.
sem-5
p21ras
0
Here, we demonstrate that E2F-1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the $T1$ subunit, $T2$.
NF-kappaB
p50
0
TRADD-TRAF2 and $T1$$T2$ and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
TRADD
TRAF2
0
In this study, we demonstrate that $T1$ is coupled to the protein-tyrosine kinase $T2$ and can act as a substrate for p56lck.
CD5
p56lck
1
Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact $T1$, which enhances the complementarity of the viral IL-6-$T2$ binding interfaces.
gp130
gp130
0
$T1$ encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and $T2$ immunoprecipitates.
CIP1
Cdk2
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$) receptor, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
IL-10
0
The binding of $T1$ or IL-1beta to $T2$ is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL-1alpha
IL1R
1
Type I interferons bind to two cell surface receptors, ifnar1 and $T1$$T2$ and ifnar2, as the first step in the activation of several signal transduction pathways that elicit an anti-viral state and an anti-proliferative response.
ifnar2
ifnar1
0
Using the human $T1$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, $T2$, and a ubiquitin-like protein UBL1.
RAD52
p53
0
Instead, 14-3-3 may facilitate the association of $T1$ with $T2$ in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.
cdc25
Raf-1
1
Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of $T1$, $T2$ and ErbB4 in cell lines expressing all of these ErbB-family receptors.
ErbB2
ErbB3
0
The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both $T1$ and $T2$.
IRS-1
Shc
0
Although IRS-1 is thought to interact with the $T1$$T2$, the nature of the interaction has not been defined.
insulin
insulin receptor
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, $T1$-Cdk4, and $T2$-Cdk4 complexes.
cyclin D1
cyclin D2
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
The similarities in biofunctions and differences in ligand binding proteins between $T1$ and IL-6 prompted us to investigate whether $T2$ shares common signal transduction mechanisms with IL-6.
IL-11
IL-11
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T1$ for binding to $T2$.
RbAP46
Rb
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and $T1$$T2$ ( LTbetaR ) and HVEM / TR2 receptors .
HVEM
lymphotoxin beta receptor
0
$T1$ and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified $T2$ and Lyn reassociated in vitro, demonstrating their direct interaction.
Syk
Syk
0
In patients with a complete response to $T1$, the levels of $T2$ were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-alpha
IFN-gamma
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, $T1$$T2$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.
HCC-4
Liver-expressed chemokine
0
Expression of $T1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T2$-expressing cells responded only to FGF-1.
FGFR3
FGFR3 IIIb
0
CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase ($T1$$T2$ (ADA) on the surface of T cells and T cell lines.
ADA
adenosine deaminase
0
COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both $T1$$T2$ cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.
IL-4
IL-4R
0
Cross-family dimerization of transcription factors Fos/Jun and $T1$/$T2$ alters DNA binding specificity.
ATF
CREB
1
In vivo labelling with 32P(i) also showed a four- to fivefold increase in Y-394 occupancy in $T1$ when associated with $T2$.
p56lck
CD5
1
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the $T1$$T2$ and the calcium effector protein, calmodulin (CaM).
calcium effector protein
GAP-43
0
Involvement of $T1$ signal transducer gp130 in $T2$-mediated signal transduction.
IL-6
IL-11
0
Both the GT155-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on $T1$, a characteristic of many $T2$ interactions.
GT155
calnexin
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$/TR2 receptors.
TR2
HVEM
0
Levels of $T1$(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only $T2$ increases in HPEC cultures.
p16
p16
0
The aim of the present study was to determine possible inotropic effects mediated by endothelin $T1$ and $T2$ receptors in human myocardial trabeculae from the right atrium and the left ventricle.
ET(A)
ET(B)
0
We find that p53, p21(CIP1) and p15($T1$$T2$) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
INK4b
CIP1
0
In the yeast-based cloning system, the only strong interaction that was detected between $T1$ and the calcium effector protein, calmodulin ($T2$).
GAP-43
CaM
1
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, $T1$$T2$ specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
FosB
USF
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors $T1$ and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with $T2$ family proteins as Bcl-2.
Bax
Bcl-2
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as protein phosphatase 1 ($T1$$T2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
PP1C
serine-threonine phosphatase 2A catalytic subunit
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, $T1$, and $T2$, were explored with a yeast two-hybrid system.
Mcl-1
Bax
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T1$-Cdk2, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin E
cyclin D1
0
Jak1 and Jak3 associated with $T1$ and gamma c, respectively; IL-2 induced Jak3-$T2$ and increased Jak3-gamma c associations.
IL-2R beta
IL-2R beta
0
While the function of $T1$ is not yet clear, its structure and pattern of expression suggest a role for $T2$ in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.
RIZ
RIZ
0
By contrast stimulation with TPO leads to the formation of a $T1$ complex containing $T2$.
Grb2
JAK2
1
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to $T1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and $T2$ are necessary and sufficient for stable association with TBP.
TBP
c-Jun
0
Thus, Phe93 and Phe205 are important binding determinants for both $T1$ and $T2$, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the EPOR for productive ligand binding.
EPO
EMP1
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T2$/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
utrophin
1
This protein, designated $T1$ (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of $T2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF-related protein
Flt4
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the $T1$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and $T2$/p130.
myogenic basic helix-loop-helix
pRb2
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
The TAFII55-interacting region of $T1$ was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila $T2$.
Sp1
TAFII110
1
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$$T2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
IL-6 receptor
0
Ligation of the extracellular domain of the cell surface receptor Fas/$T1$$T2$/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells.
APO-1
Fas
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R $T1$$T2$ is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
gp130
sIL-6R
0
In addition, we show that in extracts depleted of TBP and $T1$-associated factors, transcription from the U1 promoter is restored by recombinant $T2$ but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
Interaction with $T1$ subunit of $T2$ is required for transcriptional activation by serum response factor.
RAP74
TFIIF
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, $T1$, FLICE/MACH, and TRAFs) associated with both of the p60 and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
RIP
p80
0
The interaction between interleukin-6 (IL-6) and $T1$$T2$ (IL-6) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
interleukin-6
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor ($T1$) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
sIL-6R
gp130
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma
IFN-gamma
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric ($T1$$T2$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
IL-6
IL-6
0
A point mutation in FADD, analogous to the lpr mutation of $T1$, abolishes its ability to bind $T2$, suggesting a death domain to death domain interaction.
Fas
Fas
0
PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of $T1$, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and $T2$-chain (23%).
neuropilin-1
PDGF A
0
Using co-immunoprecipitation and protein-protein association assays, we show that both $T1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and $T2$ are necessary and sufficient for stable association with TBP.
c-Fos
c-Jun
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor $T1$$T2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
UBF
Rb
0
Cleavage of $T1$ by $T2$ and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
Ln-5
MMP2
1
$T1$ interacts with protein phosphatases PP2A and $T2$ and disrupts a G2/M cell-cycle checkpoint.
HOX11
PP1
1
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-3
0
Interaction of the $T1$ subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
p85
IGF-1R
0
Crystal structure of the heterodimeric bZIP transcription factor $T1$-$T2$ bound to DNA.
c-Fos
c-Jun
1
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$ and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat3
Stat1
0
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
p56lck
0
To study the mechanism underlying the apparent functional cooperation between $T1$ and $T2$, we explored the possibility of protein-protein interactions between these two transcription factors.
YY1
Sp1
0
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase $T1$$T2$) and Src-family kinase p53/56Lyn (Lyn) contribute to signaling via the B-cell antigen receptor complex.
p53
Syk
0
The interaction between interleukin-6 ($T1$) and $T2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
IL-6 receptor
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$) protein $T2$ and the pocket proteins pRb, p107 and pRb2/p130.
bHLH
MyoD
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), $T1$$T2$), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
aromatic L-amino acid decarboxylase
TH
0
Here we show that $T1$ directly interacts with TRAF2 and FADD, signal transducers that activate $T2$ and induce apoptosis, respectively.
TRADD
NF-kappa B
0
Their order of selection was $T1$ effusion, C4 serum, $T2$-effusion, and C3 effusion.
alpha1AT
TNFalpha
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of $T1$$T2$ blocked the interaction of gp12O-CD4 complexes with CCR-5.
gp12O
gp120
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal $T1$$T2$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
gp120
gp120
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
INK4b
0
The $T1$ and $T2$ families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.
Fos
Jun
1
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ alpha chain ($T2$ R alpha) has been designed and characterized.
IFN-gamma receptor
IFN-gamma
0
Mutagenesis of the $T1$ receptor ($T2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
erythropoietin
EPOR
1
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits Shc, probably via $T1$$T2$ complex recruits Shc, probably via Grb2.
Grb2
c-Cbl
0
Taken together these data suggest that the 76-kDa receptor is a novel high affinity IL-7R that may be necessary for $T1$$T2$ that may be necessary for IL-7 driven proliferation in human T cells.
IL-7
IL-7R
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a $T1$$T2$-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor ($T2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
sIL-6R
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$$T2$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-2
keratinocyte growth factor
0
$T1$- and $T2$-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
TAP
tapasin
0
Using the cytoplasmic domain of $T1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
Fas
LPR
0
This activation with $T1$ and IGF-1R beta was 4-fold less as compared to $T2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
p85
IR beta
1
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EBP
1
This activation with $T1$ and $T2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
p85
IGF-1R beta
1
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor ($T1$) and the IGF-1 receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IR
IGF-1R
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including $T1$, $T2$, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-X-L
Bcl-X-S
0
Our data suggest that TR6 inhibits the interactions of $T1$ with $T2$ / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
LIGHT
HVEM
1
The molar concentration of $T1$ required to induce maximum cell migration is 20- to 200-fold greater than that required for $T2$ or I309, respectively.
LEC
RANTES
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding $T1$ and $T2$ mimetic peptide.
EPO
EPO
0
Discrete protein interactions with the $T1$/c-Cbl complex in $T2$- and TPO-mediated myeloid cell proliferation.
Grb2
SCF
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ receptor were found to be redundantly required for receptor function and for activation of $T2$ but not for Stat1 or Stat5.
IL-10
Stat3
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T2$ (p48).
hsp90
Hip
0
Thus $T1$ is a cellular oncogene that targets PP2A and $T2$, both of which are targets for oncogenic viruses and chemical tumour promoters.
HOX11
PP1
1
Functional studies in Jurkat T lymphocytic cells point to the importance of both the E2F and NF-kappaB binding sites in $T1$$T2$ and NF-kappaB binding sites in E2F-1 mediated repression of HIV-1 promoter, in vivo.
E2F-1
E2F
0
Both the bHLHZip and the N-terminal regions of $T1$ are required for efficient interaction with $T2$.
Fra1
USF
1
The binding of IL-1alpha or IL-1beta to $T1$ is an early step in $T2$ signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL1R
IL-1
0
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the BMP type II receptor ($T1$$T2$ and BR-Ib) and the BMP type II receptor (BR-II).
BR-II
BR-Ia
0
We present evidence that $T1$ (pp54 and $T2$/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.
mitogen-activated protein-serine (MAP) kinases
pp42
0
Here , we demonstrate that $T1$ specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / $T2$ ) .
TR6
CD95L
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
dTAFII40
0
TRAP is highly similar to an identified murine $T1$$T2$ is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.
CD40 ligand
TRAP
0
This $T1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since $T2$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Syk
0
These observations suggest that the products of the $T1$ and $T2$ genes are involved in transcription.
CSA
CSB
0
This overview summarizes the current knowledge on $T1$ ($T2$) in the progression of atherosclerosis and the influence of MMPs in aneurysm formation.
plasminogen activator inhibitor-1
PAI-1
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for $T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
Crosslinking of iodinated acidic FGF (aFGF) and $T1$$T2$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
basic FGF
acidic FGF
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of $T1$ possessing enhanced killing activity, but not the functionally inactive mutants $T2$-LPR and Fas-FD8.
Fas
Fas
0
After a brief historical incursion regarding $T1$ of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, $T2$, D and G cathepsin and ending with the conversion enzyme and chymase.
RAS
tonin
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$$T2$), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
INK4b
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S $T1$$T2$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3a
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of $T1$, $T2$, and three additional proteins, p54, p50, and p23.
hsp90
hsp70
0
Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to $T1$, a $T2$ from Caenorhabditis elegans.
DAF-4
BMP type II receptor
0
Surprisingly, the N-terminal third of $T1$ alone bound CaM more strongly than did intact $T2$, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.
GAP-43
GAP-43
0
We report an interaction between the human $T1$ or $T2$ hydrophilic loop and Rab11, a small GTPase belonging to the Ras-related superfamily.
PS1
PS2
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the $T1$$T2$/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
SCF
Grb2
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the $T1$$T2$ bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
p53
MDM2
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T1$, YY1, USF, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
Sp1
CTF
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and $T1$$T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IGF-1R beta
IGF-1R
0
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and $T1$$T2$ and Shc: implications for insulin control of ras signalling.
Shc
IRS1
0
In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the $T1$$T2$ and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.
Raf-1
JAK2
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex ($T2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TATA-binding protein
SNAPc
0
$T1$ ($T2$), a desmosomal component lacking a transmembrane domain, has been implicated in this interaction, although most studies have been conducted with cells that contain few or no desmosomes, and efforts to demonstrate direct interactions between desmoplakin and intermediate filaments have not been successful.
Desmoplakin
DPI
0
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, CCR-5 and CXCR-4, respectively, as well as the primary receptor $T1$$T2$ and CXCR-4, respectively, as well as the primary receptor CD4 (refs 1-6).
CD4
CCR-5
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including Sp1, $T2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
YY1
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
Jif-1
c-Jun
0
Both the GT155-$T1$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many $T2$ interactions.
calnexin
calnexin
0
$T1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with $T2$ family proteins as Bcl-2.
Bcl-2
Bcl-2
0
The interaction between interleukin-6 (IL-6) and $T1$ ($T2$) is the initial and most specific step in the IL-6 signaling pathway.
IL-6 receptor
IL-6R
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ($T1$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T2$/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
ER
cyclinA
0
We found that ADA was associated with $T1$ on T cell lines lacking either $T2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
CD26
ADA
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant $T1$ and $T2$ (a CBP-related protein).
CBP
p300
0
Since $T1$ is typically found in a complex with $T2$ and hsp70, we have further characterized its interactions with these proteins.
p60
hsp90
1
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human $T1$ and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
IL-6
IL-6
0
Bacterially overexpressed human $T1$ was used to raise several monoclonal antibodies to $T2$.
p23
p23
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase ($T1$), aromatic L-amino acid decarboxylase ($T2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
TH
AADC
0
$T1$ is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and $T2$.
Myogenin
E47
1
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by $T1$$T2$ but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TFIID
TBP
0
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase $T1$$T2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
SKR2
ActRII
0
The physical interaction between $T1$ and $T2$ may thus form the basis for the functional interplay observed previously.
YY1
Sp1
1
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and $T1$ to $T2$.
pp120
CD5
1
Together, these results suggest that $T1$ and TAFII60 are important targets for transmitting activation signals between $T2$ and the initiation complex.
TAFII40
p53
1
We show that $T1$ interacts with $T2$ both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.
hTAFII28
hTAFII18
1
Thus, $T1$ functions as a bridge between U2AF65 and the enhancer complex to recruit $T2$ to the adjacent intron.
U2AF35
U2AF65
0
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or $T1$$T2$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.
IL-6
gp130
0
Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and $T1$$T2$- and TPO-mediated myeloid cell proliferation.
TPO
SCF
0
The high affinity interleukin-6 ($T1$) signaling complex consists of $T2$ and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein gp130.
IL-6
IL-6
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM / TR2 and $T2$ , thereby suppressing LIGHT-mediated HT29 cell death .
TR6
LTbetaR
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM / $T2$ and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
LIGHT
TR2
1
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early $T1$$T2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
hsp90
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$ adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma R alpha
IFN-gamma SC1
0
Although $T1$ associates with IRS-1 and $T2$, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
Shc
1
We observed that the protein $T1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit ($T2$), as well as protein phosphatase 1 (PP1C) in mammalian cells.
HOX11
PP2AC
1
The interaction between $T1$ (IL-6) and IL-6 receptor ($T2$) is the initial and most specific step in the IL-6 signaling pathway.
interleukin-6
IL-6R
1
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
neurotrophin-3
TrkB
0
Cloning of the complete coding region for human $T1$ using the two hybrid system and expression of $T2$ in E. coli.
protein phosphatase inhibitor 2
inhibitor 2
0
After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PTPmu, the cadherins associated with $T1$ are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for $T2$.
PTPmu
PTPmu
0
The pleiotropic biological activities of interleukin-1 ($T1$) are mediated by its type I receptor ($T2$).
IL-1
IL-1RI
1
The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-$T1$$T2$ inhibitory domain bound to the phosphorylated cyclin A-cyclin-dependent kinase 2 (Cdk2) complex has been determined at 2.3 angstrom.
cyclin-dependent kinase 2
p27Kip1 kinase
0
These same p53 residues are also involved in transactivation, supporting the hypothesis that $T1$ inactivates $T2$ by concealing its transactivation domain.
MDM2
p53
1
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related ($T1$$T2$ (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
mGITR
GITR ligand
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit ($T1$$T2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
PP2AC
serine-threonine phosphatase 2A catalytic subunit
0
Gel retardation/immunoblot analysis using purified $T1$ and $T2$ homodimers reveals the presence of complexes containing both proteins.
E2F-1
p50
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$ in binding $T2$.
TRKB receptor
BDNF
1
Cell surface PS1 formed complexes in vivo with actin-binding protein $T1$ ($T2$), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.
filamin
ABP-280
0
$T1$ is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the $T2$ gene products E12 and E47.
Myogenin
E2A
0
The structure provides evidence that the $T1$-$T2$ complex forms in vivo and may have a critical role in the p53 pathway of tumor suppression.
53BP2
p53
1
$T1$ recognizes one FGFR isoform known as the $T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-7
FGFR2 IIIb
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$) protein MyoD and the pocket proteins pRb, $T2$ and pRb2/p130.
bHLH
p107
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a $T1$$T2$ but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
The Ras and $T1$$T2$ and Raf1 proto-oncogenes transduce extracellular signals that promote cell growth.
Raf1
Ras
0
$T1$$T2$ was derived by linking the two peptide chains of the IFN-gamma dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.
IFN-gamma
IFN-gamma SC1
0
The current data are consistent with the main role of the IFN-gamma dimer being to decrease the dissociation constant of $T1$$T2$ dimer being to decrease the dissociation constant of IFN-gamma for its cellular receptors.
IFN-gamma
IFN-gamma
0
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that $T1$$T2$, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
Shc
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and $T1$$T2$ or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
TFIIB
TFIIB
0
Here we report the crystal structure of human dimeric $T1$ in complex with two high affinity $T2$ extracellular domains(BRIAec).
BMP-2
BMP receptor IA
0
The genes for MPIF-2/eotaxin-2 (SCYA24) and $T1$ ($T2$) are localized within a region of approximately 40 kilobases.
eotaxin-3
SCYA26
0
We suggest that activation of the cell cycle by the Ras/$T1$$T2$/Raf1 pathways might be mediated in part by Cdc25.
Raf1
Ras
0
Thus, these two TNFR1-TRADD signaling cascades appear to bifurcate at $T1$$T2$ signaling cascades appear to bifurcate at TRADD.
TRADD
TRADD
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that $T1$$T2$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
Ras
0
Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient $T1$$T2$, we suggest that a stable IL-6 dimer may be an efficient IL-6 antagonist.
IL-6
gp130
0
Substitution of Ala for Leu13 or Phe36 generates monomeric $T1$ subunits that cannot bind $T2$.
RII beta
AKAP75
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine $T1$$T2$) protein [4].
glucocorticoid-induced TNFR-related (mGITR) protein
mGITR
0
$T1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 (Flk-1) and $T2$.
VEGF
FLT-1
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$, and the $T2$.
dystrophin related protein
Torpedo 87K protein
0
Two proteins have been described as constituents of the $T1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the $T2$ receptor, but neither of these proteins binds IL-13.
IL-4
IL-2
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$ adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma SC1
0
These findings indicate that the $T1$/$T2$ and ATF/CREB families of transcription factors are not as distinct as was previously thought.
Fos
Jun
0
The crystal structure of $T1$$T2$ has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6.
IFN-gamma
IFN-gamma SC1
0
The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated $T1$ (for '$T2$'), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.
ATM
AT mutated
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
p15
0
In neurons cAMP-dependent protein kinase II beta ($T1$$T2$ (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).
PKAII beta
cAMP-dependent protein kinase II beta
0
Thus, phFGFR encodes a human FGF receptor with high affinity for both $T1$ and $T2$.
aFGF
bFGF
0
$T1$ binds exclusively to the underphosphorylated form of Rb and fails to bind to $T2$ mutants derived from patients with retinoblastoma.
Elf-1
Rb
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$$T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, $T1$$T2$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGFR2
FGF-7
0
The hGH and $T1$ receptors ($T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRL
hGHR
0
LEC induced maximal migration of $T1$ and $T2$ transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.
CCR1
CCR8
0
rIL-10R expressed in an $T1$-dependent mouse pro-B cell line (Ba/F3) binds $T2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.
IL-3
hIL-10
0
A cDNA clone, designated TRAP ($T1$$T2$ (TNF-related activation protein) was isolated from a collection of T cell activation genes.
TNF-related activation protein
TRAP
0
$T1$ and $T2$ involvement in the osteogenic properties of the HeLa cell line.
BMP-4
BMP-6
0
Activation of lacZ upon interaction of $T1$ with $T2$(delta C-43) was 4-fold less as compared to IR beta.
p85
IR beta
1
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric ($T1$ $T2$ gp130)2 complex.
IL-6
IL-6R
1
In contrast, the renaturation rate for $T1$ with the groE chaperonins mirrored the committed renaturation rates following $T2$ depletion.
rhodanese
groEL
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$$T2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
IL-6
0
Thus , TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$- and LIGHT-mediated cell death .
LIGHT
FasL
0
B61 is a ligand for the $T1$$T2$ receptor protein-tyrosine kinase.
ECK receptor protein-tyrosine kinase
ECK
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
In neurons cAMP-dependent protein kinase II beta (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit ($T1$$T2$ (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).
RII beta
cAMP-dependent protein kinase II beta
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T1$, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sE-selectin
sICAM-1
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human $T2$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
TFIID
0
Mutagenesis of the regulatory subunit ($T1$) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for $T2$ dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
RII beta
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric ($T2$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-II
0
Bcl-2 also interacted with Bcl-X-L and $T1$ and with the dominant inhibitors Bax and Bcl-X-S. $T2$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Mcl-1
Bcl-X-L
0
As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted $T1$ multiprotein complex contains $T2$, which is a major candidate for providing the protein unfoldase activity required for hsp90 association.
pp60src
hsp70
1
We also found another armadillo-protein, $T1$, interacted with $T2$.
p0071
PS1
1
The crystal structure of the human $T1$-$T2$ (CDK2)-ATP complex has been determined at 2.3 A resolution.
cyclinA
cyclin-dependent kinase2
1
Interferon-gamma and several other cytokines that are known to activate $T1$ were also found to stimulate $T2$ activity toward MEK-1 in mammalian cells.
JAK2 kinase
Raf-1 kinase
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T1$$T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
MyoD
ITF-2b
0
Finally, anti-IL-6R antibody inhibited the ability of IL-6, but not $T1$$T2$, but not IL-11, to transduce early signals in TF-1 cells.
IL-11
IL-6
0
The receptor chains bind to the 'wrist' epitopes of the $T1$ dimer and contact both $T2$ monomers.
BMP-2
BMP-2
0
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like $T1$$T2$ are similar, and like gammac, IL-13Ralpha is located on chromosome X.
gammac
gammac
0
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the calcium effector protein, $T1$ ($T2$).
calmodulin
CaM
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and $T1$$T2$, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bax
Bcl-X-L
0
After T cell activation, the phosphorylation of $T1$ results in the release of Elf-1, which is correlated temporally with the activation of $T2$-mediated transcription.
Rb
Elf-1
0
The SH2/SH3 domain-containing protein $T1$ interacts with tyrosine-phosphorylated IRS1 and $T2$: implications for insulin control of ras signalling.
GRB2
Shc
1
Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal Jak3 activation, suggesting that mutations of $T1$$T2$ activation, suggesting that mutations of Jak3 may result in an XSCID-like phenotype.
Jak3
Jak3
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, $T1$, $T2$, and a ubiquitin-like protein UBL1.
RAD51
p53
0
The extracellular cysteine-rich domain of the TNF-R is homologous to the nerve growth factor receptor and the $T1$ $T2$.
B cell activation protein
Bp50
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$ and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
LTbetaR
0
$T1$/$T2$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.
Vav
c-Cbl
1
These analyses showed that the ability of PBMC to proliferate to $T1$ correlated with expression of the p76 IL-7R, and not with expression of the p90 $T2$.
IL-7
IL-7R
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
interleukin-1 beta
FADD
0
Moreover we found that, upon SCF stimulation, the $T1$/$T2$ complex recruits Shc, probably via Grb2.
Grb2
c-Cbl
1
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing $T1$$T2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
RESULTS: Using Cox univariate analysis, we determined that angiolymphatic tumor emboli and non-well-differentiated tumor cells were two significant conventional pathologic predictors of tumor recurrence, and that ErbB-1 and $T1$$T2$ and ErbB-3 were also significant predictors.
ErbB-3
ErbB-1
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/$T2$).
TR6
CD95L
1
Functional participation of the IL-2 receptor gamma chain in $T1$$T2$ chain in IL-7 receptor complexes.
IL-7 receptor
IL-2 receptor gamma
0
SREBP transcriptional activity is mediated through an interaction with the $T1$$T2$.
CREB
CREB-binding protein
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO-binding protein
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-$T1$$T2$-p60-hsp70 complex.
hsp70
hsp90
0
In addition we have been able to identify complexes of $T1$ and RBP1 in vivo that are dissociated in the presence of purified human papillomavirus $T2$ protein.
pRB
E7
0
The high affinity interleukin-6 ($T1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T2$ receptor and the affinity converter/signal transducing protein gp130.
IL-6
IL-6
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for IL-4 signaling, it could not replace the function of $T1$ in allowing enhanced $T2$ binding activity.
gammac
IL-2
0
We studied the human $T1$ ($T2$)/hIL-6R binding interface by a combination of molecular modelling and site-directed mutagenesis.
IL-6
hIL-6
0
Raf-1 is a serine/threonine protein kinase positioned downstream of Ras in the $T1$$T2$ is a serine/threonine protein kinase positioned downstream of Ras in the mitogen-activated protein kinase cascade.
mitogen-activated protein kinase
Raf-1
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/$T1$$T2$ and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cdk2
E2F4
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$ or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
TBP
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ($T1$, FADD/$T2$, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
TRADD
MORT
0
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain $T2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTAFII30
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine $T1$$T2$), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
glucocorticoid-induced TNFR-related (mGITR) protein
hGITR
0
The binding of $T1$ or IL-1beta to IL1R is an early step in $T2$ signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL-1alpha
IL-1
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
Abeta
0
Since $T1$ is typically found in a complex with hsp90 and $T2$, we have further characterized its interactions with these proteins.
p60
hsp70
1
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after $T1$$T2$ associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
insulin
GRB2
0
Inhibin also binds to $T1$ through its beta subunit, competes with the binding of activin to $T2$, but fails to form the ActRII.
ActRII
ActRII
0
CD5 associates with the $T1$ (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
T-cell receptor zeta chain
TcR zeta
0
Most familial early-onset Alzheimer's disease cases are caused by mutations in the presenilin 1 ($T1$$T2$ (PS1) gene.
PS1
presenilin 1
0
The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein $T1$$T2$ (FasL).
Fas
Fas ligand
0
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of $T1$ and a protein of approximately 60 kDa designated $T2$ (calnexin-associated protein of 60 kDa).
GT155
CAP-60
1
Interaction of the regulatory subunit ($T1$) of $T2$ with RII-anchoring proteins occurs through an amphipathic helix binding motif.
RII
cAMP-dependent protein kinase
0
We present here the crystal structure of the 1:1 complex of $T1$ bound to the extracellular domain of the $T2$.
hGH
hPRLR
1
The interactions between $T1$ and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of $T2$ to phosphotyrosines on both IRS-1 and Shc.
GRB2
GRB2
0
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of $T1$: Fas itself, and a novel 74 kDa protein we have named RIP, for $T2$.
Fas
receptor interacting protein
1
The genes for $T1$/eotaxin-2 ($T2$) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
SCYA24
0
SF3a interacts with U2 snRNP in the presence of $T1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for $T2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3b
SF3a
0
These findings strongly suggest that CD26 may be closely associated with the $T1$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of $T2$ with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD45
CD26
0
Eotaxin-3 competed the binding of (125)$T1$$T2$ competed the binding of (125)I-eotaxin to CCR3-expressing L1.2 cells with an IC(50) of 13 nM.
I-eotaxin
Eotaxin-3
0
hPRL does not bind to the hGH receptor, but $T1$ binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGHR
1
This suggests that one domain of IFN-gamma is sufficient to recruit IFN-gamma R alpha and $T1$$T2$ R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma
0
We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins BMP-4 and $T1$$T2$ and BMP-6 by the grafted HeLa cells.
BMP-6
BMP-4
0
These results suggest that $T1$ has two distinct receptor-binding sites that function to dimerize $T2$ receptors in a sequential fashion.
TPO
TPO
0
The interaction between interleukin-6 (IL-6) and $T1$ receptor ($T2$) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
IL-6R
1
Expression of $T1$$T2$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.
FGFR3
FGFR3 IIIc
0
Previously, a mammalian protein that directly associates with $T1$-rapamycin has been identified and its encoding gene has been cloned from both human (designated $T2$) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S.
FKBP12
FRAP
1
The splicing factor U2AF (U2 snRNP auxiliary factor) is a heterodimer with subunits of 65 and 35 kD ($T1$ and $T2$).
U2AF65
U2AF35
1
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and $T1$$T2$ immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
c-Cbl
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD ($T1$) to $T2$ homodimers and PDGF receptor-alpha/beta heterodimers.
PDGF-CC
PDGF receptor-alpha
1
In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of $T1$$T2$ (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.
CD3
CD26
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of $T1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF ($T2$) in vitro.
Rb
upstream binding factor
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$$T2$ and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p67-phox
p22-phox
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding $T1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
MyoD
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous $T1$-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with $T2$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
Rb
RbAP46
0
The 120-kDa serine/threonine phosphorylated protein that coprecipitated with $T1$ resembled the Syk-associated $T2$ by several criteria.
PLC gamma 1
pp120
0
Furthermore, a partial $T1$ complex containing Drosophila TATA binding protein ($T2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TFIID
dTBP
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R
delta C-43
0
These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of $T1$ with $T2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD26
CD45
1
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the $T1$$T2$-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated Rb-kinase activity.
CDK6
CDK6
0
Elf-1 binds exclusively to the underphosphorylated form of $T1$ and fails to bind to $T2$ mutants derived from patients with retinoblastoma.
Rb
Rb
0
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, $T1$$T2$, EGFR and Shc, which specifically binds the SH2 domain of GRB2 with high affinity.
EGFR
IRS-1
0
CD9 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of CD44 and $T1$$T2$ was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of CD44 and syndecan, but not of cadherins.
syndecan
CD9
0
A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the pp60src tyrosine kinase and $T1$$T2$) has been used here to form complexes between the pp60src tyrosine kinase and hsp90.
hsp90
hsp90
0
We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of $T1$ and $T2$ bound to DNA.
c-Fos
c-Jun
1
Syk and $T1$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and $T2$ reassociated in vitro, demonstrating their direct interaction.
Lyn
Lyn
0
Thus, pp120 may serve as a link between $T1$ and $T2$, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.
Syk
PLC gamma 1
1
Interleukin-2 (IL-2) signaling requires the dimerization of the $T1$$T2$) signaling requires the dimerization of the IL-2 receptor beta.
IL-2
IL-2
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and $T1$$T2$) protein.
Cockayne syndrome group B (CSB) protein
CSB
0
The gamma chain of the interleukin-2 ($T1$) receptor is shared with the functional $T2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
IL-2
IL-4 receptor
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibromodulin
procollagen I
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
creatine kinase
HLH462
0
In addition, hsp90 in the lysate complexes with wild-type $T1$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, $T2$, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.
pp60v-src
pp60c-src
0
Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing $T1$$T2$ induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.
E2F
MyoD
0
Taken together, these data suggest that $T1$ and p21ras cooperate to activate $T2$.
JAK2
Raf-1
0
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form $T1$$T2$ (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
ActRII
activin type II receptor kinase
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between $T1$$T2$; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.
hTAFII20
TBP
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since $T1$-Lyn associations were not detected in pre-B and myeloma cell lines and $T2$ from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Syk
0
Vav/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which $T1$$T2$/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.
c-Cbl
Vav
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the $T1$$T2$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
p76
IL-7R
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, $T1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ($T2$) as well as with the general transcription factor TFIIB.
hTAFII32
VP16
1
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
hGITR
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
TBP
PTF
0
The helical cytokine $T1$ and its specific binding subunit $T2$ form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses.
interleukin (IL) 6
IL-6R alpha
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cdk2
MyoD
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits $T1$, probably via $T2$.
Shc
Grb2
1
Interaction with $T1$ subunit of TFIIF is required for transcriptional activation by $T2$.
RAP74
serum response factor
1
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T2$ and Hip (p48).
p60
hsp70
0
Analysis of p53, p21(CIP1), $T1$$T2$), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p15
CIP1
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors $T1$ and $T2$ can be used in the differential diagnosis of serous effusion.
C3
C4
0
Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which $T1$$T2$ is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.
Ras
Raf-1
0
Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, $T1$$T2$ has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6M
IL-6D
0
TR6 (decoy receptor 3 ($T1$$T2$ (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.
DcR3
TR6
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
Jif-1
c-Jun
0
$T1$ ($T2$) is a major substrate of the insulin receptor and has been implicated in insulin signaling.
Insulin receptor substrate 1
IRS-1
0
The tyrosine kinases Flt4, Flt1, and Flk1 (or $T1$$T2$, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
KDR
Flt4
0
We show that $T1$ interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, $T2$ also interacts directly with TBP.
hTAFII28
hTAFII28
0
A 51-residue region from the conserved C-terminal region of TBP, previously shown to be the binding site for the viral activator protein E1A, interacts with $T1$ and $T2$ proteins.
c-Fos
c-Jun
0
A mutant form of human interferon-gamma ($T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma
interferon-gamma
0
The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein $T1$$T2$ activation through its interaction with the death domain protein TRADD.
TRADD
NF-kappa B
0
Thus, $T1$ is likely to play a role in sorting $T2$ to lysosomes.
SNX1
EGFR
0
TAP- and tapasin-dependent $T1$$T2$-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
HLA-E
tapasin
0
The MDM2 oncoprotein is a cellular inhibitor of the $T1$ tumor suppressor in that it can bind the transactivation domain of $T2$ and downregulate its ability to activate transcription.
p53
p53
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T1$ (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EBP
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
TR2
LIGHT
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ($T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
ER
Estrogen Receptor
0
In addition, $T1$ associates with three different CDKs: CDK2, CDK4, and $T2$.
p27
CDK6
1
Here, we show that $T1$ interacts strongly with RIP, another death domain protein that was shown previously to associate with $T2$ antigen.
TRADD
Fas
0
In addition, activation of PI 3-kinase was detected in anti-$T1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by $T2$ to activate PI 3-kinase.
IRS-1
gastrin
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila $T1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator $T2$ (VP16) as well as with the general transcription factor TFIIB.
TAFII40
viral protein 16
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with $T1$, $T2$, p53, and a ubiquitin-like protein UBL1.
RAD52
RAD51
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T2$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
Rb
0
IL-2, IL-4, $T1$ (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases $T2$ and Jak3.
IL-7
Jak1
0
In contrast, in normal nasal tissues, $T1$ labeling was only found in the vascular wall, and the expression was weaker--a finding demonstrating that $T2$ is upregulated in nasal polyps.
COX-2
COX-2
0
These findings indicate that the Fos/Jun and $T1$/$T2$ families of transcription factors are not as distinct as was previously thought.
ATF
CREB
0
Crosslinking of iodinated acidic FGF (aFGF) and $T1$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both $T2$ and bFGF.
basic FGF
aFGF
0
In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with Stat3 or block $T1$$T2$ or block Stat3 activation.
Stat3
Stat3
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-$T1$$T2$ is the central organizing component of an hsp90-p60-hsp70 complex.
hsp70
p60
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$ (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
bicoid
0
A protein kinase designated IRAK ($T1$$T2$ (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.
IL-1 receptor-associated kinase
IRAK
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/BR-II, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-$T2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin A
Cdk2
1
Expressed in a murine myeloma, $T1$ was identified as a ligand for CD40 by binding to a soluble $T2$ construct.
TRAP
CD40
1
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
cyclin E
0
In summary, $T1$ signaling pathway utilizes two GRB2-containing complexes; $T2$.
FGFR3
Shc
0
The $T1$ oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of $T2$ and downregulate its ability to activate transcription.
MDM2
p53
1
Co-immunoprecipitation experiments demonstrated an association between $T1$ and $T2$ in resting normal human T cells.
Elf-1
Rb
1
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the $T1$$T2$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and $T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
gp91-phox
cytochrome b558
0
Using immunoprecipitation techniques, we have determined the rates at which rhodanese and $T1$ ($T2$) are released from groEL in a form committed to refold to active enzyme.
glutamine synthetase
GS
0
Influence of $T1$ ($T2$) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
interleukin-6
IL-6
0
Although the individual amino acids in $T1$ involved in binding to nerve growth factor (NGF) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
TrkC
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits $T1$ and $T2$) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p22-phox
gp91-phox
1
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ($T1$$T2$ complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
PR
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the $T1$-Sos complex may contribute to the activation of the $T2$ pathway by gastrin.
Grb2
mitogen-activated protein kinase
0
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase $T1$ to form $T2$.beta:beta.
SKR2
ActRII
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$ / TR2 and $T2$ , thereby suppressing LIGHT-mediated HT29 cell death .
HVEM
LTbetaR
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained FGF-2 like affinity for $T1$$T2$-L4/7) retained FGF-2 like affinity for FGFR1 and for KGFR.
FGFR1
FGF2
0
The $T1$ (ICE) processes the inactive $T2$ precursor to the proinflammatory cytokine.
interleukin-1beta (IL-1beta) converting enzyme
IL-1beta
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether $T1$, alpha-1-antitrypsin (alpha1AT), and complement factors $T2$ and C4 can be used in the differential diagnosis of serous effusion.
TNFalpha
C3
0
$T1$, cyclin D, $T2$(INK4d) and p27(KIP1) decrease in both cell types.
pRB
p19
0
In vitro and in vivo experiments support the hypothesis that Grb2 mediates the association of c-Kit with $T1$$T2$ mediates the association of c-Kit with c-Cbl.
c-Cbl
Grb2
0
Coexpression of the alpha and betaL subunits of the human $T1$ (IFNalpha) receptor is required for the induction of an antiviral state by human $T2$.
interferon alpha
IFNalpha
0
Cross-linking of 125I-$T1$ and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for $T2$, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-beta
0
The same domain of RIN1 that binds $T1$ also interacts with 14-3-3 proteins, extending the similarity between $T2$ and other RAS effectors.
RAS
RIN1
0
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
Nerve growth factor
NGF
0
Human $T1$ was first characterized as a $T2$ binding protein based on the properties of its carboxyl-terminal domain.
RIN1
RAS
1
These findings indicate that the $T1$/Jun and ATF/$T2$ families of transcription factors are not as distinct as was previously thought.
Fos
CREB
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or $T1$ (type II) were characterized using $T2$ mutant proteins for analysis of interactions with receptor ectodomains.
ActR-II
BMP-2
0
Here it is shown that the $T1$ subunits correspond to three of the 17S $T2$-specific polypeptides.
SF3a
U2 snRNP
0
These findings indicate that the $T1$/Jun and $T2$/CREB families of transcription factors are not as distinct as was previously thought.
Fos
ATF
0
The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced $T1$ recruitment or conformational changes in $T2$-promoter complexes.
TFIID
TFIID
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the $T1$$T2$ SH2 domain, with the SCF-activated c-Kit.
SCF
Grb2
0
The high affinity interleukin-6 ($T1$$T2$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein gp130.
IL-6
interleukin-6
0
Residues in human $T1$ (hLIF) crucial for binding to both the human $T2$ (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.
leukemia inhibitory factor
LIF receptor
1
Interaction of the $T1$ subunit of PI 3-kinase with the insulin receptor (IR) and the $T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
p85
IGF-1 receptor
0
RIP also interacts weakly with the $T1$ tumor necrosis factor receptor ($T2$) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.
p55
TNFR1
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained FGF-2 like affinity for FGFR1 and for $T1$$T2$-L4/7) retained FGF-2 like affinity for FGFR1 and for KGFR.
KGFR
FGF2
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and $T1$$T2$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IGF-1R beta
IR
0
Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor $T1$$T2$: three subunits of the human transcription factor TFIID.
TFIID
hTAFII28
0
The $T1$ (IL-1beta) converting enzyme ($T2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
interleukin-1beta
ICE
1
The HFE-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of $T1$$T2$-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.
HFE
HFE
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$), whereas $T2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
KGFR
FGF-2
0
Therefore, 1) the presence of GRs and COX-2 in nasal polyps from nonallergic patients, as well as upregulation of $T1$$T2$ in nasal polyps from nonallergic patients, as well as upregulation of COX-2 expression, suggests that inflammation may play an important role in the pathophysiology of nasal polyps; and 2) glucocorticoid could be a potential treatment method for suppressing inflammatory processes.
COX-2
COX-2
0
These results, along with other recent findings, suggest a novel role for the interaction between $T1$ and $T2$.
GAP-43
CaM
1
Cross-family dimerization of transcription factors Fos/$T1$ and ATF/$T2$ alters DNA binding specificity.
Jun
CREB
0
$T1$ is a member of a large orphan receptor protein-tyrosine kinase family headed by EPH, and we suggest that ligands for other members of this family will be related to $T2$, and can be isolated in the same way.
ECK
B61
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/$T1$$T2$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
Ras
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as $T1$$T2$ homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Grb2
Src
0
The high affinity $T1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T2$ receptor and the affinity converter/signal transducing protein gp130.
interleukin-6
IL-6
0
Molecular cloning of a novel human CC chemokine ($T1$) that is a functional ligand of $T2$.
Eotaxin-3
CC chemokine receptor 3
1
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, CCR-5 and CXCR-4, respectively, as well as the primary receptor $T1$$T2$, respectively, as well as the primary receptor CD4 (refs 1-6).
CD4
CXCR-4
0
$T1$ protein interacts with CSB protein and with $T2$ protein, a subunit of the human RNA polymerase II transcription factor IIH.
CSA
p44
1
Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than $T1$$T2$ is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6D
IL-6M
0
In all cells tested, $T1$ activated Stat1 and $T2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
IL-10
Stat3
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, $T2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin A
cyclin E
0
Finally, activated FGFR3 was also found to result in phosphorylation of $T1$ but reduced phosphorylation of $T2$.
phospholipase C-gamma
c-Src
0
SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of $T1$$T2$ contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.
EGFR
SNX1
0
Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and $T1$$T2$ and E47.
E47
E12
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$ (NIK) [8].
NIK
NF-kappaB-inducing kinase
0
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and $T1$$T2$, hTAF31 and hTAF20/15.
hTAF20/15
hTAF80
0
Here we show that TRADD directly interacts with $T1$ and $T2$, signal transducers that activate NF-kappa B and induce apoptosis, respectively.
TRAF2
FADD
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
collagenase
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these $T1$$T2$ and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
HLA-E
HLA-E
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and $T2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
calreticulin
0
Some of these extracellular stimuli arrest cells in the G1 phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein $T1$ and its partner $T2$.
Rb
E2F-1
1
A physical interaction between $T1$ and $T2$ suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on CDK4.
CDC37
CDK4
1
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T1$, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-3
eotaxin
0
Use of deletion mutants of $T1$ suggested that $T2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Using radiolabeled $T1$ protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding $T2$ interacting proteins.
PU.1
PU.1
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
NGF-receptor
p75
0
The type II cAMP-dependent protein kinase is localized to specific subcellular environments through the binding of the regulatory subunit (RII) dimer to $T1$$T2$) dimer to RII-anchoring proteins.
RII
RII
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase ($T1$), aromatic L-amino acid decarboxylase (AADC), and $T2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
TH
GTP cyclohydrolase I
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
MCP-2
0
Surprisingly, the N-terminal third of $T1$ alone bound CaM more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with $T2$.
GAP-43
CaM
0
The extracellular domain of the human $T1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T2$ (BDNF).
neurotrophin TRKB receptor
brain-derived neurotrophic factor
1
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$ observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma R alpha
IFN-gamma
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/$T1$$T2$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cdk2
pRb2
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of $T1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional $T2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
$T1$ induces chemotaxis and adhesion by interacting with $T2$ and CCR8.
LEC
CCR1
1
Of these 400, $T1$ ($T2$), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.
interferon regulatory factor 4
IRF4
0
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and $T1$$T2$ and gammac are similar, and like gammac, IL-13Ralpha is located on chromosome X.
gammac
IL-13Ralpha
0
Based on the structure of the closely related $T1$-$T2$ complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.
lymphotoxin alpha
tumor necrosis factor receptor I
1
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ($T1$), the major cytoplasmic substrate of the $T2$ receptor.
IRS-1
insulin
0
$T1$ ($T2$), a novel growth factor that binds to PDGF alpha and beta receptor.
Platelet-derived growth factor C
PDGF-C
0
DCs express more $T1$ and $T2$ mRNA than T cells.
CCR5
CXCR4
0
The $T1$ Cdk-interacting protein $T2$ is a potent inhibitor of G1 cyclin-dependent kinases.
p21
Cip1
0
Interaction of IL-2R beta and gamma c chains with Jak1 and $T1$$T2$ and Jak3: implications for XSCID and XCID.
Jak3
Jak1
0
Associations of $T1$ with RAD52, UBL1, $T2$, and RAD51 proteins in a yeast two-hybrid system.
UBE2I
p53
1
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and $T1$$T2$ transactivation requires the interactions of both RPB5 and TFIIB.
TFIIB
HBx
0
An $T1$ complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cyclinA
0
We propose that $T1$ and c-Jun proteins function as transcriptional activators, in part by recruiting $T2$ to form complexes to initiate RNA synthesis.
c-Fos
TBP
1
The high affinity interleukin-6 (IL-6) signaling complex consists of $T1$ and two membrane-associated receptor components: a low affinity but specific $T2$ and the affinity converter/signal transducing protein gp130.
IL-6
IL-6 receptor
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$$T2$) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p47-phox
gp91-phox
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cyclinA
0
Both the GT155-$T1$ and the $T2$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
calnexin
GT155
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that $T1$$T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
Sos1
0
Both the GT155-$T1$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on $T2$, a characteristic of many calnexin interactions.
calnexin
GT155
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, $T1$ and $T2$.
hTAFII20
hTAFII18
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-$T1$ associations were not detected in pre-B and myeloma cell lines and $T2$ from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
$T1$ does not bind to the $T2$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGH
0
TNFalpha, $T1$, and complement factors C3 and $T2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
alpha1AT
C4
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTAFII30
0
Antibodies to $T1$ did not affect the proportion of keratinocytes that adhered to laminin 1, $T2$ and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.
CD9
type IV collagen
0
Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two $T1$ and two $T2$ molecules.
IL-6R alpha
gp130
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$$T2$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.
bHLH
myogenic basic helix-loop-helix
0
Cytokines IL-1alpha, $T1$, $T2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
IL-6
0
The amount of CDK4 and CDK6 associated with $T1$ does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with $T2$ is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
p27
p27
0
Sos; these two complexes may alternatively link FGFG3 to $T1$$T2$ to mitogen-activated protein kinase.
mitogen-activated protein kinase
FGFG3
0
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the $T1$, calmodulin ($T2$).
calcium effector protein
CaM
0
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for $T1$$T2$ dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind FGFR1.
KGFR
FGF-2
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the $T1$ (sIL-6R)2 complex to couple with the soluble portion of $T2$.
IL-6D
gp130
0
Here we report that (1) there is an accumulation of $T1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor $T2$ (upstream binding factor) in vitro.
Rb
UBF
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, $T1$, p50, and $T2$.
p54
p23
0
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-$T1$$T2$-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
Abeta
LexA
0
$T1$ was associated with alpha 3 beta 1 but not alpha 5 beta 1; small amounts of $T2$ also co-immunoprecipitated with antibodies to alpha 2 beta 1 and alpha 6 beta 4.
CD9
CD9
0
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an $T1$$T2$ bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
Abeta
Abeta
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T2$/CD95L).
TR6
FasL
1
Thus, during p53-mediated suppression of cell proliferation, p21 and $T1$$T2$-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
PCNA
p53
0
Functional participation of the $T1$ receptor gamma chain in $T2$ receptor complexes.
IL-2
IL-7
0
An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor ($T1$) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing $T2$.
TNF-R2
TNF-R2
0
Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the $T1$-$T2$ heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.
Fos
Jun
1
CREB is activated through phosphorylation by protein kinase A ($T1$), but precisely how phosphorylation stimulates $T2$ function is unknown.
PKA
CREB
0
We have exploited the availability of the cloned $T1$, XPD, p62, $T2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPB
p44
0
$T1$/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor $T2$, in which c-Cbl is hyperphosphorylated on tyrosine residues.
Vav
CTLA-4
0
Two lines of evidence support the notion that RbAP46 and $T1$ have homologous Rb-binding properties: first, several mutated $T2$ proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
simian virus 40 T antigen
Rb
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
p76
0
Two human genes were identified that could interact with $T1$ to perform START in yeast containing a $T2$ mutation.
cyclin E
cdc28
0
The amount of CDK4 and $T1$ associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of $T2$ associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK6
CDK2
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
MyoD
0
CD5 interaction with $T1$$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
p56lck
ith
0
We found that the human $T1$ ($T2$) physically interacted with p53 via its DNA binding domain.
TR subtype beta 1
h-TR beta 1
0
A newly identified member of tumor necrosis factor receptor superfamily ( $T1$ ) suppresses $T2$-mediated apoptosis .
TR6
LIGHT
0
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
ith
0
$T1$ and 80K-H.$T2$.
Sos
pp66
0
$T1$-$T2$ and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
TRADD
TRAF2
1
$T1$ could compete efficiently for $T2$ binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.
MCP-3
gp120
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with $T1$$T2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of $T1$$T2$ was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of c-Jun homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).
QM
PS1
0
$T1$ binds the complex as an extended structure interacting with both cyclin A and $T2$.
p27Kip1
Cdk2
1
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor
interferon-gamma
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with $T1$$T2$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
Using a yeast two-hybrid strategy to identify other proteins that interact with and potentially regulate $T1$, we isolated a clone encoding the carboxyl-terminal half of the $T2$ of heterotrimeric G-proteins.
Raf-1
G beta 2 subunit
1
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine $T1$$T2$ (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
glucocorticoid-induced TNFR-related (mGITR) protein
GITR ligand
0
Here , we demonstrate that $T1$ specifically binds two cellular ligands , $T2$ ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / CD95L ) .
TR6
LIGHT
1
Thymocyte activation induces the association of $T1$ and $T2$ with CD5.
phosphatidylinositol 3-kinase
pp120
0
We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and $T1$/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of $T2$.
pp42
c-jun
1
Here we show that $T1$/Jun-interacting factor (Jif)-1, a negative regulator of c-Jun, is a candidate to mediate the function of $T2$ in the cell.
QM
PS1
0
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and $T1$$T2$ is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and TFIIB.
TFIIB
HBx
0
Cross-linking of 125I-$T1$ and 125I-$T2$ to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-beta
0
The three-dimensional structure of the complex between human $T1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein $T2$ (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
H-Ras
p120GAP
1
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( $T1$ ) and Fas ligand ( FasL / $T2$ ) .
herpes virus entry mediator ( HVEM ) - L
CD95L
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with $T1$; however, additional interactions between hTAFII20 and $T2$ or hTAFII30 were detected.
TBP
hTAFII28
0
IL-7-driven proliferation is mediated via high affinity $T1$, and accordingly, Scatchard analysis revealed that, like the $T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
p90
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$$T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF
NGF-receptor
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with PTF, consistent with the previous report of a $T2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TATA-binding protein
PTF
0
$T1$ specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with $T2$.
USF
c-Jun
0
Furthermore, a partial TFIID complex containing Drosophila $T1$ (dTBP), human $T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TATA binding protein
TAFII250
0
We have cloned cDNAs encoding three novel TAFIIs [$T1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, $T2$ and hTAFII18.
TATA-binding protein
hTAFII20
0
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 $T1$, and not with expression of the p90 $T2$.
IL-7R
IL-7R
0
Here we report the crystal structure of human dimeric $T1$ in complex with two high affinity BMP receptor IA extracellular domains($T2$).
BMP-2
BRIAec
1
Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate $T1$$T2$ activity toward MEK-1 in mammalian cells.
Raf-1
Raf-1 kinase
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$, hyaluronidase, fibronectin, cd44, $T2$, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
fibromodulin
0
Antibodies to $T1$ did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and $T2$, but did inhibit motility of keratinocytes on tissue culture plastic.
CD9
fibronectin
0
We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated CC chemokine receptor 3 ($T1$$T2$ (CC CKR3).
CC CKR3
CC chemokine receptor 3
0
We find that $T1$ is the human homologue of Drosophila $T2$.
hTAFII32
TAFII40
0
Interestingly, both $T1$ and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same $T2$ molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.
GRB2
IRS-1
1
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both $T1$ beta and $T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IGF-1R
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral $T1$ and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral $T2$, which is necessary for receptor activation.
IL-6
IL-6
0
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, $T1$, FosB, or with $T2$.
Fra2
c-Jun
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
sICAM-1
0
A region of the beta subunit of the $T1$$T2$ different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state.
interferon alpha
interferon alpha receptor
0
CCR5 was first characterized as a receptor for MIP-1alpha, MIP-1beta, and $T1$$T2$, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
RANTES
MIP-1beta
0
Here we show that the general transcription factor $T1$ is also a target for a transcriptional activator, namely serum response factor (SRF), which binds to the $T2$ promoter.
TFIIF
c-fos
0
The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T1$ receptor and the affinity converter/signal transducing protein $T2$.
IL-6
gp130
0
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like gammac, $T1$$T2$, IL-13Ralpha is located on chromosome X.
IL-13Ralpha
gammac
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T2$ complexes containing hsp70 and Hip (p48).
PR
PR
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
CD3
TcR zeta
0
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and $T1$ (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases $T2$ and Jak3.
IL-9
Jak1
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of $T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/$T2$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T1$$T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cyclinA
MyoD
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPO-binding protein
0
Characterization of $T1$ binding to human $T2$ on T cells and its biologic role in immune response.
adenosine deaminase
CD26
1
In this study, we simulated interactions of all amphipathic helices of $T1$ and A-I with $T2$ and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.
apolipoproteins E
Abeta
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain ($T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma R alpha
interferon-gamma
0
A double point mutation in the activation domain of p53 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both $T1$ and $T2$.
TAFII40
TAFII60
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, $T1$, $T2$/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
RIP
FLICE
0
In a previous work, we predicted and demonstrated that the 29-42-residue fragment of $T1$ ($T2$) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.
beta-amyloid peptide
Abeta peptide
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding $T2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO
1
We report here that Grb2 also interacts with tyrosine-phosphorylated $T1$ in response to $T2$.
IRS-1
gastrin
0
These findings strongly suggest that $T1$ may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with $T2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD26
CD45
0
The $T1$ enzymes $T2$ and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.
MAP kinase
pp54
0
In patients with a complete response to $T1$, the levels of IFN-gamma were higher at 24 weeks following $T2$ treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-alpha
IFN-alpha
0
These data demonstrate that Stat3 but not Stat1 or $T1$ is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
IL-10 receptor
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as $T1$, $T2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Grb2
Crk
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or $T1$$T2$ (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
ActR-II
BMPR-IA
0
$T1$ suppressed $T2$-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.
PS1
c-jun
0
Shedding of the extracellular domain of $T1$ was induced by 4 beta-phorbol 12-myristate 13-acetate but not by $T2$ or TNF-beta.
TNF-R2
TNF-alpha
0
COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both $T1$$T2$ cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.
IL-4
IL-13R
0
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members (ErbB-1, neu/ErbB-2, ErbB-3, and $T1$$T2$, neu/ErbB-2, ErbB-3, and ErbB-4) and tumor recurrence.
ErbB-4
ErbB-1
0
CIP1 encodes a novel 21 kd protein that is found in cyclin A, $T1$, $T2$, and Cdk2 immunoprecipitates.
cyclin D1
cyclin E
0
Human spleen tyrosine kinase $T1$ associates with the Src-family kinase p53/$T2$ and a 120-kDa phosphoprotein.
p72Syk
56Lyn
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$ receptor ( $T2$ ) and HVEM / TR2 receptors .
lymphotoxin beta
LTbetaR
1
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
HVEM
LTbetaR
0
In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific $T1$$T2$-specific hTAFII.
hTAFII
TFIID beta
0
This protein, designated VEGF-related protein (VRP), specifically binds to the extracellular domain of $T1$, stimulates the tyrosine phosphorylation of $T2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
Flt4
Flt4
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from $T1$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by $T2$ to activate PI 3-kinase.
gastrin
gastrin
0
The $T1$ gene mapped to chromosome 1q23, near the gene for the TNF homolog $T2$/CD95 ligand [5].
hGITRL
Fas
0
The $T1$ gene product ($T2$) is a nuclear phosphoprotein that regulates cell cycle progression.
retinoblastoma
Rb
0
One was CDC2-HS, and the second was the human homolog of Xenopus $T1$$T2$-HS, and the second was the human homolog of Xenopus CDK2.
CDK2
CDC2
0
Despite binding to only one $T1$, $T2$ is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.
IFN-gamma R alpha
IFN-gamma SC1
1
VRP fails to bind appreciably to the extracellular domain of Flt1 or $T1$$T2$ fails to bind appreciably to the extracellular domain of Flt1 or Flk1.
Flk1
VRP
0
Immunoelectronmicroscopic analysis showed that $T1$/$T2$ and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.
QM
Jif-1
0
Thus, TR6 may play a regulatory role for suppressing in $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.
FasL
TR6
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an $T1$-$T2$-hsp70 complex.
hsp90
p60
1
RESULTS: TH, $T1$ and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-$T2$, AAV-AADC and AAV-GCH.
AADC
TH
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; $T1$ induced Jak3-IL-2R beta and increased $T2$-gamma c associations.
IL-2
Jak3
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T1$$T2$ ( FasL / CD95L ) .
Fas
Fas ligand
0
A truncated version of the integral membrane glycoprotein $T1$ ($T2$) was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.
Glut 1
GT155
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$$T2$ and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.
p53
p16
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T1$-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
trk
p75
0
Tumour-suppressor genes, such as the human $T1$ ($T2$), are widely recognized as being vital in the control of cell growth and tumour formation.
retinoblastoma susceptibility gene
Rb
0
Endothelial cell mitogenesis was abolished in mutants lacking KDR affinity; however, $T1$$T2$ affinity; however, FLT-1 deficient mutants induced normal proliferation.
FLT-1
KDR
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$, that interacts with RAD52, $T2$, p53, and a ubiquitin-like protein UBL1.
UBE2I
RAD51
1
Here we report that (1) there is an accumulation of $T1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional $T2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-$T1$$T2$, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.
CD26
CD45
0
In agreement, mAb to the previously cloned $T1$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the $T2$ IL-7R.
IL-7R
p76
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D ($T1$$T2$ resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.
sIL-6R
IL-6D
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cyclinA
Estrogen Receptor
0
Our results demonstrated that the first 82 amino acids (AAs) (AAs 265-346) of the cytoplasmic domain of the betaL chain are sufficient to activate the $T1$-Stat pathway and trigger an antiviral state after $T2$ binding to the receptor.
Jak
IFNalpha2
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T2$)-L) and Fas ligand (FasL/CD95L).
TR6
HVEM
0
$T1$ binds multiple CC-chemokines: $T2$ acts as a natural antagonist.
CCR5
MCP-3
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 $T1$$T2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
IL-7R
0
Additionally, in the absence of $T1$, an interaction between a two-domain $T2$ fragment and CCR-5 was observed.
gp120
CD4
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with $T1$ and/or ErbB4, suggesting that signalling by $T2$ is mediated by ErbB3 and/or ErbB4 receptors.
ErbB3
neuregulin-2
0
An $T1$ complex containing mainly E2F4 and pRb2/p130 ($T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F
0
$T1$ was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of $T2$ and syndecan, but not of cadherins.
CD9
CD44
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface $T1$$T2$ on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.
CD26
ADA
0
Together, these results suggest that TAFII40 and $T1$$T2$ and TAFII60 are important targets for transmitting activation signals between p53 and the initiation complex.
TAFII60
TAFII40
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$ and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F4
0
Cytokines measurements during $T1$ treatment showed a trend to decreasing levels of $T2$ at 4, 12, and 24 weeks.
IFN-alpha
IL-4
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / $T1$$T2$ ) and HVEM / TR2 receptors .
TR2
LTbetaR
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the $T1$ IL-7R but not T-cell clones that express predominantly the p76 $T2$.
p90
IL-7R
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released $T1$ binds to cell surface $T2$, and this complex is capable of reducing the local concentration of adenosine.
ADA
CD26
1
The $T1$ ($T2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
interleukin-1beta (IL-1beta) converting enzyme
ICE
0
rIL-10R expressed in an $T1$-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to $T2$.
IL-3
hIL-10
0
pRB, $T1$, $T2$(INK4d) and p27(KIP1) decrease in both cell types.
cyclin D
p19
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ ($T2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
heat shock protein 90
hsp90
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EBP
0
Structure of the $T1$ tumor suppressor bound to the ankyrin and SH3 domains of $T2$.
p53
53BP2
1
We have previously identified a nuclear protein of M(r)265K, CBP, that binds specifically to the $T1$-phosphorylated form of $T2$.
PKA
CREB
1
Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with $T1$$T2$ plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/c-Cbl complex when non-tyrosine or tyrosine kinase receptors are activated.
Grb2
c-Cbl
0
PDGF-CC exhibits greater mitogenic potency than $T1$ and comparable or greater mitogenic activity than $T2$ and PDGF-BB on several mesenchymal cell types.
PDGF-AA
PDGF-AB
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human $T1$, $T2$, and Cdk3, but not with Cdk4.
Cdc2
Cdk2
0
Furthermore, this mutational analysis implicates KDR, but not $T1$$T2$, but not FLT-1, in VEGF induction of endothelial cell proliferation.
FLT-1
KDR
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T1$, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
It contains an Rb-binding motif that shares an antigenic epitope with the C terminus of $T1$$T2$-binding motif that shares an antigenic epitope with the C terminus of E1A.
E1A
Rb
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and $T1$$T2$ (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMPR-II
BMPR-IA
0
Crystal structure of the hereditary haemochromatosis protein HFE complexed with $T1$$T2$ receptor.
transferrin receptor
transferrin
0
Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, $T1$ and $T2$ in cell lines expressing all of these ErbB-family receptors.
ErbB3
ErbB4
0
Thus, hGITRL and $T1$$T2$ and hGITR may modulate T lymphocyte survival in peripheral tissues.
hGITR
hGITRL
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased $T1$$T2$-IL-2R beta and increased Jak3-gamma c associations.
Jak3
Jak3
0
$T1$ showed genetic interactions with the CDC28 gene, suggesting that it functioned at START by interacting with the $T2$ protein.
Cyclin E
CDC28
1
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
sICAM-1
0
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins $T1$$T2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
Ht 21
P150
0
$T1$ and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either $T2$ or B2 but not A or D1.
cdc25A
cyclin B1
0
CIP1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and $T1$$T2$, and Cdk2 immunoprecipitates.
Cdk2
cyclin E
0
The $T1$-susceptibility gene product binds directly to the human TATA-binding protein-associated factor $T2$.
retinoblastoma
TAFII250
1
Interleukin-2 (IL-2) signaling requires the dimerization of the $T1$$T2$.
IL-2
IL-2 receptor beta
0
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of $T1$$T2$ is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.
c-Cbl
c-Cbl
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits $T1$$T2$/c-Cbl complex recruits Shc, probably via Grb2.
Shc
Grb2
0
Thus, the C-terminal domain in $T1$ appears to exert a negative control on binding of $T2$ thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway.
IGF-1R
p85
1
We investigated whether phosphatidylinositol (PI) 3-kinase, which binds to tyrosine-phosphorylated $T1$, interacts with $T2$ following T cell activation.
ITAM
CD5
0
Our data suggest that TR6 inhibits the interactions of $T1$ with $T2$/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
HVEM
1
CD5 associates with the T-cell receptor zeta chain ($T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
TcR zeta
T-cell receptor zeta chain (TcR zeta)/CD3
0
Physical interaction of mammalian $T1$ with $T2$ .CDC37 was originally identified as a Start gene in budding yeast and has been shown to be required for association of CDC28 with cyclins.
CDC37
CDK4
1
Expressions of $T1$, $T2$ and GCH were detected by Western blot analysis.
TH
AADC
0
A comparative study of $T1$ and $T2$ expression in de novo and ex adenoma carcinoma of the colorectum.
E-cadherin
stromelysin-3
0
$T1$ cleaved the Ln-5 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on $T2$ that triggers cell motility.
MMP2
Ln-5
0
GAP-43 (neuromodulin, B-50, $T1$), a $T2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
F1
protein kinase C
1
The interaction between interleukin-6 (IL-6) and $T1$$T2$) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
IL-6
0
The interleukin-1beta (IL-1beta) converting enzyme ($T1$) processes the inactive $T2$ precursor to the proinflammatory cytokine.
ICE
IL-1beta
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain ($T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma
interferon-gamma
0
Activation of lacZ upon interaction of p85 with IR beta(delta C-43) was 4-fold less as compared to $T1$$T2$(delta C-43) was 4-fold less as compared to IR beta.
IR beta
IR beta
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for $T1$$T2$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
MIP-1beta
gp120
0
Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like $T1$, was readily phosphorylated by $T2$ in vitro.
cyclin A
pp60c-src
1
Activin type I receptors, SKR1 and $T1$$T2$ and SKR2, were first cloned from well differentiated human hepatoma cells (HepG2).
SKR2
SKR1
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30
0
A 51-residue region from the conserved C-terminal region of TBP, previously shown to be the binding site for the viral activator protein $T1$, interacts with $T2$ and c-Jun proteins.
E1A
c-Fos
0
MyoD prevents cyclinA/cdk2 containing $T1$$T2$ prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
E2F
MyoD
0
hTAFII20 is the homologue of $T1$, an alternatively spliced form of d$T2$ (p32).
p22
TAFII30 alpha
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as $T1$, HCC-4, NCC-4, and $T2$.
LMC
CCL16
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$ (IR) and the $T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin receptor
IGF-1 receptor
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$ heterodimers, consistent with the reported function of QM/Jif-1.
Jif-1
c-Fos
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T1$) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sCAM
sE-selectin
0
RIP also interacts weakly with the p55 tumor necrosis factor receptor ($T1$) intracellular domain, but not with a mutant version of $T2$ corresponding to the murine lprcg mutation.
TNFR1
Fas
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the $T1$$T2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
p76
IL-7R
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( $T1$ ) and $T2$ ligand ( FasL / CD95L ) .
herpes virus entry mediator ( HVEM ) - L
Fas
0
The type II cAMP-dependent protein kinase is localized to specific subcellular environments through the binding of the regulatory subunit (RII) dimer to $T1$$T2$ is localized to specific subcellular environments through the binding of the regulatory subunit (RII) dimer to RII-anchoring proteins.
RII
type II cAMP-dependent protein kinase
0
Determination of TNFalpha, complement factors $T1$ and $T2$, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
C3
C4
0
The results showed that $T1$ and IL-6 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ($T2$) expression in TF-1 cells.
IL-11
junB
1
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NIK
TNFR-associated factor 2
0
Antibodies to $T1$ detect similar levels of $T2$ in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that p23 is a conserved protein of broad tissue distribution.
p23
p23
0
hTAFII20 is the homologue of $T1$, an alternatively spliced form of dTAFII30 alpha ($T2$).
p22
p32
0
The Fos/$T1$ and ATF/$T2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
Jun
CREB
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the $T1$$T2$ binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
TAP
HLA-E
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of $T1$ to Raf/330; however, the Raf-1-binding proteins, $T2$ and 14-3-3, had no effect.
G beta gamma
Ras
0
The interactions between $T1$ and CDC2, or $T2$, may be important at the G1 to S transition in human cells.
cyclin E
CDK2
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, $T2$, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor
FGFR2
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of $T1$ resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of $T2$.
IL-6D
gp130
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for $T1$$T2$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
MIP-1beta
MIP-1beta
0
METHODS: The genes for dopamine synthetic enzymes, $T1$ (TH), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I ($T2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
tyrosine hydroxylase
GCH
0
We studied the human $T1$ (hIL-6)/$T2$ binding interface by a combination of molecular modelling and site-directed mutagenesis.
IL-6
hIL-6R
1
Here, we demonstrate that E2F-1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the NF-kappaB subunit, $T1$$T2$ enhancer region and to interact with the NF-kappaB subunit, p50.
p50
NF-kappaB
0
A $T1$ mutant lacking its N-terminal RING finger domain is a dominant-negative inhibitor of TNF-mediated $T2$ activation, but does not affect TNF-induced apoptosis.
TRAF2
NF-kappa B
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ receptor (sIL-6R) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
gp130
0
$T1$ and Jak3 associated with IL-2R beta and gamma c, respectively; $T2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
Jak1
IL-2
0
A protein, $T1$ (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor ($T2$) containing the lysosomal targeting code.
sorting nexin-1
EGFR
1
We have exploited the availability of the cloned $T1$, $T2$, p62, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPB
XPD
0
Following linkage studies which were most consistent with a beta spectrin gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of $T1$$T2$ gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of beta spectrin repeat 17.
beta spectrin
beta spectrin
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/$T1$ ($T2$) and have identified a novel CC chemokine termed eotaxin-3.
eotaxin-2
SCYA24
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the $T1$ and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and $T2$, which interact with guanine nucleotide exchange factors specific for the Ras family.
TCR
Crk-L
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T1$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
Sp1
Tat
0
$T1$ was also shown to cleave the precursor of $T2$ (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
ICE
interferon-gamma inducing factor
1
$T1$ binds to the $T2$ transactivation domain and phosphorylates it on Ser-63 and Ser-73.
JNK1
c-Jun
1
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-$T1$$T2$-hsp70 complex.
hsp70
p60
0
Additionally, in the absence of $T1$, an interaction between a two-domain CD4 fragment and $T2$ was observed.
gp120
CCR-5
0
The similarities in biofunctions and differences in ligand binding proteins between $T1$ and $T2$ prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.
IL-11
IL-6
0
Moreover we found that, upon $T1$ stimulation, the Grb2/$T2$ complex recruits Shc, probably via Grb2.
SCF
c-Cbl
0
Functional participation of the IL-2 receptor gamma chain in $T1$$T2$ chain in IL-7 receptor complexes.
IL-7
IL-2 receptor gamma
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$ R alpha complex.
IFN-gamma R alpha
IFN-gamma
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$$T2$.
HLA-E
HLA-E
0
The human pituitary hormones, $T1$ (hGH) and prolactin ($T2$), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
hPRL
0
Human spleen tyrosine kinase $T1$ associates with the Src-family kinase p53/56Lyn and a $T2$.
p72Syk
120-kDa phosphoprotein
1
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T1$/$T2$ containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cyclinA
cdk2
1
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ mimetic peptide.
EPO mimetic peptide
EPO
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when $T1$$T2$ complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.
MyoD
E2F
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T1$$T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO-binding protein
0
This protein, designated $T1$-related protein (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of $T2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF
Flt4
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated $T1$ proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to $T2$.
Rb
Rb
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
interleukin (IL) 1
transforming growth factors (TGF) beta1
0
Interactions between $T1$ and the $T2$ receptor.
brain-derived neurotrophic factor
TRKB
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T1$/$T2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cyclinA
cdk2
1
Characterization of the retinoblastoma binding proteins RBP1 and $T1$$T2$ and RBP2.
RBP2
RBP1
0
Immunoprecipitation studies confirm that the four $T1$ subunits originally found to copurify during conventional chromatography indeed form a tightly associated complex; they further show that the $T2$ so defined, including the gamma and delta subunits specifically, is essential for transcription of both class II and class III snRNA genes.
PTF
PTF
0
We recently reported that $T1$ interaction with the $T2$ (Raf-CRD, residues 139-184) may be required for Raf-1 activation.
Ras
Raf-1 cysteine-rich domain
1
In contrast to hTAFII28, hTAFII18 is a $T1$$T2$, hTAFII18 is a TFIID beta-specific hTAFII.
TFIID
hTAFII28
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the $T1$$T2$.
TAP
HLA-E
0
We observed that the protein $T1$ interacted with protein $T2$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
HOX11
serine-threonine phosphatase 2A
0
Unlike human $T1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral $T2$-gp130 binding interfaces.
IL-6
IL-6
0
Expressed in a murine myeloma, $T1$ was identified as a ligand for $T2$ by binding to a soluble CD40 construct.
TRAP
CD40
1
Peptide growth factors, as well as the immediate early gene products $T1$, v-Fos, and $T2$, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.
c-Jun
c-Myc
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$$T2$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor
FGF-7
0
TRADD is a $T1$$T2$ is a TNFR1-associated signal transducer that is involved in activating both pathways.
TNFR1
TRADD
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 (hsp90), $T2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
PR
p23
0
We have identified a new TNF-related ligand, designated human GITR ligand ($T1$$T2$ (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
hGITRL
GITR ligand
0
CD26, a T cell activation Ag, also known as $T1$$T2$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
CD26
0
hPRL does not bind to the hGH receptor, but $T1$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGH
hGH
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/$T1$$T2$/HLH462.
HLH462
Id3
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of $T1$$T2$ function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-1
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T1$ and Hip ($T2$).
hsp70
p48
0
Furthermore, activated $T1$ was not able to induce dissociation of $T2$.
FGFR3
GRB2
0
Platelet-derived growth factor C ($T1$), a novel growth factor that binds to $T2$ and beta receptor.
PDGF-C
PDGF alpha
1
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding $T1$$T2$ (EPO) receptor are important for binding EPO and EPO mimetic peptide.
EPO
erythropoietin
0
MyoD prevents cyclinA/cdk2 containing $T1$$T2$/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
E2F
cyclinA
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75
p140trk (trkA) tyrosine kinase receptor
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/$T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
Interestingly, both GRB2 and $T1$$T2$ and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.
phosphatidylinositol-3 (PI-3) kinase
GRB2
0
Here , we demonstrate that $T1$ specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T2$ ( FasL / CD95L ) .
TR6
Fas ligand
1
We also found another $T1$, p0071, interacted with $T2$.
armadillo-protein
PS1
0
TFIID is a multisubunit protein complex comprised of the $T1$ ($T2$) and multiple TBP-associated factors (TAFs).
TATA-binding protein
TBP
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with $T1$, RAD51, p53, and a ubiquitin-like protein $T2$.
RAD52
UBL1
0
Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which $T1$$T2$ signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.
Ras
Ras
0
This protein, designated VEGF-related protein ($T1$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of $T2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VRP
Flt4
0
In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human $T1$ and the $T2$.
IRS-1
insulin receptor
1
In neurons cAMP-dependent protein kinase II beta ($T1$) is sequestered in the dendritic cytoskeleton because the regulatory subunit ($T2$) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).
PKAII beta
RII beta
0
The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 ($T1$$T2$) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.
ST-3
E-cadherin
0
Characterization of $T1$ (Apo-1, CD95)-$T2$ interaction.
Fas
Fas ligand
1
Here we present biochemical evidence for the structural relevance of histone homologies in the human $T1$ subunits $T2$, hTAF31 and hTAF20/15.
TFIID
hTAF80
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$, hyaluronidase, fibronectin, cd44, fibromodulin, and $T2$) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
decorin
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin (EPO) receptor
EPO
0
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the $T1$ protein .Originally identified as a 'mitotic cyclin', $T2$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
Rb
cyclin A
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of $T1$$T2$ heterodimers, consistent with the reported function of QM/Jif-1.
QM
c-Fos
0
The six most frequently observed $T1$ mutations disrupt $T2$ binding in vitro.
p53
53BP2
1
We have identified a new TNF-related ligand, designated human $T1$ (hGITRL), and its human receptor ($T2$), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
GITR ligand
hGITR
1
Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with $T1$ and significantly decreased the rate of $T2$ fibril formation.
A beta
A beta
0
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T1$, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
TrkC
TrkB
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta($T1$$T2$ and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
p85
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to $T1$, indicating that the observed $T2$-Abeta interaction was specific.
Abeta
Abeta
0
We observed that the protein $T1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as $T2$ (PP1C) in mammalian cells.
HOX11
protein phosphatase 1
1
There was extensive co-localisation of $T1$ and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, $T2$ was not found in focal adhesions.
CD9
CD9
0
$T1$ also interacted with $T2$ and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-2
Bcl-X-L
1
$T1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate Raf-1 kinase activity toward $T2$ in mammalian cells.
Interferon-gamma
MEK-1
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
1
Concentrations of glial fibrillary acidic protein (GFAp) and light subunit neurofilament protein ($T1$$T2$) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
NFL
GFAp
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor
IFN-gamma
0
$T1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with $T2$ (ADA) on the surface of T cells and T cell lines.
CD26
adenosine deaminase
1
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-1
0
Thus, Phe93 and Phe205 are important binding determinants for both EPO and $T1$, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the $T2$ for productive ligand binding.
EMP1
EPOR
1
We show that hTAFII28 interacts with $T1$ both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with $T2$.
hTAFII18
TBP
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, tonin, D and $T1$$T2$, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
G cathepsin
isorenin
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of $T1$$T2$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
IRS-1
PI 3-kinase
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10 (IL-10) receptor
IL-10
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
CTF
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal $T1$ binding inhibition was 80% for MCP-2, but only 30% for $T2$.
gp120
MIP-1beta
1
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$ and members of the $T2$ family.
p53
bcl-2
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta
LIGHT
0
We have exploited the availability of the cloned XPB, XPD, p62, $T1$, and p34 genes (all of which encode polypeptide subunits of $T2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p44
TFIIH
0
We report chemotaxis and competitive binding studies that show $T1$ binds to and activates CCR1 and $T2$ transfected HEK-293 cells.
LEC
CCR8
1
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ interaction with p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
CD5
0
CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor $T1$ (also known as the $T2$/RANTES receptor).
CC CKR1
MIP-1 alpha
0
A neutralizing polyclonal antibody to LEC was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of $T1$$T2$ required to induce chemotaxis was a property of LEC and not as a result of an irrelevant protein contamination.
LEC
LEC
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T1$$T2$.
IL-2
IL-2 receptor
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator ($T2$)-L) and Fas ligand (FasL/CD95L).
LIGHT
HVEM
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$, $T2$, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
hyaluronidase
0
For the calibration, we used two sets of proteins, the $T1$-Max-$T2$ helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.
Myc
Mxi1
0
The crystal structure of the $T1$ core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of $T2$ in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of p53.
p53
p53
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/$T1$$T2$/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Fos
c-Jun
0
The interactions of $T1$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early $T2$ complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
PR
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
cyclinA
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the $T2$.
beta 1-syntrophin
Torpedo 87K protein
1
Here, we show that TRADD interacts strongly with $T1$, another death domain protein that was shown previously to associate with $T2$ antigen.
RIP
Fas
1
Deglycosylation studies showed that the p90 and p76 $T1$$T2$ and p76 IL-7R are not simply differently glycosylated isoforms of a single receptor.
IL-7R
p90
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPOR
0
A 51-residue region from the conserved C-terminal region of $T1$, previously shown to be the binding site for the viral activator protein E1A, interacts with c-Fos and $T2$ proteins.
TBP
c-Jun
1
This Syk-$T1$ interaction may be dependent on the stage of B-cell differentiation, since $T2$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T1$$T2$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
alpha-1-antitrypsin
TNFalpha
0
However, $T1$ was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not $T2$.
MIP-1 beta
CC CKR3
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S $T1$, which suggests a function for $T2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3a
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF
trk
0
The IL-1 family currently consists of two agonists, $T1$ and IL-1beta, and one antagonist, $T2$.
IL-1alpha
IL-1ra
0
Interaction of the p85 subunit of $T1$ with the insulin receptor (IR) and the IGF-1 receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
IGF-1R
1
$T1$ is a transcriptional modulator that communicates with transcription factor IIB and the $T2$.
Hepatitis B virus X protein
RNA polymerase II subunit 5
0
$T1$ (TTR), a second major CSF protein, formed SDS-stable complexes with $T2$ and significantly decreased the rate of A beta fibril formation.
Transthyretin
A beta
1
We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor ($T1$$T2$ release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (CaR).
CaR
gastrin
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$ beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R beta
IGF-1R
0
RB, the protein product of the $T1$$T2$, the protein product of the retinoblastoma tumor-suppressor gene, regulates the activity of specific transcription factors.
retinoblastoma
RB
0
Shared and unique determinants of the $T1$ are important for binding $T2$ and EPO mimetic peptide.
erythropoietin (EPO) receptor
EPO
1
An $T1$ complex containing mainly E2F4 and pRb2/$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
p130
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of $T1$$T2$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
IRS-1
IRS-1
0
Using a yeast interaction assay, we find that SRF binds the $T1$ subunit of TFIIF and that $T2$'s transcriptional activation domain is the region involved in this binding.
RAP74
SRF
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to $T1$, FGFR2, and $T2$ but interacts poorly with KGFR.
FGFR1
FGFR4
0
Our data suggest that TR6 inhibits the interactions of $T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
TR6
0
The $T1$ family currently consists of two agonists, $T2$ and IL-1beta, and one antagonist, IL-1ra.
IL-1
IL-1alpha
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, $T1$/MACH, and TRAFs) associated with both of the p60 and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
FLICE
p80
1
In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human $T1$ and the $T2$ receptor.
IRS-1
insulin
0
These proteins, $T1$ (PLA2) and 14-3-3 beta ($T2$), are members of the 14-3-3 family of proteins.
14-3-3 zeta
HS1
0
RIP: a novel protein containing a death domain that interacts with Fas/$T1$$T2$/APO-1 (CD95) in yeast and causes cell death.
APO-1
Fas
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/$T1$$T2$ observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma
0
A point mutation in $T1$, analogous to the lpr mutation of Fas, abolishes its ability to bind $T2$, suggesting a death domain to death domain interaction.
FADD
Fas
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and $T1$, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
calreticulin
TAP
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
keratinocyte growth factor receptor
FGFR4
0
Sos and $T1$$T2$ and 80K-H.pp66.
80K-H
Sos
0
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of $T1$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
p53
MDM2
1
The molar ratio of serum retinol-binding protein (RBP) to $T1$$T2$) to transthyretin (TTR) is not useful to assess vitamin A status during infection in hospitalised children.
transthyretin
RBP
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with $T1$ and inhibits the binding of the natural $T2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
CCR-5
CCR-5
0
Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired $T1$$T2$ by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.
granulysin
perforin
0
Unlabeled TNF-alpha and TNF-beta were equally effective at displacing the binding of labeled $T1$$T2$ were equally effective at displacing the binding of labeled TNF-alpha to TNF-R expressing cells.
TNF-alpha
TNF-beta
0
A mutant form of human interferon-gamma ($T1$) that binds one IFN-gamma receptor alpha chain ($T2$) has been designed and characterized.
IFN-gamma SC1
IFN-gamma R alpha
1
These results demonstrate that Rb interacts specifically with a lineage-restricted $T1$$T2$ interacts specifically with a lineage-restricted Ets transcription factor.
Ets
Rb
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the $T1$$T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
bcl-2
p21
0
The molar ratio of serum retinol-binding protein ($T1$) to transthyretin ($T2$) is not useful to assess vitamin A status during infection in hospitalised children.
RBP
TTR
0
Interaction of $T1$ and gamma c chains with $T2$ and Jak3: implications for XSCID and XCID.
IL-2R beta
Jak1
1
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that $T1$$T2$ stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
insulin
0
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members ($T1$, neu/$T2$, ErbB-3, and ErbB-4) and tumor recurrence.
ErbB-1
ErbB-2
0
Transcription factor $T1$ consists of $T2$ (TBP) and at least eight TBP-associated factors (TAFs).
TFIID
TATA binding protein
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing $T1$$T2$, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Bcl-X-S
Bcl-X-L
0
$T1$ stimulates tyrosine phosphorylation of $T2$ and its association with Grb2 and the phosphatidylinositol 3-kinase.
Gastrin
insulin receptor substrate 1
1
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired $T1$$T2$ acquired ADA from an extracellular source.
ADA
ADA
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T1$, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sICAM-1
sVCAM-1
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cyclinA
MyoD
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
Fas
FD8
0
The gamma chain of the $T1$ (IL-2) receptor is shared with the functional $T2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
interleukin-2
IL-4
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
HVEM
lymphotoxin beta receptor
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/$T1$ ($T2$) and FLT-1.
fetal liver kinase 1
Flk-1
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine IL-10 receptor were found to be redundantly required for receptor function and for activation of $T1$ but not for $T2$ or Stat5.
Stat3
Stat1
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
sCAM
0
hPRL does not bind to the hGH receptor, but hGH binds to both the $T1$ and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGHR
hPRLR
0
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of $T2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
MDM2
p53
0
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ ($T1$) and LEU2 ($T2$) genes under the control of LexA-dependent operators.
beta-galactosidase
leucine utilization
0
The data thus demonstrate specific binding of platelet FXIII to $T1$ and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet $T2$.
HSP27
FXIII
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
sVCAM-1
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/dystrophin related protein, and the $T2$.
utrophin
Torpedo 87K protein
0
Both the $T1$-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many $T2$ interactions.
GT155
calnexin
0
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated $T1$$T2$-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated Rb-kinase activity.
Rb
CDK6
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from $T1$$T2$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
gastrin
IRS-1
0
Each of these molecules binds to the type I $T1$$T2$ (IL1R).
IL-1
type I IL-1 receptor
0
METHODS: The genes for dopamine synthetic enzymes, $T1$ (TH), aromatic L-amino acid decarboxylase (AADC), and $T2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
tyrosine hydroxylase
GTP cyclohydrolase I
0
Using co-immunoprecipitation and protein-protein association assays, we show that both $T1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of $T2$ and c-Jun are necessary and sufficient for stable association with TBP.
c-Fos
c-Fos
0
Presenilin 1 ($T1$$T2$ (PS1) is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.
PS1
Presenilin 1
0
$T1$ does not bind to the hGH receptor, but $T2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGH
0
Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with phospholipase C-gamma 1 ($T1$$T2$ (PLC gamma 1).
PLC gamma 1
phospholipase C-gamma 1
0
GAP-43 (neuromodulin, B-50, $T1$$T2$, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
F1
B-50
0
The rates of extensive $T1$ expression and decreased $T2$ expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively).
ST-3
E-cadherin
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p140trk
NGF
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/$T1$$T2$ heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
We have exploited the availability of the cloned XPB, XPD, p62, $T1$, and $T2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p44
p34
0
Correlations between GFAp and $T1$$T2$ and NFL in CSF as markers for astrogliosis and neurodegeneration, and clinical and biological data were investigated.
NFL
GFAp
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or $T1$, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or $T2$ receptors.
ErbB4
ErbB4
0
Activated $T1$ predominantly interacts with $T2$.
FGFR3
GRB2
1
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and $T1$$T2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IGF-1R beta
IR beta
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T1$$T2$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.
IL-2
IL-2
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
KIP2
0
We show that the POU homeodomain of $T1$ and the evolutionarily conserved C-terminal core domain of $T2$ are both required and sufficient for the interaction.
Oct2
TBP
1
These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor $T1$, first identified as the cell cycle regulatory protein $T2$.
TAFII250
CCG1
0
Thus HOX11 is a cellular oncogene that targets $T1$ and $T2$, both of which are targets for oncogenic viruses and chemical tumour promoters.
PP2A
PP1
0
In transfected COS-1 cells, osteogenic protein (OP)-1/$T1$, and less efficiently BMP-4, bound to $T2$.
BMP-7
BMPR-II
1
$T1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor ($T2$)/fetal liver kinase 1 (Flk-1) and FLT-1.
VEGF
KDR
0
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like $T1$$T2$ and gammac are similar, and like gammac, IL-13Ralpha is located on chromosome X.
gammac
IL-13Ralpha
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked $T1$$T2$ and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
IL-10
Stat1
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ($T1$, $T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
TRADD
FADD
0
Thus, these two $T1$-$T2$ signaling cascades appear to bifurcate at TRADD.
TNFR1
TRADD
0
The precise function of $T1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the $T2$.
c-Cbl
epidermal growth factor receptor
0
Since $T1$ and $T2$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.
hsp90
hsp70
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T1$$T2$ receptor.
insulin receptor
insulin
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$ ($T2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
transporter associated with antigen processing
TAP
0
The analysis of complexes of $T1$ with CSF proteins in a KBr gradient revealed an association of $T2$ only with free proteins and not with lipoprotein particles.
A beta
A beta
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature $T1$$T2$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
hsp70
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both $T1$ and p33cdk2, and that $T2$ immune complexes exhibit appreciable histone H1 kinase activity.
p34cdc2
cyclin D1
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronidase
collagenase
0
The aim of the present study was to elucidate whether intracellular expression of $T1$ and $T2$ by NK cells might be associated with progression of cancer.
granulysin
perforin
0
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
E1A
1
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, $T1$$T2$ family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-X-S
Bcl-2
0
USF specifically interacts with Fra1 but not with other closely related family members, $T1$, Fra2, FosB, or with $T2$.
c-Fos
c-Jun
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
MyoD
0
In the baculovirus coexpression system, Raf-1 was activated by $T1$ in the presence of $T2$.
JAK2
p21ras
0
Interaction of the $T1$ subunit of PI 3-kinase with the insulin receptor (IR) and the $T2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
p85
IGF-1
0
IL-2, IL-4, $T1$$T2$, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-7
IL-2
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T1$ ($T2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
alpha-1-antitrypsin
alpha1AT
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; $T1$ induced Jak3-$T2$ and increased Jak3-gamma c associations.
IL-2
IL-2R beta
0
hPRL does not bind to the $T1$ receptor, but hGH binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGHR
0
The structure of the $T1$-$T2$-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.
FGF1
FGFR2
1
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of $T1$$T2$ dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind FGFR1.
FGF-7
FGF-2
0
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MIP-1beta
1
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or $T1$, suggesting that signalling by neuregulin-2 is mediated by $T2$ and/or ErbB4 receptors.
ErbB4
ErbB3
0
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
ADA
ADA
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-$T2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
0
As expected, overexpression of either $T1$/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T2$ promoter by the myogenic transcription factor MyoD.
Id3
creatine kinase
0
MyoD prevents cyclinA/cdk2 containing $T1$$T2$ containing E2F complexes formation in terminally differentiated myocytes.
E2F
cdk2
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the $T1$ and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
p60
p80
0
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
Sp1
1
RANTES interacts with $T1$ and $T2$ with CXCR4 receptors.
CCR5
SDF-1
0
Comparisons with the $T1$-$T2$ complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGHR
1
$T1$ also activated $T2$ in Ba/F3 cells that stably expressed the murine IL-10 receptor.
IL-10
Stat5
1
Whereas IL-13Ralpha serves as an alternative accessory protein to the common $T1$ ($T2$) for IL-4 signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.
cytokine receptor gamma chain
gammac
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by $T1$, a specific inhibitor of the $T2$.
CrmA
interleukin-1 beta-converting enzyme
1
Here we show that Vav and $T1$ form inducible molecular complexes in $T2$-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
c-Cbl
TCR
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
IL-7R
0
The binding of IL-1alpha or $T1$ to $T2$ is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
IL-1beta
IL1R
1
Characterization of the $T1$ binding proteins RBP1 and $T2$.
retinoblastoma
RBP2
1
Transfection of G alpha i2 and nucleobindin in COS cells increased $T1$ expression relative to cells transfected with $T2$ and mock vector.
G alpha i2
G alpha i2
0
The potency of eotaxin-3 as a $T1$ ligand seems, however, to be approximately 10-fold less than that of $T2$.
CCR3
eotaxin
1
A 120-kDa phosphoprotein ($T1$) associated with $T2$ and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
pp120
CD5
1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$$T2$, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
MORT
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( $T1$ ) and $T2$ ( FasL / CD95L ) .
herpes virus entry mediator ( HVEM ) - L
Fas ligand
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$ receptor (IR) and the IGF-1 receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
IGF-1R
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
soluble cell adhesion molecules
0
Peptide sequencing and Western blot analysis established that the 265-kD protein was $T1$ ($T2$),a recently identified transcriptional coactivator.
CBP
CREB-binding protein
0
Tumor necrosis factor (TNF) can induce apoptosis and activate NF-kappa B through signaling cascades emanating from $T1$ ($T2$).
TNF receptor 1
TNFR1
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor ($T1$)/$T2$ (Flk-1) and FLT-1.
KDR
fetal liver kinase 1
0
Furthermore, p21 blocks the ability of $T1$ to activate $T2$, the principal replicative DNA polymerase.
PCNA
DNA polymerase delta
1
Here we show that QM/$T1$, a negative regulator of c-Jun, is a candidate to mediate the function of $T2$ in the cell.
Jun-interacting factor (Jif)-1
PS1
0
Levels of p21 protein are increased in senescent cells and $T1$$T2$ protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells.
p21
p21
0
HBx and $T1$ specifically bound to transcription factor IIB ($T2$) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
RPB5
TFIIB
0
We find that p53, p21(CIP1) and $T1$$T2$, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
p15
p53
0
The results of his3 activation indicated that $T1$, N + C-SH2 and C-SH2 interact with both IR beta and $T2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
p85
IGF-1R beta
1
RIP: a novel protein containing a death domain that interacts with $T1$/APO-1 ($T2$) in yeast and causes cell death.
Fas
CD95
0
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind $T1$$T2$ for KGFR and its biological potency but did not result in the ability to bind FGFR1.
FGFR1
FGF-7
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
collagenase
0
$T1$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, $T2$, and CCL16.
Liver-expressed chemokine
NCC-4
0
A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with $T1$ and is sufficient to activate the $T2$-Stat pathway and induce an antiviral state.
Jak1
Jak
0
This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (pRB) or its relatives p107 and $T1$$T2$) or its relatives p107 and p103.
p103
pRB
0
Thymocyte activation induces the association of phosphatidylinositol 3-kinase and $T1$ with $T2$.
pp120
CD5
1
Identification of an 11-kDa $T1$-rapamycin-binding domain within the 289-kDa $T2$ and characterization of a critical serine residue.
FKBP12
FKBP12-rapamycin-associated protein
0
CIP1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and $T1$$T2$, cyclin E, and Cdk2 immunoprecipitates.
Cdk2
cyclin D1
0
Eotaxin-3 induced transient calcium mobilization specifically in $T1$ ($T2$)-expressing L1.2 cells with an EC(50) of 3 nM.
CC chemokine receptor 3
CCR3
0
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and $T1$$T2$ and hsp70.
hsp70
hsp90
0
The correlation of SRF-RAP74 binding with transcriptional activation suggests that $T1$$T2$ binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.
RAP74
RAP74
0
$T1$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and $T2$ from rat brain.
alpha-Actinin-2
PSD-95
1
Abnormal levels of $T1$ and $T2$ were significantly associated with increasing CSF cell number and protein concentration, and with the absence of lymph nodes or the absence of trypanosomes in lymph node aspirate.
GFAp
NFL
0
We find that p53, p21(CIP1) and p15($T1$$T2$(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
INK4b
p15
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the $T1$, and can be immunoprecipitated with NMDA receptors and $T2$ from rat brain.
NMDA receptor
PSD-95
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and $T1$$T2$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
p76
IL-7R
0
The $T1$ gene is identical to a gene, $T2$, (ref 7,8), implicated in cell-cycle progression.
hTAFII250
CCG1
0
In the baculovirus coexpression system, $T1$ was activated by JAK2 in the presence of $T2$.
Raf-1
p21ras
0
$T1$ can bind either hsp70 or $T2$ independently and in an ATP-independent manner.
P60
hsp90
1
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of $T1$$T2$ adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma SC1
0
Transcription factor TFIID consists of TATA binding protein ($T1$) and at least eight $T2$-associated factors (TAFs).
TBP
TBP
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
cytochrome b558
NADPH oxidase
0
$T1$ ($T2$), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.
Transthyretin
TTR
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$ associates with the transporter associated with antigen processing (TAP) and $T2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
calreticulin
1
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
TAFII250
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-$T2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
Cdk2
0
We report an interaction between the human PS1 or $T1$ hydrophilic loop and $T2$, a small GTPase belonging to the Ras-related superfamily.
PS2
Rab11
1
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the $T1$$T2$ and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
TAP
HLA-E
0
Cytokines $T1$, $T2$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
IL-1beta
0
The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced $T1$$T2$ nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in TFIID-promoter complexes.
TFIID
TFIID
0
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ($T1$$T2$ (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
MPIF-2
myeloid progenitor inhibitory factor 2
0
Mutants P206R, P206D, and P206F displayed reduced cytotoxicity toward $T1$-positive cells with a concomitant decrease in the binding affinity for the recombinant $T2$-immunoglobulin Fc fusion proteins.
Fas
Fas
0
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
sCAM
0
IL-10 also activated $T1$ in Ba/F3 cells that stably expressed the murine $T2$ receptor.
Stat5
IL-10
0
HFE binds to the $T1$$T2$ binds to the transferrin receptor (TfR), a receptor by which cells acquire iron-loaded transferrin.
transferrin
HFE
0
Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the $T1$$T2$ receptor alpha chain.
IL-5 receptor
IL-5
0
The death domain of tumor necrosis factor (TNF) receptor-1 ($T1$) triggers distinct signaling pathways leading to apoptosis and $T2$ activation through its interaction with the death domain protein TRADD.
TNFR1
NF-kappa B
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or ErbB4, suggesting that signalling by $T1$ is mediated by ErbB3 and/or $T2$ receptors.
neuregulin-2
ErbB4
0
Biochemical studies established that some coactivators are associated with the $T1$ ($T2$) to form the TFIID complex.
TATA-binding protein
TBP
0
TRAP is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/$T1$$T2$ is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.
lymphotoxin
TRAP
0
The interactions between GRB2 and these two proteins require ligand activation of the $T1$ and are mediated by the binding of the SH2 domain of $T2$ to phosphotyrosines on both IRS-1 and Shc.
insulin receptor
GRB2
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 $T1$$T2$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
IL-7
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$$T2$ (IL-10) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10 (IL-10) receptor
interleukin 10
0
In normal human cells, but not in many tumour cells, $T1$ exists in a quaternary complex with a cyclin, a CDK, and the $T2$ (PCNA).
p21
proliferating-cell nuclear antigen
1
Analysis of p53, p21(CIP1), $T1$(INK4b), p16(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p15
KIP2
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 $T1$$T2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
IL-7R
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
TAFII250
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits $T1$$T2$ complex recruits Shc, probably via Grb2.
Shc
c-Cbl
0
We have cloned cDNAs encoding three novel TAFIIs [$T1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and $T2$.
TATA-binding protein
hTAFII18
0
The interactions of $T1$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ($T2$) or in mature PR complexes (hsp90).
hsp70
hsp70
0
PDGF-CC exhibits greater mitogenic potency than $T1$ and comparable or greater mitogenic activity than PDGF-AB and $T2$ on several mesenchymal cell types.
PDGF-AA
PDGF-BB
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 ($T2$), the major cytoplasmic substrate of the insulin receptor.
gastrin
IRS-1
1
Here we show that the general transcription factor $T1$ is also a target for a transcriptional activator, namely $T2$ (SRF), which binds to the c-fos promoter.
TFIIF
serum response factor
0
SF3a interacts with U2 snRNP in the presence of $T1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and $T2$ in the incorporation of U2 snRNP into the spliceosome.
SF3b
SF3b
0
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
soluble cell adhesion molecules
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$/CD3 or CD4.
CD4
TcR zeta
0
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
eotaxin
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$) and HVEM/TR2 receptors.
HVEM
LTbetaR
0
CD5 associates with the T-cell receptor zeta chain ($T1$)/$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
TcR zeta
CD3
1
In addition, 80K-H. $T1$$T2$.
GRB2
80K-H
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and Fas ligand ($T2$/CD95L).
HVEM
FasL
0
Involvement of $T1$ signal transducer $T2$ in IL-11-mediated signal transduction.
IL-6
gp130
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ beta (delta C-43).
delta C-4
IGF-1R
0
Interaction of the p85 subunit of $T1$ with the insulin receptor (IR) and the $T2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
IGF-1
0
$T1$ also binds to ActRII through its beta subunit, competes with the binding of activin to $T2$, but fails to form the ActRII.
Inhibin
ActRII
0
Finally, anti-IL-6R antibody inhibited the ability of IL-6, but not $T1$$T2$ antibody inhibited the ability of IL-6, but not IL-11, to transduce early signals in TF-1 cells.
IL-11
IL-6R
0
Following gastrin stimulation, we observed a time- and dose-dependent association of $T1$ with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T2$).
IRS-1
PI 3-kinase
1
The potency of $T1$ as a $T2$ ligand seems, however, to be approximately 10-fold less than that of eotaxin.
eotaxin-3
CCR3
1
Interaction of the p85 subunit of PI 3-kinase with the $T1$ receptor (IR) and the $T2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
IGF-1
0
Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast $T1$$T2$ and relation of its 60-kD subunit to yeast PRP9.
PRP9
U2 snRNP
0
The high affinity interleukin-6 ($T1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein $T2$.
IL-6
gp130
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T1$, YY1, $T2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
Sp1
USF
0
The amount of $T1$ and $T2$ associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK4
CDK6
0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, EBP) of the $T1$$T2$, EBP) of the EPOR.
EPOR
EPO binding protein
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), $T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
endothelin-1
0
Peptide growth factors, as well as the immediate early gene products c-Jun, $T1$, and $T2$, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.
v-Fos
c-Myc
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T2$-LPR and Fas-FD8.
Fas
Fas
0
The $T1$ and $T2$ receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hPRL
0
IL-2, $T1$, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases $T2$ and Jak3.
IL-4
Jak1
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with $T2$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TATA-binding protein
PTF
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein ($T1$), human TAFII250, dTAFII60, and $T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
dTBP
dTAFII40
0
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of Raf-1 coimmunoprecipitated with JAK2 in lysates of cells in which $T1$$T2$ coimmunoprecipitated with JAK2 in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.
JAK2
Raf-1
0
This $T1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and $T2$ from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Syk
0
$T1$ binds to the $T2$ (TfR), a receptor by which cells acquire iron-loaded transferrin.
HFE
transferrin receptor
1
We report here that recombinant B61 induces autophosphorylation of $T1$ in intact cells, consistent with $T2$ being an authentic ligand for ECK.
ECK
B61
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of $T1$, hsp70, and three additional proteins, p54, $T2$, and p23.
hsp90
p50
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$/Jif-1.
Jif-1
QM
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
TFIID
Tat
0
$T1$ recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the $T2$ receptor intracellular domain.
Stat3
interleukin-10
0
Monomeric ($T1$) and dimeric ($T2$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
IL-6D
0
$T1$ exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than $T2$ and PDGF-BB on several mesenchymal cell types.
PDGF-CC
PDGF-AB
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common $T1$ (gammac) for $T2$ signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.
cytokine receptor gamma chain
IL-4
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, $T2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
USF
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
p53
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NIK
hGITR
0
The interaction of $T1$ with RAD52 is mediated by $T2$'s self-association region.
UBE2I
RAD52
0
The genes for $T1$/eotaxin-2 (SCYA24) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
eotaxin-3
0
Physical interaction of mammalian CDC37 with CDK4 $T1$$T2$ .CDC37 was originally identified as a Start gene in budding yeast and has been shown to be required for association of CDC28 with cyclins.
.CDC37
CDK4
0
The glut 1 glucose transporter interacts with calnexin and $T1$$T2$ and calreticulin.
calreticulin
calnexin
0
The interleukin-1beta ($T1$) converting enzyme (ICE) processes the inactive $T2$ precursor to the proinflammatory cytokine.
IL-1beta
IL-1beta
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T1$ (hTFIID alpha and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII30
hTFIID beta
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$$T2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
KGFR
keratinocyte growth factor receptor
0
$T1$ binds exclusively to the underphosphorylated form of $T2$ and fails to bind to Rb mutants derived from patients with retinoblastoma.
Elf-1
Rb
0
This protein, designated VEGF-related protein ($T1$), specifically binds to the extracellular domain of $T2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VRP
Flt4
1
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T1$$T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sICAM-1
endothelin-1
0
This suggests that one domain of IFN-gamma is sufficient to recruit IFN-gamma R alpha and $T1$$T2$ is sufficient to recruit IFN-gamma R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma
0
Analysis of p53, p21(CIP1), p15($T1$), p16(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
KIP2
0
The Fos/Jun and $T1$/$T2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
ATF
CREB
0
A physical interaction between $T1$ and CDK4 suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on $T2$.
CDC37
CDK4
0
The POU domains of the $T1$ and Oct2 transcription factors mediate specific interaction with $T2$.
Oct1
TBP
1
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned $T1$, and imply that the p90 and p76 $T2$ have different extracellular domains.
IL-7R
IL-7R
0
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of $T1$$T2$ and Shc: implications for insulin control of ras signalling.
ras
IRS1
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for $T1$$T2$ heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
$T1$ ($T2$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.
Liver-expressed chemokine
LEC
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, $T1$$T2$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.
HCC-4
LEC
0
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by $T1$$T2$ gene expression elicited by IL-11 or IL-6 in TF-1 cells.
IL-11
junB
0
$T1$ exhibits greater mitogenic potency than $T2$ and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.
PDGF-CC
PDGF-AA
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the $T1$ fragment fused to $T2$, indicating that the observed Abeta-Abeta interaction was specific.
B42
Abeta
0
In vitro translation studies identified the 66-kDa protein as the protein product of $T1$, and subcellular fractionation experiments showed that $T2$ is mainly present in the cytosol fraction, although significant amounts are also present in membrane and nuclear fractions.
WASP
p66WASP
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding $T2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPO
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to $T1$$T2$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGFR1
FGF-7
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and $T2$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FADD
Fas
1
Coexpression of the alpha and betaL subunits of the human interferon alpha ($T1$$T2$ (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.
IFNalpha
interferon alpha
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate $T1$ function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for $T2$/Bcl-2 homodimerization.
Bcl-2
Bcl-2
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for $T1$$T2$ function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-2
0
Taken together, our results suggest that $T1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T2$ receptor.
IRS-1
insulin
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal $T1$-forming enzymes, starting with isorenin, tonin, D and G cathepsin and ending with the conversion enzyme and $T2$.
angiotensin
chymase
0
$T1$ is activated through phosphorylation by $T2$ (PKA), but precisely how phosphorylation stimulates CREB function is unknown.
CREB
protein kinase A
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-FD5, a mutant of $T2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FADD
Fas
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T1$$T2$.
TAP
HLA-E
0
The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the $T1$$T2$ gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(EGF)-like domain gives rise to two isoforms (alpha and beta).
epidermal growth factor
neuregulin-2
0
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of $T1$ for $T2$ and its biological potency but did not result in the ability to bind FGFR1.
FGF-7
KGFR
1
A bacterially expressed 318-amino acid fragment, $T1$ (418-736), containing the amphipathic helix region, was able to bind $T2$.
Ht 31
RII alpha
1
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T1$, MCP-3, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-2
eotaxin
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
Fas
LPR
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, $T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGFR2
FGFR2 IIIb
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both $T1$$T2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IR beta
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor
FGFR2 IIIb
0
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6D
IL-6
0
In contrast, $T1$ complexes containing $T2$ are incapable of phosphorylating histone H1.
p27
CDK2
1
RIN1 interacts with the "effector domain" of $T1$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of $T2$, a known RAS effector.
RAS
RAF1
0
Cotransfection of $T1$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve $T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITRL
TNFR-associated factor 2
0
These results suggest that RB can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with $T1$, in particular with $T2$.
TFIID
TAFII250
0
The molecular adapter $T1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as $T2$, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
c-Cbl
Grb2
1
In vitro protein-protein interaction assays reveal that as observed with Drosophila $T1$, $T2$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor TFIIB.
TAFII40
hTAFII32
0
Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact $T1$, which enhances the complementarity of the viral $T2$-gp130 binding interfaces.
gp130
IL-6
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/$T2$ and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
TR2
1
$T1$ antagonists emerge from alterations in the low-affinity binding epitope for receptor $T2$.
BMP-2
BMPR-II
0
Since $T1$ and hsp70 do not readily associate on their own, it appears that $T2$ is the central organizing component of an hsp90-p60-hsp70 complex.
hsp90
p60
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
Interestingly, both GRB2 and $T1$ can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby $T2$ could provide the core for a large signalling complex.
phosphatidylinositol-3 (PI-3) kinase
IRS-1
0
Mouse $T1$ does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of $T2$.
IL-10
IL-10
0
In transfected COS-1 cells, osteogenic protein (OP)-1/$T1$$T2$/BMP-7, and less efficiently BMP-4, bound to BMPR-II.
BMP-7
osteogenic protein (OP)-1
0
The helical cytokine $T1$ and its specific binding subunit IL-6R alpha form a 1:1 complex which, by promoting homodimerization of the signalling subunit $T2$ on the surface of target cells, triggers intracellular responses.
interleukin (IL) 6
gp130
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, cyclin E-Cdk2, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
Cdk2
cyclin D2
0
The tyrosine kinases Flt4, Flt1, and Flk1 (or $T1$$T2$, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
KDR
Flt1
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T1$/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$$T2$) and Fas ligand (FasL/CD95L).
HVEM
herpes virus entry mediator (HVEM)-L
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$, might be one mechanism used by gastrin to activate $T2$.
p85
PI 3-kinase
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including $T1$, $T2$, K5, and K6.
K1
K2
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, cyclin E-$T2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin A
Cdk2
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/$T1$$T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MORT
FADD
0
Mouse IL-10 does not bind to $T1$, and $T2$-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.
hIL-10R
hIL-10R
0
Lastly, in agreement with our findings for yeast cells, we show that the $T1$ is unable to phosphorylate an $T2$ protein containing a deletion of amino acids 45 to 516 when expressed in COS cells.
insulin receptor
IRS-1
0
Here we show that $T1$ and $T2$ form inducible molecular complexes in TCR-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
Vav
c-Cbl
1
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
interleukin-1 beta-converting enzyme
FADD
0
Associations of UBE2I with RAD52, UBL1, $T1$, and $T2$ proteins in a yeast two-hybrid system.
p53
RAD51
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to $T1$; however, the $T2$-binding proteins, Ras and 14-3-3, had no effect.
Raf/330
Raf-1
0
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
$T1$ and its counter-receptor $T2$ (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30 ligand
1
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
MCP-1
0
CD26, a T cell activation Ag, also known as $T1$,is directly associated with adenosine deaminase ($T2$) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
ADA
1
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
TrkA
TrkC
0
Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of $T1$ and $T2$ receptors in embryonic spinal cord and brain tissues enriched in the two receptors.
trkA
p75
0
These data demonstrate that Stat3 but not $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat1
Stat3
0
Moreover, similar $T1$ sequences are required for binding PP-1 alpha 2 and $T2$.
p110RB
SV40 large T antigen
1
Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely $T1$ ($T2$), which binds to the c-fos promoter.
serum response factor
SRF
0
The $T1$ gene product, $T2$, regulates cell proliferation by binding to and inhibiting the activity of key growth promoting proteins.
retinoblastoma
pRB
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including $T2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
Sp1
0
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and $T2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
TBP
TBP
0
$T1$ SC1 was derived by linking the two peptide chains of the $T2$ dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.
IFN-gamma
IFN-gamma
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
trk
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin ($T1$), and complement factors $T2$ and C4 can be used in the differential diagnosis of serous effusion.
alpha1AT
C3
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the $T1$$T2$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.
IL-6D
IL-6
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the $T1$ IL-7R but not T-cell clones that express predominantly the $T2$ IL-7R.
p90
p76
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to $T1$ and was somewhat increased (2-fold) for $T2$ beta (delta C-43).
IR beta
IGF-1R
0
The cloned CSB gene encodes a member of a protein family that includes the yeast $T1$$T2$ gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.
Snf2
CSB
0
SF3a interacts with $T1$ in the presence of SF3b to generate a structure similar to 17S $T2$, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
U2 snRNP
0
TR6 ( $T1$ ( $T2$ ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
decoy receptor 3
DcR3
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$$T2$, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
hyaluronic acid synthase 2
0
Here, a direct interaction between the activation domain of $T1$ and two subunits of the $T2$ complex, TAFII40 and TAFII60, is reported.
p53
TFIID
0
OBJECTIVE: To assess the usefulness of the molar ratio of serum $T1$ (RBP) to transthyretin ($T2$) to determine vitamin A (VA) status during infection.
retinol-binding protein
TTR
0
In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the $T1$, $T2$ (CaM).
calcium effector protein
calmodulin
0
In this report, it is demonstrated that $T1$ contains a sequence motif that is highly related to the $T2$ binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.
Elf-1
Rb
0
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID beta
0
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of $T1$ and pp120 to $T2$.
PI 3-kinase
CD5
1
$T1$ controls CDK activity, thereby affecting cell-cycle control, whereas $T2$ functions in both DNA replication and repair.
p21
PCNA
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ($T2$).
PR
p48
0
An E2F complex containing mainly E2F4 and $T1$/p130 ($T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
pRb2
E2F
0
$T1$ suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in $T2$.
PS1
PS1
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related ($T1$$T2$), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
mGITR
hGITRL
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, p54, $T1$, and $T2$.
p50
p23
0
The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-$T1$$T2$-cyclin-dependent kinase 2 (Cdk2) complex has been determined at 2.3 angstrom.
cyclin-dependent kinase 2
cyclin A
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of $T1$ by $T2$ and may therefore be considered as a natural antagonist for CCR5.
CCR5
MIP-1beta
1
In vitro, purified $T1$ subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of $T2$ (Raf/330).
G beta gamma
Raf-1
1
At least two of the subunits of $T1$ (XPB and $T2$ proteins) are implicated in the disease xeroderma pigmentosum (XP).
TFIIH
XPD
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), $T1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T2$ and Hip (p48).
p23
hsp70
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
0
Structure of the $T1$ oncoprotein bound to the $T2$ tumor suppressor transactivation domain.
MDM2
p53
1
A few general transcription factors, in particular $T1$ and $T2$, have been found to bind transcriptional activators.
TFIID
TFIIB
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ (KGFR), whereas FGF-2 binds well to FGFR1, $T2$, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor receptor
FGFR2
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$ associates with the $T2$ (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
transporter associated with antigen processing
1
The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T1$$T2$ and the affinity converter/signal transducing protein gp130.
IL-6
IL-6 receptor
0
$T1$ is also present in immunoaffinity-purified hsp90 complexes along with $T2$ and another protein, p60.
p23
hsp70
0
The interactions between $T1$ and $T2$, or CDK2, may be important at the G1 to S transition in human cells.
cyclin E
CDC2
1
Expression of $T1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T2$-expressing cells responded only to FGF-1.
FGFR3 IIIc
FGFR3 IIIb
0
We have therefore investigated whether the octamer binding proteins might physically interact with $T1$, the TATA box binding protein component of the $T2$ factor.
TBP
TFIID
0
pRB, $T1$, p19(INK4d) and $T2$(KIP1) decrease in both cell types.
cyclin D
p27
0
The crystal structure of the p53 core domain bound to the $T1$ protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of $T2$ in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of p53.
53BP2
p53
0
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named $T1$$T2$ itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.
RIP
Fas
0
This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between $T1$ and $T2$.
Rb
UBF
1
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the $T1$ IL-7R, and not with expression of the p90 $T2$.
p76
IL-7R
0
$T1$ (neuromodulin, B-50, F1), a $T2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
GAP-43
protein kinase C
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-$T2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Rb
Cdk2
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/$T2$ related protein, and the Torpedo 87K protein.
utrophin
dystrophin
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), $T1$ (AADC), and GTP cyclohydrolase I ($T2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
aromatic L-amino acid decarboxylase
GCH
0
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 $T1$, and not with expression of the $T2$ IL-7R.
IL-7R
p90
0
$T1$ contains a death domain homologous to the death domains of $T2$ and TNFR-1.
FADD
Fas
0
We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with $T1$ bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
IL-6R alpha
gp130
0
Bone morphogenetic proteins (BMPs) belong to the large transforming growth factor-beta ($T1$$T2$ (TGF-beta) superfamily of multifunctional cytokines.
TGF-beta
transforming growth factor-beta
0
Expression of 14-3-3 proteins in Xenopus oocytes enhanced $T1$ activity and promoted $T2$-dependent oocyte maturation.
Raf-1
Raf-1
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human $T1$, $T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII250
dTAFII60
0
METHODS: The genes for dopamine synthetic enzymes, $T1$ (TH), aromatic L-amino acid decarboxylase ($T2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
tyrosine hydroxylase
AADC
0
The death-inducing receptor $T1$ is activated when cross-linked by the type II membrane protein $T2$ ligand (FasL).
Fas
Fas
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-$T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
MyoD
0
Because IL-10 inhibits macrophage activation by $T1$$T2$ inhibits macrophage activation by IFN-gamma, this relationship suggests possible shared receptor or signal transduction pathway components.
IFN-gamma
IL-10
0
$T1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors $T2$ and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-2
Bax
1
Crosslinking of iodinated acidic FGF ($T1$$T2$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
aFGF
acidic FGF
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T1$$T2$, indicating that IL-15 uses components of the IL-2 receptor.
IL-2
IL-2
0
In vitro transcription assay demonstrates that $T1$ represses $T2$ mediated transcription in a cell-free system.
E2F-1
NF-kappaB
0
$T1$ also binds to $T2$ through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.
Inhibin
ActRII
1
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/$T1$ (Flk-1) and $T2$.
fetal liver kinase 1
FLT-1
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and $T1$$T2$ and Grb2/c-Cbl are present in different complexes.
Grb2
Sos1
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of $T2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TBP
TBP
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and $T1$$T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
p80
FADD
0
We recently reported that Ras interaction with the $T1$ ($T2$, residues 139-184) may be required for Raf-1 activation.
Raf-1 cysteine-rich domain
Raf-CRD
0
Here we show that $T1$/Jun-interacting factor (Jif)-1, a negative regulator of $T2$, is a candidate to mediate the function of PS1 in the cell.
QM
c-Jun
1
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor ($T1$)/fetal liver kinase 1 ($T2$) and FLT-1.
KDR
Flk-1
0
Our results demonstrated that CaR was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked $T1$$T2$ was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked gastrin release.
gastrin
CaR
0
On a cell membrane containing both proteins, $T1$ would 'lie down' parallel to the membrane, such that the $T2$ helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the TfR dimerization domain.
HFE
HFE
0
$T1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased $T2$-gamma c associations.
Jak1
Jak3
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using $T1$$T2$ (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMP-2
BMPR-IA
0
Interaction of mammalian splicing factor $T1$ with $T2$ and relation of its 60-kD subunit to yeast PRP9.
SF3a
U2 snRNP
1
As a result of this physical interaction, binding of $T1$ to its hormone response elements either as homodimer or as a heterodimer with the retinoic X receptor was inhibited by $T2$ in a concentration-dependent manner.
h-TR beta 1
p53
0
Thus, during myogenic differentiation, formation of E2F4 and $T1$/$T2$ containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
pRb2
p130
0
$T1$ is also present in immunoaffinity-purified hsp90 complexes along with hsp70 and another protein, $T2$.
p23
p60
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
transforming growth factors (TGF) beta1
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell $T1$ complexes hTAFII28, hTAFII20 and $T2$.
TFIID
hTAFII18
0
Intriguingly, $T1$-$T2$ binding is directly antagonized by Ca2+/calmodulin.
NR1
alpha-actinin
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate $T1$ function, and indicate that requirements for Bcl-2/$T2$ heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
Vav/$T1$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor $T2$, in which c-Cbl is hyperphosphorylated on tyrosine residues.
c-Cbl
CTLA-4
0
Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in $T1$ involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkC
neurotrophin-3
1
GAP-43 (neuromodulin, $T1$, F1), a $T2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
B-50
protein kinase C
1
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of $T1$$T2$/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
QM
c-Jun
0
Bcl-2 also interacted with $T1$ and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. $T2$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-X-L
Bcl-X-L
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with $T2$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TBP
PTF
0
The crystal structure shows that $T1$ consists of three immunoglobulin-like domains which wrap around $T2$ in a manner distinct from the structures of previously described cytokine-receptor complexes.
s-IL1R
IL-1beta
1
Finally, activated $T1$ was also found to result in phosphorylation of $T2$ but reduced phosphorylation of c-Src.
FGFR3
phospholipase C-gamma
0
In this article, we demonstrate that $T1$ associates with a complex containing cadherins, alpha- and $T2$ in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.
PTPmu
beta-catenin
1
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$.
gastrin
insulin receptor
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either $T1$ or p107 in vivo, and the specificity of pRB or $T2$ binding is mediated by the E2F subunit.
pRB
p107
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-$T1$$T2$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.
p60
hsp70
0
The 2.8 A crystal structure of a complex between the extracellular portions of $T1$ and TfR shows two $T2$ molecules which grasp each side of a twofold symmetric TfR dimer.
HFE
HFE
0
These data demonstrate that the p90 $T1$$T2$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
IL-7R
p90
0
Since p60 is typically found in a complex with hsp90 and $T1$$T2$ and hsp70, we have further characterized its interactions with these proteins.
hsp70
hsp90
0
However, in cell lines with defined combinations of ErbBs, $T1$ only activates those with ErbB3 and/or $T2$, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.
neuregulin-2beta
ErbB4
1
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
E1A
0
Gel retardation and methylation interference assays show that $T1$ is able to bind specifically to a site embedded within the two $T2$ elements.
E2F-1
NF-kappaB
0
When transfected into COS cells the cloned cDNA directed the expression of a $T1$ showing a single class of affinity (KD = 2(-8) nM) and specificity for human GM-CSF but not $T2$.
GM-CSF-R
interleukin-3
0
CCR5 was first characterized as a receptor for MIP-1alpha, MIP-1beta, and $T1$$T2$, MIP-1beta, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
RANTES
MIP-1alpha
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/BR-II, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
$T1$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of $T2$ into the spliceosome.
SF3a
U2 snRNP
0
Analysis of p53, p21(CIP1), p15($T1$$T2$), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
CIP1
0
Of these 400, interferon regulatory factor 4 (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and $T1$$T2$), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.
pim 2
IRF4
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
eotaxin
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, $T1$, and three additional proteins, p54, $T2$, and p23.
hsp70
p50
0
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
CD5
CD3
0
BMP-2 is a homodimeric cysteine knot protein that, as a member of the $T1$$T2$ is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta (TGF-beta) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.
transforming growth factor-beta
BMP-2
0
A mutant form of human interferon-gamma ($T1$) that binds one IFN-gamma receptor alpha chain ($T2$ R alpha) has been designed and characterized.
IFN-gamma SC1
IFN-gamma
0
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of $T1$$T2$ interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.
ras
GRB2
0
From Scatchard analyses, the Kd:s for binding of $T1$ and $T2$ to hFGFR-1 were estimated to 25 pM and 41 pM, respectively.
aFGF
bFGF
0
$T1$ binds to the transferrin receptor (TfR), a receptor by which cells acquire iron-loaded $T2$.
HFE
transferrin
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as $T1$$T2$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.
LMC
LEC
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by $T1$$T2$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
CrmA
FADD
0
Interferon-gamma and several other cytokines that are known to activate $T1$ were also found to stimulate $T2$ kinase activity toward MEK-1 in mammalian cells.
JAK2 kinase
Raf-1
0
Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing $T1$$T2$ upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.
E2F
p21
0
Binding assays with truncation mutants of GST-$T1$ indicate that the region located between amino acids 136 and 239 is a primary determinant for interaction with $T2$.
Raf
G beta gamma
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$$T2$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3 IIIb
FGFR3
0
An $T1$ complex containing mainly E2F4 and $T2$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
pRb2
0
However, MIP-1 beta was also an agonist for $T1$ but not CC CKR1; MCP-3 was an agonist for $T2$ but not CC CKR3.
CC CKR3
CC CKR1
0
Their order of selection was alpha1AT effusion, $T1$ serum, $T2$-effusion, and C3 effusion.
C4
TNFalpha
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .
lymphotoxin beta
LIGHT
0
Using co-immunoprecipitation and protein-protein association assays, we show that both $T1$ and $T2$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.
c-Fos
c-Jun
0
Mutagenesis of the $T1$ ($T2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
erythropoietin receptor
EPOR
0
The $T1$ protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus $T2$ protein.
retinoblastoma
E1A
0
$T1$ is a core $T2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTAFII
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ($T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
LTbetaR
LIGHT
0
hTAFII18 is a novel $T1$$T2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.
hTAFII
hTAFII18
0
Involvement of IL-6 signal transducer gp130 in $T1$$T2$ in IL-11-mediated signal transduction.
IL-11
gp130
0
A protein, $T1$ (SNX1), was identified in a human cell line that bound to a region of the $T2$ (EGFR) containing the lysosomal targeting code.
sorting nexin-1
epidermal growth factor receptor
1
Collectively, the novel function of $T1$ via QM/$T2$ influences c-jun-mediated transcription and apoptosis.
PS1
Jif-1
0
Evidently, large hydrophobic side chains of Leu13 and Phe36 play pivotal roles in stabilizing $T1$-$T2$ interactions.
RII beta
RII beta
1
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned $T1$$T2$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
p76
0
Cross-family dimerization of transcription factors $T1$/$T2$ and ATF/CREB alters DNA binding specificity.
Fos
Jun
1
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned $T1$$T2$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
IL-7R
p90
0
To identify specific $T1$-protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with $T2$ from human platelet lysates and erythroleukemia cells.
HSP27
HSP27
0
Determination of $T1$, complement factors C3 and C4, and $T2$ may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
TNFalpha
alpha1AT
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto $T1$$T2$ and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
HLA-E
HLA-E
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for $T1$$T2$ and may therefore be considered as a natural antagonist for CCR5.
CCR5
MIP-1beta
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor ($T1$$T2$ ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
hGITR
GITR
0
In HeLa cells, $T1$ is expressed at the G1 to S transition, and the protein forms stable complexes with $T2$.
Cdi1
Cdk2
1
After a brief historical incursion regarding $T1$ of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, tonin, D and $T2$ and ending with the conversion enzyme and chymase.
RAS
G cathepsin
0
Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified $T1$ and $T2$ reassociated in vitro, demonstrating their direct interaction.
Syk
Lyn
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T1$ ($T2$/CD95L).
Fas ligand
FasL
0
Furthermore, we have identified a short sequence motif (YV/IN) present in $T1$, EGFR and Shc, which specifically binds the SH2 domain of $T2$ with high affinity.
IRS-1
GRB2
1
However, $T1$ was also an agonist for CC CKR3 but not CC CKR1; $T2$ was an agonist for CC CKR1 but not CC CKR3.
MIP-1 beta
MCP-3
0
The $T1$ glucose transporter interacts with calnexin and $T2$.
glut 1
calreticulin
1
Here , we demonstrate that $T1$ specifically binds two cellular ligands , LIGHT ( $T2$ ) and Fas ligand ( FasL / CD95L ) .
TR6
herpes virus entry mediator ( HVEM ) - L
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Comparisons with the hGH-hGHR complex reveal how $T1$$T2$ complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGHR
0
Both the GT155-$T1$ and the GT155-$T2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
calnexin
CAP-60
0
Transfection of G alpha i2 and $T1$ in COS cells increased $T2$ expression relative to cells transfected with G alpha i2 and mock vector.
nucleobindin
G alpha i2
0
GAP-43 (neuromodulin, B-50, F1), a $T1$ ($T2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
protein kinase C
PKC
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
FD5
Fas
0
Jak1 and $T1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased $T2$-gamma c associations.
Jak3
Jak3
0
The 2.8 A crystal structure of a complex between the extracellular portions of $T1$ and TfR shows two HFE molecules which grasp each side of a twofold symmetric $T2$ dimer.
HFE
TfR
0
Deglycosylation studies showed that the p90 and $T1$$T2$ and p76 IL-7R are not simply differently glycosylated isoforms of a single receptor.
p76
p90
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T1$$T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sVCAM-1
soluble cell adhesion molecules
0
The deduced amino acid sequences of human alpha 1- and $T1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like $T2$, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 2-syntrophin
beta 1-syntrophin
0
Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral $T1$-$T2$ binding interfaces.
IL-6
gp130
1
In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently $T1$$T2$/BMP-7, and less efficiently BMP-4, bound to BMPR-II.
BMP-4
osteogenic protein (OP)-1
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain ($T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma R alpha
IFN-gamma
0
Activation of lacZ upon interaction of $T1$ with IR beta(delta C-43) was 4-fold less as compared to $T2$.
p85
IR beta
1
Sos complex following $T1$$T2$ complex following Sos phosphorylation.
Sos
Sos
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of $T1$ and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
TBP
PTF
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor $T2$/HLH462.
ITF-2
Id3
0
Consistent with its role as a coactivator, $T1$ augments the activity of phosphorylated $T2$ to activate transcription of cAMP-responsive genes.
CBP
CREB
1
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, $T1$$T2$ and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Crk
TCR
0
Furthermore, we demonstrate that $T1$ binds directly to $T2$ in vitro and in vivo.
RB
hTAFII250
1
$T1$: a kinase associated with the $T2$.
IRAK
interleukin-1 receptor
1
$T1$ stimulates tyrosine phosphorylation of $T2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Gastrin
insulin receptor
0
The switch II region of Ras is stabilized by $T1$, thus allowing glutamine-61 of $T2$, mutation of which activates the oncogenic potential, to participate in catalysis.
GAP-334
Ras
0
We report an interaction between the human $T1$ or PS2 hydrophilic loop and $T2$, a small GTPase belonging to the Ras-related superfamily.
PS1
Rab11
1
Here, we demonstrate that $T1$ may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the NF-kappaB subunit, $T2$.
E2F-1
p50
1
pRB, cyclin D, $T1$(INK4d) and p27($T2$) decrease in both cell types.
p19
KIP1
0
When transfected into COS cells the cloned cDNA directed the expression of a $T1$ showing a single class of affinity (KD = 2(-8) nM) and specificity for human $T2$ but not interleukin-3.
GM-CSF-R
GM-CSF
1
PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of $T1$, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular $T2$ (25%) and PDGF A-chain (23%).
neuropilin-1
endothelial growth factor
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble $T1$ interacts specifically with CCR-5 and inhibits the binding of the natural $T2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
CD4
CCR-5
0
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein ($T1$) to $T2$ (TTR) to determine vitamin A (VA) status during infection.
RBP
transthyretin
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, $T1$, D and $T2$ and ending with the conversion enzyme and chymase.
tonin
G cathepsin
0
Jak1 and Jak3 associated with $T1$ and gamma c, respectively; $T2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
IL-2R beta
IL-2
0
SF3a interacts with U2 snRNP in the presence of $T1$$T2$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3b
SF3a
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric ($T1$ IL-6R $T2$)2 complex.
IL-6
gp130
0
Insulin receptor substrate 1 (IRS-1) is a major substrate of the insulin receptor and has been implicated in $T1$$T2$) is a major substrate of the insulin receptor and has been implicated in insulin signaling.
insulin
IRS-1
0
As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted $T1$ multiprotein complex contains hsp70, which is a major candidate for providing the protein unfoldase activity required for $T2$ association.
pp60src
hsp90
0
The crystal structure of the $T1$ core domain bound to the $T2$ protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of p53.
p53
53BP2
1
The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T1$ and the affinity converter/signal transducing protein $T2$.
IL-6 receptor
gp130
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
interleukin (IL) 1
0
These interactions are UBE2I-specific, since another DNA repair-related ubiquitin-conjugating enzyme, $T1$ ($T2$), does not interact with these proteins.
RAD6
UBC2
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both $T1$ and $T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
IGF-1R
0
At least two of the subunits of TFIIH ($T1$ and $T2$ proteins) are implicated in the disease xeroderma pigmentosum (XP).
XPB
XPD
0
After T cell activation, the phosphorylation of $T1$ results in the release of $T2$, which is correlated temporally with the activation of Elf-1-mediated transcription.
Rb
Elf-1
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the $T2$ gene encoding the ligand binding domain.
FGFR3
FGFR3
0
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the $T1$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
p53
MDM2
0
In vitro and in vivo experiments support the hypothesis that Grb2 mediates the association of $T1$ with $T2$.
c-Kit
c-Cbl
1
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of $T1$ and $T2$ are necessary and sufficient for stable association with TBP.
c-Fos
c-Jun
0
$T1$ and $T2$ have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).
Flt1
Flk1
0
Several genes are involved in this process, and two have been the focus of recent interest: the $T1$ (NRAMP1) gene and the genes coding for the $T2$.
natural resistance-associated protein
vitamin D receptor
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ($T1$) as well as with the general transcription factor $T2$.
VP16
TFIIB
0
USF specifically interacts with Fra1 but not with other closely related family members, $T1$, Fra2, $T2$, or with c-Jun.
c-Fos
FosB
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, $T1$ and $T2$/p130.
p107
pRb2
0
RESULTS: $T1$, $T2$ and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-GCH.
TH
AADC
0
Here, we describe the molecular cloning and characterization of $T1$, a distant relative of the $T2$ group that is activated by dual phosphorylation at Thr and Tyr during the UV response.
JNK1
MAP kinase
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTAFII28
TAFII30 beta
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , $T1$ ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( $T2$ / CD95L ) .
LIGHT
FasL
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the $T1$$T2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
p76
IL-7R
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein $T1$ and the pocket proteins pRb, p107 and pRb2/$T2$.
MyoD
p130
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human $T1$, dTAFII60, and $T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII250
dTAFII40
0
Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ($T1$), which is distantly related to DAF-4, a $T2$ from Caenorhabditis elegans.
BMPR-II
BMP type II receptor
0
However, in cell lines with defined combinations of ErbBs, $T1$ only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by $T2$ and/or ErbB4 receptors.
neuregulin-2beta
ErbB3
0
The potency of eotaxin-3 as a CCR3 ligand seems, however, to be approximately 10-fold less than that of $T1$$T2$ as a CCR3 ligand seems, however, to be approximately 10-fold less than that of eotaxin.
eotaxin
eotaxin-3
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that $T1$ is associated with both p34cdc2 and p33cdk2, and that $T2$ immune complexes exhibit appreciable histone H1 kinase activity.
cyclin D1
cyclin D1
0
These findings strongly suggest that $T1$ may be closely associated with the $T2$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD26
CD45
0
The POU domains of the $T1$ and $T2$ transcription factors mediate specific interaction with TBP.
Oct1
Oct2
0
Thus, during $T1$-mediated suppression of cell proliferation, $T2$ and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
p53
p21
0
VRP fails to bind appreciably to the extracellular domain of Flt1 or $T1$$T2$ or Flk1.
Flk1
Flt1
0
The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein $T1$ ($T2$) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
p120GAP
GAP-334
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to $T1$; however, the Raf-1-binding proteins, $T2$ and 14-3-3, had no effect.
Raf/330
Ras
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to $T1$$T2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IR beta
IGF-1R beta
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by $T1$$T2$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MIP-1beta
MCP-3
0
Nuclear extracts deficient in $T1$ were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant $T2$.
U2AF35
U2AF35
0
The primary amino acid sequence of $T1$ shares similarity with that of pelle,a protein kinase that is essential for the activation of a $T2$ homolog in Drosophila.
IRAK
NF-kappa B
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that $T2$ expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
GRB2, a small protein comprising one SH2 domain and two SH3 domains, represents the human homologue of the Caenorhabditis elegans protein, $T1$$T2$, a small protein comprising one SH2 domain and two SH3 domains, represents the human homologue of the Caenorhabditis elegans protein, sem-5.
sem-5
GRB2
0
Using the cytoplasmic domain of $T1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
Fas
Fas
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal $T1$ binding inhibition was 80% for $T2$, but only 30% for MIP-1beta.
gp120
MCP-2
1
$T1$ and its counter-receptor CD30 ligand (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30
TNFalpha
0
Cross-family interaction between the bHLHZip $T1$ and bZip $T2$ proteins results in down-regulation of AP1 activity.
USF
Fra1
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T2$-LPR and Fas-FD8.
Fas
Fas
0
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTFIID beta
0
Recombinant $T1$ binds directly to $T2$ both in vitro and in yeast, and participates in the formation of the TFIID complex.
hTAFII250
TBP
1
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ($T1$)/$T2$ to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
MPIF-2
eotaxin-2
0
The $T1$ agonist IRL 1620 had a positive inotropic effect only in some trabeculae, and the $T2$ antagonist BQ 788 (1 microM) almost completely blocked this effect.
ET(B) receptor
ET(B) receptor
0
In transfected cells, wild-type $T1$ repressed the hormone-dependent transcriptional activation of $T2$.
p53
h-TR beta 1
1
Two potentially oncogenic cyclins, cyclin A and $T1$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', $T2$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
cyclin D1
cyclin A
0
The interaction between interleukin-6 (IL-6) and $T1$$T2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
IL-6
IL-6 receptor
0
The ultraviolet (UV) response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by $T1$ and $T2$.
AP-1
NF-kappa B
0
Cell surface $T1$ formed complexes in vivo with actin-binding protein $T2$ (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.
PS1
filamin
1
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), $T1$ ($T2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
aromatic L-amino acid decarboxylase
AADC
0
In normal human cells, but not in many tumour cells, $T1$ exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen ($T2$).
p21
PCNA
1
$T1$ binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for $T2$.
U2AF65
U2AF35
0
cdc25A and $T1$ display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either $T2$ or B2 but not A or D1.
cdc25B
cyclin B1
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins $T1$, p107 and pRb2/$T2$.
pRb
p130
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / $T1$$T2$ / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
TR2
HVEM
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ ($T2$) and Fas ligand (FasL/CD95L).
LIGHT
herpes virus entry mediator (HVEM)-L
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ ($T2$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPO
0
Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the $T1$$T2$ receptor intracellular domain.
interleukin-10 receptor
interleukin-10
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-$T1$$T2$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
Ras
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-$T2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FADD
FD5
1
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
sVCAM-1
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like $T1$$T2$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
Fas
FADD
0
Several genes are involved in this process, and two have been the focus of recent interest: the $T1$ ($T2$) gene and the genes coding for the vitamin D receptor.
natural resistance-associated protein
NRAMP1
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
elastin
0
Here we show that TRADD directly interacts with TRAF2 and $T1$, signal transducers that activate $T2$ and induce apoptosis, respectively.
FADD
NF-kappa B
1
Interaction of the p85 subunit of PI 3-kinase with the $T1$ (IR) and the $T2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin receptor
IGF-1
0
$T1$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ($T2$).
hTAFII20
p32
0
Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind $T1$$T2$ dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind FGFR1.
FGFR1
FGF-2
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
TATA binding protein
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
Further investigation indicated that the ITF-2b/$T1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T2$/HLH462.
MyoD
Id3
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the $T1$$T2$, and imply that the p90 and p76 IL-7R have different extracellular domains.
p90
IL-7R
0
As expected, overexpression of either $T1$/HLH462 or $T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
Id3
ITF-2b
0
$T1$ binds the complex as an extended structure interacting with both $T2$ and Cdk2.
p27Kip1
cyclin A
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Both the $T1$-calnexin and the $T2$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
GT155
GT155
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p21rac
NADPH oxidase
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, $T1$-$T2$, and cyclin D2-Cdk4 complexes.
cyclin D1
Cdk4
1
HOX11 interacts with protein phosphatases PP2A and $T1$$T2$ and PP1 and disrupts a G2/M cell-cycle checkpoint.
PP1
PP2A
0
We investigated whether $T1$, which binds to tyrosine-phosphorylated ITAM, interacts with $T2$ following T cell activation.
phosphatidylinositol (PI) 3-kinase
CD5
0
The IL-1 family currently consists of two agonists, IL-1alpha and $T1$, and one antagonist, $T2$.
IL-1beta
IL-1ra
0
Interactions of the $T1$ protein with itself and other members of the Bcl-2 family, including $T2$, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-2
Bcl-X-L
1
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the $T1$ bound to an $T2$-mimetic peptide (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EBP
EPO
0
Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring $T1$$T2$ dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
RII beta
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of $T1$ and a component ($T2$) identical in sequence to the PTF gamma reported here.
TBP
SNAPc43
0
Cross-linking of 125I-TNF-alpha and 125I-$T1$ to 293/$T2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-beta
TNF-R2
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
IL-7R
0
The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of $T1$ and IGF-1R and $T2$ or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).
IR
p85
0
The molar concentration of LEC required to induce maximum cell migration is 20- to 200-fold greater than that required for $T1$ or $T2$, respectively.
RANTES
I309
0
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, regulated on activation, normal T expressed and secreted (RANTES), and $T1$$T2$), and monocyte chemoattractant protein-3 (MCP-3), but the receptors involved have not been defined.
monocyte chemoattractant protein-3
RANTES
0
These data are consistent with a model wherein $T1$/CDK complexes sequester the CDK2-dependent kinase inhibitory activity of $T2$.
cyclin D
p27
0
The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PLC gamma 1 resembled the $T1$-associated $T2$ by several criteria.
Syk
pp120
1
In transient expression assays, we found that $T1$ and $T2$ can functionally cooperate to synergistically activate transcription.
PU.1
NF-IL6 beta
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin ($T1$$T2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
alpha1AT
TNFalpha
0
In certain cancers, $T1$ amplification is a common event and contributes to the inactivation of $T2$.
MDM2
p53
0
FGFR3 utilizes two different pools of adapter protein GRB2 to link to $T1$$T2$ utilizes two different pools of adapter protein GRB2 to link to Ras.
Ras
FGFR3
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$), whereas FGF-2 binds well to FGFR1, $T2$, and FGFR4 but interacts poorly with KGFR.
KGFR
FGFR2
0
Previous studies on the assembly of progesterone receptor ($T1$) complexes in vitro have suggested that $T2$ assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.
PR
PR
0
Stimulation of fibroblast growth factor receptor 3 ($T1$$T2$ (FGFR3) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.
FGFR3
fibroblast growth factor receptor 3
0
Surprisingly, the N-terminal third of GAP-43 alone bound $T1$ more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with $T2$.
CaM
CaM
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 ($T1$) and have identified a novel CC chemokine termed $T2$.
SCYA24
eotaxin-3
0
Influence of $T1$ (IL-6) dimerization on formation of the high affinity hexameric $T2$.receptor complex.
interleukin-6
IL-6
0
The interaction between interleukin-6 (IL-6) and $T1$ (IL-6R) is the initial and most specific step in the $T2$ signaling pathway.
IL-6 receptor
IL-6
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for $T1$$T2$), suggesting that Phe93 is also important for EMP1 binding.
EMP1
EMP1
0
Reconstitution of the multiprotein complex of pp60src, hsp90, and $T1$$T2$, and p50 in a cell-free system.
p50
hsp90
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin ($T1$$T2$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
alpha1AT
TNFalpha
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for $T1$ and 205,000 and 244,000 for $T2$, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-beta
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$) and HVEM/TR2 receptors.
TR2
LTbetaR
0
Coassociation of CD26 ($T1$) with $T2$ on the surface of human T lymphocytes.
dipeptidyl peptidase IV
CD45
1
RIN1 interacts with the "effector domain" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of $T1$, a known $T2$ effector.
RAF1
RAS
1
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing $T1$$T2$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$$T2$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
IL-1beta
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and $T1$$T2$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
p76
p90
0
Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the $T1$$T2$ and the RNA polymerase II subunit 5.
RNA polymerase II subunit 5
transcription factor IIB
0
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain $T2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTAFII30
0
The two residues of $T1$ that contribute the majority of free energy for $T2$ binding, Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact.
hLIF
hLIF-R
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T2$/CD95L).
LIGHT
FasL
0
Proto-oncoprotein $T1$ interacts with $T2$ in activated thymocytes and peripheral T cells.
Vav
c-Cbl
1
This suggests that one domain of IFN-gamma is sufficient to recruit $T1$ and $T2$ into a complex competent for eliciting biological activity.
IFN-gamma R alpha
IFN-gamma R beta
0
Computer-aided analysis of secondary structure, performed on four $T1$-anchoring protein sequences (the $T2$, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
RII
microtubule-associated protein 2
0
Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate $T1$ activity toward $T2$ in mammalian cells.
Raf-1 kinase
MEK-1
1
However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; $T1$ was an agonist for $T2$ but not CC CKR3.
MCP-3
CC CKR1
1
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the $T1$ bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for $T2$ binding.
EBP
EMP1
1
Additionally, in the absence of gp120, an interaction between a two-domain $T1$ fragment and $T2$ was observed.
CD4
CCR-5
1
We have exploited the availability of the cloned XPB, $T1$, p62, $T2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPD
p44
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, $T1$, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
CTF
Tat
0
$T1$, $T2$, p19(INK4d) and p27(KIP1) decrease in both cell types.
pRB
cyclin D
0
This is the first report to demonstrate that two of cytosolic components of $T1$, $T2$ binding to p67-phox each other.
cytochrome b558
p47-phox
0
A neutralizing polyclonal antibody to LEC was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of $T1$$T2$ was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of LEC and not as a result of an irrelevant protein contamination.
LEC
LEC
0
Activation of $T1$ inducing factor mediated by $T2$ converting enzyme.
interferon-gamma
interleukin-1beta
0
Furthermore, a partial $T1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, $T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TFIID
dTAFII60
0
Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the Grb2/$T1$$T2$/c-Cbl.
c-Cbl
Grb2
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the $T1$ fragment fused to Abeta, indicating that the observed $T2$-Abeta interaction was specific.
B42
Abeta
0
We recently reported that Ras interaction with the $T1$$T2$ (Raf-CRD, residues 139-184) may be required for Raf-1 activation.
Raf-1
Raf-1 cysteine-rich domain
0
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of $T1$$T2$ and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.
Vav
Vav
0
The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein $T1$ ($T2$).
Fas ligand
FasL
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or $T1$ in vivo, and the specificity of pRB or p107 binding is mediated by the $T2$ subunit.
p107
E2F
0
Here we show that beta:$T1$ binds to the $T2$ (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
beta activin
activin type II receptor kinase
1
Isothermal titration calorimetry shows that IFN-gamma SC1 forms a 1:1 complex with its high-affinity receptor ($T1$$T2$) with an affinity of 27(+/- 9) nM.
IFN-gamma
IFN-gamma R alpha
0
SF3a interacts with U2 snRNP in the presence of $T1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of $T2$ into the spliceosome.
SF3b
U2 snRNP
0
Together, these studies describe a third member of the PDGF family ($T1$) as a potent mitogen for cells of mesenchymal origin in in vitro and in vivo systems with a binding pattern similar to $T2$.
PDGF-C
PDGF-AB
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
MyoD
0
Interactions of the $T1$ protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, $T2$, and Bax, were explored with a yeast two-hybrid system.
Bcl-2
Mcl-1
1
Calreticulin, the soluble homologue of calnexin, was also shown to interact with $T1$$T2$, was also shown to interact with GT155 only when the protein bore a correctly modified oligosaccharide group.
GT155
calnexin
0
Although many different types of proliferating cells contain $T1$ protein, neither the interactions of $T2$ with cyclin/CDK complexes nor the consequences of this interaction during the mitotic cycle have been fully explored.
p27
p27
0
Two potentially oncogenic cyclins, cyclin A and $T1$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the $T2$ protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
cyclin D1
Rb
1
These results suggest that the RAD52-dependent processes, cell cycle control, $T1$$T2$-dependent processes, cell cycle control, p53-mediated pathway(s), and ubiquitination interact through human UBE2I.
p53
RAD52
0
Since $T1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an $T2$-p60-hsp70 complex.
hsp90
hsp90
0
We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the $T1$:$T2$ interaction and report here that CBP can activate transcription through a region in its carboxy terminus.
phosphoCREB
CBP
1
Mouse IL-10 does not bind to hIL-10R, and $T1$-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of $T2$.
hIL-10R
IL-10
0
However, MIP-1 beta was also an agonist for CC CKR3 but not $T1$; $T2$ was an agonist for CC CKR1 but not CC CKR3.
CC CKR1
MCP-3
0
When expressed in mammalian cells, the $T1$ binding domain of $T2$ can act as a dominant negative signal transduction blocker.
RAS
RIN1
1
Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with Syk--in particular, a serine/threonine phosphorylated protein 120 kDa in size ($T1$$T2$--in particular, a serine/threonine phosphorylated protein 120 kDa in size (pp120).
pp120
Syk
0
However, the various $T1$/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or $T2$ binding is mediated by the E2F subunit.
E2F
p107
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase ($T1$) blocked the binding of G beta gamma to $T2$; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
beta ARK
Raf/330
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$, a specific inhibitor of the interleukin-1 beta-converting enzyme.
interleukin-1 beta
CrmA
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, $T1$ (KDR)/$T2$ (Flk-1) and FLT-1.
kinase insert domain-containing receptor
fetal liver kinase 1
0
To determine the role of each of these receptors in $T1$ driven proliferation, $T2$ expression and proliferative capacity were monitored during mitogenic stimulation.
IL-7
IL-7R
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of $T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
QM
PS1
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and $T1$ co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
TBP
Oct1
1
TR6 ($T1$$T2$ (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.
decoy receptor 3
TR6
0
Here, we demonstrate that E2F-1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the $T1$$T2$ enhancer region and to interact with the NF-kappaB subunit, p50.
NF-kappaB
NF-kappaB
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein $T1$$T2$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.
MyoD
myogenic basic helix-loop-helix
0
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
sCAM
0
The death domain of $T1$ ($T2$) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.
tumor necrosis factor (TNF) receptor-1
TNFR1
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/$T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
CD3
CD5
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
IL 1ra
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and $T1$ competed for binding with IL-2, indicating that IL-15 uses components of the $T2$ receptor.
IL-15
IL-2
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits $T1$/$T2$ interaction.
CD30
CD30L
1
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T1$ ligand ( $T2$ / CD95L ) .
Fas
FasL
0
$T1$ prevents cyclinA/$T2$ containing E2F complexes formation in terminally differentiated myocytes.
MyoD
cdk2
0
Peptide growth factors, as well as the immediate early gene products c-Jun, $T1$, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with $T2$ products.
v-Fos
E2A
0
Both the GT155-calnexin and the GT155-$T1$ interactions were dependent on the presence of a correctly modified oligosaccharide group on $T2$, a characteristic of many calnexin interactions.
CAP-60
GT155
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
sCAM
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and $T1$$T2$ ) and HVEM / TR2 receptors .
HVEM
LTbetaR
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
keratinocyte growth factor
FGFR4
0
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the $T1$$T2$, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras/mitogen-activated protein kinase signal transduction pathway.
ras
JAK2
0
$T1$ also activated Stat5 in Ba/F3 cells that stably expressed the murine $T2$.
IL-10
IL-10 receptor
0
Interferon-gamma and several other cytokines that are known to activate $T1$ kinase were also found to stimulate $T2$ kinase activity toward MEK-1 in mammalian cells.
JAK2
Raf-1
0
Levels of p16(INK4a) and $T1$($T2$) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
p57
KIP2
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$$T2$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
IL-1beta
0
CD30 and its counter-receptor CD30 ligand ($T1$$T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30L
CD30
0
The T-cell antigen $T1$ acts as a receptor and substrate for the protein-tyrosine kinase $T2$.
CD5
p56lck
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
Estrogen Receptor
0
How Rb acts to bring about this suppression is not clear but one clue is that the $T1$ protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of $T2$ essential for such binding frequently contain mutations in tumour cells.
Rb
Rb
0
These results suggest that $T1$ can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with TFIID, in particular with $T2$.
RB
TAFII250
1
$T1$ ($T2$) expression in various cell types is induced by hypoxia and other stimuli.
Vascular endothelial growth factor
VEGF
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$, a mutant of $T2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FD5
Fas
0
CD5 associates with the $T1$ ($T2$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
TcR zeta
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the $T1$$T2$ observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex.
IFN-gamma
IFN-gamma
0
Sos in complex with a previously identified 90-kDa protein and designated protein $T1$$T2$ in complex with a previously identified 90-kDa protein and designated protein 80K-H.
80K-H
Sos
0
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
sE-selectin
0
$T1$ expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds $T2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.
rIL-10R
hIL-10
1
$T1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-7
keratinocyte growth factor receptor
1
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T1$) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sCAM
sVCAM-1
0
These data are consistent with a model wherein $T1$/CDK complexes sequester the $T2$-dependent kinase inhibitory activity of p27.
cyclin D
CDK2
0
Crystal structure of the $T1$ complexed with $T2$.
type-I interleukin-1 receptor
interleukin-1beta
1
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T2$.
IL-15
IL-2 receptor
0
Association of CDK4 with both $T1$ and $T2$ may also imply a mechanistic link between the functions of CDC37 and HSP90.
CDC37
HSP90
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ($T1$, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the $T2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
TRADD
p60
1
Regulation of the $T1$-related transcription factor $T2$ by binding to the retinoblastoma protein.
Ets
Elf-1
0
We find that p53, p21($T1$$T2$, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
CIP1
p53
0
hTAFII20 is the homologue of p22, an alternatively spliced form of d$T1$ ($T2$).
TAFII30 alpha
p32
0
The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus $T1$$T2$, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.
E1A
RIZ
0
Here we report the three-dimensional structure of $T1$ bound to the extracellular domain of $T2$ (s-IL1R) at 2.5 A resolution.
IL-1beta
IL1R
1
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$ or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
TBP
0
Here we show that QM/Jun-interacting factor (Jif)-1, a negative regulator of $T1$, is a candidate to mediate the function of $T2$ in the cell.
c-Jun
PS1
0
In the present study we evaluated tyrosine phosphorylation of $T1$ and the interaction of the Grb2/$T2$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
c-Cbl
c-Cbl
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T1$ (alpha1AT), and complement factors $T2$ and C4 can be used in the differential diagnosis of serous effusion.
alpha-1-antitrypsin
C3
0
In resting human epithelial and fibroblastic cells, $T1$ is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by $T2$ (GSK-3).
c-Jun
glycogen synthase kinase 3
1
We have cloned and characterized human $T1$ and a second isoform of human $T2$.
acidic (alpha 1-) syntrophin
basic (beta 2-) syntrophin
0
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the $T1$ receptor ($T2$) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).
insulin-like growth factor-I
IGF-IR
0
This $T1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-$T2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Lyn
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
sCAM
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S $T1$, which suggests a function for SF3a and $T2$ in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3b
0
Following this hypothesis, we altered in $T1$ and $T2$ residues predicted to reside in the contact region and to interact with each other.
hIL-6
hIL-6R
1
In vitro and in nonproliferating cells, $T1$ associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either $T2$, CDK6, or CDK2.
p27
CDK4
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T1$, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FD5
Fas
0
Furthermore, a partial TFIID complex containing Drosophila $T1$ (dTBP), human TAFII250, dTAFII60, and $T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TATA binding protein
dTAFII40
0
We have examined early signals triggered by $T1$ or $T2$ in a multifactor-dependent human erythroleukemic cell line, TF-1.
IL-11
IL-6
0
SF3a interacts with $T1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and $T2$ in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3b
0
$T1$ also interacts with TBP, but it interacts more strongly with hTAFII28 and $T2$.
hTAFII18
hTAFII30
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and $T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p21rac
cytochrome b558
0
RIN1 interacts with the "effector domain" of RAS and employs some $T1$ determinants that are common to, and others that are distinct from, those required for the binding of $T2$, a known RAS effector.
RAS
RAF1
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), $T1$, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
endothelin-1
soluble cell adhesion molecules
0
$T1$-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor $T2$.
CD4
CCR-5
0
hTAFII28 is a core $T1$ present in both of the previously described $T2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTFIID
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p67-phox
cytochrome b558
0
Activation of $T1$ upon ligand binding resulted in activation of $T2$ pathway.
FGFR3
mitogen-activated protein kinase
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of $T2$, utrophin/dystrophin related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin
1
The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [$T1$ ($T2$)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.
stromelysin-3
ST-3
0
We observed that the protein HOX11 interacted with protein $T1$$T2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
serine-threonine phosphatase 2A
serine-threonine phosphatase 2A catalytic subunit
0
Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/$T1$$T2$ homodimers via interaction with QM/Jif-1.
Jif-1
c-Jun
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$, and TRAFs) associated with both of the $T2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
p60
1
However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not $T1$$T2$ was an agonist for CC CKR1 but not CC CKR3.
CC CKR3
MCP-3
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$, and $T2$ competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.
IL-15
IL-15
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 ($T2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
PR
hsp90
0
The death domain of $T1$ (TNFR1) triggers distinct signaling pathways leading to apoptosis and $T2$ activation through its interaction with the death domain protein TRADD.
tumor necrosis factor (TNF) receptor-1
NF-kappa B
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell $T1$ complexes $T2$, hTAFII20 and hTAFII18.
TFIID
hTAFII28
0
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII
hTFIID
0
In the baculovirus coexpression system, $T1$ was activated by $T2$ in the presence of p21ras.
Raf-1
JAK2
1
The results show that myogenin heterodimerizes with E12 and $T1$$T2$ and E47 in vivo, but it does not homodimerize to a measurable extent.
E47
E12
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate $T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
$T1$ (neuromodulin, B-50, F1), a protein kinase C ($T2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
GAP-43
PKC
1
Computer-aided analysis of secondary structure, performed on four $T1$-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins $T2$ and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
RII
Ht 21
0
Crystal structure of the type-I $T1$ receptor complexed with $T2$.
interleukin-1
interleukin-1beta
0
Physical interaction of mammalian CDC37 with $T1$ .CDC37 was originally identified as a Start gene in budding yeast and has been shown to be required for association of $T2$ with cyclins.
CDK4
CDC28
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$$T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
UBE2I
UBC9
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed $T1$-$T2$ interaction was specific.
Abeta
Abeta
1
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha $T1$ and $T2$ were both potent agonists for CC CKR3 and CC CKR1.
MIP
RANTES
0
Two lines of evidence support the notion that $T1$ and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated $T2$ proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
RbAP46
Rb
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and $T1$$T2$, and Cockayne syndrome group B (CSB) protein.
Cockayne syndrome group B (CSB) protein
XPG
0
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that $T1$ did not transport $T2$ to the surface.
CD26
ADA
0
The crystal structure of the human $T1$ inhibitory domain bound to the phosphorylated cyclin A-cyclin-dependent kinase 2 ($T2$) complex has been determined at 2.3 angstrom.
p27Kip1 kinase
Cdk2
1
Flt1 and $T1$ have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor ($T2$).
Flk1
VEGF
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, cyclin E-$T2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Cdk2
Cdk2
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
NGF
p140trk (trkA) tyrosine kinase receptor
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 $T1$$T2$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
IL-7R
0
Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to $T1$, type IV collagen and $T2$, but did inhibit motility of keratinocytes on tissue culture plastic.
laminin 1
fibronectin
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and Fas ligand (FasL/$T2$).
herpes virus entry mediator (HVEM)-L
CD95L
0
As $T1$ forms complexes with beta 1 integrins and the integrins are known to regulate keratinocyte behaviour, we investigated $T2$ expression and function in human epidermal keratinocytes.
CD9
CD9
0
In vitro binding studies demonstrated that the intracellular segment of $T1$ binds directly to the intracellular domain of E-cadherin, but not to alpha- or $T2$.
PTPmu
beta-catenin
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IR beta
0
The X-ray structure of a $T1$-$T2$ receptor complex.
growth hormone
prolactin
0
$T1$ binds to $T2$ with a 1:1 stoichiometry.
IL-1beta
s-IL1R
1
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that $T1$ transactivation requires the interactions of both $T2$ and TFIIB.
HBx
RPB5
1
Previous studies on the assembly of progesterone receptor ($T1$$T2$ (PR) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.
PR
progesterone receptor
0
Molecular studies of the multiprotein TFIID complex have identified a primary $T1$ ($T2$), TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.
TATA binding subunit
TBP
0
Of these 400, interferon regulatory factor 4 (IRF4), $T1$$T2$ (IRF4), cyclin B2, TBP-associated factor, eukaryotic elongation factor and pim 2 were up-regulated more than 3.5 fold.
cyclin B2
interferon regulatory factor 4
0
The $T1$-susceptibility gene product binds directly to the human $T2$ TAFII250.
retinoblastoma
TATA-binding protein-associated factor
0
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like gammac, $T1$$T2$ are similar, and like gammac, IL-13Ralpha is located on chromosome X.
IL-13Ralpha
gammac
0
The catalytic domain of activated collagenase I ($T1$) is absolutely required for interaction with its specific inhibitor, $T2$ (TIMP-1).
MMP-1
tissue inhibitor of metalloproteinases-1
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-II
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ (PI 3-kinase).
PI 3-kinase
phosphatidylinositol 3-kinase
0
Here we report the three-dimensional structure of $T1$ bound to the extracellular domain of IL1R ($T2$) at 2.5 A resolution.
IL-1beta
s-IL1R
1
LEC induces chemotaxis and adhesion by interacting with CCR1 and $T1$$T2$ and CCR8.
CCR8
CCR1
0
The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that $T1$ dimer is formed through direct binding at two independent and differently oriented sites on $T2$.
gp130
IL-6
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component ($T2$) identical in sequence to the PTF gamma reported here.
TATA-binding protein
SNAPc43
0
Thus, $T1$ may serve as a link between $T2$ and PLC gamma 1, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.
pp120
Syk
1
As observed with the homologous Drosophila proteins, $T1$ interacts directly with $T2$; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.
hTAFII20
TBP
1
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that $T1$$T2$ or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
HBx
TFIIB
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with $T1$ and/or $T2$, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.
ErbB3
ErbB4
0
Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for EPO binding but is critical for $T1$$T2$ and EMP1 binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EMP1
EPO
0
Further, anti-CD5 and anti-$T1$$T2$ and anti-p56lck coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.
p56lck
CD5
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common $T1$ (gammac) for IL-4 signaling, it could not replace the function of $T2$ in allowing enhanced IL-2 binding activity.
cytokine receptor gamma chain
gammac
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and $T1$) that translocate to membrane and bind to $T2$.
p21rac
cytochrome b558
1
Associations of UBE2I with $T1$, UBL1, $T2$, and RAD51 proteins in a yeast two-hybrid system.
RAD52
p53
0
Moreover, mutation of $T1$ residues 143-145 impairs binding of 14-3-3, but not $T2$, to the Raf-CRD.
Raf-1
Ras
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$$T2$.
transporter associated with antigen processing
HLA-E
0
A model is presented whereby the trimeric complex of IL-6R, gp130, and $T1$$T2$, and IL-6M forms before the functional hexamer.
IL-6M
gp130
0
The retinoblastoma-susceptibility gene product binds directly to the human $T1$ $T2$.
TATA-binding protein-associated factor
TAFII250
0
Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase ($T1$$T2$ (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
P13-K
tyrosine kinase, phosphatidylinositol 3-kinase
0
The interaction between interleukin-6 (IL-6) and IL-6 receptor ($T1$) is the initial and most specific step in the $T2$ signaling pathway.
IL-6R
IL-6
0
We present evidence that $T1$ ($T2$ and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.
mitogen-activated protein-serine (MAP) kinases
pp54
0
Both the $T1$-calnexin and the GT155-$T2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
GT155
CAP-60
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and $T1$) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to $T2$.
gp91-phox
cytochrome b558
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-$T1$ complexes with $T2$.
CD4
CCR-5
1
These results suggest that both $T1$ and $T2$ receptors mediate positive inotropic responses at both the atrial and ventricular level in the human heart.
ET(A)
ET(B)
0
For the calibration, we used two sets of proteins, the Myc-Max-$T1$$T2$-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.
Mxi1
Max
0
TRADD-TRAF2 and $T1$-FADD interactions define two distinct $T2$ signal transduction pathways.
TRADD
TNF receptor 1
0
$T1$ and $T2$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.
Jak1
Jak3
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-$T2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, $T1$, USF, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
YY1
CTF
0
SF3a interacts with $T1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for $T2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3a
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex $T1$, the nucleotide excision repair protein $T2$, and Cockayne syndrome group B (CSB) protein.
TFIIH
XPG
0
Both the $T1$-$T2$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
GT155
calnexin
1
In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of $T1$ zeta tyrosine residues and increased $T2$ associated p56lck tyrosine kinase activity.
CD3
CD4
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin related protein
1
A region of the beta subunit of the $T1$ different from box 1 interacts with Jak1 and is sufficient to activate the $T2$-Stat pathway and induce an antiviral state.
interferon alpha receptor
Jak
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin ($T1$), and complement factors C3 and $T2$ can be used in the differential diagnosis of serous effusion.
alpha1AT
C4
0
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the $T1$ protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an $T2$ (SPF) as well as a candidate proto-oncogene.
Rb
S-phase-promoting factor
0
In this study the origin and function of the $T1$ and $T2$ molecules have been investigated.
p90
p76
0
The proximal sequence element (PSE)-binding transcription factor ($T1$$T2$ (PTF) specifically recognizes the PSEs of both RNA polymerase II- and RNA polymerase III-transcribed small nuclear RNA (snRNA) genes.
PTF
proximal sequence element (PSE)-binding transcription factor
0
This suggests that $T1$ may link $T2$ activation to molecules that regulate GTP binding proteins.
c-Cbl
TCR
0
Flt1 and $T1$ have been shown to play key roles in vascular development; these two receptors bind and are activated by $T2$ (VEGF).
Flk1
vascular endothelial growth factor
1
$T1$ utilizes two different pools of adapter protein $T2$ to link to Ras.
FGFR3
GRB2
0
Two previously unidentified human cdc25 genes have been isolated, $T1$$T2$ genes have been isolated, cdc25A and cdc25B.
cdc25A
cdc25
0
These antibodies specifically immunoprecipitate $T1$ in complex with $T2$ in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.
p23
hsp90
1
The apparent affinity of the interaction between $T1$ and CCR-5 was dramatically lower in the absence of soluble $T2$.
gp120
CD4
0
Expression of $T1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to $T2$.
FGFR3
FGF-1
0
We have previously identified a nuclear protein of M(r)265K, $T1$, that binds specifically to the $T2$-phosphorylated form of CREB.
CBP
PKA
0
$T1$ interacts with the "effector domain" of $T2$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.
RIN1
RAS
1
In addition we have been able to identify complexes of pRB and $T1$ in vivo that are dissociated in the presence of purified human papillomavirus $T2$ protein.
RBP1
E7
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
FADD
Fas
0
Analysis of p53, p21($T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
CIP1
p53
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of $T1$$T2$ may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-CRD
0
This region of the betaL chain, required for $T1$ binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with $T2$ kinases.
Jak1
Jak
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$$T2$, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
hyaluronic acid synthase 2
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for $T1$$T2$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
MCP-2
MIP-1beta
0
We used the interaction trap, a yeast genetic selection for interacting proteins, to isolate human $T1$ ($T2$).
cyclin-dependent kinase interactor 1
Cdi1
0
Co-expression of exogenous Fra1 restored the $T1$$T2$ restored the AP1 activity in a dose-dependent manner.
AP1
Fra1
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for $T1$$T2$ differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-X-S
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using $T1$$T2$ for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMP-2
BMP-2
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
p57
0
Bcl-2 also interacted with $T1$ and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as $T2$.
Bcl-X-L
Bcl-2
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, $T1$$T2$, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Bcl-X-L
Bcl-2
0
Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and $T1$$T2$ complex in SCF- and TPO-mediated myeloid cell proliferation.
TPO
c-Cbl
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Further investigation indicated that the $T1$/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/$T2$.
ITF-2b
HLH462
0
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, $T1$ and $T2$.
hTAF31
hTAF20/15
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
FADD
Fas
0
Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and $T1$$T2$ and bFGF.
bFGF
aFGF
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by $T1$$T2$ but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
c-Jun
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with $T1$ homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and $T2$, which interact with guanine nucleotide exchange factors specific for the Ras family.
Src
Crk-L
0
These proteins, $T1$ (PLA2) and $T2$ (HS1), are members of the 14-3-3 family of proteins.
14-3-3 zeta
14-3-3 beta
0
Endothelin-1 ($T1$) and $T2$ had a strong positive inotropic effect in all trabeculae.
ET-1
ET-3
0
The hGH and $T1$ receptors (hGHR and $T2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRL
hPRLR
1
These proteins, 14-3-3 zeta ($T1$) and $T2$ (HS1), are members of the 14-3-3 family of proteins.
PLA2
14-3-3 beta
0
Physical interaction of mammalian CDC37 with CDK4 $T1$ was originally identified as a Start gene in budding yeast and has been shown to be required for association of $T2$ with cyclins.
.CDC37
CDC28
0
Several genes are involved in this process, and two have been the focus of recent interest: the natural resistance-associated protein (NRAMP1) gene and the genes coding for the $T1$$T2$) gene and the genes coding for the vitamin D receptor.
vitamin D receptor
NRAMP1
0
Both the $T1$-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on $T2$, a characteristic of many calnexin interactions.
GT155
GT155
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ($T1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and $T2$.
TBP
hTAFII18
0
In this study, we demonstrate that CD5 is coupled to the protein-tyrosine kinase $T1$ and can act as a substrate for $T2$.
p56lck
p56lck
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the $T1$ and associates with $T2$ homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
TCR
Src
0
We now report the isolation and expression of cDNAs encoding PTF gamma and $T1$ delta, as well as functional studies with cognate antibodies that recognize the native $T2$ complex in HeLa extracts.
PTF
PTF
0
Characterization of a novel high affinity human $T1$$T2$.
IL-7
IL-7 receptor
0
We present evidence that mitogen-activated protein-serine (MAP) kinases ($T1$ and $T2$/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.
pp54
pp42
0
In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human IRS-1 and the $T1$$T2$.
insulin
insulin receptor
0
Crosslinking of iodinated acidic FGF (aFGF) and $T1$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and $T2$.
basic FGF
bFGF
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Interaction of p85 subunit of PI 3-kinase with $T1$$T2$ with insulin and IGF-1 receptors analysed by using the two-hybrid system.
insulin
PI 3-kinase
0
TRADD-TRAF2 and TRADD-$T1$ interactions define two distinct $T2$ signal transduction pathways.
FADD
TNF receptor 1
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$ / TR2 and LTbetaR , thereby suppressing $T2$-mediated HT29 cell death .
HVEM
LIGHT
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$ and $T2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3 IIIb
FGFR3 IIIc
0
Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes $T1$$T2$ is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.
Raf-1
Raf-1
0
These results indicated that HBx is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and TFIIB through communication with RPB5 and $T1$$T2$ and TFIIB.
TFIIB
RPB5
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding $T1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EBP
0
Crosslinking of iodinated $T1$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both $T2$ and bFGF.
acidic FGF
aFGF
0
The first cDNA from the $T1$ family to be cloned was designated E2F-1, and multiple $T2$ family members have now been identified.
E2F
E2F
0
The results are not due to general misfolding since mutant $T1$ monomers bind cAMP and inhibit the catalytic subunit of $T2$ with the same affinity and efficacy as wild-type RII beta dimers.
RII beta
PKAII beta
0
Recombinant $T1$ induces the tyrosine-phosphorylation of ErbB2, $T2$ and ErbB4 in cell lines expressing all of these ErbB-family receptors.
neuregulin-2beta
ErbB3
1
As observed with the homologous Drosophila proteins, $T1$ interacts directly with TBP; however, additional interactions between hTAFII20 and $T2$ or hTAFII30 were detected.
hTAFII20
hTAFII28
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein ($T1$), human $T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
dTBP
TAFII250
0
$T1$ is the homologue of p22, an alternatively spliced form of d$T2$ (p32).
hTAFII20
TAFII30 alpha
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, $T1$ (KDR)/fetal liver kinase 1 ($T2$) and FLT-1.
kinase insert domain-containing receptor
Flk-1
0
Each of these molecules binds to the type I $T1$ receptor ($T2$).
IL-1
IL1R
0
CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/$T1$$T2$/RANTES receptor).
RANTES
MIP-1 alpha
0
Secreted $T1$ is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface LT-alpha-$T2$ complex.
LT-alpha
LT-beta
0
On a cell membrane containing both proteins, $T1$ would 'lie down' parallel to the membrane, such that the HFE helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the $T2$ dimerization domain.
HFE
TfR
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IGF-1R beta
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
Nerve growth factor
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the $T1$, but neither of these proteins binds $T2$.
IL-2 receptor
IL-13
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of $T1$$T2$ may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-CRD
0
The human pituitary hormones, $T1$ (hGH) and $T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
prolactin
0
Interaction of the $T1$ subunit of PI 3-kinase with the insulin receptor ($T2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
p85
IR
0
These results suggest that $T1$ can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with $T2$, in particular with TAFII250.
RB
TFIID
0
$T1$ and $T2$ were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable "folding arrested" complexes with groEL.
Rhodanese
glutamine synthetase
0
Additional analysis revealed the presence of transcripts for both the activating ($T1$) and inhibitory ($T2$) isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.
ITF-2a
ITF-2b
0
p27Kip1 binds the complex as an extended structure interacting with both cyclin A and $T1$$T2$ and Cdk2.
Cdk2
cyclin A
0
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain hTAFII30 ($T2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID
0
Cotransfection of $T1$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor $T2$, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITRL
NF-kappaB
0
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: $T1$ and TPO, induce $T2$ tyrosine phosphorylation.
SCF
c-Cbl
1
The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the $T1$/$T2$, which belongs to the family of G protein-coupled receptors.
gastrin
CCKB receptor
0
We have exploited the availability of the cloned XPB, XPD, p62, p44, and $T1$ genes (all of which encode polypeptide subunits of $T2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p34
TFIIH
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$$T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
p53
0
The high affinity $T1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific $T2$ and the affinity converter/signal transducing protein gp130.
interleukin-6
IL-6 receptor
0
The $T1$-$T2$-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.
hsp90
p60
1
$T1$ and sP- and $T2$ levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.
Endothelin-1
sE-selectin
0
Phosphorylation of recombinant human $T1$ proteins in vitro by $T2$ decreases their DNA-binding activity.
c-Jun
GSK-3
1
$T1$: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the $T2$ activation domain.
JNK1
c-Jun
1
Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity $T1$$T2$s(BRIAec).
BMP receptor IA
BMP receptor IA extracellular domain
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta($T1$$T2$ beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
IGF-1R
0
The extracellular domain of the human $T1$$T2$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).
neurotrophin TRKB receptor
TRKB
0
$T1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate $T2$ activity toward MEK-1 in mammalian cells.
Interferon-gamma
Raf-1 kinase
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
interleukin (IL) 1
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ($T1$$T2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
PR
0
$T1$ and several other cytokines that are known to activate $T2$ kinase were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.
Interferon-gamma
JAK2
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-II
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the $T1$$T2$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
TCR
c-Cbl
0
Since hsp90 and $T1$ do not readily associate on their own, it appears that $T2$ is the central organizing component of an hsp90-p60-hsp70 complex.
hsp70
p60
0
The amount of CDK4 and $T1$ associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with $T2$ is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK6
p27
0
MAIN OUTCOME MEASURES: $T1$/$T2$ molar ratio after 7 days hospitalisation.
RBP
TTR
0
This observation supports a model in which p60 functions at an intermediate stage of $T1$$T2$ functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.
PR
p60
0
These data suggest that anchoring proteins interact with $T1$$T2$ alpha via an amphipathic helix binding motif.
RII alpha
RII
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three $T1$$T2$ to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-R2
TNF-beta
0
Bcl-2 also interacted with $T1$ and Mcl-1 and with the dominant inhibitors $T2$ and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-X-L
Bax
0
The interactions between $T1$ and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both $T2$ and Shc.
GRB2
IRS-1
0
Analysis of p53, p21($T1$), p15(INK4b), p16(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
CIP1
KIP2
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of $T1$$T2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
phosphatidylinositol 3-kinase
p85
0
Subsequently, supernatants from selected cell lines were fractionated directly by receptor affinity chromatography, resulting in the single-step purification of $T1$, a protein previously identified as the product of an early response gene induced by $T2$.
B61
tumour necrosis factor-alpha
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including Sp1, YY1, USF, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
CTF
0
Competitive binding of $T1$ and calmodulin to the $T2$.
alpha-actinin
NMDA receptor
1
Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) TFIID, termed $T1$$T2$, termed hTAFII32.
hTAFII32
TFIID
0
$T1$ contains a death domain homologous to the death domains of Fas and $T2$.
FADD
TNFR-1
0
Cloning of $T1$, a ligand for $T2$ on human T cells.
TRAP
CD40
1
Syk and $T1$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified $T2$ and Lyn reassociated in vitro, demonstrating their direct interaction.
Lyn
Syk
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, tonin, D and $T1$$T2$-forming enzymes, starting with isorenin, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
G cathepsin
angiotensin
0
This suggests that one domain of IFN-gamma is sufficient to recruit $T1$$T2$ is sufficient to recruit IFN-gamma R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma
0
Y429 and Y441 occur in an imperfect $T1$ ($T2$)-like sequence.
immunoreceptor tyrosine-based activation motif
ITAM
0
Our results indicate that the trkA and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity $T1$$T2$ and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
NGF
trkA
0
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, $T2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
USF
1
Using co-immunoprecipitation and protein-protein association assays, we show that both $T1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with $T2$.
c-Fos
TBP
0
GAP-43 ($T1$, B-50, F1), a $T2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
neuromodulin
protein kinase C
1
In addition, $T1$ in the lysate complexes with wild-type $T2$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.
hsp90
pp60v-src
1
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the $T1$$T2$ bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
B42
Abeta
0
A secondary consequence of destabilizing RII beta dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind $T1$$T2$ dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind AKAP75.
AKAP75
RII beta
0
Isothermal titration calorimetry shows that $T1$ forms a 1:1 complex with its high-affinity receptor ($T2$) with an affinity of 27(+/- 9) nM.
IFN-gamma SC1
IFN-gamma R alpha
1
The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T1$ ($T2$).
brain-derived neurotrophic factor
BDNF
0
Human $T1$, a new cyclin that interacts with two members of the $T2$ gene family.
cyclin E
CDC2
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
TR6
0
The similarities in biofunctions and differences in ligand binding proteins between IL-11 and $T1$ prompted us to investigate whether $T2$ shares common signal transduction mechanisms with IL-6.
IL-6
IL-11
0
The activation domain of $T1$ interacts with the basal transcription factor $T2$ through a domain that is conserved in the yeast coactivator ADA-1 (ref.
CBP
TFIIB
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T1$) and $T2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.
TAP
calreticulin
0
A 51-residue region from the conserved C-terminal region of $T1$, previously shown to be the binding site for the viral activator protein E1A, interacts with $T2$ and c-Jun proteins.
TBP
c-Fos
1
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the $T1$$T2$ and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.
bcl-2
p16
0
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD5
CD3
0
In the end we refer to the relations between circulating $T1$ of renal origin and the extrarenal $T2$ specific to tissue underlying the fact that the two RAS components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.
RAS
RAS
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$$T2$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.
CCKB G protein-coupled receptor
IRS-1
0
The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-$T1$ ($T2$) complex has been determined at 2.3 angstrom.
cyclin-dependent kinase 2
Cdk2
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. $T1$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as $T2$.
Bcl-X-L
Bcl-2
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
insulin receptor substrate 1
insulin
0
A double point mutation in the activation domain of $T1$ impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both $T2$ and TAFII60.
p53
TAFII40
1
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble $T1$ interacts specifically with $T2$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
CD4
CCR-5
1
The tumor-free patients expressed $T1$ at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of $T2$ compared to healthy controls ( P<0.0001).
granulysin
granulysin
0
Temporally following this growth arrest, the cells develop a senescence morphology and express $T1$$T2$ (SA-beta-gal).
senescence-associated beta-galactosidase
beta-galactosidase
0
The predicted amino acid sequence of $T1$ is 60% identical and 73% similar to mouse $T2$ (mIL-10R).
hIL-10R
IL-10R
0
An arginine side chain (arginine-789) of $T1$ is supplied into the active site of $T2$ to neutralize developing charges in the transition state.
GAP-334
Ras
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with $T1$; however, additional interactions between hTAFII20 and hTAFII28 or $T2$ were detected.
TBP
hTAFII30
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and $T1$ or $T2$ (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMPR-II
ActR-II
0
However, the function of HSP27 and the identity of proteins that interact with $T1$$T2$ and the identity of proteins that interact with HSP27 remain unknown.
HSP27
HSP27
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and $T2$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
0
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, $T1$ and Shc, which specifically binds the SH2 domain of $T2$ with high affinity.
EGFR
GRB2
1
$T1$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the $T2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
alpha-Actinin-2
NMDA receptor
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$ and TATA-bound TBP during promoter activation.
TBP
PTF
0
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the $T1$$T2$ that binds and phosphorylates the c-Jun activation domain.
c-Jun
Ha-Ras
0
The Fos/$T1$ and $T2$/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
Jun
ATF
0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant CBP and p300 (a $T1$$T2$ (a CBP-related protein).
CBP
p300
0
The helical cytokine interleukin (IL) 6 and its specific binding subunit $T1$ form a 1:1 complex which, by promoting homodimerization of the signalling subunit $T2$ on the surface of target cells, triggers intracellular responses.
IL-6R alpha
gp130
0
$T1$, alpha1AT, and complement factors $T2$ and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
TNFalpha
C3
0
Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring $T1$$T2$ reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
cAMP-dependent protein kinase II beta
0
Sequential immunoprecipitation identified the 72-kDa protein associated with $T1$ as $T2$.
PLC gamma 1
Syk
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
cyclinA
0
The cloning of a complementary DNA encoding a human $T1$ TAF, $T2$, that has no known homolog in Drosophila TFIID is now described.
TFIID
TAFII55
0
$T1$ is a ligand for the $T2$.
B61
ECK receptor protein-tyrosine kinase
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein $T1$ and the pocket proteins pRb, p107 and $T2$/p130.
MyoD
pRb2
0
We observed that the protein $T1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as protein phosphatase 1 ($T2$) in mammalian cells.
HOX11
PP1C
1
$T1$ also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the $T2$.
Inhibin
ActRII
0
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase $T1$/56Lyn ($T2$) contribute to signaling via the B-cell antigen receptor complex.
p53
Lyn
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or $T1$$T2$ but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TFIIIB
TBP
0
In vitro and in vivo experiments support the hypothesis that Grb2 mediates the association of $T1$$T2$ mediates the association of c-Kit with c-Cbl.
c-Kit
Grb2
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, $T2$ (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/CD95L).
TR6
LIGHT
1
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for $T1$ signaling, it could not replace the function of gammac in allowing enhanced $T2$ binding activity.
IL-4
IL-2
0
Analysis of the human interleukin-6/human $T1$$T2$ receptor binding interface at the amino acid level: proposed mechanism of interaction.
interleukin-6 receptor
interleukin-6
0
IL-2, $T1$, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and $T2$.
IL-4
Jak3
0
In addition, hsp90 in the lysate complexes with wild-type $T1$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with $T2$.
pp60v-src
hsp90
0
The $T1$/Jun and ATF/$T2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
Fos
CREB
0
In addition, $T1$ associates with three different CDKs: CDK2, $T2$, and CDK6.
p27
CDK4
1
We screened for proteins that bind to $T1$ from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the QM/$T2$ gene.
PS1
Jif-1
1
RESULTS: $T1$, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-$T2$.
TH
GCH
0
$T1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as $T2$.
Bcl-2
Bcl-2
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / TR2 and $T1$ , thereby suppressing $T2$-mediated HT29 cell death .
LTbetaR
LIGHT
0
These data imply that IL-6-induced dimerization of $T1$$T2$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
sIL-6R
IL-6
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with $T1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component ($T2$) identical in sequence to the PTF gamma reported here.
PTF
SNAPc43
0
In patients with a complete response to IFN-alpha, the levels of IFN-gamma were higher at 24 weeks following $T1$ treatment than that of pre-treatment (P = 0.04), and the levels of $T2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-alpha
IL-4
0
These results suggest that distinct domains of $T1$ participate in the TNF signaling cascades leading to apoptosis and $T2$ activation.
RIP
NF-kappa B
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk ($T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
trkA
p140trk (trkA) tyrosine kinase receptor
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor
IFN-gamma receptor alpha chain
0
$T1$ suppresses the function of $T2$ homodimers via interaction with QM/Jif-1.
Presenilin 1
c-Jun
0
The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like $T1$, human $T2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 1-syntrophin
beta 2-syntrophin
0
We report here that recombinant B61 induces autophosphorylation of ECK in intact cells, consistent with $T1$ being an authentic ligand for $T2$.
B61
ECK
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with PTF, consistent with the previous report of a PTF-related complex ($T2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TBP
SNAPc
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
TRAF2
0
We recently reported that Ras interaction with the $T1$ cysteine-rich domain ($T2$, residues 139-184) may be required for Raf-1 activation.
Raf-1
Raf-CRD
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$, fibromodulin, and $T2$) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
decorin
0
The $T1$ is located in the NH2-terminal negative regulatory domain of $T2$ and is highly homologous to cysteine-rich domains found in protein kinase C family members.
Raf-CRD
Raf-1
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as $T1$, HCC-4, $T2$, and CCL16.
LMC
NCC-4
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T1$/ $T2$) oligomers in the absence of ligand.
BR-Ia
BR-Ib
1
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
TBP
Oct1
0
In addition, a possible role for Gas6, the product of $T1$$T2$, the product of growth arrest-specific gene 6, in atherosclerotic lesion development is put into perspective.
growth arrest-specific gene 6
Gas6
0
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, $T2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
YY1
1
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human $T2$ and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6D
IL-6
0
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of $T1$: $T2$ itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.
Fas
Fas
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$) protein MyoD and the pocket proteins pRb, p107 and $T2$/p130.
bHLH
pRb2
0
$T1$ contains a region of homology to a yeast vacuolar sorting protein, and overexpression of $T2$ decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.
SNX1
SNX1
0
Discrete protein interactions with the Grb2/c-Cbl complex in $T1$$T2$ complex in SCF- and TPO-mediated myeloid cell proliferation.
SCF
c-Cbl
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
interleukin-1 beta
Fas
0
IL-10 also activated $T1$ in Ba/F3 cells that stably expressed the murine $T2$.
Stat5
IL-10 receptor
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), endothelin-1, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
soluble cell adhesion molecules
0
Crystal structure of the hereditary haemochromatosis protein $T1$ complexed with $T2$ receptor.
HFE
transferrin
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$ (TAP) and calreticulin, and that $T2$ expression is TAP-dependent and tapasin-dependent.
transporter associated with antigen processing
HLA-E
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase ($T1$), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I ($T2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
TH
GCH
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and Fas ligand (FasL/$T2$).
HVEM
CD95L
0
The interaction between interleukin-6 ($T1$) and IL-6 receptor (IL-6R) is the initial and most specific step in the $T2$ signaling pathway.
IL-6
IL-6
0
Additionally we have examined interactions between TFIIH components, the human NER protein $T1$, and the $T2$ protein which is implicated in Cockayne syndrome (CS).
XPG
CSB
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$$T2$/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
HVEM
0
The interactions between $T1$ and these two proteins require ligand activation of the $T2$ and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and Shc.
GRB2
insulin receptor
0
$T1$ induces chemotaxis and adhesion by interacting with CCR1 and $T2$.
LEC
CCR8
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ receptor ( LTbetaR ) and HVEM / TR2 receptors .
lymphotoxin beta receptor
lymphotoxin beta
0
Interactions of the $T1$ protein with itself and other members of the Bcl-2 family, including Bcl-X-L, $T2$, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bcl-2
Bcl-X-S
1
Here we show that the general transcription factor $T1$ is also a target for a transcriptional activator, namely serum response factor ($T2$), which binds to the c-fos promoter.
TFIIF
SRF
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 $T1$$T2$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
IL-7R
p90
0
We find that p53, p21(CIP1) and p15($T1$$T2$(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
INK4b
p21
0
We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-$T1$ was capable of precipitating $T2$ from T cell lysates.
CD26
CD45
0
This $T1$-$T2$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Lyn
1
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$ (IGF-I) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
insulin-like growth factor-I
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Cross-family dimerization of transcription factors $T1$/Jun and ATF/$T2$ alters DNA binding specificity.
Fos
CREB
0
Using a soluble $T1$/$T2$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD8alpha
0
A large epitope 1 for high-affinity $T1$ binding was detected spanning the interface of the $T2$ dimer.
BMPR-IA
BMP-2
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T2$ complexes containing hsp70 and Hip (p48).
heat shock protein 90
PR
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the $T1$$T2$) and the BMP type II receptor (BR-II).
BMP type II receptor
BR-Ib
0
We suggest that activation of the cell cycle by the Ras/$T1$ pathways might be mediated in part by $T2$.
Raf1
Cdc25
0
Nuclear protein $T1$ is a coactivator for the transcription factor $T2$.
CBP
CREB
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T1$$T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
TAP
HLA-E
0
Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and $T1$ binding activities of $T2$.
AKAP75
RII beta
1
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named $T1$, for $T2$.
RIP
receptor interacting protein
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T1$/$T2$ ligation.
TcR zeta
CD3
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T2$ activity and the inability of cells to re-enter the cell cycle.
cdk2
E2F
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both $T1$$T2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
NR1
alpha-Actinin-2
0
Scatchard analysis of in vitro binding between Raf/330 and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and $T1$$T2$ revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and beta ARK (Kd = 87 +/- 24 nM).
beta ARK
G beta gamma
0
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and $T1$$T2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
Ht 31
P150
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$$T2$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.
IL-15
IL-2
0
Flow cytometric analysis demonstrated high levels of perforin and $T1$$T2$ and granulysin expression by CD3(-) CD16(+) cells in healthy controls.
granulysin
perforin
0
Suramin induced high-affinity trimerization of $T1$ (Kd = 0.10 microM at 20 degrees C) and dimerization of $T2$ (Kd = 0.86 microM at 20 degrees C).
C8
C9
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, $T1$, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
CTF
E1A
0
Surprisingly, the N-terminal third of GAP-43 alone bound $T1$ more strongly than did intact $T2$, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.
CaM
GAP-43
1
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the $T1$ SH2 domain, with the SCF-activated $T2$.
Grb2
c-Kit
1
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the $T1$$T2$, a central component of the ras/mitogen-activated protein kinase signal transduction pathway.
ras
Raf-1
0
In addition, previous work indicated that p300 and $T1$ might be involved in $T2$-mediated repression.
CBP
YY1
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ($T2$).
heat shock protein 90
p48
0
$T1$ and IGIF were diminished in the sera of $T2$-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
Interferon-gamma
ICE
0
Determination of TNFalpha, complement factors C3 and C4, and $T1$$T2$, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
alpha1AT
C4
0
The objective of this study was to measure the concentrations of $T1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and $T2$ can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
C4
0
Cross-linking of 125I-$T1$ and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three $T2$ molecules.
TNF-alpha
TNF-R2
0
Inhibin also binds to $T1$ through its beta subunit, competes with the binding of activin to ActRII, but fails to form the $T2$.
ActRII
ActRII
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$$T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
FADD
0
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase $T1$/$T2$ (Lyn) contribute to signaling via the B-cell antigen receptor complex.
p53
56Lyn
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T1$), $T2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
hsp90
p23
0
$T1$ binds independently to two transmembrane receptors, the $T2$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p75 neurotrophin receptor
1
TNFalpha, $T1$, and complement factors $T2$ and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
alpha1AT
C3
0
Identification of $T1$ will further promote our understanding of the control of eosinophil trafficking and other $T2$-mediated biological phenomena.
eotaxin-3
CCR3
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
p85
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T1$ binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPOR
1
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T1$$T2$, indicating that IL-15 uses components of the IL-2 receptor.
IL-2 receptor
IL-2
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the $T1$$T2$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
p76
IL-7
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules $T1$ and beta, transforming growth factors (TGF) beta1 and 2, $T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
tumour necrosis factors (TNF) alpha
interleukin (IL) 1
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
phosphatidylinositol 3-kinase
gastrin
0
$T1$: a novel protein containing a death domain that interacts with Fas/$T2$ (CD95) in yeast and causes cell death.
RIP
APO-1
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$$T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
transporter associated with antigen processing
HLA-E
0
A GT155 mutant that was not glycosylated (AGGT155) did not associate with calnexin or $T1$$T2$ or CAP-60.
CAP-60
calnexin
0
All CC-chemokines currently available were tested for their ability to compete with [(125)I]-$T1$ binding on a stable cell line expressing recombinant $T2$, and/or to induce a functional response in these cells.
MIP-1beta
CCR5
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, $T1$$T2$, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Mcl-1
Bcl-X-L
0
Cloning and characterization of a specific $T1$ binding protein structurally related to the $T2$ receptor alpha chain.
interleukin (IL)-13
IL-5
0
Crosslinking of iodinated acidic FGF ($T1$) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and $T2$.
aFGF
bFGF
0
Human RIN1 was first characterized as a $T1$$T2$ binding protein based on the properties of its carboxyl-terminal domain.
RAS binding protein
RAS
0
An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/$T1$$T2$) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.
TNF-R2
TNF-R2
0
Using the human $T1$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein $T2$.
RAD52
UBL1
0
In competition experiments, the carboxyl terminus of $T1$ ($T2$) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
beta-adrenergic receptor kinase
beta ARK
0
$T1$ was first characterized as a receptor for MIP-1alpha, $T2$, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).
CCR5
MIP-1beta
1
Both $T1$ and $T2$ bind to all E2F family members in vivo, and each complex is capable of activating transcription.
hDP-1
hDP-2
0
Activation of $T1$$T2$ mediated by interleukin-1beta converting enzyme.
interferon-gamma
interferon-gamma inducing factor
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T1$, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$$T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p75
0
TNFalpha, alpha1AT, and complement factors $T1$ and $T2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.
C3
C4
0
Here we show that $T1$ and $T2$ from human B lymphocytes can interact directly.
Syk
Lyn
1
Molecular studies of the multiprotein TFIID complex have identified a primary TATA binding subunit ($T1$$T2$ complex have identified a primary TATA binding subunit (TBP), TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.
TBP
TFIID
0
$T1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the $T2$/RANTES receptor).
CC CKR3
MIP-1 alpha
0
We demonstrate that $T1$ forms a specific complex with the cytoplasmic domain of the $T2$ when both are expressed as hybrid proteins in yeast cells.
IRS-1
insulin receptor
1
Furthermore, a partial $T1$ complex containing Drosophila TATA binding protein (dTBP), human $T2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TFIID
TAFII250
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T1$ ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO-binding protein
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing $T1$$T2$, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Bcl-X-S
Bcl-2
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding $T1$$T2$) receptor are important for binding EPO and EPO mimetic peptide.
EPO
EPO
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ (delta C-43).
delta C-4
IGF-1R beta
0
Both the GT155-calnexin and the $T1$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many $T2$ interactions.
GT155
calnexin
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector $T1$$T2$ downstream effector p21 are induced.
p21
MyoD
0
In the yeast-based cloning system, the only strong interaction that was detected between $T1$ and the calcium effector protein, $T2$ (CaM).
GAP-43
calmodulin
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
CD14
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta receptor
lymphotoxin beta
0
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein $T1$, regulated on activation, normal T expressed and secreted (RANTES), and monocyte chemoattractant protein-3 ($T2$), but the receptors involved have not been defined.
(MIP)-1 alpha
MCP-3
0
We report chemotaxis and competitive binding studies that show $T1$ binds to and activates $T2$ and CCR8 transfected HEK-293 cells.
LEC
CCR1
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$, p67-phox, and $T2$) that translocate to membrane and bind to cytochrome b558.
p47-phox
p21rac
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T1$$T2$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
Both hDP-1 and $T1$ bind to all $T2$ family members in vivo, and each complex is capable of activating transcription.
hDP-2
E2F
0
Based on the structure of the closely related $T1$-tumor necrosis factor receptor I complex, a molecular model of the $T2$ homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.
lymphotoxin alpha
FasL
0
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring $T1$ (beta-galactosidase) and $T2$ (leucine utilization) genes under the control of LexA-dependent operators.
lacZ
LEU2
0
Unlike human $T1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral IL-6-$T2$ binding interfaces.
IL-6
gp130
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral $T1$ and human $T2$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.
IL-6
gp130
1
Characterization of Fas (Apo-1, CD95)-$T1$$T2$ interaction.
Fas
Fas ligand
0
Shared and unique determinants of the $T1$ ($T2$) receptor are important for binding EPO and EPO mimetic peptide.
erythropoietin
EPO
0
The correlation of SRF-RAP74 binding with transcriptional activation suggests that $T1$$T2$-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.
RAP74
SRF
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30L
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/BR-II, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
We recently reported that Ras interaction with the $T1$ (Raf-CRD, residues 139-184) may be required for $T2$ activation.
Raf-1 cysteine-rich domain
Raf-1
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
LexA
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained $T2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
neurotrophin-3
0
A physical interaction between $T1$ and CDK4 suggests that $T2$ may regulate the mammalian cell cycle through a direct effect on CDK4.
CDC37
CDC37
0
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
p60
hsp90
0
IL-2, $T1$$T2$, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-4
IL-2
0
Furthermore, the amount of $T1$ is significantly lower than the amount of $T2$ in these cells.
p27
cyclin D3
0
Mutations within the KDR site had minimal effect on $T1$$T2$ site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect KDR binding.
FLT-1
KDR
0
The phagocyte NADPH oxidase is a complex of membrane $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
cytochrome b558
NADPH oxidase
0
The $T1$-p60-$T2$ multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.
hsp90
hsp70
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
FADD
LPR
0
In addition, we show that in extracts depleted of $T1$ and $T2$-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific $T1$$T2$ is a TFIID beta-specific hTAFII.
hTAFII
hTAFII18
0
Specific cleavage of laminin-5 ($T1$) by matrix metalloprotease-2 ($T2$) was shown to induce migration of breast epithelial cells.
Ln-5
MMP2
1
CD5 associates with the $T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
T-cell receptor zeta chain (TcR zeta)/CD3
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$ (Immunotech, France), $T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
endothelin-1
0
The amount of $T1$ and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of $T2$ associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK4
CDK2
0
p23 is also present in immunoaffinity-purified $T1$ complexes along with $T2$ and another protein, p60.
hsp90
hsp70
0
Interactions with human $T1$ and mouse $T2$ were confirmed using glutathione transferase-tagged cDNAs.
PARP
replication factor 1a
0
$T1$ ($T2$) induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.
Bone morphogenetic protein-2
BMP-2
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, $T1$$T2$, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
RIP
TRADD
0
The screen identified interactions involving $T1$ and two 14-3-3 isoforms, $T2$, human unconventional myosin IC, and a recently identified SH3 domain containing protein, SH3 P17.
c-Cbl
cytokeratin 18
1
Vav/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which $T1$$T2$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.
c-Cbl
c-Cbl
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing $T1$$T2$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PLC gamma 1 resembled the $T1$$T2$ resembled the Syk-associated pp120 by several criteria.
Syk
PLC gamma 1
0
Cloning and characterization of hTAFII18, $T1$ and $T2$: three subunits of the human transcription factor TFIID.
hTAFII20
hTAFII28
1
We have detected a specific association of $T1$ with the molecular chaperon HSP90 and a 44-kDa protein that we identify as mammalian $T2$.
CDK4
CDC37
1
Significantly, $T1$ partially activates $T2$ and potentiates the activation caused by UV.
Ha-Ras
JNK1
1
HFE binds to the transferrin receptor ($T1$), a receptor by which cells acquire iron-loaded $T2$.
TfR
transferrin
0
$T1$ interacts with $T2$ and SDF-1 with CXCR4 receptors.
RANTES
CCR5
1
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R beta
IGF-1R
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
sE-selectin
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
TR6
LTbetaR
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-$T1$$T2$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.
hsp70
hsp70
0
The Fos/$T1$$T2$/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.
Jun
Fos
0
Analysis of p53, p21(CIP1), p15($T1$$T2$(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
p15
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
p57
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor alpha chain
IFN-gamma
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
p21CIP1
Cdk4
0
RESULTS: TH, $T1$ and $T2$ were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-GCH.
AADC
GCH
0
We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, $T1$ and RBP2, cloned originally by their interaction with $T2$.
RBP1
pRB
1
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ are important for binding EPO and EPO mimetic peptide.
EPO
erythropoietin (EPO) receptor
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$), whereas FGF-2 binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
KGFR
FGFR4
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T1$ binding: MCP-2, MCP-3, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-4
1
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and $T1$$T2$ family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bax
Bcl-2
0
As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted pp60src multiprotein complex contains $T1$, which is a major candidate for providing the protein unfoldase activity required for $T2$ association.
hsp70
hsp90
0
Two proteins have been described as constituents of the $T1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds $T2$.
IL-4
IL-13
0
Through their interaction with the ErbB family of receptors ($T1$, ErbB3 and $T2$), neuregulins help to regulate cell growth and differentiation in many tissues.
ErbB2
ErbB4
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for $T1$$T2$ differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-X-S
0
Moreover, $T1$ was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by $T2$ in vitro.
cyclin D1
pp60c-src
1
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor ($T1$$T2$ (SPF) as well as a candidate proto-oncogene.
SPF
S-phase-promoting factor
0
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the $T1$$T2$-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
B42
LexA
0
MMP2 cleaved the Ln-5 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on $T1$$T2$ gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.
Ln-5
Ln-5
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits $T1$ and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and $T2$) that translocate to membrane and bind to cytochrome b558.
p22-phox
p21rac
0
Thus, TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$- and LIGHT-mediated cell death.
LIGHT
FasL
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$ related protein, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin
0
We further demonstrated that apolipoprotein E2 and E3 but not $T1$$T2$ and E3 but not apolipoprotein E4 can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.
apolipoprotein E4
apolipoprotein E2
0
Surprisingly, the N-terminal third of $T1$ alone bound $T2$ more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.
GAP-43
CaM
1
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
CD3
CD3
0
Here we report that stimulation of $T1$-mediated transcription by $T2$ is partially abrogated at the nonpermissive temperature in ts13 cells.
Sp1
RB
0
The structures of TfR alone and complexed with $T1$ differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between $T2$ chains.
HFE
TfR
0
Gastrin stimulates tyrosine phosphorylation of $T1$$T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
insulin receptor substrate 1
insulin
0
Activation of $T1$ mediated by $T2$.
interferon-gamma inducing factor
interleukin-1beta converting enzyme
1
Following gastrin stimulation, we observed a time- and dose-dependent association of $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
IRS-1
gastrin
0
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine $T1$$T2$), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
glucocorticoid-induced TNFR-related (mGITR) protein
hGITRL
0
Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and $T1$$T2$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.
hsp70
hsp70
0
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the $T1$ alpha helix and, in particular, on a triad of $T2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
p53
p53
0
The sequences that confer on $T1$ its specific binding to $T2$ have not been identified.
FGF-7
KGFR
1
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor $T1$, via a pathway that appeared to involve TNFR-associated factor 2 ($T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
TRAF2
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human $T1$ and the extracellular ("soluble") portions of the $T2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
IL-6 receptor
0
The switch II region of $T1$ is stabilized by $T2$, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.
Ras
GAP-334
1
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated $T1$$T2$-associated Rb-kinase activity.
Rb
p27
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-$T1$, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
Cdk2
cyclin D2
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$/CCKB G protein-coupled receptor and the $T2$ receptor.
gastrin
insulin
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T2$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
0
Presenilin 1 ($T1$$T2$ (PS1) mutations account for the majority of early-onset dominant cases of familial Alzheimer's disease.
PS1
Presenilin 1
0
We found that ADA was associated with CD26 on T cell lines lacking either ADA or $T1$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
dipeptidyl peptidase IV
ADA
0
$T1$ can bind either $T2$ or hsp90 independently and in an ATP-independent manner.
P60
hsp70
1
Here, a direct interaction between the activation domain of $T1$ and two subunits of the TFIID complex, $T2$ and TAFII60, is reported.
p53
TAFII40
1
Cyclin E showed genetic interactions with the CDC28 gene, suggesting that it functioned at START by interacting with the $T1$$T2$ gene, suggesting that it functioned at START by interacting with the CDC28 protein.
CDC28
CDC28
0
Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 ($T1$) that activates human $T2$.
IL-6
gp130
1
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$$T2$/CCKB G protein-coupled receptor and the insulin receptor.
CCKB
gastrin
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$$T2$/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
FLICE
0
In contrast, in the absence of p21ras, coexpression of JAK2 and $T1$$T2$, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.
Raf-1
p21ras
0
Cotransfection of $T1$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 ($T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITRL
TRAF2
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to $T1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of $T2$ and c-Jun are necessary and sufficient for stable association with TBP.
TBP
c-Fos
0
The interaction of UBE2I with $T1$ is mediated by $T2$'s self-association region.
RAD52
RAD52
0
Endothelin-1 ($T1$$T2$ (ET-1) and ET-3 had a strong positive inotropic effect in all trabeculae.
ET-1
Endothelin-1
0
We now show that full-length RIN1 interacts with activated $T1$ in mammalian cells and defines a minimum region of 434 aa required for efficient $T2$ binding.
RAS
RAS
0
Only weak $T1$ binding activity was found in cells transfected with only $T2$; however, the combination of both IL-13Ralpha and IL-4Ralpha resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the IL-13 receptor.
IL-13
IL-13Ralpha
1
We found that $T1$ and $T2$ can form a physical complex.
YY1
Sp1
1
$T1$ also interacts weakly with the $T2$ tumor necrosis factor receptor (TNFR1) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.
RIP
p55
0
Intriguingly, NR1-$T1$ binding is directly antagonized by Ca2+/$T2$.
alpha-actinin
calmodulin
0
Although the individual amino acids in TrkA involved in binding to $T1$ (NGF) and those in TrkC involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
neurotrophin-3
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase ($T1$) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, $T2$ and 14-3-3, had no effect.
beta ARK
Ras
0
hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast $T1$$T2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.
TAFIISPT3
hTAFII18
0
The cytokine-activated tyrosine kinase $T1$ activates $T2$ in a p21ras-dependent manner.
JAK2
Raf-1
1
Molecular determinants of the interaction between the C-terminal domain of Alzheimer's $T1$ and $T2$ alpha-helices.
beta-amyloid peptide
apolipoprotein E
1
Coexpression of the alpha and betaL subunits of the human interferon alpha ($T1$) receptor is required for the induction of an antiviral state by human $T2$.
IFNalpha
IFNalpha
0
The first cDNA from the $T1$ family to be cloned was designated $T2$, and multiple E2F family members have now been identified.
E2F
E2F-1
0
In addition, previous work indicated that $T1$ and $T2$ might be involved in YY1-mediated repression.
p300
CBP
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-$T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
Estrogen Receptor
0
Measurement of $T1$ I3A,I5A interaction with the human thyroid AKAP, $T2$, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.
RII alpha
Ht 31
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-2
FGFR2 IIIb
0
Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, $T1$$T2$ subunits hTAF80, hTAF31 and hTAF20/15.
hTAF31
TFIID
0
Molecular studies of the multiprotein TFIID complex have identified a primary $T1$$T2$ complex have identified a primary TATA binding subunit (TBP), TBP-associated factors (TAFs) that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation.
TATA binding subunit
TFIID
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with $T1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
PTF
PTF
0
The carboxy-terminal region of dystrophin has previously been shown to interact directly with alpha1 syntrophin, a cytoplasmic component of the $T1$$T2$ has previously been shown to interact directly with alpha1 syntrophin, a cytoplasmic component of the dystrophin-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.
dystrophin
dystrophin
0
As observed with the homologous Drosophila proteins, $T1$ interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or $T2$ were detected.
hTAFII20
hTAFII30
0
Interaction of the $T1$ subunit of PI 3-kinase with the $T2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
p85
insulin receptor
0
Characterization of Fas (Apo-1, $T1$$T2$, CD95)-Fas ligand interaction.
CD95
Apo-1
0
Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase ($T1$$T2$ (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
P13-K
protein kinase C
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / $T1$$T2$ / TR2 receptors .
TR2
HVEM
0
RESULTS: $T1$, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-$T2$, AAV-AADC and AAV-GCH.
TH
TH
0
However, whether 14-3-3 proteins interact directly with the $T1$ and how this interaction may mediate $T2$ function has not been determined.
Raf-CRD
Raf-1
0
Two cDNA clones encoding a receptor for human $T1$ ($T2$) were isolated by expression screening of a library made from human placental mRNA.
granulocyte-macrophage colony-stimulating factor
hGM-CSF-R
1
TFIID is a multisubunit protein complex comprised of the $T1$$T2$ is a multisubunit protein complex comprised of the TATA-binding protein (TBP) and multiple TBP-associated factors (TAFs).
TATA-binding protein
TFIID
0
Mutagenesis of the regulatory subunit ($T1$) of $T2$ reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
cAMP-dependent protein kinase II beta
0
We report here that recombinant $T1$ induces autophosphorylation of ECK in intact cells, consistent with $T2$ being an authentic ligand for ECK.
B61
B61
0
In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific $T1$$T2$ beta-specific hTAFII.
hTAFII
TFIID
0
The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-$T1$$T2$ binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger CD30 signaling.
CD30
CD30L
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and $T1$ competed for binding with $T2$, indicating that IL-15 uses components of the IL-2 receptor.
IL-15
IL-2
0
An E2F complex containing mainly $T1$ and $T2$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F4
pRb2
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ($T1$) protein MyoD and the pocket proteins pRb, p107 and pRb2/$T2$.
bHLH
p130
0
Although Fos/$T1$ and $T2$/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
Jun
ATF
0
In contrast to hTAFII28, hTAFII18 is a $T1$$T2$ is a TFIID beta-specific hTAFII.
TFIID beta
hTAFII18
0
SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of $T1$$T2$ decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.
EGFR
SNX1
0
Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the $T1$$T2$ receptor, but neither of these proteins binds IL-13.
IL-2 receptor
IL-2
0
In addition we have been able to identify complexes of $T1$ and $T2$ in vivo that are dissociated in the presence of purified human papillomavirus E7 protein.
pRB
RBP1
1
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as $T1$ binding protein, $T2$) of the EPOR.
EPO
EBP
1
This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble $T1$$T2$/CD30L system and for designing assays for soluble CD30L.
CD30L
CD30
0
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form $T1$$T2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
ActRII
ActRII
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that $T1$ is associated with both p34cdc2 and $T2$, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.
cyclin D1
p33cdk2
1
$T1$ showed genetic interactions with the $T2$ gene, suggesting that it functioned at START by interacting with the CDC28 protein.
Cyclin E
CDC28
1
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the $T1$ bound to an EPO-mimetic peptide ($T2$), suggesting that Phe93 is also important for EMP1 binding.
EBP
EMP1
1
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature $T2$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
p60
PR
0
The apparent targeting of the $T1$-$T2$ interaction by oncoproteins of DNA tumour viruses strongly suggests that formation of this complex is functionally important.
RbAP46
Rb
1
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from $T1$$T2$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
gastrin
PI 3-kinase
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
IL-7R
0
14-3-3 protein, however, has no effect on the $T1$-kinase activity of $T2$.
cdc25A
Raf-1
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T1$-Cdk2, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
cyclin E
Cdk4
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T2$.
TrkC
TrkA
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and $T1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and $T2$ are necessary and sufficient for stable association with TBP.
c-Jun
c-Jun
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T1$ and $T2$ (p48).
hsp70
Hip
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing $T1$$T2$ amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
IGF-1R
0
Although $T1$ is a critical effector of $T2$ signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.
Raf-1
Ras
0
A $T1$ model based on $T2$ indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer.
VEGF
PDGFb
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the $T1$-activated $T2$.
SCF
c-Kit
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), $T1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ($T2$).
p23
p48
0
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and $T1$$T2$, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-9
IL-2
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
0
CIP1 encodes a novel 21 kd protein that is found in $T1$, cyclin D1, $T2$, and Cdk2 immunoprecipitates.
cyclin A
cyclin E
0
$T1$: a novel protein containing a death domain that interacts with $T2$/APO-1 (CD95) in yeast and causes cell death.
RIP
Fas
1
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, $T1$, $T2$, or with c-Jun.
Fra2
FosB
0
Concentrations of glial fibrillary acidic protein (GFAp) and light subunit neurofilament protein ($T1$$T2$ (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
NFL
light subunit neurofilament protein
0
A region of the beta subunit of the $T1$ receptor different from box 1 interacts with $T2$ and is sufficient to activate the Jak-Stat pathway and induce an antiviral state.
interferon alpha
Jak1
0
CD5 associates with the T-cell receptor zeta chain ($T1$$T2$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
TcR zeta
CD5
0
Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the $T1$ homotrimer bound to three $T2$ molecules was generated using knowledge-based protein modeling methods.
FasL
Fas
1
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor ($T1$) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
sIL-6R
IL-6
0
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, regulated on activation, normal T expressed and secreted ($T1$), and monocyte chemoattractant protein-3 ($T2$), but the receptors involved have not been defined.
RANTES
MCP-3
0
Interaction of the p85 subunit of $T1$ with the insulin receptor (IR) and the $T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
IGF-1 receptor
1
Under these conditions, a ternary complex of $T1$, JAK2, and $T2$ was observed.
p21ras
Raf-1
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. $T1$ displayed the same pattern of combinatorial interactions with $T2$ family proteins as Bcl-2.
Bcl-X-L
Bcl-2
0
We propose that $T1$ is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to $T2$ activation.
c-Jun
protein kinase C
1
The crystal structure of the homodimeric BB isoform of human recombinant platelet-derived growth factor ($T1$$T2$ (PDGF-BB) has been determined by X-ray analysis to 3.0 A resolution.
PDGF-BB
BB isoform of human recombinant platelet-derived growth factor
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, $T1$$T2$ homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Crk
Src
0
The human pituitary hormones, $T1$ ($T2$) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
hGH
0
In vitro experiments showed that the stable $T1$/$T2$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
Grb2
c-Cbl
1
In yeast, $T1$ interacts with cyclin-dependent kinases, including human Cdc2, Cdk2, and Cdk3, but not with $T2$.
Cdi1
Cdk4
0
Determination of $T1$, complement factors $T2$ and C4, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
TNFalpha
C3
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$ receptor (IR) and the $T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
IGF-1 receptor
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, $T1$, $T2$, and p23.
p54
p50
0
By using the growth factor dependent M-07e cell line, we found that both c-Mpl and $T1$ ligands, namely: SCF and TPO, induce $T2$ tyrosine phosphorylation.
c-Kit
c-Cbl
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits $T1$$T2$ MAb M81 also completely inhibits CD30/CD30L interaction.
CD30
CD30L
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/$T1$$T2$/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-2
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of $T1$ to $T2$; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
G beta gamma
Raf/330
1
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired $T1$$T2$-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.
ADA
CD26
0
Many of the same signaling molecules, including $T1$ ($T2$), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
protein kinase C
PKC
0
It binds homophilically, i.e., $T1$ on the surface of one cell binds to $T2$ on an apposing cell, and the binding site lies within the immunoglobulin domain.
PTPmu
PTPmu
1
The gamma chain of the interleukin-2 ($T1$$T2$ (IL-2) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
IL-2
interleukin-2
0
Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding $T1$/$T2$, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with FLT-1 binding.
KDR
Flk-1
0
We report here that recombinant $T1$ induces autophosphorylation of ECK in intact cells, consistent with B61 being an authentic ligand for $T2$.
B61
ECK
0
Specific binding of the transglutaminase, $T1$, to $T2$.
platelet factor XIII
HSP27
1
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with $T1$$T2$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
We found that $T1$ was associated with CD26 on T cell lines lacking either $T2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
ADA
0
Our data suggest that TR6 inhibits the interactions of $T1$$T2$ inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
LIGHT
TR6
0
$T1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-$T2$ and increased Jak3-gamma c associations.
Jak1
IL-2R beta
0
The high affinity $T1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein $T2$.
interleukin-6
gp130
0
In contrast to LexA/Bcl-2 fusion proteins, expression of a LexA/$T1$$T2$ fusion proteins, expression of a LexA/Bax protein was lethal to yeast.
Bax
Bcl-2
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both $T1$$T2$ in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
RPB5
RPB5
0
Based on the structure of the closely related $T1$-tumor necrosis factor receptor I complex, a molecular model of the FasL homotrimer bound to three $T2$ molecules was generated using knowledge-based protein modeling methods.
lymphotoxin alpha
Fas
0
The $T1$-susceptibility gene product binds directly to the human $T2$-associated factor TAFII250.
retinoblastoma
TATA-binding protein
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ are important for binding EPO and EPO mimetic peptide.
EPO mimetic peptide
erythropoietin (EPO) receptor
0
In this study, we demonstrate that $T1$ is coupled to the protein-tyrosine kinase p56lck and can act as a substrate for $T2$.
CD5
p56lck
1
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
TNFR-associated factor 2
0
$T1$ protein fused to the Drosophila protein bicoid ($T2$-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
LexA
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with $T1$$T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
RAD52
UBC9
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
FGF-2
KGFR
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the $T1$-$T2$ complex.
cyclin A
Cdk2
1
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the $T1$/c-Cbl complex with signaling proteins upon activation of non-tyrosine ($T2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
Grb2
c-Mpl
0
Using a protein interaction cloning technique, we identified cDNAs that encode a novel $T1$-binding protein, termed $T2$.
Bcl-2
BAG-1
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T1$) and calreticulin, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
TAP
TAP
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T1$/$T2$).
FasL
CD95L
0
Both the GT155-calnexin and the $T1$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on $T2$, a characteristic of many calnexin interactions.
GT155
GT155
0
The gamma chain of the interleukin-2 ($T1$$T2$ is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
IL-2
interleukin-2 (IL-2) receptor
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
TRAF2
0
The amount of $T1$ and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with $T2$ is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK4
p27
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits Shc, probably via $T1$$T2$ stimulation, the Grb2/c-Cbl complex recruits Shc, probably via Grb2.
Grb2
SCF
0
We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the $T1$ ($T2$).
calcium-sensing receptor
CaR
0
$T1$ and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and $T2$ reassociated in vitro, demonstrating their direct interaction.
Syk
Lyn
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-$T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
Estrogen Receptor
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p47-phox
cytochrome b558
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII230
E1A
0
Coexpression of CD5 with $T1$ in the baculovirus expression system resulted in the phosphorylation of $T2$ on tyrosine residues.
p56lck
CD5
0
In addition, p27 associates with three different CDKs: CDK2, $T1$, and $T2$.
CDK4
CDK6
0
Bcl-2 also interacted with Bcl-X-L and $T1$ and with the dominant inhibitors $T2$ and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Mcl-1
Bax
0
We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of $T1$$T2$ and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.
CREB
YY1
0
LexA protein fused to the Drosophila protein bicoid (LexA-$T1$) failed to interact with the B42 fragment fused to $T2$, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
Abeta
0
Transient expression in COS-1 cells and immunoprecipitation using an antiserum raised against a C-terminal peptide, gave rise to two components, representing mature (130 kDa) and precursor (115 kDa) forms of the $T1$ encoded polypeptide, which was denoted $T2$.
phFGFR
hFGFR-1
0
RESULTS: After 7 days hospitalisation, molar $T1$:$T2$ ratio (mean+/-s.d.)
RBP
TTR
0
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
sICAM-1
0
$T1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/$T2$ receptor).
CC CKR3
RANTES
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), $T1$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and $T2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
endothelin-1
sVCAM-1
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with $T1$ family proteins as $T2$.
Bcl-2
Bcl-2
0
Assaying of $T1$, complement factors, and $T2$ in the diagnosis of malignant serous effusions.
tumor necrosis factor alpha
alpha-1-antitrypsin
0
Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for $T1$$T2$ reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
cAMP-dependent protein kinase II beta
0
RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the $T1$ and $T2$ intracellular domains.
Fas
TNFR1
0
Although $T1$ has a higher binding affinity for immobilized $T2$, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6D
sIL-6R
1
Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient $T1$$T2$ but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient IL-6 antagonist.
IL-6
IL-6R
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with $T1$$T2$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
Src
c-Cbl
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, $T1$, CTF, adenoviral $T2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
USF
E1A
0
RESULTS: TH, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-$T1$ and AAV-$T2$.
AADC
GCH
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T1$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
IL-6
IL-6
0
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, EGFR and $T1$, which specifically binds the SH2 domain of $T2$ with high affinity.
Shc
GRB2
1
The proto-oncogene c-jun is a component of the $T1$$T2$ is a component of the AP-1 transcription factor family involved in the mediation of nuclear events elicited by extracellular stimuli.
AP-1
c-jun
0
The same domain of RIN1 that binds RAS also interacts with 14-3-3 proteins, extending the similarity between $T1$ and other $T2$ effectors.
RIN1
RAS
0
A point mutation in $T1$, analogous to the lpr mutation of $T2$, abolishes its ability to bind Fas, suggesting a death domain to death domain interaction.
FADD
Fas
0
Crosslinking of iodinated acidic FGF (aFGF) and $T1$ ($T2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
basic FGF
bFGF
0
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members (ErbB-1, neu/ErbB-2, ErbB-3, and $T1$$T2$, ErbB-3, and ErbB-4) and tumor recurrence.
ErbB-4
ErbB-2
0
Tumor necrosis factor (TNF) can induce apoptosis and activate $T1$ through signaling cascades emanating from TNF receptor 1 ($T2$).
NF-kappa B
TNFR1
0
We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between $T1$ and the two targets IRS-1 and $T2$.
GRB2
Shc
1
Liver-expressed chemokine ($T1$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, $T2$, and CCL16.
LEC
NCC-4
0
HFE binds to the $T1$ receptor ($T2$), a receptor by which cells acquire iron-loaded transferrin.
transferrin
TfR
0
However, MIP-1 beta was also an agonist for $T1$ but not CC CKR1; $T2$ was an agonist for CC CKR1 but not CC CKR3.
CC CKR3
MCP-3
0
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that $T2$ did not transport ADA to the surface.
CD26
CD26
0
Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the $T1$ gene products $T2$ and E47.
E2A
E12
0
One was $T1$$T2$-HS, and the second was the human homolog of Xenopus CDK2.
CDC2-HS
CDC2
0
In addition, previous work indicated that $T1$ and CBP might be involved in $T2$-mediated repression.
p300
YY1
0
Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of $T1$ and glutamine-61 of $T2$, and even its mutation to alanine would disturb the arrangements of residues in the transition state.
GAP-334
Ras
0
Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric $T1$$T2$ (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
IL-6.receptor
interleukin-6
0
$T1$ cleaved the $T2$ subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.
MMP2
Ln-5 gamma2
0
The objective of this study was to measure the concentrations of $T1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin ($T2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
alpha1AT
0
SF3a interacts with $T1$ in the presence of $T2$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
U2 snRNP
SF3b
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$$T2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID alpha
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T2$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$, cd44, $T2$, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
fibromodulin
0
Although Fos/Jun and $T1$/$T2$ were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
ATF
CREB
0
$T1$ inhibited $T2$-induced cytotoxicity in HT29 cells.
TR6
LIGHT
0
Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human $T1$ ($T2$) that activates human gp130.
interleukin-6
IL-6
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T1$-Cdk2, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
cyclin E
Cdk4
0
$T1$ specifically interacts with $T2$ but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
USF
Fra1
1
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / $T1$$T2$ inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
TR2
TR6
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between $T1$ and hTAFII28 or $T2$ were detected.
hTAFII20
hTAFII30
1
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with $T1$ and inhibits the binding of the natural CCR-5 ligands, $T2$ and MIP-1beta (refs 7, 8).
CCR-5
macrophage inflammatory protein (MIP)-1alpha
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early $T1$$T2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
PR
0
FGFR3 utilizes two different pools of adapter protein GRB2 to link to $T1$$T2$ to link to Ras.
Ras
GRB2
0
Expression cloning and characterization of a human $T1$$T2$.
IL-10
IL-10 receptor
0
Coexpression of $T1$ with p56lck in the baculovirus expression system resulted in the phosphorylation of $T2$ on tyrosine residues.
CD5
CD5
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
pRb2
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an $T1$$T2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EPO
EPO-mimetic peptide
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T1$, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-3
MCP-4
0
Analysis of the human $T1$/human $T2$ receptor binding interface at the amino acid level: proposed mechanism of interaction.
interleukin-6
interleukin-6
0
After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including $T1$, the cadherins associated with PTPmu are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for $T2$.
PTPmu
PTPmu
0
$T1$ also activated Stat5 in Ba/F3 cells that stably expressed the murine $T2$ receptor.
IL-10
IL-10
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T1$$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
MyoD
HLH462
0
Thus, $T1$$T2$ R alpha binding does not result in a large conformational change in the AB loop as previously suggested.
IFN-gamma R alpha
IFN-gamma
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T1$/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha $T1$ and RANTES were both potent agonists for CC CKR3 and $T2$.
MIP
CC CKR1
0
$T1$, a member of the spectrin/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule $T2$.
alpha-Actinin-2
PSD-95
0
Further investigation indicated that the ITF-2b/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T1$/$T2$.
Id3
HLH462
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , $T1$ ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( FasL / $T2$ ) .
LIGHT
CD95L
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin ($T1$) receptor ($T2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPOR
1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T2$, utrophin/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin
1
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and $T1$ beta respectively), and is the homologue of Drosophila (d)$T2$.
hTFIID
TAFII30 beta
0
Levels of p16($T1$) and $T2$(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
INK4a
p57
0
The Oct1 POU domain, which is highly homologous to the $T1$ POU domain, likewise mediates interaction with $T2$.
Oct2
TBP
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
MCP-1
0
In contrast to hTAFII28, hTAFII18 is a $T1$$T2$ is a TFIID beta-specific hTAFII.
TFIID
hTAFII18
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto $T1$$T2$ complex and loaded onto HLA-E molecules.
HLA-E
TAP
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, $T2$/dystrophin related protein, and the Torpedo 87K protein.
dystrophin
utrophin
0
HFE binds to the $T1$ (TfR), a receptor by which cells acquire iron-loaded $T2$.
transferrin receptor
transferrin
0
However, $T1$ was also an agonist for CC CKR3 but not $T2$; MCP-3 was an agonist for CC CKR1 but not CC CKR3.
MIP-1 beta
CC CKR1
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ($T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
ER
MyoD
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$-induced Stat3 phosphorylation in a cell-free system.
Stat3
IL-10
0
The $T1$-interacting region of Sp1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila $T2$.
TAFII55
TAFII110
0
These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R $T1$$T2$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.
gp130
IL-6
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and $T1$$T2$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.
IL-15
IL-2
0
Activation of lacZ upon interaction of p85 with IR beta(delta C-43) was 4-fold less as compared to $T1$$T2$) was 4-fold less as compared to IR beta.
IR beta
delta C-43
0
Alanine-scanning mutagenesis was used to identify a positively charged surface in $T1$ that mediates binding to KDR/$T2$.
VEGF
Flk-1
0
These interactions are $T1$-specific, since another DNA repair-related ubiquitin-conjugating enzyme, RAD6 ($T2$), does not interact with these proteins.
UBE2I
UBC2
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits $T1$ and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to $T2$.
p22-phox
cytochrome b558
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; $T1$ induced $T2$-IL-2R beta and increased Jak3-gamma c associations.
IL-2
Jak3
0
Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in $T1$$T2$ site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect KDR binding.
FLT-1
KDR
0
One clone encodes a novel $T1$ catalytic subunit (PP-1 alpha 2), which differs from the originally defined $T2$ by an amino-terminal 11-amino-acid insert.
type 1 protein phosphatase
PP-1 alpha
0
Cotransfection of hGITRL and $T1$$T2$ and hGITR in Jurkat T leukemia cells inhibited antigen-receptor-induced cell death.
hGITR
hGITRL
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/$T1$, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
MORT
p80
1
It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for $T1$, $T2$ and interleukin-2 (beta-chain) and also to the prolactin receptor.
interleukin-6
erythropoietin
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
TAFII55 is shown to interact with the largest subunit ($T1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
TAFII230
Tat
0
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and $T1$$T2$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.
junB
gp130
0
$T1$ activity and the regulatory p85 subunit of $T2$ associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.
PI 3-kinase
PI 3-kinase
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
Cdk2
0
Levels of $T1$ were slightly increased following $T2$ treatment (P = 0.09).
IFN-gamma
IFN-alpha
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit ($T1$), as well as protein phosphatase 1 ($T2$) in mammalian cells.
PP2AC
PP1C
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T1$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
eotaxin
1
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, $T1$$T2$ but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
Fra2
Fra1
0
Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward ifnar2 results in linear function over the whole range of affinities investigated, suggesting that $T1$$T2$ results in linear function over the whole range of affinities investigated, suggesting that ifnar2 binding is the rate-determining step in cellular activation.
ifnar2
ifnar2
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, $T1$$T2$ family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Mcl-1
Bcl-2
0
Bcl-2 also interacted with Bcl-X-L and $T1$ and with the dominant inhibitors Bax and $T2$.
Mcl-1
Bcl-X-S
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, $T1$$T2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-10
IL-6
0
An expression plasmid encoding the human 75-kDa $T1$ ($T2$) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2.
tumor necrosis factor (TNF) type 2 receptor
TNF-R2
0
Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and $T1$$T2$ gene products E12 and E47.
E47
E2A
0
$T1$ transcriptional activation mediated by coactivators TAFII40 and $T2$.
p53
TAFII60
1
In addition, we show that in extracts depleted of TBP and $T1$-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by $T2$ or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TFIID
0
The ability of $T1$ to initiate transcription is augmented by the presence of a TATA motif or binding sites for transcription factor $T2$.
YY1
Sp1
0
By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of $T1$ contributes to high affinity receptor binding and is critical for $T2$ recognition.
FGF-7
KGFR
1
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T1$, and also bound $T2$, although with lower affinity compared with TrkB.
TrkC
brain-derived neurotrophin
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
MCP-4
0
Activation of lacZ upon interaction of p85 with IR beta($T1$$T2$(delta C-43) was 4-fold less as compared to IR beta.
delta C-43
IR beta
0
Like mIL-10R, hIL-10R is structurally related to $T1$$T2$, hIL-10R is structurally related to IFNR.
IFNR
mIL-10R
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T1$, MCP-3, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-2
MCP-1
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T1$ (hTFIID alpha and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII30
hTFIID
0
$T1$ ($T2$, B-50, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
GAP-43
neuromodulin
0
We have detected a specific association of $T1$ with the molecular chaperon $T2$ and a 44-kDa protein that we identify as mammalian CDC37.
CDK4
HSP90
1
hPRL does not bind to the $T1$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGH
hGH
0
Unlike human $T1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact $T2$, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.
IL-6
gp130
1
Transthyretin ($T1$), a second major CSF protein, formed SDS-stable complexes with $T2$ and significantly decreased the rate of A beta fibril formation.
TTR
A beta
1
BMP-2 is a homodimeric cysteine knot protein that, as a member of the $T1$ ($T2$) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.
transforming growth factor-beta
TGF-beta
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$ related protein, and the $T2$.
dystrophin
Torpedo 87K protein
0
Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, $T1$$T2$, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6M
sIL-6R
0
Levels of p16(INK4a) and $T1$(KIP2) rise in HUCs during progressive passages, whereas only $T2$ increases in HPEC cultures.
p57
p16
0
alpha-Actinin-2, a member of the spectrin/$T1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule $T2$.
dystrophin
PSD-95
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the $T1$$T2$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
Grb2
c-Cbl
0
The $T1$ and hPRL receptors (hGHR and $T2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hPRLR
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human $T1$ and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
gp130
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ alpha and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID beta
0
TRADD-$T1$ and TRADD-FADD interactions define two distinct $T2$ signal transduction pathways.
TRAF2
TNF receptor 1
0
In the end we refer to the relations between circulating RAS of renal origin and the extrarenal $T1$ specific to tissue underlying the fact that the two $T2$ components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.
RAS
RAS
0
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both $T1$ and $T2$, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.
p34cdc2
p33cdk2
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/BR-II, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Cloning and characterization of $T1$, $T2$ and hTAFII28: three subunits of the human transcription factor TFIID.
hTAFII18
hTAFII20
1
Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, $T1$, with another SH2-containing protein, $T2$.
SHPTP2
Grb7
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T1$-$T2$.
Fas
FD8
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the $T1$$T2$ and the phosphatidylinositol 3-kinase.
phosphatidylinositol 3-kinase
Grb2
0
Although the individual amino acids in TrkA involved in binding to $T1$ ($T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
NGF
0
Cross-linking of 125I-$T1$ and 125I-TNF-beta to 293/$T2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-R2
0
$T1$ was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating $T2$ and facilitating its export.
ICE
IGIF
1
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, $T1$ MIP and $T2$ were both potent agonists for CC CKR3 and CC CKR1.
(MIP)-1 alpha
RANTES
0
The products of the RBP1 and RBP2 genes are ubiquitously expressed, large (200 kDa for $T1$ and 195 kDa for $T2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP1
RBP2
0
Expressed in a murine myeloma, TRAP was identified as a ligand for CD40 by binding to a soluble $T1$$T2$ by binding to a soluble CD40 construct.
CD40
CD40
0
PS1 suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in $T1$$T2$-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.
PS1
c-jun
0
The interaction between $T1$ and $T2$ is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.
Vav
c-Cbl
1
Calreticulin, the soluble homologue of $T1$$T2$, the soluble homologue of calnexin, was also shown to interact with GT155 only when the protein bore a correctly modified oligosaccharide group.
calnexin
Calreticulin
0
These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the $T1$ protein kinase, but also activate the cdc25 tyrosine phosphatase, of which $T2$ is the physiological substrate.
cdc2
cdc2
0
Antibody-mediated cross-linking studies or studies on CD5 knockout mice implicate $T1$$T2$ knockout mice implicate CD5 as a co-stimulatory or negative regulatory molecule.
CD5
CD5
0
Taken together, these data suggest that $T1$ and $T2$ cooperate to activate Raf-1.
JAK2
p21ras
1
Replacement of Val20-Leu21 with Ala-Ala produced a dimeric $T1$ protein that binds $T2$ approximately 4% as avidly as wild-type RII beta.
RII beta
AKAP75
1
This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent $T1$$T2$ functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.
PR
p60
0
265, 21561-21566) we have shown that dimerization of $T1$ was required for interaction with the cytoskeletal component $T2$.
RII alpha
microtubule-associated protein 2
1
The results showed that $T1$ and $T2$ can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (junB) expression in TF-1 cells.
IL-11
IL-6
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
NF-kappaB
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of $T1$$T2$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
MCP-3
0
Mutagenesis studies of the human $T1$$T2$.
erythropoietin
erythropoietin receptor
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T1$$T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sCAM
soluble cell adhesion molecules
0
Scatchard analysis of in vitro binding between $T1$ and $T2$ revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and beta ARK (Kd = 87 +/- 24 nM).
Raf/330
G beta gamma
1
Cotransfection of hGITRL and $T1$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor $T2$, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITR
NF-kappaB
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$ G protein-coupled receptor and the $T2$ receptor.
CCKB
insulin
0
Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of $T1$, ErbB3 and $T2$ in cell lines expressing all of these ErbB-family receptors.
ErbB2
ErbB4
0
Interaction of $T1$ subunit of PI 3-kinase with $T2$ and IGF-1 receptors analysed by using the two-hybrid system.
p85
insulin
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that $T1$ expression is $T2$-dependent and tapasin-dependent.
HLA-E
TAP
0
HFE binds to the $T1$ ($T2$), a receptor by which cells acquire iron-loaded transferrin.
transferrin receptor
TfR
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and $T1$ are necessary and sufficient for stable association with $T2$.
c-Jun
TBP
1
By contrast the Ras exchanger factor (Sos1) was not detected in anti-$T1$$T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
c-Cbl
Sos1
0
In the assembly of a prespliceosome, $T1$ (snRNP) functions in pre-messenger RNA (mRNA) splicing together with splicing factors (SFs) 3a, $T2$, and several other proteins.
U2 small nuclear ribonucleoprotein
SF3b
0
We have exploited the availability of the cloned $T1$, XPD, p62, p44, and p34 genes (all of which encode polypeptide subunits of $T2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPB
TFIIH
0
A region of the beta subunit of the $T1$ receptor different from box 1 interacts with Jak1 and is sufficient to activate the $T2$-Stat pathway and induce an antiviral state.
interferon alpha
Jak
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained $T1$ like affinity for FGFR1 and for $T2$.
FGF-2
KGFR
1
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
NIK
TRAF2
0
For the calibration, we used two sets of proteins, the $T1$-$T2$-Mxi1 helix-loop-helix proteins, and wild-type and dimerization-defective versions of the lambda cI repressor.
Myc
Max
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and $T2$ (FasL/CD95L).
LIGHT
Fas ligand
0
In addition, activation of PI 3-kinase was detected in anti-$T1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate $T2$.
IRS-1
PI 3-kinase
0
$T1$ induced maximal migration of $T2$ and CCR8 transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.
LEC
CCR1
0
Two lines of evidence support the notion that RbAP46 and $T1$ have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with $T2$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
simian virus 40 T antigen
RbAP46
0
$T1$ protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to $T2$, indicating that the observed Abeta-Abeta interaction was specific.
LexA
Abeta
0
Granulysin has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of $T1$$T2$ has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells.
perforin
Granulysin
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-$T1$, and $T2$-Cdk4 complexes.
Cdk4
cyclin D2
0
In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the $T1$$T2$ resulted in an overall decrease in the Raf-1 kinase activity.
Raf-1
Raf-1
0
CREB is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates $T1$$T2$ is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates CREB function is unknown.
CREB
CREB
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and $T1$$T2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
NR2B
alpha-Actinin-2
0
Their order of selection was $T1$ effusion, C4 serum, TNFalpha-effusion, and $T2$ effusion.
alpha1AT
C3
0
ICE was also shown to cleave the precursor of $T1$ (IGIF) at the authentic processing site with high efficiency, thereby activating $T2$ and facilitating its export.
interferon-gamma inducing factor
IGIF
0
The stimulation of $T1$-mediated transcription by RB in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human $T2$.
Sp1
TAFII250
0
$T1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hPRLR
0
In the present report, we demonstrated that modulation of $T1$ from T cell surface induced by anti$T2$ (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.
CD26
CD26
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$$T2$ in binding BDNF.
TRKB
TRKB receptor
0
On the other hand, cells expressing ADA and $T1$$T2$ and CD26 on the surface were much more resistant to the inhibitory effect of adenosine.
CD26
ADA
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$, and IL-15 competed for binding with $T2$, indicating that IL-15 uses components of the IL-2 receptor.
IL-15
IL-2
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
This protein, designated $T1$ ($T2$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF-related protein
VRP
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R
p85
0
Mutagenesis of the $T1$ receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to $T2$ (EPO) binding.
erythropoietin
erythropoietin
0
LexA protein fused to the Drosophila protein bicoid ($T1$-bicoid) failed to interact with the B42 fragment fused to $T2$, indicating that the observed Abeta-Abeta interaction was specific.
LexA
Abeta
0
In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or $T1$$T2$, CDK6, or CDK2.
CDK2
CDK4
0
Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, $T1$ and $T2$, but did inhibit motility of keratinocytes on tissue culture plastic.
type IV collagen
fibronectin
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound $T1$$T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
p90
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
procollagen I
0
The crystal structure of the p53 core domain bound to the $T1$ protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of $T2$.
53BP2
p53
0
These analyses showed that the ability of PBMC to proliferate to $T1$ correlated with expression of the p76 $T2$, and not with expression of the p90 IL-7R.
IL-7
IL-7R
0
Here, we demonstrate that $T1$ may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the $T2$ enhancer region and to interact with the NF-kappaB subunit, p50.
E2F-1
NF-kappaB
0
These cells contain a temperature-sensitive mutation in the $T1$ $T2$, first identified as the cell cycle regulatory protein CCG1.
TATA-binding protein-associated factor
TAFII250
0
A protein ligand for the $T1$$T2$ has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.
ECK
ECK receptor protein-tyrosine kinase
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
insulin
insulin
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$ binds well to $T2$, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-2
FGFR1
1
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
p130
0
We used alanine substitution of $T1$ residues that contact $T2$ in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding.
EBP
EMP1
1
$T1$ is a ligand for the $T2$ receptor protein-tyrosine kinase.
B61
ECK
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ receptor alpha chain ($T2$) has been designed and characterized.
IFN-gamma
IFN-gamma R alpha
0
The screen identified interactions involving c-Cbl and two 14-3-3 isoforms, $T1$, human unconventional myosin IC, and a recently identified SH3 domain containing protein, $T2$.
cytokeratin 18
SH3 P17
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, $T1$ and pRb2/$T2$.
p107
p130
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these $T1$$T2$.
HLA-E
HLA-E
0
Cyclin E produced in E. coli bound and activated the $T1$ protein in extracts from human G1 cells, and antibodies against $T2$ immunoprecipitated a histone H1 kinase from HeLa cells.
CDC2
cyclin E
0
These data demonstrate that the p90 $T1$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 $T2$ have different extracellular domains.
IL-7R
IL-7R
0
These findings indicate that $T1$ is involved in the activation of $T2$ by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.
ATM
c-Abl
1
The correlation of $T1$-$T2$ binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.
SRF
RAP74
1
PI 3-kinase activity and the regulatory p85 subunit of $T1$ associated with $T2$ in pervanadate-stimulated, but not in unstimulated thymocytes.
PI 3-kinase
CD5
1
$T1$ (IRS-1) is a major substrate of the $T2$ and has been implicated in insulin signaling.
Insulin receptor substrate 1
insulin receptor
1
Immunoblotting studies were used to confirm the binding of $T1$ from fresh platelet lysates to the $T2$ fusion protein.
FXIII
HSP27
1
In the present study we evaluated tyrosine phosphorylation of $T1$ and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ($T2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
c-Cbl
c-Mpl
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain ($T1$) for IL-4 signaling, it could not replace the function of gammac in allowing enhanced $T2$ binding activity.
gammac
IL-2
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits CD30/$T1$$T2$ MAb M81 also completely inhibits CD30/CD30L interaction.
CD30L
CD30L
0
$T1$ was also shown to cleave the precursor of $T2$ inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
ICE
interferon-gamma
0
Cellular $T1$ as well as the recombinant Src homology 2 (SH2) domains of $T2$ bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.
p85
p85
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ (KGFR), whereas FGF-2 binds well to $T2$, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor receptor
FGFR1
0
Interaction of the p85 subunit of $T1$ with the $T2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
insulin receptor
1
Furthermore, a partial $T1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and $T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TFIID
dTAFII40
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for $T1$ and SF3b in the incorporation of $T2$ into the spliceosome.
SF3a
U2 snRNP
0
When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to $T1$, IRAK rapidly associated with the $T2$ complex and was phosphorylated.
IL-1
IL-1RI
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
tumour necrosis factors (TNF) alpha
0
The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein $T1$$T2$ p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
p120GAP
GTPase-activating protein
0
Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by $T1$$T2$ is required for transcriptional activation by serum response factor.
serum response factor
TFIIF
0
We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between $T1$ and the two targets $T2$ and Shc.
GRB2
IRS-1
1
The precise function of $T1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the $T2$ receptor.
c-Cbl
epidermal growth factor
0
Comparison of the wild-type receptor-binding domain and the Asp111-containing domain of $T1$$T2$ SC1 show that they are structurally equivalent but have very different electrostatic surface potentials.
IFN-gamma SC1
IFN-gamma
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, $T2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Cdk2
cyclin E
0
Human RIN1 was first characterized as a $T1$$T2$ was first characterized as a RAS binding protein based on the properties of its carboxyl-terminal domain.
RAS binding protein
RIN1
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$$T2$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.
gastrin
IRS-1
0
We have identified a new TNF-related ligand, designated human GITR ligand ($T1$), and its human receptor ($T2$), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4].
hGITRL
hGITR
1
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$ and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R
p85
0
ICE was also shown to cleave the precursor of $T1$ inducing factor ($T2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
interferon-gamma
IGIF
0
We now show that full-length RIN1 interacts with activated RAS in mammalian cells and defines a minimum region of 434 aa required for efficient $T1$$T2$ interacts with activated RAS in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding.
RAS
RIN1
0
ICE was also shown to cleave the precursor of $T1$ inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating $T2$ and facilitating its export.
interferon-gamma
IGIF
0
Monoclonal antibodies to the beta chain of the $T1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T2$.
IL-2
IL-2 receptor
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/$T1$$T2$ function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-2
0
Determination of TNFalpha, complement factors C3 and C4, and $T1$$T2$ and C4, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.
alpha1AT
C3
0
RANTES interacts with CCR5 and $T1$$T2$ interacts with CCR5 and SDF-1 with CXCR4 receptors.
SDF-1
RANTES
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
CD26
ADA
0
These analyses showed that the ability of PBMC to proliferate to $T1$ correlated with expression of the p76 IL-7R, and not with expression of the $T2$ IL-7R.
IL-7
p90
0
This transcriptional activity is inhibited by association with the $T1$ (pRB) or its relatives p107 and $T2$.
retinoblastoma tumor suppressor protein
p103
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T1$$T2$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .
HVEM
LIGHT
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, $T1$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
YY1
Tat
0
Scatchard analysis of in vitro binding between Raf/330 and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between $T1$$T2$ and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and beta ARK (Kd = 87 +/- 24 nM).
G beta gamma
Raf/330
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ (IRS-1), the major cytoplasmic substrate of the $T2$.
insulin receptor substrate 1
insulin receptor
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
This information is useful for applying these MAbs in functional studies to further investigate the CD30/$T1$$T2$/CD30L system and for designing assays for soluble CD30L.
CD30L
CD30
0
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after $T1$$T2$, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
insulin
Shc
0
An E2F complex containing mainly $T1$ and pRb2/$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F4
p130
1
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p22-phox
NADPH oxidase
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
CD26
dipeptidyl peptidase IV
0
In this report, it is demonstrated that $T1$ contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of $T2$ both in vitro and in vivo.
Elf-1
Rb
1
Furthermore, a partial $T1$ complex containing Drosophila $T2$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TFIID
TATA binding protein
0
The gamma chain of the $T1$ is shared with the functional $T2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
interleukin-2 (IL-2) receptor
IL-4
0
The data thus demonstrate specific binding of platelet FXIII to $T1$ and suggest that $T2$ may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.
HSP27
HSP27
0
The crystal structure of the human cyclinA-$T1$ ($T2$)-ATP complex has been determined at 2.3 A resolution.
cyclin-dependent kinase2
CDK2
0
The precise function of $T1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that $T2$ is a negative regulator of the epidermal growth factor receptor.
c-Cbl
c-Cbl
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 ($T2$), the major cytoplasmic substrate of the insulin receptor.
insulin
IRS-1
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ were found to be redundantly required for receptor function and for activation of Stat3 but not for $T2$ or Stat5.
IL-10 receptor
Stat1
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
dTAFII40
0
We also show that RIP is a serine-threonine kinase that is recruited by $T1$ to $T2$ in a TNF-dependent process.
TRADD
TNFR1
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding $T1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPOR
0
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to $T1$$T2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
erythropoietin
EPOR
0
Cluster Group B antibodies, including M67 and Ki-1, do not affect $T1$ binding to $T2$.
CD30L
CD30
1
$T1$ contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the $T2$ and TNFR1 intracellular domains.
RIP
Fas
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and $T1$ have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
gp130
IL-6
0
A bacterially expressed 318-amino acid fragment, Ht 31 (418-736), containing the amphipathic helix region, was able to bind $T1$$T2$.
RII
RII alpha
0
Coassociation of $T1$ ($T2$) with CD45 on the surface of human T lymphocytes.
CD26
dipeptidyl peptidase IV
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
trkA
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T1$$T2$.
insulin
insulin receptor
0
By using several different experimental systems we show that $T1$ efficiently associates with Oct1 and $T2$.
TBP
Oct2
1
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for $T2$ or Stat5.
IL-10
Stat1
0
The levels of $T1$ mRNA in tissues were generally low; in peripheral blood T cells, however, antigen-receptor stimulation led to a substantial induction of $T2$ transcripts.
hGITR
hGITR
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, $T1$, fibronectin, cd44, $T2$, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronidase
fibromodulin
0
The $T1$ ($T2$) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.
retinoblastoma protein
p110RB
0
Furthermore, a partial TFIID complex containing Drosophila $T1$ ($T2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TATA binding protein
dTBP
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that $T1$ uses components of the $T2$.
IL-15
IL-2 receptor
1
Granulysin has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of $T1$$T2$ in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells.
perforin
perforin
0
Analysis of $T1$, p21(CIP1), p15(INK4b), p16(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p53
KIP2
0
$T1$, cyclin D, p19($T2$) and p27(KIP1) decrease in both cell types.
pRB
INK4d
0
Both the GT155-calnexin and the GT155-$T1$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many $T2$ interactions.
CAP-60
calnexin
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with $T1$$T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Grb2
insulin
0
The human pituitary hormones, growth hormone ($T1$) and $T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hGH
prolactin
0
In contrast, physical interaction is not necessary for $T1$ to repress $T2$- and CREB-mediated transcription.
YY1
Sp1
0
In addition, $T1$ dissociates from $T2$ upon binding of MHC class I leader sequence peptides.
HLA-E
TAP
1
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T1$ ( FasL / $T2$ ) .
Fas ligand
CD95L
0
Collectively, $T1$ is yet another functional ligand for $T2$.
eotaxin-3
CCR3
1
In contrast to hTAFII28, hTAFII18 is a $T1$$T2$, hTAFII18 is a TFIID beta-specific hTAFII.
TFIID beta
hTAFII28
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on $T1$$T2$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with CCR-5.
gp120
CD4
0
$T1$ activity and the regulatory $T2$ subunit of PI 3-kinase associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.
PI 3-kinase
p85
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTFIID alpha
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$, $T2$, and p21rac) that translocate to membrane and bind to cytochrome b558.
p47-phox
p67-phox
1
Interaction of the p85 subunit of PI 3-kinase with the $T1$ receptor ($T2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
IR
0
CD5 associates with the $T1$$T2$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
CD5
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a $T1$-related complex (SNAPc) containing substoichiometric levels of $T2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
PTF
TBP
0
Fusion proteins were created by linking the Abeta fragment to a $T1$ DNA-binding domain (bait) and also to a $T2$ transactivation domain (prey).
LexA
B42
0
The tyrosine kinases $T1$, $T2$, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
Flt4
Flt1
0
Their order of selection was $T1$ effusion, $T2$ serum, TNFalpha-effusion, and C3 effusion.
alpha1AT
C4
0
Crystal structure of the $T1$ cyclin-dependent-kinase inhibitor bound to the cyclin A-$T2$ complex.
p27Kip1
Cdk2
1
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ($T1$) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sCAM
sICAM-1
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/$T1$$T2$ differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bax
Bcl-X-S
0
These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the $T1$ protein kinase, but also activate the $T2$ tyrosine phosphatase, of which cdc2 is the physiological substrate.
cdc2
cdc25
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
TrkA
TrkB
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p75
NGF
0
In patients with a complete response to $T1$, the levels of IFN-gamma were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of $T2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-alpha
IL-4
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of $T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
The crystal structure of the 109-residue amino-terminal domain of $T1$ bound to a 15-residue transactivation domain peptide of $T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
p53
1
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$ protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
LexA
0
The protein product of $T1$ proto-oncogene is known to interact with several proteins, including $T2$, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.
c-cbl
Grb2
1
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with $T1$$T2$ blocked the interaction of gp12O-CD4 complexes with CCR-5.
CCR-5
gp120
0
We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating $T1$$T2$, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.
CD45
CD45
0
Characterization of $T1$ ($T2$, CD95)-Fas ligand interaction.
Fas
Apo-1
0
We present evidence that mitogen-activated protein-serine (MAP) kinases ($T1$ and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of $T2$.
pp54
c-jun
1
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either $T1$$T2$ substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
TFIIB
HBx
0
COS-7 cells co-transfected with the cloned $T1$ cDNA and $T2$ cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.
IL-13R
IL-4R
0
Due to its increased affinity for the IL-6R but its decreased ability to couple with $T1$, we suggest that a stable $T2$ dimer may be an efficient IL-6 antagonist.
gp130
IL-6
1
Collectively, the novel function of PS1 via $T1$/$T2$ influences c-jun-mediated transcription and apoptosis.
QM
Jif-1
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, $T1$$T2$, and three additional proteins, p54, p50, and p23.
p54
hsp70
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
Rb
Cdk4
0
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named RIP, for $T1$$T2$ itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.
receptor interacting protein
Fas
0
Taken together our results demonstrate that $T1$ plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/$T2$ complex when non-tyrosine or tyrosine kinase receptors are activated.
c-Cbl
c-Cbl
0
Positive inotropic responses mediated by endothelin $T1$ and $T2$ receptors in human myocardial trabeculae.
ET(A)
ET(B)
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, $T1$, $T2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
YY1
USF
0
Associations of UBE2I with RAD52, $T1$$T2$, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.
UBL1
RAD52
0
$T1$ has been identified as an effector molecule co-localized with $T2$ in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells.
Granulysin
perforin
0
The pleiotropic biological activities of $T1$ ($T2$) are mediated by its type I receptor (IL-1RI).
interleukin-1
IL-1
0
In vivo association between $T1$ and $T2$ has been demonstrated by co-immunoprecipitation.
USF
Fra1
1
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-$T1$$T2$ blocked the interaction of gp12O-CD4 complexes with CCR-5.
CD4
gp120
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75
trkA
0
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ($T1$) and tyrosine kinase ($T2$) receptors leading to myeloid cell proliferation.
c-Mpl
c-Kit
0
This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking $T1$$T2$ complexes lacking p60.
p60
PR
0
The correlation between $T1$ and MHC class I surface expression might be relevant to the function of $T2$.
HLA-E
HLA-E
0
Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for EPO binding but is critical for $T1$$T2$ binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EMP1
EPO
0
In competition experiments, the carboxyl terminus of $T1$ (beta ARK) blocked the binding of $T2$ to Raf/330; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.
beta-adrenergic receptor kinase
G beta gamma
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, $T1$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
USF
Tat
0
Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity $T1$ extracellular domains($T2$).
BMP receptor IA
BRIAec
0
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
MCP-3
0
The tyrosine kinases Flt4, Flt1, and $T1$$T2$, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
Flk1
Flt1
0
Since hsp90 and $T1$ do not readily associate on their own, it appears that p60 is the central organizing component of an $T2$-p60-hsp70 complex.
hsp70
hsp90
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$$T2$(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
p21
0
$T1$ binding by $T2$ is blocked by MAb that recognize epitopes belonging to cluster Group A (like Ber-H2, Ber-H8, and HRS-4) as well as cluster Group C (like HeFi-1 and M44).
CD30L
CD30
1
The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/$T1$$T2$ protein, a component of the transcriptional regulator Swi/Snf.
Snf
Snf2
0
Characterization of Fas (Apo-1, $T1$)-$T2$ interaction.
CD95
Fas ligand
1
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
IGF-1R beta
0
We now report the isolation and expression of cDNAs encoding $T1$ gamma and $T2$ delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.
PTF
PTF
0
Here , we demonstrate that $T1$ specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( $T2$ / CD95L ) .
TR6
FasL
1
We have engineered and purified recombinant $T1$ head and $T2$ tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.
K5
DPI
1
In addition, PCR analysis of $T1$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the $T2$ IL-7R is a previously undescribed splice variant of the cloned IL-7R.
p76
p76
0
Residues in human leukemia inhibitory factor ($T1$) crucial for binding to both the human LIF receptor (R) and $T2$ were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.
hLIF
gp130
1
Our analyses demonstrate that the XPB, XPD, p44, and $T1$$T2$, and p62 proteins interact with each other.
p62
p44
0
We show that the physical interaction between $T1$ and $T2$, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.
YY1
p300
1
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor alpha chain
interferon-gamma
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the $T2$.
alpha 1-syntrophin
Torpedo 87K protein
1
Transcription factor TFIID consists of TATA binding protein ($T1$$T2$ (TBP) and at least eight TBP-associated factors (TAFs).
TBP
TATA binding protein
0
Recent studies indicate that the structural integrity of the $T1$ is also critical for $T2$ interaction with 14-3-3 proteins.
Raf-CRD
Raf-1
0
When human embryonic kidney cells (cell line 293) over-expressing $T1$ or HeLa cells were exposed to IL-1, IRAK rapidly associated with the $T2$ complex and was phosphorylated.
IL-1RI
IL-1RI
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
TFIID
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, $T1$ MIP and RANTES were both potent agonists for $T2$ and CC CKR1.
(MIP)-1 alpha
CC CKR3
1
By contrast the $T1$ exchanger factor ($T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Ras
Sos1
1
Cloning and characterization of a specific $T1$ binding protein structurally related to the $T2$ alpha chain.
interleukin (IL)-13
IL-5 receptor
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
TR6
LIGHT
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T2$ (p48).
PR
Hip
0
The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the $T1$$T2$-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.
hsp90
p60
0
Deletion of this domain impairs $T1$'s ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support $T2$-activated transcription.
RAP74
SP1
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, $T2$/dystrophin related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
utrophin
1
We have cloned a cDNA encoding an $T1$ binding protein ($T2$) from the Caki-1 human renal carcinoma cell line.
IL-13
IL-13R
1
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing $T2$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
p60
heat shock protein 90
0
Delineation of the binding regions of these three proteins revealed that HBx, $T1$, and $T2$ each has two binding regions for the other two proteins.
RPB5
TFIIB
0
$T1$ and several other cytokines that are known to activate $T2$ were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.
Interferon-gamma
JAK2 kinase
1
The 2.8 A crystal structure of a complex between the extracellular portions of HFE and $T1$ shows two $T2$ molecules which grasp each side of a twofold symmetric TfR dimer.
TfR
HFE
0
We used alanine substitution of $T1$ residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and $T2$ binding.
EBP
EPO
1
We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, $T1$ and $T2$, cloned originally by their interaction with pRB.
RBP1
RBP2
0
Moreover, while $T1$ inhibited the $T2$ promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.
ITF-2b
creatine kinase
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
IL-6 receptor
0
Analysis of p53, p21(CIP1), p15(INK4b), $T1$$T2$), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p16
CIP1
0
RESULTS: TH, $T1$ and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-$T2$.
AADC
GCH
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
TrkA
brain-derived neurotrophin
0
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of $T1$$T2$: implications for insulin control of ras signalling.
ras
Shc
0
Delineation of the binding regions of these three proteins revealed that $T1$, RPB5, and $T2$ each has two binding regions for the other two proteins.
HBx
TFIIB
0
Concentrations of glial fibrillary acidic protein (GFAp) and $T1$$T2$) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
light subunit neurofilament protein
GFAp
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature $T1$$T2$ complexes (hsp70) or in mature PR complexes (hsp90).
PR
PR
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, $T1$$T2$, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
RIP
MORT
0
The cytokine, designated interleukin-15 ($T1$$T2$ (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2.
IL-15
interleukin-15
0
$T1$ encodes a novel 21 kd protein that is found in $T2$, cyclin D1, cyclin E, and Cdk2 immunoprecipitates.
CIP1
cyclin A
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$$T2$ inhibits the interactions of LIGHT with HVEM / TR2 and LTbetaR , thereby suppressing LIGHT-mediated HT29 cell death .
HVEM
TR6
0
GAP-43 (neuromodulin, $T1$, F1), a protein kinase C ($T2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
B-50
PKC
1
By contrast stimulation with TPO leads to the formation of a $T1$$T2$ leads to the formation of a Grb2 complex containing JAK2.
Grb2
TPO
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$$T2$ subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
p85
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of $T1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
HLA-E
TAP
0
This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking $T1$$T2$ functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.
p60
p60
0
The results of this study suggest that $T1$ activity may be regulated by its interaction with the cell cycle regulatory protein, $T2$.
NF-kappaB
E2F-1
1
Cytokines $T1$, IL-1beta, $T2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
IL-6
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that $T1$$T2$ are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with c-Abl in response to radiation damage.
ATM
c-Abl
0
SF3a interacts with U2 snRNP in the presence of $T1$ to generate a structure similar to 17S $T2$, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3b
U2 snRNP
0
We have exploited the availability of the cloned XPB, $T1$, $T2$, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPD
p62
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of $T2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TATA-binding protein
TBP
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to $T2$.
HLA-E
HLA-E
0
$T1$ interaction with $T2$ ties mitogenic signal transduction to cell cycle activation.
Raf1
Cdc25 phosphatase
1
Although Fos/$T1$ and ATF/$T2$ were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
Jun
CREB
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB
hGITRL
0
The tyrosine kinases Flt4, Flt1, and $T1$ (or $T2$) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.
Flk1
KDR
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral $T1$ and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of $T2$ and site III of viral IL-6, which is necessary for receptor activation.
IL-6
gp130
0
The crystal structure of the $T1$ core domain bound to the 53BP2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of p53 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of $T2$.
p53
p53
0
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that $T1$$T2$ associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
GRB2
0
A newly identified member of tumor necrosis factor receptor superfamily ($T1$) suppresses $T2$-mediated apoptosis.
TR6
LIGHT
0
Thus, $T1$ encodes a human FGF receptor with high affinity for both $T2$ and bFGF.
phFGFR
aFGF
1
Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like gammac, $T1$$T2$ and gammac are similar, and like gammac, IL-13Ralpha is located on chromosome X.
IL-13Ralpha
IL-13Ralpha
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector $T1$$T2$ complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.
p21
E2F
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
Estrogen Receptor
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain ($T1$) for $T2$ signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.
gammac
IL-4
0
Transcription factor TFIID consists of TATA binding protein ($T1$$T2$ consists of TATA binding protein (TBP) and at least eight TBP-associated factors (TAFs).
TBP
TFIID
0
A domain is conserved between $T1$ and the PRDI-BF1/$T2$ differentiation factor.
RIZ
Blimp-1
0
$T1$ associates with the $T2$ after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.
SHPTP2
platelet-derived growth factor (PDGF) receptor
1
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ ($T2$), the major cytoplasmic substrate of the insulin receptor.
insulin receptor substrate 1
IRS-1
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T1$$T2$ (NGF), were substituted with those from human TrkA.
TrkA
nerve growth factor
0
We had previously shown that the ubiquitous $T1$ and the lymphoid-specific $T2$ transcription factors stimulate transcription at the level of stable preinitiation complex formation.
Oct1
Oct2
0
Further investigation indicated that the ITF-2b/$T1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/$T2$.
MyoD
HLH462
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, $T1$, $T2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
USF
CTF
0
We recently reported that Ras interaction with the $T1$ cysteine-rich domain (Raf-CRD, residues 139-184) may be required for $T2$ activation.
Raf-1
Raf-1
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex $T1$, the nucleotide excision repair protein XPG, and Cockayne syndrome group B ($T2$) protein.
TFIIH
CSB
0
Flow cytometric analysis demonstrated high levels of perforin and $T1$ expression by $T2$(-) CD16(+) cells in healthy controls.
granulysin
CD3
0
The results show that $T1$ heterodimerizes with $T2$ and E47 in vivo, but it does not homodimerize to a measurable extent.
myogenin
E12
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .
TR2
LIGHT
0
Endogenous $T1$-$T2$ complexes were detected in human CSF by immunoprecipitation.
TTR
A beta
1
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/$T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bax
Bax
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ($T1$-MyoD) chimerae, we found that estrogen directed $T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
ER
MyoD
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that $T1$$T2$ substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
HBx
HBx
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$ and Fas-FD5, a mutant of $T2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
The $T1$/$T2$ family of transcription factors is one of the main targets of cytokines and other agents that induce HIV-1 gene expression.
NF-kappaB
Rel
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta($T1$$T2$) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
delta C-43
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the $T1$$T2$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
phosphatidylinositol 3-kinase
Gastrin
0
Interaction of mammalian splicing factor $T1$ with U2 snRNP and relation of its 60-kD subunit to yeast $T2$.
SF3a
PRP9
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and $T1$ in the incorporation of $T2$ into the spliceosome.
SF3b
U2 snRNP
0
We further demonstrated that apolipoprotein E2 and E3 but not $T1$ can decrease the fusogenic activity of $T2$(29-42) via a direct interaction.
apolipoprotein E4
Abeta
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by $T1$ and/or $T2$ receptors.
ErbB3
ErbB4
0
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases $T1$ and $T2$.
Jak1
Jak3
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ($T1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, $T2$ and hTAFII18.
TBP
hTAFII20
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$$T2$ G protein-coupled receptor and the insulin receptor.
CCKB G protein-coupled receptor
CCKB
0
Interleukin-2 (IL-2) signaling requires the dimerization of the $T1$$T2$ (IL-2) signaling requires the dimerization of the IL-2 receptor beta.
IL-2
Interleukin-2
0
$T1$ also interacts with $T2$, but it interacts more strongly with hTAFII28 and hTAFII30.
hTAFII18
TBP
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
Fas
LPR
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
TNFR-associated factor 2
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, $T1$$T2$, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibronectin
hyaluronidase
0
$T1$ and $T2$ were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
Interferon-gamma
IGIF
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain $T1$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTAFII30
TAFII30 beta
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human $T2$ and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
IL-6
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/BR-II, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-$T1$ binding: MCP-2, $T2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-3
1
Based on the structure of the closely related lymphotoxin alpha-$T1$ complex, a molecular model of the FasL homotrimer bound to three $T2$ molecules was generated using knowledge-based protein modeling methods.
tumor necrosis factor receptor I
Fas
0
The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [$T1$$T2$) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.
stromelysin-3
E-cadherin
0
The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T1$$T2$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).
brain-derived neurotrophic factor
TRKB
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 $T1$$T2$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
IL-7
0
Shared and unique determinants of the $T1$$T2$ are important for binding EPO and EPO mimetic peptide.
erythropoietin
erythropoietin (EPO) receptor
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with $T1$$T2$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
RAD52
RAD52
0
The same domain of $T1$ that binds RAS also interacts with 14-3-3 proteins, extending the similarity between $T2$ and other RAS effectors.
RIN1
RIN1
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind $T2$ (NGF), were substituted with those from human TrkA.
TrkC
nerve growth factor
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric ($T1$/BR-II, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
$T1$ negatively regulates $T2$ activity by interactions with the Raf-1 cysteine-rich domain.
14-3-3 zeta
raf-1
1
Overexpression of the intact $T1$ protein induces both $T2$ activation and apoptosis.
RIP
NF-kappa B
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$/CCKB G protein-coupled receptor and the $T2$.
gastrin
insulin receptor
0
Transcriptional synergy with $T1$ (C/EBP delta, $T2$).
NF-IL6 beta
CRP3
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by $T1$/$T2$ but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
c-Jun
1
hTAFII28 is a core $T1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTAFII
TAFII30 beta
0
The 2.8 A crystal structure of a complex between the extracellular portions of HFE and $T1$ shows two HFE molecules which grasp each side of a twofold symmetric $T2$ dimer.
TfR
TfR
0
Association of CDK4 with both CDC37 and $T1$ may also imply a mechanistic link between the functions of CDC37 and $T2$.
HSP90
HSP90
0
The structures of $T1$ alone and complexed with HFE differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between $T2$ chains.
TfR
TfR
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/$T1$$T2$ complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cdk2
E2F
0
We further demonstrated that $T1$ and E3 but not apolipoprotein E4 can decrease the fusogenic activity of $T2$(29-42) via a direct interaction.
apolipoprotein E2
Abeta
1
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, $T1$$T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
RAD51
UBC9
0
The internal binding site thus revealed was not altered by further mutating Y960/F for $T1$ or Y950/F for $T2$.
IR
IGF-1R
0
A physical interaction between CDC37 and CDK4 suggests that $T1$ may regulate the mammalian cell cycle through a direct effect on $T2$.
CDC37
CDK4
1
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or $T1$$T2$ gene expression elicited by IL-11 or IL-6 in TF-1 cells.
IL-6
junB
0
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors $T1$ and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as $T2$.
Bax
Bcl-2
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$ binds well to FGFR1, $T2$, and FGFR4 but interacts poorly with KGFR.
FGF-2
FGFR2
1
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an $T1$$T2$ is the central organizing component of an hsp90-p60-hsp70 complex.
hsp90
p60
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein $T1$ and the pocket proteins $T2$, p107 and pRb2/p130.
MyoD
pRb
0
COS-7 cells transfected with the $T1$ cDNA bind IL-13 with high affinity but do not bind $T2$.
IL-13R
IL-4
0
In this report we show that in response to $T1$, $T2$ forms a stable complex with two tyrosine-phosphorylated proteins.
insulin
GRB2
0
The binding of hTAFII28 and $T1$$T2$ and hTAFII30 requires distinct domains of hTAFII18.
hTAFII30
hTAFII28
0
$T1$ is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products $T2$ and E47.
Myogenin
E12
1
Thus, U2AF35 functions as a bridge between $T1$ and the enhancer complex to recruit $T2$ to the adjacent intron.
U2AF65
U2AF65
0
Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two $T1$, two IL-6R alpha and two $T2$ molecules.
IL-6
gp130
1
We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of $T1$, IL-6, and $T2$, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.
IL-1beta
IL-10
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R beta
delta C-43
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of $T1$ or p107 binding is mediated by the $T2$ subunit.
pRB
E2F
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the $T1$ bound to an $T2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EBP
EPO-mimetic peptide
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
IL-6M
IL-6
0
A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the $T1$ ($T2$) containing the lysosomal targeting code.
epidermal growth factor receptor
EGFR
0
The $T1$-$T2$ complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.
HFE
TfR
1
Enhanced degradation of $T1$ receptors by a sorting $T2$, SNX1.
EGF
nexin
0
Interaction of $T1$ subunit of $T2$ with insulin and IGF-1 receptors analysed by using the two-hybrid system.
p85
PI 3-kinase
0
Alanine-scanning mutagenesis was used to identify a positively charged surface in VEGF that mediates binding to $T1$/$T2$.
KDR
Flk-1
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the $T1$-binding proteins, $T2$ and 14-3-3, had no effect.
Raf-1
Ras
1
We recently reported that $T1$ interaction with the $T2$ cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.
Ras
Raf-1
0
Additionally we have examined interactions between $T1$ components, the human NER protein $T2$, and the CSB protein which is implicated in Cockayne syndrome (CS).
TFIIH
XPG
0
The growth-promoting effects of $T1$ on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the $T2$/CCKB receptor, which belongs to the family of G protein-coupled receptors.
gastrin
gastrin
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by $T1$$T2$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.
CrmA
Fas
0
An E2F complex containing mainly E2F4 and pRb2/p130 ($T1$-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cyclinA
0
We investigated whether $T1$, which binds to tyrosine-phosphorylated $T2$, interacts with CD5 following T cell activation.
phosphatidylinositol (PI) 3-kinase
ITAM
1
Thus, the C-terminal domain in $T1$ appears to exert a negative control on binding of p85 thereby providing a possible regulatory mechanism for direct activation of the $T2$ pathway.
IGF-1R
PI 3-kinase
0
Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of $T1$: Fas itself, and a novel 74 kDa protein we have named $T2$, for receptor interacting protein.
Fas
RIP
1
Interaction of $T1$ and N+C-SH2 with $T2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
p85
IR beta
1
$T1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 $T2$ proteins--through a distinct amino-terminal domain.
TAFII55
Tat
0
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by $T1$$T2$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.
IL-11
gp130
0
The $T1$ glucose transporter interacts with $T2$ and calreticulin.
glut 1
calnexin
1
IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and $T1$$T2$, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
Jak3
IL-2
0
Concentrations of glial fibrillary acidic protein (GFAp) and light subunit neurofilament protein ($T1$$T2$ (GFAp) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
NFL
glial fibrillary acidic protein
0
Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that delta-catenin interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PS1, but not with that of $T1$$T2$ interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PS1, but not with that of PS-2.
PS-2
delta-catenin
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$ containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cdk2
0
Using epitope-tagging, interaction of $T1$ basic-helix-loop-helix protein with the $T2$ protein encoded by this novel cDNA was confirmed by immunoprecipitation experiments in COS7 cells.
E47
eip1
1
We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both $T1$$T2$ in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding.
EMP1
EMP1
0
Studies in vivo and in vitro demonstrated a highly specific interaction between the SH3 domains of $T1$ and $T2$.
p47nck
Wiskott-Aldrich syndrome protein
1
The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator $T1$$T2$ gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.
Swi
CSB
0
Comparisons with the hGH-hGHR complex reveal how $T1$$T2$-hGHR complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGH
0
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ($T1$ and $T2$) and the BMP type II receptor (BR-II).
BR-Ia
BR-Ib
0
XPG protein interacts with multiple subunits of $T1$$T2$ protein interacts with multiple subunits of TFIIH and with CSB protein.
TFIIH
XPG
0
By using several different experimental systems we show that TBP efficiently associates with $T1$ and $T2$.
Oct1
Oct2
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$ (IR) and the IGF-1 receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin receptor
IGF-1R
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, $T1$$T2$, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
p53
UBC9
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NIK
NF-kappaB
0
Like mIL-10R, $T1$$T2$, hIL-10R is structurally related to IFNR.
hIL-10R
mIL-10R
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$$T2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-2
keratinocyte growth factor receptor
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, $T1$$T2$, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Mcl-1
Bcl-X-S
0
This protein, designated $T1$-related protein ($T2$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF
VRP
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and $T1$$T2$ substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
TFIIB
HBx
0
We also found another $T1$, $T2$, interacted with PS1.
armadillo-protein
p0071
0
pRB, cyclin D, p19($T1$) and p27($T2$) decrease in both cell types.
INK4d
KIP1
0
$T1$ (PDGF-C), a novel growth factor that binds to $T2$ and beta receptor.
Platelet-derived growth factor C
PDGF alpha
1
The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of $T1$ and $T2$ and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).
IR
IGF-1R
0
Due to its increased affinity for the IL-6R but its decreased ability to couple with $T1$$T2$ but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient IL-6 antagonist.
gp130
IL-6R
0
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the $T1$ receptor ($T2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IGF-1
IGF-1R
0
$T1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
FGF-7
KGFR
0
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
eotaxin
0
In vivo complexes of $T1$ and $T2$ were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged G beta 2.
Raf-1
G beta gamma
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
Fas
FD8
0
Characterization of Fas ($T1$, CD95)-$T2$ ligand interaction.
Apo-1
Fas
0
Gastrin stimulates tyrosine phosphorylation of $T1$ and its association with $T2$ and the phosphatidylinositol 3-kinase.
insulin receptor substrate 1
Grb2
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas $T1$ binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
FGF-2
FGFR4
1
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and RANTES were both potent agonists for $T1$ and $T2$.
CC CKR3
CC CKR1
0
These findings imply that $T1$ and IL-6 share similar early signaling events with the possibility of using the same signal transducer, $T2$.
IL-11
gp130
0
Using a yeast interaction assay, we find that $T1$ binds the RAP74 subunit of TFIIF and that $T2$'s transcriptional activation domain is the region involved in this binding.
SRF
SRF
0
Sos and $T1$.$T2$.
80K-H
pp66
1
However, $T1$ was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for $T2$ but not CC CKR3.
MIP-1 beta
CC CKR1
0
This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking $T1$$T2$ assembly to facilitate formation of subsequent PR complexes lacking p60.
p60
PR
0
It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or $T1$$T2$ or IL-6 in TF-1 cells.
IL-6
IL-11
0
Thus, our data show that both calnexin and $T1$$T2$ and calreticulin interact with Glut 1 in a glycosylation-dependent manner.
calreticulin
calnexin
0
The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase p53/$T1$ ($T2$) contribute to signaling via the B-cell antigen receptor complex.
56Lyn
Lyn
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the $T1$-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T2$.
Grb2
gastrin
0
These findings suggest that FADD may play an important role in the proximal signal transduction of $T1$$T2$ may play an important role in the proximal signal transduction of Fas.
Fas
FADD
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T1$ and $T2$-FD8.
LPR
Fas
0
Association of CDK4 with both CDC37 and HSP90 may also imply a mechanistic link between the functions of $T1$ and $T2$.
CDC37
HSP90
0
Functional participation of the IL-2 receptor gamma chain in $T1$$T2$ receptor complexes.
IL-7 receptor
IL-7
0
In all cells tested, $T1$ activated $T2$ and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
IL-10
Stat1
1
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
soluble cell adhesion molecules
0
The death domain of tumor necrosis factor (TNF) receptor-1 ($T1$) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein $T2$.
TNFR1
TRADD
1
The products of the $T1$ and $T2$ genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP1
RBP2
0
Biochemical studies established that some coactivators are associated with the TATA-binding protein ($T1$) to form the $T2$ complex.
TBP
TFIID
0
hPRL does not bind to the $T1$ receptor, but hGH binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hPRLR
0
Here we show that QM/$T1$, a negative regulator of $T2$, is a candidate to mediate the function of PS1 in the cell.
Jun-interacting factor (Jif)-1
c-Jun
1
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6D
IL-6 receptor
0
Additionally we have examined interactions between $T1$ components, the human NER protein XPG, and the $T2$ protein which is implicated in Cockayne syndrome (CS).
TFIIH
CSB
0
When the ligand binds, IL-1RI initiates a signaling cascade that results in the activation of the transcription regulator $T1$ ($T2$).
nuclear factor kappa B
NF-kappa B
0
$T1$ fails to bind appreciably to the extracellular domain of $T2$ or Flk1.
VRP
Flt1
0
The results are not due to general misfolding since mutant $T1$ monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild-type $T2$ dimers.
RII beta
RII beta
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM / $T1$ and $T2$ , thereby suppressing LIGHT-mediated HT29 cell death .
TR2
LTbetaR
0
In this article, we demonstrate that PTPmu associates with a complex containing $T1$- and $T2$ in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.
cadherins, alpha
beta-catenin
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ($T1$, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
TRADD
p80
1
Jak1 and $T1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced $T2$-IL-2R beta and increased Jak3-gamma c associations.
Jak3
Jak3
0
Here we show that a complex of $T1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and $T2$ (refs 7, 8).
gp120
MIP-1beta
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned $T1$$T2$ is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
IL-7R
0
Finally, activated $T1$ was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of $T2$.
FGFR3
c-Src
0
How $T1$ acts to bring about this suppression is not clear but one clue is that the Rb protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of $T2$ essential for such binding frequently contain mutations in tumour cells.
Rb
Rb
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds $T1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
Fas
Fas
0
Characterization of Fas ($T1$, CD95)-$T2$ interaction.
Apo-1
Fas ligand
1
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as $T1$$T2$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
protein phosphatase 1
serine-threonine phosphatase 2A
0
Expression of $T1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including $T2$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.
FGFR3 IIIc
FGF-1
0
TR6 ($T1$ ($T2$)) is a new member of the tumor necrosis factor receptor (TNFR) family.
decoy receptor 3
DcR3
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTFIID
TAFII30 beta
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$ ($T2$) has been designed and characterized.
IFN-gamma receptor alpha chain
IFN-gamma R alpha
0
Crystal structure of the type-I $T1$$T2$ complexed with interleukin-1beta.
interleukin-1
type-I interleukin-1 receptor
0
Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type $T1$$T2$ approximately 4% as avidly as wild-type RII beta.
RII beta
AKAP75
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind nerve growth factor ($T2$), were substituted with those from human TrkA.
TrkC
NGF
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and $T2$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-II
0
We have selected such mutations in the transcription factor $T1$ that affect its ability to heterodimerize with $T2$.
E2F1
DP1
1
Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors $T1$ and $T2$.
Bax
Bcl-X-S
0
Native $T1$ also formed a heterodimer with $T2$,and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.
C8
C5
1
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned $T1$$T2$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.
IL-7R
IL-7R
0
We show that $T1$ interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with $T2$.
hTAFII28
TBP
0
Expression of $T1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including $T2$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.
FGFR3
FGF-1
0
Activity of RNA polymerase I transcription factor $T1$ blocked by $T2$ gene product.
UBF
Rb
1
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
CIP1
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
NGF
TrkB
0
Sos complex via the adapter protein $T1$$T2$ complex via the adapter protein Shc.
Shc
Sos
0
Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a $T1$$T2$/56Lyn and a 120-kDa phosphoprotein.
120-kDa phosphoprotein
p53
0
The protein product of $T1$ proto-oncogene is known to interact with several proteins, including Grb2, Crk and $T2$, and is thought to regulate signalling by many cell surface receptors.
c-cbl
PI3 kinase
1
We next tested whether IL-11 induced signaling can be inhibited by anti-$T1$$T2$ induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions.
gp130
IL-11
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a $T1$-related complex (SNAPc) containing substoichiometric levels of TBP and a component ($T2$) identical in sequence to the PTF gamma reported here.
PTF
SNAPc43
0
In contrast to hTAFII28, $T1$$T2$, hTAFII18 is a TFIID beta-specific hTAFII.
hTAFII18
hTAFII28
0
Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that delta-catenin interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of $T1$, but not with that of $T2$.
PS1
PS-2
0
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, $T1$$T2$ specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
Fra2
USF
0
CD26, a T cell activation Ag, also known as $T1$,is directly associated with $T2$ (ADA) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
adenosine deaminase
1
$T1$ was significantly more potent than $T2$ in both atrial (P < 0.001) and ventricular (P < 0.05) trabeculae.
ET-1
ET-3
0
Here, we quantitatively mapped the complete binding region of $T1$ on $T2$ by 35 individual mutations to alanine and isosteric residues.
ifnar2
interferon (IFN)alpha2
1
RESULTS: $T1$, AADC and $T2$ were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-AADC and AAV-GCH.
TH
GCH
0
The HFE-TfR complex suggests a binding site for transferrin on $T1$$T2$-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.
TfR
HFE
0
The high affinity interleukin-6 (IL-6) signaling complex consists of $T1$ and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter/signal transducing protein $T2$.
IL-6
gp130
0
We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and $T1$$T2$ in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding.
EPO
EMP1
0
FXIII also was shown to coprecipitate with $T1$ in immunoprecipitation studies and to colocalize with $T2$ in immunofluorescence studies of intact glass-activated platelets.
HSP27
HSP27
0
Interaction of the p85 subunit of $T1$$T2$ subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
p85
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6R alpha bind a single $T1$ molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
gp130
gp130
0
Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect $T1$$T2$ site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect KDR binding.
KDR
KDR
0
TNF-dependent recruitment of the protein kinase $T1$ to the $T2$ signaling complex.
RIP
TNF receptor-1
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/$T1$$T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Sos1
Sos1
0
We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with $T1$ bind a single $T2$ molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130.
IL-6R alpha
gp130
1
These results suggest that the RAD52-dependent processes, cell cycle control, p53-mediated pathway(s), and ubiquitination interact through human $T1$$T2$-mediated pathway(s), and ubiquitination interact through human UBE2I.
UBE2I
p53
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing $T1$$T2$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric $T1$$T2$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
gp120
MIP-1beta
0
$T1$ is shown to interact with the largest subunit ($T2$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TAFII55
TAFII230
1
We have exploited the availability of the cloned XPB, $T1$, p62, p44, and p34 genes (all of which encode polypeptide subunits of $T2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPD
TFIIH
0
One protein is the major insulin receptor substrate $T1$ and the second is the SH2 domain-containing oncogenic protein, $T2$.
IRS-1
Shc
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, $T1$$T2$ protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with RAD52, RAD51, p53, and a ubiquitin-like protein UBL1.
RAD51
RAD52
0
RESULTS: TH, AADC and $T1$ were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-$T2$ and AAV-GCH.
GCH
AADC
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha $T1$ and RANTES were both potent agonists for $T2$ and CC CKR1.
MIP
CC CKR3
0
After a brief historical incursion regarding $T1$ of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, tonin, D and G cathepsin and ending with the conversion enzyme and $T2$.
RAS
chymase
0
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
CD5
TcR zeta
0
Mouse $T1$ does not bind to hIL-10R, and $T2$-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.
IL-10
hIL-10R
0
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein $T1$, and Cockayne syndrome group B ($T2$) protein.
XPG
CSB
1
By contrast stimulation with TPO leads to the formation of a Grb2 complex containing $T1$$T2$ leads to the formation of a Grb2 complex containing JAK2.
JAK2
TPO
0
Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I-TNF-alpha and approximately 5-fold lower affinity for $T1$$T2$ and approximately 5-fold lower affinity for TNF-beta (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell.
TNF-beta
TNF-alpha
0
In addition, PCR analysis of $T1$-expressing cells could not detect splicing of the extracellular domain of the cloned $T2$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
p76
IL-7R
0
COS-7 cells transfected with the IL-13R cDNA bind $T1$ with high affinity but do not bind $T2$.
IL-13
IL-4
0
We recently reported that $T1$ interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for $T2$ activation.
Ras
Raf-1
0
Unlabeled TNF-alpha and TNF-beta were equally effective at displacing the binding of labeled $T1$$T2$ and TNF-beta were equally effective at displacing the binding of labeled TNF-alpha to TNF-R expressing cells.
TNF-alpha
TNF-alpha
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T1$ ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO
0
$T1$ protein interacts with multiple subunits of TFIIH and with $T2$ protein.
XPG
CSB
1
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or $T1$, suggesting that signalling by $T2$ is mediated by ErbB3 and/or ErbB4 receptors.
ErbB4
neuregulin-2
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 $T1$$T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
p90
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and $T1$$T2$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
Ras
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
FD5
LPR
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with $T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
TBP
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R beta
IR beta
0
Transcriptional synergy with NF-IL6 beta (C/$T1$$T2$ (C/EBP delta, CRP3).
EBP delta
NF-IL6 beta
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$ and $T2$ IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3 IIIb
FGFR3
0
$T1$ cleaved the $T2$ gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.
MMP2
Ln-5
1
The multisubunit transcription factor IID ($T1$$T2$ (TFIID) is thought to be a primary target for site-specific activators of transcription.
TFIID
transcription factor IID
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$ containing complex following serum stimulation and this correlates with suppression of $T2$ activity and the inability of cells to re-enter the cell cycle.
E2F4
E2F
0
In vitro-binding assays demonstrated that $T1$ isoforms preferentially bind the hypophosphorylated form of $T2$.
PP-1 alpha
p110RB
1
The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of $T1$ with the same affinity and efficacy as wild-type $T2$ dimers.
PKAII beta
RII beta
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned $T1$$T2$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
IL-7R
0
By using the growth factor dependent M-07e cell line, we found that both $T1$ and c-Kit ligands, namely: SCF and TPO, induce $T2$ tyrosine phosphorylation.
c-Mpl
c-Cbl
0
The results of his3 activation indicated that $T1$, N + C-SH2 and C-SH2 interact with both $T2$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
p85
IR
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
delta C-4
IGF-1R
0
$T1$ induced maximal migration of CCR1 and $T2$ transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.
LEC
CCR8
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with $T1$ from co-transfected Cos1 cells and $T2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
Oct2
TBP
0
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the CDK6 protein mediates, in part, the $T1$$T2$-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated Rb-kinase activity.
p27
CDK6
0
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of Raf-1 coimmunoprecipitated with JAK2 in lysates of cells in which $T1$$T2$ in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.
JAK2
JAK2
0
In contrast, physical interaction is not necessary for YY1 to repress $T1$- and $T2$-mediated transcription.
Sp1
CREB
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T1$ ($T2$).
Hip
p48
0
The genes for MPIF-2/eotaxin-2 ($T1$) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
SCYA24
SCYA26
0
$T1$ is a $T2$ that controls progression through G1 of the mammalian cell cycle.
CDK4
cyclin D-dependent kinase
0
Deletion of this domain impairs RAP74's ability to support $T1$-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support $T2$-activated transcription.
SRF
SP1
0
Two previously unidentified human cdc25 genes have been isolated, $T1$ and $T2$.
cdc25A
cdc25B
0
This is the first report to demonstrate that two of cytosolic components of $T1$, p47-phox binding to $T2$ each other.
cytochrome b558
p67-phox
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, $T1$$T2$, K5, and K6.
K5
K2
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T1$, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with $T1$$T2$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with CCR-5.
CCR-5
CD4
0
In yeast, $T1$ interacts with cyclin-dependent kinases, including human $T2$, Cdk2, and Cdk3, but not with Cdk4.
Cdi1
Cdc2
1
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2/$T1$ complex with signaling proteins upon activation of non-tyrosine ($T2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
c-Cbl
c-Mpl
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T1$/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
0
The predicted amino acid sequence of $T1$ is 60% identical and 73% similar to mouse IL-10R ($T2$).
hIL-10R
mIL-10R
0
How $T1$ acts to bring about this suppression is not clear but one clue is that the $T2$ protein forms complexes with the transforming oncoproteins of several DNA tumour viruses, and that two regions of Rb essential for such binding frequently contain mutations in tumour cells.
Rb
Rb
0
Isothermal titration calorimetry shows that $T1$ SC1 forms a 1:1 complex with its high-affinity receptor ($T2$ R alpha) with an affinity of 27(+/- 9) nM.
IFN-gamma
IFN-gamma
0
Characterization of Fas (Apo-1, $T1$)-$T2$ ligand interaction.
CD95
Fas
0
The cyclin-dependent kinase $T1$ associates with $T2$, D, and E and has been implicated in the control of the G1 to S phase transition in mammals.
Cdk2
cyclins A
0
Flow cytometric analysis demonstrated high levels of perforin and $T1$ expression by CD3(-) $T2$(+) cells in healthy controls.
granulysin
CD16
0
Bcl-2 also interacted with Bcl-X-L and $T1$ and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with $T2$ family proteins as Bcl-2.
Mcl-1
Bcl-2
0
The motif may represent an activating domain that has to be provided to $T1$ by intermolecular interaction with $T2$.
cdc25
cyclin B
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/$T2$.
ITF-2
HLH462
0
MMP2 cleaved the $T1$$T2$ subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.
Ln-5
Ln-5 gamma2
0
Thus, our data show that both calnexin and $T1$ interact with $T2$ in a glycosylation-dependent manner.
calreticulin
Glut 1
1
The protein product of c-cbl proto-oncogene is known to interact with several proteins, including $T1$, Crk and $T2$, and is thought to regulate signalling by many cell surface receptors.
Grb2
PI3 kinase
0
Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of $T1$$T2$), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.
A beta
TTR
0
Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding $T1$$T2$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.
hsp90
hsp70
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD3
T-cell receptor zeta chain (TcR zeta)/CD3
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and $T1$$T2$, and imply that the p90 and p76 IL-7R have different extracellular domains.
p76
IL-7R
0
Further, $T1$'s central charged cluster domain is required for binding to $T2$'s activation domain.
RAP74
SRF
0
Liver-expressed chemokine ($T1$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and $T2$.
LEC
CCL16
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T1$/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
1
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and Fas ligand ( $T1$ / $T2$ ) .
FasL
CD95L
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$) receptor are important for binding EPO and EPO mimetic peptide.
EPO mimetic peptide
EPO
0
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T2$ complexes containing hsp70 and Hip (p48).
p60
PR
0
The extracellular domain of the human neurotrophin $T1$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor ($T2$).
TRKB
BDNF
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$$T2$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3 IIIb
FGFR3
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and $T1$$T2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
Sos1
0
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins $T1$ and $T2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
Ht 21
Ht 31
0
Here we show that beta:$T1$ binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form $T2$.beta:beta.
beta activin
ActRII
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with $T1$, indicating that $T2$ uses components of the IL-2 receptor.
IL-2
IL-15
0
Co-transfection of human TBP and $T1$$T2$ and Oct2 expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.
Oct2
TBP
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal $T1$-forming enzymes, starting with $T2$, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
angiotensin
isorenin
0
The structure also reveals the final six C-terminal amino acid residues of $T1$ (residues 253-258) that have not been observed in any other reported $T2$ structures.
IFN-gamma SC1
IFN-gamma
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat3
0
In competition experiments, the carboxyl terminus of $T1$ (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, $T2$ and 14-3-3, had no effect.
beta-adrenergic receptor kinase
Ras
0
In addition to this unique pathway, $T1$ also links to $T2$.
FGFR3
GRB2
0
Here we show that $T1$ binds $T2$ constitutively in control cells but not in AT cells.
ATM
c-Abl
1
Regulation of the $T1$-related transcription factor Elf-1 by binding to the $T2$ protein.
Ets
retinoblastoma
0
The similarities in biofunctions and differences in ligand binding proteins between $T1$ and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with $T2$.
IL-11
IL-6
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, $T1$$T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
FLICE
FADD
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, $T1$, MCP-4, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-3
MCP-1
0
We found that $T1$ was associated with $T2$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
CD26
1
This Syk-$T1$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and $T2$ from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$-$T2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
FD5
0
Together with analyses of native $T1$ complexes and accompanying crystallographic studies, the results suggest that there is a histone octamer-like TAF complex within $T2$.
TFIID
TFIID
0
The interleukin-1beta ($T1$) converting enzyme ($T2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
IL-1beta
ICE
1
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
decorin
collagenase
0
Our analyses demonstrate that the XPB, XPD, $T1$$T2$, p44, and p62 proteins interact with each other.
p44
XPD
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced $T1$-$T2$ and increased Jak3-gamma c associations.
Jak3
IL-2R beta
1
However, the various E2F/DP complexes display strong differences in the ability to bind to either $T1$ or p107 in vivo, and the specificity of $T2$ or p107 binding is mediated by the E2F subunit.
pRB
pRB
0
pRB, cyclin D, $T1$(INK4d) and $T2$(KIP1) decrease in both cell types.
p19
p27
0
Computer-aided analysis of secondary structure, performed on four $T1$-anchoring protein sequences (the microtubule-associated protein 2, $T2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
RII
P150
0
Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the $T1$$T2$-converting enzyme.
interleukin-1 beta-converting enzyme
interleukin-1 beta
0
Other recent studies have identified human $T1$ ($T2$) as a putative G1 cyclin and candidate proto-oncogene.
cyclin D1
PRAD1
0
$T1$ also interacts with TBP, but it interacts more strongly with $T2$ and hTAFII30.
hTAFII18
hTAFII28
1
Comparison of messenger RNA gene expression of extracellular matrix proteins ($T1$, $T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
procollagen I
collagenase
0
Both $T1$ and hDP-2 bind to all $T2$ family members in vivo, and each complex is capable of activating transcription.
hDP-1
E2F
0
Although $T1$ associates with $T2$ and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
GRB2
IRS-1
1
Interaction domains were mapped to codons 374-400 for $T1$ and to codons 106-179 for $T2$, a region including the fourth GTP-binding domain.
PS1
Rab11
1
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
CD4
CD5
0
Using a yeast interaction assay, we find that SRF binds the $T1$ subunit of $T2$ and that SRF's transcriptional activation domain is the region involved in this binding.
RAP74
TFIIF
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits $T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p22-phox
cytochrome b558
0
The $T1$-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the $T2$-binding drug geldanamycin.
hsp90
hsp90
0
BMP-2 is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta ($T1$$T2$ is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta (TGF-beta) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.
TGF-beta
BMP-2
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both $T1$ and NR2B subunits of the $T2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.
NR1
NMDA receptor
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, $T1$/MACH, and TRAFs) associated with both of the $T2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
FLICE
p60
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component ($T1$) identical in sequence to the $T2$ gamma reported here.
SNAPc43
PTF
0
Thrombopoietin ($T1$$T2$ (TPO) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.
TPO
Thrombopoietin
0
Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase ($T1$$T2$), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
P13-K
PKC
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
p75
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as $T1$, $T2$, NCC-4, and CCL16.
LMC
HCC-4
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with $T1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of $T2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
PTF
TBP
0
A model is presented whereby the trimeric complex of $T1$, $T2$, and IL-6M forms before the functional hexamer.
IL-6R
gp130
1
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of $T2$ dimerization on binding to the receptor complex.
IL-6D
IL-6
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ (EPO) receptor are important for binding EPO and EPO mimetic peptide.
EPO
erythropoietin
0
These cells contain a temperature-sensitive mutation in the $T1$ TAFII250, first identified as the cell cycle regulatory protein $T2$.
TATA-binding protein-associated factor
CCG1
0
Deglycosylation studies showed that the p90 and p76 $T1$$T2$ IL-7R are not simply differently glycosylated isoforms of a single receptor.
IL-7R
p76
0
However, the various $T1$/DP complexes display strong differences in the ability to bind to either pRB or $T2$ in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.
E2F
p107
0
The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that $T1$ may participate in the cellular localization and/or enzymatic regulation of platelet $T2$.
HSP27
FXIII
1
$T1$ and $T2$ oncoproteins form a complex that regulates transcription from promoters containing AP-1 binding sites.
Fos
Jun
1
Furthermore, $T1$ can be activated in vitro in a $T2$-dependent manner.
Cdc25 phosphatase
Raf1
1
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of $T1$$T2$ and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.
c-Cbl
Vav
0
In transfected COS-1 cells, $T1$/BMP-7, and less efficiently BMP-4, bound to $T2$.
osteogenic protein (OP)-1
BMPR-II
1
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing $T1$$T2$/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
pRb2
0
$T1$ activity and the regulatory p85 subunit of PI 3-kinase associated with $T2$ in pervanadate-stimulated, but not in unstimulated thymocytes.
PI 3-kinase
CD5
0
The kinetics of amyloid fibril formation by $T1$ ($T2$) are typical of a nucleation-dependent polymerization mechanism.
beta-amyloid peptide
Abeta
0
Two proteins have been described as constituents of the $T1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the $T2$, but neither of these proteins binds IL-13.
IL-4
IL-2 receptor
0
Due to its increased affinity for the $T1$ but its decreased ability to couple with gp130, we suggest that a stable $T2$ dimer may be an efficient IL-6 antagonist.
IL-6R
IL-6
1
Activation of $T1$ decreases phosphorylation of $T2$ at sites that negatively regulate its DNA-binding activity.
protein kinase C
c-Jun
1
In contrast, mutant $T1$ either had no effect or activated the transcriptional activity of $T2$ depending on the type of hormone response elements.
p53
h-TR beta 1
0
The similarities in biofunctions and differences in ligand binding proteins between IL-11 and $T1$ prompted us to investigate whether IL-11 shares common signal transduction mechanisms with $T2$.
IL-6
IL-6
0
Previous studies on the assembly of progesterone receptor (PR) complexes in vitro have suggested that $T1$$T2$ (PR) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.
PR
progesterone receptor
0
In vivo complexes of Raf-1 and G beta gamma were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged $T1$$T2$ and G beta gamma were isolated from human embryonic kidney 293-T cells transfected with epitope-tagged G beta 2.
G beta 2
Raf-1
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T1$, although with lower affinity compared with $T2$.
brain-derived neurotrophin
TrkB
1
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and $T1$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport $T2$ to the surface.
ADA
ADA
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T1$, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ($T1$), the major cytoplasmic substrate of the $T2$.
IRS-1
insulin receptor
0
In the second of a series of experiments designed to identify $T1$-Src homology 3 (SH3)-binding molecules, we report the cloning of SAKAP II ($T2$) from an HL60 cDNA expression library.
p47nck
Src A box Nck-associated protein II
0
Present data concerning the $T1$-$T2$ system of extrarenal origin.
renin
angiotensin
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of $T1$-$T2$ complexes with CCR-5.
gp12O
CD4
1
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature $T1$$T2$) or in mature PR complexes (hsp90).
PR
hsp70
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/$T1$, and TRAFs) associated with both of the p60 and $T2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.
MACH
p80
1
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding $T1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EPO-binding protein
0
JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the $T1$/$T2$ signal transduction pathway.
ras
mitogen-activated protein kinase
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for $T1$$T2$ to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-beta
TNF-beta
0
Two potentially oncogenic cyclins, $T1$ and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an $T2$ (SPF) as well as a candidate proto-oncogene.
cyclin A
S-phase-promoting factor
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ $T2$, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
The molecular adapter $T1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, $T2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.
c-Cbl
Crk
1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, $T1$$T2$/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
RIP
FADD
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
NGF
0
The carboxy-terminal region of $T1$ has previously been shown to interact directly with $T2$, a cytoplasmic component of the dystrophin-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.
dystrophin
alpha1 syntrophin
1
rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds $T1$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to $T2$.
hIL-10
hIL-10
0
Levels of p16($T1$) and p57(KIP2) rise in HUCs during progressive passages, whereas only $T2$ increases in HPEC cultures.
INK4a
p16
0
$T1$: a novel protein containing a death domain that interacts with Fas/APO-1 ($T2$) in yeast and causes cell death.
RIP
CD95
1
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or $T1$$T2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
IGF-1R
IR beta
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of $T1$, hsp70, and three additional proteins, $T2$, p50, and p23.
hsp90
p54
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat1
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained $T1$$T2$-L4/7) retained FGF-2 like affinity for FGFR1 and for KGFR.
FGF-2
FGF2
0
Interaction of the regulatory subunit ($T1$) of cAMP-dependent protein kinase with $T2$-anchoring proteins occurs through an amphipathic helix binding motif.
RII
RII
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for $T1$ and $T2$ in the incorporation of U2 snRNP into the spliceosome.
SF3a
SF3b
0
The interleukin-1beta ($T1$$T2$ (IL-1beta) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.
IL-1beta
interleukin-1beta
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, $T2$/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Native $T1$ and $T2$ formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.
C8
C9
1
$T1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T2$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
FGF-7
KGFR
1
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins $T1$$T2$, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
Ht 21
microtubule-associated protein 2
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/$T1$, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Levels of p16($T1$) and p57($T2$) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
INK4a
KIP2
0
In synchronized human osteosarcoma cells, $T1$ is induced in early G1 and becomes associated with $T2$, a Cdk-binding subunit.
cyclin D1
p9Ckshs1
1
We performed cell-free in vitro infection of primary bone marrow derived $T1$+ cells using semi-purified HHV8 and a mature $T2$ dependent T cell line, KIT 225, using highly concentrated viral stocks prepared from an infectious molecular clone of HTLV-1.
CD34
IL-2
0
This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble $T1$$T2$ system and for designing assays for soluble CD30L.
CD30L
CD30L
0
However, MIP-1 beta was also an agonist for $T1$ but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not $T2$.
CC CKR3
CC CKR3
0
A protein kinase designated IRAK ($T1$$T2$ (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.
IL-1
IRAK
0
Secreted LT-alpha is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface $T1$-$T2$ complex.
LT-alpha
LT-beta
1
The crystal structure of the human $T1$ inhibitory domain bound to the phosphorylated $T2$-cyclin-dependent kinase 2 (Cdk2) complex has been determined at 2.3 angstrom.
p27Kip1 kinase
cyclin A
1
An E2F complex containing mainly $T1$ and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the $T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F4
cyclinA
0
Sos; these two complexes may alternatively link FGFG3 to $T1$$T2$; these two complexes may alternatively link FGFG3 to mitogen-activated protein kinase.
mitogen-activated protein kinase
Sos
0
Using a yeast interaction assay, we find that $T1$ binds the $T2$ subunit of TFIIF and that SRF's transcriptional activation domain is the region involved in this binding.
SRF
RAP74
1
These data demonstrate that Stat3 but not Stat1 or $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
Stat3
0
We have exploited the availability of the cloned $T1$, XPD, $T2$, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPB
p62
0
Interaction of the p85 subunit of $T1$ with the insulin receptor ($T2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
PI 3-kinase
IR
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound $T1$$T2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T1$, that result from alternative splicing of exon III of the $T2$ gene encoding the ligand binding domain.
FGFR3 IIIc
FGFR3
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor $T1$$T2$ DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.
MyoD
MyoD
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of $T1$-CD4 complexes with $T2$.
gp12O
CCR-5
1
RIP: a novel protein containing a death domain that interacts with Fas/$T1$ ($T2$) in yeast and causes cell death.
APO-1
CD95
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-$T1$$T2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
ER
0
Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than $T1$$T2$ has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.
IL-6D
IL-6D
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
IL-10
Stat3
0
Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of $T1$$T2$ proteins results in down-regulation of AP1 activity.
AP1
Fra1
0
Analysis of p53, p21(CIP1), p15($T1$), p16(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
p57
0
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to $T1$$T2$ (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
erythropoietin
erythropoietin receptor
0
We find that $T1$, $T2$(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
p53
p21
0
Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between $T1$ and $T2$.
GT155
calnexin
1
Interaction of p85 and N+C-SH2 with IR beta ($T1$$T2$ and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
p85
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between $T1$$T2$ interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.
hTAFII20
hTAFII20
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat5
0
An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/$T1$) overexpressing $T2$.
TNF-R2
TNF-R2
0
From Scatchard analyses, the Kd:s for binding of $T1$ and bFGF to $T2$ were estimated to 25 pM and 41 pM, respectively.
aFGF
hFGFR-1
1
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, $T1$, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of $T2$ that lacks a well-conserved 63-amino acid region).
Bcl-X-L
Bcl-X
0
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2/$T1$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase ($T2$) receptors leading to myeloid cell proliferation.
c-Cbl
c-Kit
0
This suggests that one domain of $T1$ is sufficient to recruit IFN-gamma R alpha and $T2$ into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma R beta
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$$T2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cdk2
ER
0
Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T1$$T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
sICAM-1
soluble cell adhesion molecules
0
The $T1$-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic $T2$ mutants.
Ras
Ras
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or ErbB4, suggesting that signalling by $T1$ is mediated by $T2$ and/or ErbB4 receptors.
neuregulin-2
ErbB3
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, $T1$, $T2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-4
MCP-1
0
Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for $T1$$T2$ and EMP1 binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EPO
EPO
0
A protein, sorting nexin-1 ($T1$), was identified in a human cell line that bound to a region of the epidermal growth factor receptor ($T2$) containing the lysosomal targeting code.
SNX1
EGFR
1
Interaction of $T1$ with $T2$: binding and inhibition of amyloid formation.
transthyretin
amyloid beta-protein
1
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that $T1$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
HLA-E
TAP
0
VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 ($T1$) and $T2$.
Flk-1
FLT-1
0
Bcl-2 also interacted with $T1$ and Mcl-1 and with the dominant inhibitors Bax and $T2$.
Bcl-X-L
Bcl-X-S
0
Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and $T1$($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p57
KIP2
0
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), $T2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).
p60
p23
0
These findings strongly suggest that $T1$ may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of $T2$ with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.
CD26
CD26
0
Thus, $T1$ encodes a human FGF receptor with high affinity for both aFGF and $T2$.
phFGFR
bFGF
1
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain ($T1$$T2$) has been designed and characterized.
IFN-gamma
IFN-gamma R alpha
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/dystrophin related protein, and the $T2$.
dystrophin
Torpedo 87K protein
0
However, MIP-1 beta was also an agonist for $T1$ but not $T2$; MCP-3 was an agonist for CC CKR1 but not CC CKR3.
CC CKR3
CC CKR1
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T2$ (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
transporter associated with antigen processing
0
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the $T2$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
MDM2
p53
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S $T1$, which suggests a function for SF3a and SF3b in the incorporation of $T2$ into the spliceosome.
U2 snRNP
U2 snRNP
0
Crosslinking of iodinated $T1$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and $T2$.
acidic FGF
bFGF
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or $T1$ in vivo, and the specificity of pRB or $T2$ binding is mediated by the E2F subunit.
p107
p107
0
Differential expression of $T1$ and $T2$ by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.
granulysin
perforin
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or $T1$ binding is mediated by the $T2$ subunit.
p107
E2F
0
When human embryonic kidney cells (cell line 293) over-expressing $T1$ or HeLa cells were exposed to IL-1, $T2$ rapidly associated with the IL-1RI complex and was phosphorylated.
IL-1RI
IRAK
0
IL-2, IL-4, $T1$ (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and $T2$.
IL-7
Jak3
0
ICE was also shown to cleave the precursor of $T1$ ($T2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
interferon-gamma inducing factor
IGIF
0
Although the individual amino acids in TrkA involved in binding to nerve growth factor ($T1$) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
NGF
TrkC
0
Two lines of evidence support the notion that RbAP46 and $T1$ have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to $T2$.
simian virus 40 T antigen
Rb
0
We present evidence that $T1$ (pp54 and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of $T2$.
mitogen-activated protein-serine (MAP) kinases
c-jun
0
Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble $T1$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, $T2$ and MIP-1beta (refs 7, 8).
CD4
macrophage inflammatory protein (MIP)-1alpha
0
We report here the identification of one such human cellular $T1$$T2$ of relative molecular mass 46,000 (46K) (RbAP46).
Rb
Rb-associated protein
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase ($T1$$T2$-inducing kinase (NIK) [8].
NIK
NF-kappaB
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
dTBP
0
$T1$ interacts with protein phosphatases $T2$ and PP1 and disrupts a G2/M cell-cycle checkpoint.
HOX11
PP2A
1
Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by $T1$(-) $T2$(+) cells in healthy controls.
CD3
CD16
0
From Scatchard analyses, the Kd:s for binding of aFGF and $T1$ to $T2$ were estimated to 25 pM and 41 pM, respectively.
bFGF
hFGFR-1
1
Here, we demonstrate that $T1$ may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the $T2$ subunit, p50.
E2F-1
NF-kappaB
1
Shedding of the extracellular domain of $T1$ was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or $T2$.
TNF-R2
TNF-beta
0
$T1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the $T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
p90
0
USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with $T1$$T2$ but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
c-Jun
Fra1
0
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members (ErbB-1, neu/ErbB-2, $T1$$T2$, ErbB-3, and ErbB-4) and tumor recurrence.
ErbB-3
ErbB-2
0
Here we show that $T1$/$T2$, a negative regulator of c-Jun, is a candidate to mediate the function of PS1 in the cell.
QM
Jun-interacting factor (Jif)-1
0
$T1$ also interacts weakly with the p55 tumor necrosis factor receptor (TNFR1) intracellular domain, but not with a mutant version of $T2$ corresponding to the murine lprcg mutation.
RIP
Fas
0
Cytokines $T1$, IL-1beta, IL-6, $T2$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
IL-8
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of $T1$, which leads to the rapid recruitment of p85, might be one mechanism used by $T2$ to activate PI 3-kinase.
IRS-1
gastrin
0
$T1$ protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed $T2$-Abeta interaction was specific.
LexA
Abeta
0
Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and $T1$$T2$, Mcl-1, and Bax, were explored with a yeast two-hybrid system.
Bax
Bcl-X-S
0
In transfected COS-1 cells, osteogenic protein (OP)-1/BMP-7, and less efficiently $T1$, bound to $T2$.
BMP-4
BMPR-II
1
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/$T1$$T2$/CD3 or CD4.
CD3
TcR zeta
0
Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the $T1$$T2$ and BR-Ib) and the BMP type II receptor (BR-II).
BMP type II receptor
BR-Ia
0
Scatchard analysis of in vitro binding between Raf/330 and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and $T1$$T2$ and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and beta ARK (Kd = 87 +/- 24 nM).
beta ARK
Raf/330
0
In vitro and in nonproliferating cells, $T1$ associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or $T2$.
p27
CDK2
1
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with $T1$$T2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Lyn
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p67-phox
NADPH oxidase
0
A protein kinase designated IRAK ($T1$$T2$) was purified, and its complementary DNA was molecularly cloned.
IL-1
IL-1 receptor-associated kinase
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T1$-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPO
EBP
0
Association between cdc25A and $T1$/$T2$ was detected in the HeLa cells.
cyclin B1
cdc2
0
We used alanine substitution of $T1$ residues that contact EMP1 in the crystal structure to investigate the function of these residues in both $T2$ and EPO binding.
EBP
EMP1
1
In competition experiments, the carboxyl terminus of $T1$ (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the $T2$-binding proteins, Ras and 14-3-3, had no effect.
beta-adrenergic receptor kinase
Raf-1
0
This cytotoxicity could be abrogated by B42 fusion proteins containing $T1$, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of $T2$ that lacks a well-conserved 63-amino acid region).
Bcl-2
Bcl-X
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
NF-kappaB
0
Isothermal titration calorimetry shows that $T1$ SC1 forms a 1:1 complex with its high-affinity receptor ($T2$) with an affinity of 27(+/- 9) nM.
IFN-gamma
IFN-gamma R alpha
0
Immunoelectronmicroscopic analysis showed that $T1$/Jif-1 and $T2$ are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.
QM
PS1
0
$T1$n ($T2$) transactivates viral and cellular genes through a wide variety of cis-elements.
Hepatitis B virus X protei
HBx
0
Characterization of the $T1$ binding domain on the human CD30 molecule using anti-$T2$ antibodies.
CD30L
CD30
0
$T1$ physically associates with $T2$ through Src homology 3 domains.
Wiskott-Aldrich syndrome protein
Nck
1
The high affinity interleukin-6 (IL-6) signaling complex consists of $T1$ and two membrane-associated receptor components: a low affinity but specific $T2$ receptor and the affinity converter/signal transducing protein gp130.
IL-6
IL-6
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/$T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
PS1
0
Their order of selection was alpha1AT effusion, $T1$ serum, TNFalpha-effusion, and $T2$ effusion.
C4
C3
0
Here we report that (1) there is an accumulation of $T1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF ($T2$) in vitro.
Rb
upstream binding factor
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of $T1$$T2$ may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-CRD
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/$T2$ (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.
MPIF-2
eotaxin-2
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
p16
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T1$$T2$), were substituted with those from human TrkA.
TrkA
NGF
0
We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the $T1$ (TAP) and calreticulin, and that HLA-E expression is $T2$-dependent and tapasin-dependent.
transporter associated with antigen processing
TAP
0
LexA protein fused to the Drosophila protein bicoid ($T1$-$T2$) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
bicoid
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and $T1$ were both potent agonists for CC CKR3 and $T2$.
RANTES
CC CKR1
1
Lipopolysaccharide-activated $T1$-deficient (ICE-/-) Kupffer cells synthesized the $T2$ precursor but failed to process it into the active form.
ICE
IGIF
0
Monoclonal antibodies to the beta chain of the $T1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with $T2$, indicating that IL-15 uses components of the IL-2 receptor.
IL-2
IL-2
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as $T1$, Crk, and $T2$, which interact with guanine nucleotide exchange factors specific for the Ras family.
Grb2
Crk-L
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR beta
IR beta
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, $T2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
sICAM-1
0
$T1$ protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the $T2$ fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
B42
0
Cleavage of Ln-5 by $T1$ and the resulting activation of the $T2$ cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
MMP2
Ln-5
0
Here we show that beta:$T1$ binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase $T2$ to form ActRII.beta:beta.
beta activin
SKR2
0
We report here that $T1$ also interacts with tyrosine-phosphorylated $T2$ in response to gastrin.
Grb2
IRS-1
1
An expression plasmid encoding the human 75-kDa $T1$ (TNF-R2) was constructed and used to generate a stable human cell line (293/$T2$) overexpressing TNF-R2.
tumor necrosis factor (TNF) type 2 receptor
TNF-R2
0
In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase ($T1$) blocked the binding of G beta gamma to Raf/330; however, the $T2$-binding proteins, Ras and 14-3-3, had no effect.
beta ARK
Raf-1
0
On a cell membrane containing both proteins, HFE would 'lie down' parallel to the membrane, such that the $T1$ helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the $T2$ dimerization domain.
HFE
TfR
1
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, $T1$$T2$, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibromodulin
collagenase
0
Competitive binding of $T1$ and $T2$ to the NMDA receptor.
alpha-actinin
calmodulin
0
Transfection of $T1$ and $T2$ in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.
G alpha i2
nucleobindin
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/TR2 and $T1$, thereby suppressing $T2$- mediated HT29 cell death.
LTbetaR
LIGHT
0
$T1$ prevents $T2$/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
MyoD
cyclinA
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or $T1$ in vivo, and the specificity of $T2$ or p107 binding is mediated by the E2F subunit.
p107
pRB
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or $T1$$T2$ or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
RPB5
TFIIB
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$, might be one mechanism used by $T2$ to activate PI 3-kinase.
p85
gastrin
0
Antibodies to p23 detect similar levels of $T1$ in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that $T2$ is a conserved protein of broad tissue distribution.
p23
p23
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ ($T2$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TATA-binding protein
TBP
0
The binding of p56lck to CD5 induced a 10- to 15-fold increase in $T1$$T2$ induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.
p56lck
CD5
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPOR
0
We recently reported that $T1$ interaction with the Raf-1 cysteine-rich domain ($T2$, residues 139-184) may be required for Raf-1 activation.
Ras
Raf-CRD
1
Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated beta-galactosidase ($T1$$T2$ (SA-beta-gal).
SA-beta-gal
beta-galactosidase
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the $T1$$T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
p76
p90
0
GAP-43 ($T1$, B-50, F1), a protein kinase C ($T2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
neuromodulin
PKC
1
Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of $T1$ interacts with a cluster of three basic amino acid side chains of $T2$.
FasL
Fas
1
We have exploited the availability of the cloned XPB, XPD, $T1$, p44, and p34 genes (all of which encode polypeptide subunits of $T2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p62
TFIIH
0
Transfection of $T1$ and nucleobindin in COS cells increased $T2$ expression relative to cells transfected with G alpha i2 and mock vector.
G alpha i2
G alpha i2
0
We have detected a specific association of CDK4 with the molecular chaperon HSP90 and a 44-kDa protein that we identify as mammalian $T1$$T2$ and a 44-kDa protein that we identify as mammalian CDC37.
CDC37
HSP90
0
hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and $T1$$T2$ and hTAFII30.
hTAFII30
hTAFII28
0
Thus, $T1$ may serve as a link between Syk and $T2$, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.
pp120
PLC gamma 1
1
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal $T1$$T2$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
gp120
MIP-1beta
0
Isothermal titration calorimetry shows that $T1$$T2$ forms a 1:1 complex with its high-affinity receptor (IFN-gamma R alpha) with an affinity of 27(+/- 9) nM.
IFN-gamma
IFN-gamma SC1
0
The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated $T1$-cyclin-dependent kinase 2 ($T2$) complex has been determined at 2.3 angstrom.
cyclin A
Cdk2
1
Activation of interferon-gamma inducing factor mediated by $T1$$T2$ mediated by interleukin-1beta converting enzyme.
interleukin-1beta
interferon-gamma inducing factor
0
The self-association site appears to be formed by interactions between helices 1 and 2 of $T1$ repeat 17 of one dimer with helix 3 of $T2$ repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.
beta spectrin
alpha spectrin
1
Two potentially oncogenic cyclins, $T1$ and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the $T2$ protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
cyclin A
Rb
1
In the present study we evaluated tyrosine phosphorylation of $T1$ and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase ($T2$) receptors leading to myeloid cell proliferation.
c-Cbl
c-Kit
0
Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased $T1$$T2$ and increased Jak3-gamma c associations.
Jak3
IL-2R beta
0
These same $T1$ residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates $T2$ by concealing its transactivation domain.
p53
p53
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , $T1$ ( $T2$ ) and Fas ligand ( FasL / CD95L ) .
LIGHT
herpes virus entry mediator ( HVEM ) - L
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ia
0
Fusion proteins were created by linking the Abeta fragment to a $T1$$T2$ fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey).
LexA
Abeta
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three $T1$$T2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-R2
TNF-R2
0
The amount of CDK4 and $T1$ associated with $T2$ does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK6
p27
1
Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to $T1$$T2$), which is distantly related to DAF-4, a BMP type II receptor from Caenorhabditis elegans.
DAF-4
BMPR-II
0
Among these ligands, $T1$ had the remarkable property of binding $T2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MCP-3
CCR5
1
Interaction of p85 subunit of PI 3-kinase with insulin and $T1$$T2$ and IGF-1 receptors analysed by using the two-hybrid system.
IGF-1
insulin
0
In an unbiased search for potential coactivators of SREBP, we isolated a protein of 265 kD from HeLa cells that directly bound $T1$ and $T2$.
SREBP-1
SREBP-2
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
TFIID
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
transforming growth factors (TGF) beta1
0
The interaction between $T1$ (IL-6) and $T2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
interleukin-6
IL-6 receptor
1
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated $T1$ proteins that failed to bind to T also did not associate with $T2$; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
Rb
RbAP46
0
Cell surface $T1$ formed complexes in vivo with actin-binding protein filamin ($T2$), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.
PS1
ABP-280
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of $T1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-$T2$ and Fas-FD8.
Fas
LPR
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, $T2$, that interacts with the transcriptional inhibitor Id3/HLH462.
ITF-2
ITF-2b
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ($T2$).
hsp90
p48
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat1
Stat3
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 $T1$ but not T-cell clones that express predominantly the p76 $T2$.
IL-7R
IL-7R
0
The $T1$-$T2$ complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
Ras
RasGAP
1
The molar ratio of serum $T1$ (RBP) to transthyretin ($T2$) is not useful to assess vitamin A status during infection in hospitalised children.
retinol-binding protein
TTR
0
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the $T1$$T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
phosphatidylinositol 3-kinase
insulin
0
The activation domain of $T1$ interacts with the basal transcription factor TFIIB through a domain that is conserved in the yeast coactivator $T2$ (ref.
CBP
ADA-1
1
Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with $T1$/$T2$ complex when non-tyrosine or tyrosine kinase receptors are activated.
Grb2
c-Cbl
1
Despite binding to only one $T1$$T2$ R alpha, IFN-gamma SC1 is biologically active in cell proliferation, MHC class I induction, and anti-viral assays.
IFN-gamma R alpha
IFN-gamma
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of $T1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
Fas
FD8
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing $T1$$T2$ but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Bcl-X-S
Mcl-1
0
$T1$ competed the binding of (125)I-eotaxin to $T2$-expressing L1.2 cells with an IC(50) of 13 nM.
Eotaxin-3
CCR3
1
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-$T1$$T2$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with CCR-5.
CD4
CD4
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/$T1$ (SCYA24) and have identified a novel CC chemokine termed $T2$.
eotaxin-2
eotaxin-3
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for $T1$$T2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EMP1
EPO-mimetic peptide
0
RESULTS: TH, $T1$ and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-TH, AAV-$T2$ and AAV-GCH.
AADC
AADC
0
The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto $T1$$T2$.
HLA-E
HLA-E
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common $T1$ (gammac) for IL-4 signaling, it could not replace the function of gammac in allowing enhanced $T2$ binding activity.
cytokine receptor gamma chain
IL-2
0
In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor $T1$$T2$ complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.
MyoD
E2F
0
Moreover, the amino-terminal domain of $T1$ directly associates with, and is tyrosine phosphorylated by, $T2$.
RIN1
c-ABL
1
The $T1$-like domain of TPO (TPO1-153) has been fused to the $T2$ coat protein of M13 bacteriophage.
erythropoietin
gIII
0
The structures of $T1$ alone and complexed with $T2$ differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between TfR chains.
TfR
HFE
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$$T2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
keratinocyte growth factor
keratinocyte growth factor receptor
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p140trk (trkA) tyrosine kinase receptor
0
We report here that recombinant B61 induces autophosphorylation of $T1$ in intact cells, consistent with B61 being an authentic ligand for $T2$.
ECK
ECK
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T2$ receptor.
IL-15
IL-2
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous $T1$-binding properties: first, several mutated $T2$ proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
Rb
Rb
0
Two lines of evidence support the notion that $T1$ and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T2$ for binding to Rb.
RbAP46
RbAP46
0
$T1$ stimulates tyrosine phosphorylation of $T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Gastrin
insulin
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
fibromodulin
elastin
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/$T1$$T2$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
cdk2
Estrogen Receptor
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
dTAFII60
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained $T1$ like affinity for $T2$ and for KGFR.
FGF-2
FGFR1
1
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated UBE2I, that interacts with $T1$, RAD51, $T2$, and a ubiquitin-like protein UBL1.
RAD52
p53
0
$T1$ also was shown to coprecipitate with HSP27 in immunoprecipitation studies and to colocalize with $T2$ in immunofluorescence studies of intact glass-activated platelets.
FXIII
HSP27
0
These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor $T1$$T2$-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.
TAFII250
TATA-binding protein
0
An E2F complex containing mainly E2F4 and $T1$/$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
pRb2
p130
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPO-binding protein
0
The BMP receptors belong to the family of serine/threonine kinase receptors, whose activation has been investigated intensively for the $T1$ ($T2$) receptor subfamily.
transforming growth factor-beta
TGF-beta
0
Comparison of messenger RNA gene expression of extracellular matrix proteins ($T1$, collagenase, $T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
procollagen I
elastin
0
We show that the carboxy terminal "tail" of DPI associates directly with the amino terminal "head" of type II epidermal keratins, including K1, K2, K5, and $T1$$T2$, K5, and K6.
K6
K2
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R beta
IR beta
0
When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, $T1$ MIP and RANTES were both potent agonists for CC CKR3 and $T2$.
(MIP)-1 alpha
CC CKR1
1
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for $T1$$T2$ to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-beta
0
$T1$-induced interaction of primary HIV-1 $T2$ glycoproteins with the chemokine receptor CCR-5.
CD4
gp120
1
Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: $T1$ to chromosome 16q22-23 and $T2$ to chromosome 20q11.2.
beta 2-syntrophin
alpha 1-syntrophin
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated $T1$$T2$/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
c-Kit
Grb2
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ($T1$$T2$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18.
TBP
TATA-binding protein
0
Activation of $T1$ inducing factor mediated by $T2$.
interferon-gamma
interleukin-1beta converting enzyme
0
Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect $T1$$T2$ binding did not affect KDR binding.
KDR
FLT-1
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-II
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and $T1$$T2$/Sos1 and Grb2/c-Cbl are present in different complexes.
Grb2
Grb2
0
Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by $T1$ ($T2$).
vascular endothelial growth factor
VEGF
0
Our results indicate that Phe93 and Phe205 are important for both EPO and $T1$$T2$ and EMP1 binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EMP1
EPO
0
In conclusion, impaired expression of granulysin by NK cells correlates with progression of cancer, and determination of $T1$$T2$ by NK cells correlates with progression of cancer, and determination of granulysin expression might prove informative for assessing the immunological condition of cancer patients.
granulysin
granulysin
0
Functional studies in Jurkat T lymphocytic cells point to the importance of both the E2F and $T1$$T2$ and NF-kappaB binding sites in E2F-1 mediated repression of HIV-1 promoter, in vivo.
NF-kappaB
E2F
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for $T1$$T2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-R2
0
The activation domain of CBP interacts with the basal transcription factor $T1$ through a domain that is conserved in the yeast coactivator $T2$ (ref.
TFIIB
ADA-1
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for $T1$$T2$ by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
CCR5
0
COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and $T1$$T2$ and IL-13.
IL-13
IL-4
0
We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, $T1$ also interacts directly with $T2$.
hTAFII28
TBP
1
Using these methods, we have identified residues that appear to be involved in $T1$ binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and/or stability of the $T2$.
EPO
EPOR
0
Specific cleavage of laminin-5 ($T1$) by $T2$ (MMP2) was shown to induce migration of breast epithelial cells.
Ln-5
matrix metalloprotease-2
1
$T1$ interaction w$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
CD5
ith
0
Interaction of the p85 subunit of PI 3-kinase with the $T1$$T2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
insulin
insulin receptor
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that $T1$ might interact with $T2$ in response to radiation damage.
ATM
c-Abl
1
The carboxy-terminal region of dystrophin has previously been shown to interact directly with alpha1 syntrophin, a cytoplasmic component of the $T1$$T2$, a cytoplasmic component of the dystrophin-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.
dystrophin
alpha1 syntrophin
0
Biochemical studies established that some coactivators are associated with the $T1$ (TBP) to form the $T2$ complex.
TATA-binding protein
TFIID
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 $T1$$T2$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
p76
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 $T1$$T2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
p90
0
In summary, $T1$ signaling pathway utilizes two $T2$-containing complexes; Shc.
FGFR3
GRB2
0
In the present study we observe that a monoclonal antibody specific for $T1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and $T2$ (p48).
p60
Hip
0
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human $T1$$T2$-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.
ADA
CD26
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, $T1$, D and G cathepsin and ending with the conversion enzyme and $T2$.
tonin
chymase
0
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, tonin, D and $T1$ and ending with the conversion enzyme and $T2$.
G cathepsin
chymase
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
neurotrophin-3
brain-derived neurotrophin
0
$T1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced $T2$-IL-2R beta and increased Jak3-gamma c associations.
Jak1
Jak3
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD ($T1$) to PDGF receptor-alpha homodimers and $T2$/beta heterodimers.
PDGF-CC
PDGF receptor-alpha
1
Through their interaction with the ErbB family of receptors (ErbB2, ErbB3 and $T1$$T2$ and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.
ErbB4
ErbB3
0
Transcription factor TFIID consists of TATA binding protein (TBP) and at least eight $T1$$T2$ (TBP) and at least eight TBP-associated factors (TAFs).
TBP
TATA binding protein
0
Analysis of p53, p21(CIP1), $T1$$T2$(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p15
p21
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
TrkC
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
trkA
p75
0
The binding epitopes of $T1$ for BMPR-IA (type I) and $T2$ or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMP-2
BMPR-II
1
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$, that interacts with RAD52, RAD51, $T2$, and a ubiquitin-like protein UBL1.
UBE2I
p53
1
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and $T1$$T2$ and pp120 to CD5.
pp120
PI 3-kinase
0
$T1$ is a core hTAFII present in both of the previously described $T2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTFIID
0
The interaction between $T1$ ($T2$) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.
interleukin-6
IL-6
0
Binding of OP-1/$T1$ to $T2$ was also observed in nontransfected cell lines.
BMP-7
BMPR-II
1
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as protein phosphatase 1 ($T1$$T2$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
PP1C
serine-threonine phosphatase 2A
0
Mutagenesis of the $T1$ receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin ($T2$) binding.
erythropoietin
EPO
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the $T1$$T2$ and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
mitogen-activated protein kinase
Shc
0
We show that the carboxy terminal "tail" of $T1$ associates directly with the amino terminal "head" of type II epidermal keratins, including K1, $T2$, K5, and K6.
DPI
K2
1
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of $T1$, and IL-15 competed for binding with IL-2, indicating that $T2$ uses components of the IL-2 receptor.
IL-15
IL-15
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since $T1$-$T2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.
Syk
Lyn
1
HBx and $T1$ specifically bound to $T2$ (TFIIB) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
RPB5
transcription factor IIB
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD ($T1$$T2$ and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and PDGF receptor-alpha/beta heterodimers.
PDGF-CC
PDGF alpha
0
CONCLUSION: The triple transduction of $T1$, AADC and $T2$ genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.
TH
GCH
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T1$ ( $T2$ / CD95L ) .
Fas ligand
FasL
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between $T1$ and $T2$ or hTAFII30 were detected.
hTAFII20
hTAFII28
1
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed $T2$.
MPIF-2
eotaxin-3
0
Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and $T1$$T2$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
NF-kappaB-inducing kinase
hGITR
0
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, EGFR and $T1$$T2$, EGFR and Shc, which specifically binds the SH2 domain of GRB2 with high affinity.
Shc
IRS-1
0
IL-2, IL-4, $T1$ (whose receptors are known to contain gamma c), and $T2$ (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-7
IL-9
0
Coexpression of the alpha and betaL subunits of the human $T1$$T2$ (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.
interferon alpha (IFNalpha) receptor
interferon alpha
0
We have crystallized a complex between human $T1$ and a two-domain extracellular fragment of human $T2$.
FGF1
FGFR2
1
TRADD-$T1$ and TRADD-$T2$ interactions define two distinct TNF receptor 1 signal transduction pathways.
TRAF2
FADD
0
Recombinant $T1$ binds directly to TBP both in vitro and in yeast, and participates in the formation of the $T2$ complex.
hTAFII250
TFIID
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for $T1$$T2$ and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bax
0
$T1$ and RPB5 specifically bound to transcription factor IIB ($T2$) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
HBx
TFIIB
0
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T1$-expressing cells responded only to $T2$.
FGFR3 IIIb
FGF-1
0
By using the growth factor dependent M-07e cell line, we found that both $T1$ and c-Kit ligands, namely: SCF and $T2$, induce c-Cbl tyrosine phosphorylation.
c-Mpl
TPO
0
Characterization of the $T1$ binding domain on the human $T2$ molecule using anti-CD30 antibodies.
CD30L
CD30
1
We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor ($T1$), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related ($T2$) protein [4].
hGITR
mGITR
0
Cross-family interaction between the bHLHZip $T1$ and bZip Fra1 proteins results in down-regulation of $T2$ activity.
USF
AP1
0
Regulation of the Ets-related transcription factor $T1$ by binding to the $T2$ protein.
Elf-1
retinoblastoma
1
After a brief historical incursion regarding RAS of renal origin, we present the main extrarenal angiotensin-forming enzymes, starting with isorenin, $T1$$T2$, tonin, D and G cathepsin and ending with the conversion enzyme and chymase.
tonin
isorenin
0
Analysis of the human $T1$/human $T2$ binding interface at the amino acid level: proposed mechanism of interaction.
interleukin-6
interleukin-6 receptor
1
These findings indicate that the Fos/$T1$ and ATF/$T2$ families of transcription factors are not as distinct as was previously thought.
Jun
CREB
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$$T2$, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
interleukin 10 (IL-10) receptor
0
Thus $T1$ is a cellular oncogene that targets $T2$ and PP1, both of which are targets for oncogenic viruses and chemical tumour promoters.
HOX11
PP2A
1
The amount of CDK4 and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of $T1$ associated with $T2$ is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK2
p27
1
Although the individual amino acids in TrkA involved in binding to $T1$ (NGF) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
TrkC
0
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and $T1$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and $T2$ from rat brain.
NR2B
PSD-95
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by $T1$/$T2$ heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
c-Fos
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
cyclin A
cyclin D2
0
Sos; these two complexes may alternatively link $T1$$T2$; these two complexes may alternatively link FGFG3 to mitogen-activated protein kinase.
FGFG3
Sos
0
The molar ratio of serum $T1$ ($T2$) to transthyretin (TTR) is not useful to assess vitamin A status during infection in hospitalised children.
retinol-binding protein
RBP
0
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide ($T1$$T2$-mimetic peptide (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EMP1
EPO
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ $T1$$T2$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
0
Moreover, a partial recombinant $T1$ complex containing $T2$ was capable of mediating in vitro transcriptional activation by the VP16 activation domain.
TFIID
hTAFII32
0
The molar ratio of serum $T1$ (RBP) to $T2$ (TTR) is not useful to assess vitamin A status during infection in hospitalised children.
retinol-binding protein
transthyretin
0
Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding $T1$/Flk-1, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with $T2$ binding.
KDR
FLT-1
0
$T1$-TRAF2 and TRADD-FADD interactions define two distinct $T2$ signal transduction pathways.
TRADD
TNF receptor 1
0
In the end we refer to the relations between circulating $T1$ of renal origin and the extrarenal RAS specific to tissue underlying the fact that the two $T2$ components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.
RAS
RAS
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
$T1$ is a transcriptional modulator that communicates with $T2$ and the RNA polymerase II subunit 5.
Hepatitis B virus X protein
transcription factor IIB
0
The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of $T1$ to phosphotyrosines on both $T2$ and Shc.
GRB2
IRS-1
1
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of $T1$$T2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
CCR5
0
Competitive binding of alpha-actinin and $T1$ to the $T2$.
calmodulin
NMDA receptor
1
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
HVEM
LIGHT
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the $T1$$T2$/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
Grb2
Grb2
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPO
0
The cloning of a complementary DNA encoding a human TFIID TAF, $T1$, that has no known homolog in Drosophila $T2$ is now described.
TAFII55
TFIID
0
Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, $T1$, NCC-4, and $T2$.
HCC-4
CCL16
0
The interaction of $T1$ with $T2$ is mediated by RAD52's self-association region.
UBE2I
RAD52
1
This suggests that one domain of IFN-gamma is sufficient to recruit $T1$$T2$ R alpha and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma R alpha
IFN-gamma
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$ and FGFR3 IIIc, that result from alternative splicing of exon III of the $T2$ gene encoding the ligand binding domain.
FGFR3 IIIb
FGFR3
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$$T2$/CCKB G protein-coupled receptor and the insulin receptor.
CCKB G protein-coupled receptor
gastrin
0
In addition, we show that in extracts depleted of TBP and TBP-associated factors, transcription from the U1 promoter is restored by recombinant TBP but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a $T1$$T2$ or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TFIID
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T1$ (alpha1AT), and complement factors C3 and $T2$ can be used in the differential diagnosis of serous effusion.
alpha-1-antitrypsin
C4
0
We have previously identified $T1$ specific binding protein which is distinct from that of $T2$ in a number of cell lines.
IL-11
IL-6
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / $T1$$T2$ receptor ( LTbetaR ) and HVEM / TR2 receptors .
TR2
lymphotoxin beta
0
hPRL does not bind to the $T1$ receptor, but $T2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGH
0
Cytokines $T1$, IL-1beta, IL-6, IL-8, $T2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1alpha
IL-10
0
Since $T1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-$T2$-hsp70 complex.
hsp90
p60
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of $T1$$T2$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
CCR5
MCP-3
0
CD30 and its counter-receptor CD30 ligand ($T1$) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30L
TNFalpha
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ were found to be redundantly required for receptor function and for activation of $T2$ but not for Stat1 or Stat5.
IL-10 receptor
Stat3
1
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and $T1$$T2$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII60
TATA binding protein
0
$T1$ was also shown to cleave the precursor of interferon-gamma inducing factor ($T2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
ICE
IGIF
1
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
p130
0
$T1$ associates with the $T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD5
T-cell receptor zeta chain (TcR zeta)/CD3
1
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T1$$T2$-expressing cells responded only to FGF-1.
FGFR3
FGFR3 IIIb
0
$T1$ and $T2$ specifically bound to transcription factor IIB (TFIIB) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
HBx
RPB5
0
Analysis of p53, p21(CIP1), p15($T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
p53
0
In addition, $T1$ in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, $T2$, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.
hsp90
pp60c-src
1
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTFIID
TAFII30 beta
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or $T1$$T2$, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Mcl-1
Bcl-2
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein $T1$ and the pocket proteins pRb, $T2$ and pRb2/p130.
MyoD
p107
0
In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the $T1$ ($T2$).
proliferating-cell nuclear antigen
PCNA
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by $T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
PS1
0
In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased $T1$$T2$ from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.
CD4
CD26
0
Transfection of G alpha i2 and $T1$ in COS cells increased G alpha i2 expression relative to cells transfected with $T2$ and mock vector.
nucleobindin
G alpha i2
0
Residues in human leukemia inhibitory factor ($T1$) crucial for binding to both the human $T2$ (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.
hLIF
LIF receptor
1
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ ($T1$) and $T2$ (leucine utilization) genes under the control of LexA-dependent operators.
beta-galactosidase
LEU2
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
dTBP
0
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and $T1$$T2$ and p76 IL-7R have different extracellular domains.
p76
p90
0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, EBP) of the $T1$$T2$ binding protein, EBP) of the EPOR.
EPOR
EPO
0
We report here that recombinant $T1$ induces autophosphorylation of $T2$ in intact cells, consistent with B61 being an authentic ligand for ECK.
B61
ECK
1
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 $T1$$T2$ IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
p76
0
We also show that $T1$ is a serine-threonine kinase that is recruited by TRADD to $T2$ in a TNF-dependent process.
RIP
TNFR1
0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and $T1$/$T2$.
pRb2
p130
0
Their order of selection was alpha1AT effusion, C4 serum, $T1$-effusion, and $T2$ effusion.
TNFalpha
C3
0
Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for $T1$$T2$ binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EPO
EMP1
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-$T1$, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
Cdk2
cyclin D1
0
The crystal structure of the human $T1$-cyclin-dependent kinase2 ($T2$)-ATP complex has been determined at 2.3 A resolution.
cyclinA
CDK2
1
Monomeric (IL-6M) and dimeric ($T1$) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the IL-6 receptor (sIL-6R) and $T2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6D
gp130
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
p85
gastrin
0
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, $T1$ and $T2$, respectively, as well as the primary receptor CD4 (refs 1-6).
CCR-5
CXCR-4
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
NGF
brain-derived neurotrophin
0
The structure provides evidence that the 53BP2-$T1$ complex forms in vivo and may have a critical role in the $T2$ pathway of tumor suppression.
p53
p53
0
Physical interaction of mammalian $T1$ with CDK4 $T2$ was originally identified as a Start gene in budding yeast and has been shown to be required for association of CDC28 with cyclins.
CDC37
.CDC37
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the $T1$$T2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for EPO binding but is critical for $T1$$T2$ binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.
EMP1
EMP1
0
The same domain of $T1$ that binds RAS also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other $T2$ effectors.
RIN1
RAS
0
We found that in addition to MIP-1beta, MIP-1alpha, and $T1$, five other CC-chemokines could compete for [(125)I]-$T2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
RANTES
MIP-1beta
1
We found that deletion of the carboxyl-terminal 28 amino acids of PU.1 disrupted $T1$-$T2$ physical interaction.
PU.1
NF-IL6 beta
1
We previously have shown that $T1$ purified from human HeLa cells is a multisubunit complex of four polypeptides designated $T2$ alpha, -beta, -gamma, and -delta.
PTF
PTF
0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, $T1$$T2$, EBP) of the EPOR.
EBP
EPO binding protein
0
This suggests that one domain of IFN-gamma is sufficient to recruit IFN-gamma R alpha and $T1$$T2$ and IFN-gamma R beta into a complex competent for eliciting biological activity.
IFN-gamma
IFN-gamma R alpha
0
Shared and unique determinants of the $T1$$T2$) receptor are important for binding EPO and EPO mimetic peptide.
erythropoietin (EPO) receptor
EPO
0
These same $T1$ residues are also involved in transactivation, supporting the hypothesis that $T2$ inactivates p53 by concealing its transactivation domain.
p53
MDM2
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released $T1$$T2$ on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.
ADA
ADA
0
A GT155 mutant that was not glycosylated (AGGT155) did not associate with $T1$$T2$ mutant that was not glycosylated (AGGT155) did not associate with calnexin or CAP-60.
calnexin
GT155
0
This activation with p85 and $T1$$T2$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
IGF-1R
p85
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$ and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
E2F4
0
The binding epitopes of $T1$ for $T2$ (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.
BMP-2
BMPR-IA
1
ICE was also shown to cleave the precursor of interferon-gamma inducing factor ($T1$) at the authentic processing site with high efficiency, thereby activating $T2$ and facilitating its export.
IGIF
IGIF
0
Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric $T1$$T2$) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
IL-6.receptor
IL-6
0
The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and $T1$ and $T2$ or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).
IGF-1R
p85
0
Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the $T1$ monomer that interact with $T2$.
TTR
A beta
1
Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after $T1$$T2$ and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.
insulin
IRS-1
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$$T2$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
p85
IRS-1
0
The $T1$-like domain of $T2$ (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.
erythropoietin
TPO
0
Moreover we found that, upon SCF stimulation, the Grb2/c-Cbl complex recruits Shc, probably via $T1$$T2$/c-Cbl complex recruits Shc, probably via Grb2.
Grb2
Grb2
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with $T1$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
Oct2
Oct1
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$$T2$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
p85
IRS-1
0
$T1$ binding significantly increased hetero- and homo-oligomerization (except for the $T2$ homo-oligomer, which binds ligand poorly in the absence of BR-I).
BMP-2
BR-II
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ($T1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T2$ and Hip (p48).
hsp90
hsp70
0
In addition, activation of PI 3-kinase was detected in anti-$T1$$T2$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
IRS-1
PI 3-kinase
0
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of GT155 and a protein of approximately 60 kDa designated $T1$ ($T2$ of 60 kDa).
CAP-60
calnexin-associated protein
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit ($T1$), as well as $T2$ (PP1C) in mammalian cells.
PP2AC
protein phosphatase 1
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by $T1$$T2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MIP-1beta
CCR5
0
Immunoprecipitation assays also show a weak substoichiometric association of the $T1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
TATA-binding protein
PTF
0
The SH2/SH3 domain-containing protein $T1$ interacts with tyrosine-phosphorylated $T2$ and Shc: implications for insulin control of ras signalling.
GRB2
IRS1
1
However, in cell lines with defined combinations of ErbBs, $T1$ only activates those with ErbB3 and/or ErbB4, suggesting that signalling by $T2$ is mediated by ErbB3 and/or ErbB4 receptors.
neuregulin-2beta
neuregulin-2
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, $T1$, fibronectin, cd44, fibromodulin, and $T2$) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronidase
decorin
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
gastrin
insulin
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( herpes virus entry mediator ( HVEM ) - L ) and $T1$ ligand ( FasL / $T2$ ) .
Fas
CD95L
0
A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the $T1$ tyrosine kinase and $T2$.
pp60src
hsp90
1
This protein, designated $T1$-related protein (VRP), specifically binds to the extracellular domain of $T2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF
Flt4
0
Association between $T1$ and cyclin B1/$T2$ was detected in the HeLa cells.
cdc25A
cdc2
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or $T1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
keratinocyte growth factor
KGFR
0
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including $T1$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to $T2$.
FGF-1
FGF-1
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$, p67-phox, and p21rac) that translocate to membrane and bind to $T2$.
p47-phox
cytochrome b558
1
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and $T2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
sE-selectin
0
Specific cleavage of $T1$ (Ln-5) by $T2$ (MMP2) was shown to induce migration of breast epithelial cells.
laminin-5
matrix metalloprotease-2
1
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ia
0
We found that in addition to MIP-1beta, $T1$, and RANTES, five other CC-chemokines could compete for [(125)I]-$T2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
MIP-1beta
1
Analysis of the oligomerization of $T1$ and $T2$ products in vivo using a two-hybrid assay system.
myogenin
E2A
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$ and the $T2$ receptor.
CCKB G protein-coupled receptor
insulin
0
Crystal structure of the $T1$ cyclin-dependent-kinase inhibitor bound to the $T2$-Cdk2 complex.
p27Kip1
cyclin A
1
Measurement of RII alpha I3A,I5A interaction with the human $T1$, $T2$, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.
thyroid AKAP
Ht 31
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$$T2$ and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p47-phox
p22-phox
0
Together, these results suggest that TAFII40 and $T1$ are important targets for transmitting activation signals between $T2$ and the initiation complex.
TAFII60
p53
1
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin ($T1$$T2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
EPO
EPOR
0
By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of $T1$$T2$ was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of c-Jun homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).
c-Jun
PS1
0
The recently cloned $T1$ is such an $T2$.
YY1
Inr-binding protein
0
If current models of chaperonin mechanism are correct, $T1$ undergoes more rebinding and release cycles than does $T2$.
rhodanese
GS
0
Two proteins have been described as constituents of the $T1$ receptor, a approximately 140-kDa glycoprotein ($T2$) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds IL-13.
IL-4
IL-4R
0
The main $T1$ region implicated in the association with $T2$ was found to be the carboxy-terminal SH3 domain.
p47nck
p66WASP
1
These results suggest that $T1$ and $T2$ partly differ in function.
PS1
PS2
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, $T1$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for $T2$.
MCP-3
CCR5
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( LTbetaR ) and HVEM / TR2 receptors .
lymphotoxin beta receptor
LIGHT
0
Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient $T1$$T2$ dimer may be an efficient IL-6 antagonist.
IL-6
IL-6
0
Deletion analysis indicates that TBP and $T1$$T2$ and hTAFII18 bind to distinct domains of hTAFII28.
hTAFII18
TBP
0
CSA protein interacts with $T1$ protein and with $T2$ protein, a subunit of the human RNA polymerase II transcription factor IIH.
CSB
p44
0
The objective of this study was to measure the concentrations of tumor necrosis factor-alpha ($T1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors $T2$ and C4 can be used in the differential diagnosis of serous effusion.
TNFalpha
C3
0
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to $T1$ ($T2$) to determine vitamin A (VA) status during infection.
transthyretin
TTR
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein ($T1$) with PTF, consistent with the previous report of a $T2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
TBP
PTF
0
Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of $T1$$T2$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with CCR-5.
gp12O
CD4
0
The gamma chain of the $T1$ is shared with the functional $T2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
interleukin-2 (IL-2) receptor
IL-4 receptor
0
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor ($T1$) and the $T2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IR
IGF-1
0
The binding epitopes of BMP-2 for BMPR-IA (type I) and $T1$ or ActR-II (type II) were characterized using $T2$ mutant proteins for analysis of interactions with receptor ectodomains.
BMPR-II
BMP-2
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by $T1$ to activate $T2$.
gastrin
PI 3-kinase
0
The products of the RBP1 and $T1$ genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for $T2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP2
RBP2
0
Interestingly, both GRB2 and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same $T1$ molecule, suggesting a mechanism whereby $T2$ could provide the core for a large signalling complex.
IRS-1
IRS-1
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and $T1$$T2$ and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and PDGF receptor-alpha/beta heterodimers.
PDGF receptor-alpha
PDGF alpha
0
$T1$ ($T2$) is an important mediator of inflammatory disease.
Interleukin-1
IL-1
0
Two potentially oncogenic cyclins, $T1$ and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', $T2$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (SPF) as well as a candidate proto-oncogene.
cyclin A
cyclin A
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with $T1$$T2$ are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with c-Abl in response to radiation damage.
c-Abl
c-Abl
0
The rates of commitment to renaturation of $T1$ and $T2$ in the presence of the groE chaperonins.
rhodanese
glutamine synthetase
0
Two lines of evidence support the notion that RbAP46 and $T1$ have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T2$ for binding to Rb.
simian virus 40 T antigen
RbAP46
0
The $T1$ shows homology with the $T2$ receptor, and to a lesser extent, with the prolactin receptor.
IL-13R
IL-5
0
Evidence for physical interaction between the zinc-finger transcription factors $T1$ and $T2$.
YY1
Sp1
1
In a number of human T cell clones, expression of $T1$ mRNA is down-regulated after activation of the cells with anti-$T2$ Ab and phorbol ester.
hIL-10R
CD3
0
The bZIP domains of $T1$ and Jun mediate a physical association with the $T2$.
Fos
TATA box-binding protein
1
$T1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and $T2$ but interacts poorly with KGFR.
FGF-7
FGFR4
0
$T1$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and $T2$.
Liver-expressed chemokine
CCL16
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila $T1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ($T2$) as well as with the general transcription factor TFIIB.
TAFII40
VP16
0
Levels of $T1$(INK4a) and p57($T2$) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
p16
KIP2
0
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain hTAFII30 ($T2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID alpha
0
Moreover we found that, upon $T1$ stimulation, the $T2$/c-Cbl complex recruits Shc, probably via Grb2.
SCF
Grb2
0
When human embryonic kidney cells (cell line 293) over-expressing $T1$ or HeLa cells were exposed to $T2$, IRAK rapidly associated with the IL-1RI complex and was phosphorylated.
IL-1RI
IL-1
0
We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T1$ and $T2$ did not require enzymatic activity.
dipeptidyl peptidase IV
ADA
1
$T1$, which is known to bind 14-3-3 proteins, has recently been shown to associate with $T2$ and to stimulate its phosphatase activity.
Raf-1
cdc25A
1
Analysis of p53, p21(CIP1), p15($T1$$T2$(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4b
p21
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for $T1$/Bax heterodimerization may be different from those for $T2$/Bcl-2 homodimerization.
Bcl-2
Bcl-2
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/$T2$, and the Torpedo 87K protein.
dystrophin
dystrophin related protein
0
Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, $T1$, and three additional proteins, p54, p50, and $T2$.
hsp70
p23
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and $T1$$T2$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3b
SF3a
0
Reticulocyte lysate forms complexes between $T1$ and a temperature-sensitive mutant of Rous sarcoma virus $T2$, which is normally present in cytosol virtually entirely in the multiprotein complex form.
hsp90
pp60v-src
1
We have exploited the availability of the cloned XPB, XPD, $T1$, p44, and $T2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
p62
p34
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ($T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
LTbetaR
lymphotoxin beta receptor
0
The effect on $T1$ transcriptional activity results, in part, from enhanced phosphorylation of the $T2$ NH2-terminal activation domain.
AP-1
c-Jun
0
The AB loops of IFN-gamma SC1 adopt conformations similar to the ordered loops of IFN-gamma observed in the crystal structure of the $T1$/$T2$ complex.
IFN-gamma
IFN-gamma R alpha
1
The stimulation of $T1$-mediated transcription by $T2$ in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human TAFII250.
Sp1
RB
0
Two lines of evidence support the notion that $T1$ and simian virus 40 T antigen have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to $T2$.
RbAP46
Rb
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for $T1$/$T2$ homodimerization.
Bcl-2
Bcl-2
1
Scatchard analysis of in vitro binding between Raf/330 and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between $T1$$T2$ revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between G beta gamma and beta ARK (Kd = 87 +/- 24 nM).
G beta gamma
G beta gamma
0
A cDNA encoding part of the $T1$ protein sequence interacted with the $T2$ basic-helix-loop-helix only when fused to a beta-galactosidase tag.
nucleolin
E47
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
TR2
lymphotoxin beta
0
Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric $T1$$T2$) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
IL-6
IL-6
0
Levels of p16(INK4a) and $T1$$T2$(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
p57
p16
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, $T1$-Cdk2, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
cyclin E
cyclin D2
0
Interaction of the p85 subunit of PI 3-kinase with the insulin receptor ($T1$) and the $T2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.
IR
IGF-1 receptor
0
Interaction of the protein $T1$ with $T2$, as revealed by the yeast two-hybrid system.
nucleobindin
G alpha i2
1
Characterization of the CD30L binding domain on the human CD30 molecule using anti-$T1$$T2$ molecule using anti-CD30 antibodies.
CD30
CD30
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the $T2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EPOR
0
Mutation of Ala-522 to proline, which is located outside the predicted amphipathic helix region, had no effect on $T1$$T2$ binding.
RII
RII alpha
0
In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned $T1$$T2$ IL-7R is a previously undescribed splice variant of the cloned IL-7R.
IL-7R
p76
0
The $T1$-interacting region of $T2$ was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.
TAFII55
Sp1
1
The $T1$ inhibitor of cyclin-dependent kinases controls DNA replication by interaction with $T2$.
p21
PCNA
1
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of $T1$$T2$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
p85
PI 3-kinase
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T1$, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the $T1$$T2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F4
cdk2
0
We next tested whether IL-11 induced signaling can be inhibited by anti-gp130 antibodies which blocked $T1$$T2$ induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions.
IL-6
IL-11
0
In addition, p27 associates with three different CDKs: $T1$, $T2$, and CDK6.
CDK2
CDK4
0
We have exploited the availability of the cloned XPB, $T1$, p62, p44, and $T2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.
XPD
p34
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit ($T1$$T2$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
PP2AC
serine-threonine phosphatase 2A
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, IL-10 (Immunotech, France), endothelin-1, and $T2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
soluble cell adhesion molecules
0
The reciprocal loop replacement mutant (FGF2-L4/7) retained FGF-2 like affinity for FGFR1 and for $T1$$T2$ and for KGFR.
KGFR
FGFR1
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 $T1$$T2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
IL-7R
0
Although Fos/Jun and ATF/$T1$$T2$/Jun and ATF/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
CREB
Fos
0
We expressed differently tagged forms of $T1$ and used them in solution-phase binding assays to show that the soluble extracellular domains of $T2$ undergo dimerization in the absence of membranes.
gp130
gp130
0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of $T1$$T2$ activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
E2F
MyoD
0
Levels of p16($T1$$T2$(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.
INK4a
p16
0
Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and $T1$$T2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
bFGF
bFGF
0
Interaction between $T1$ protein and $T2$ in response to DNA damage.
ATM
c-Abl
1
Cytokines IL-1alpha, IL-1beta, $T1$, IL-8, IL-10 (Immunotech, France), $T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-6
endothelin-1
0
LexA protein fused to the Drosophila protein $T1$ (LexA-bicoid) failed to interact with the B42 fragment fused to $T2$, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
Abeta
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from $T1$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate $T2$.
gastrin
PI 3-kinase
0
Transfection of $T1$ and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with $T2$ and mock vector.
G alpha i2
G alpha i2
0
The amount of $T1$ and CDK6 associated with $T2$ does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
CDK4
p27
1
The resulting Trk variant recruited binding of $T1$ equivalent to $T2$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
TrkA
1
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and $T1$$T2$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.
Fas
Fas
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric ($T2$/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-II
0
No binding between p59fyn(T) and $T1$$T2$(T) and CD5 was detected in T cells.
CD5
p59fyn
0
In addition, activation of $T1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by $T2$ to activate PI 3-kinase.
PI 3-kinase
gastrin
0
The results of his3 activation indicated that $T1$, N + C-SH2 and C-SH2 interact with both $T2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
p85
IR beta
1
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, $T1$, and FGFR4 but interacts poorly with $T2$.
FGFR2
KGFR
0
In patients with a complete response to IFN-alpha, the levels of $T1$ were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of $T2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively).
IFN-gamma
IL-4
0
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$ and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
SHC
0
The formation of native heterotrimeric G alpha beta gamma complexes, as measured by pertussis toxin ADP-ribosylation of G alpha, could be disrupted by increasing amounts of $T1$$T2$ complexes, as measured by pertussis toxin ADP-ribosylation of G alpha, could be disrupted by increasing amounts of Raf/330, with an EC50 of approximately 200 nM, in close agreement with the estimated binding affinity.
Raf/330
G alpha beta gamma
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for $T1$$T2$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.
MCP-2
gp120
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T1$-$T2$ and Fas-FD8.
Fas
LPR
0
Analysis of p53, p21(CIP1), p15(INK4b), p16($T1$$T2$(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
INK4a
p21
0
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the CDK6 protein mediates, in part, the $T1$$T2$ protein mediates, in part, the p27-associated Rb-kinase activity.
p27
CDK6
0
However, expression of the death domain of $T1$ Induces apoptosis, but potently inhibits $T2$ activation by TNF.
RIP
NF-kappa B
0
$T1$, a member of the Janus kinase superfamily was found to interact functionally with $T2$, a central component of the ras/mitogen-activated protein kinase signal transduction pathway.
JAK2
Raf-1
1
$T1$ treatment of 293/$T2$ cells did not significantly affect the degree or pattern of phosphorylation.
TNF-alpha
TNF-R2
0
As expected, overexpression of either $T1$/$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
Id3
HLH462
0
The prototypic neuronal anchor protein $T1$ has a COOH-terminal 22-residue $T2$ binding (tethering) site.
AKAP75
RII beta
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed $T1$$T2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
MyoD
0
Both the GT155-calnexin and the $T1$-$T2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.
GT155
CAP-60
1
In order to characterize the signaling pathway through which $T1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T2$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3
0
In contrast to hTAFII28, hTAFII18 is a $T1$$T2$ beta-specific hTAFII.
TFIID beta
TFIID
0
The interactions of $T1$ and $T2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
hsp90
1
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a $T1$-related complex ($T2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
PTF
SNAPc
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human $T1$ through its central region and with multiple activators--including Sp1, $T2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
TFIID
YY1
0
We now report the isolation and expression of cDNAs encoding $T1$ gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native $T2$ complex in HeLa extracts.
PTF
PTF
0
$T1$-TRAF2 and TRADD-$T2$ interactions define two distinct TNF receptor 1 signal transduction pathways.
TRADD
FADD
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$$T2$ (IL-10) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
interleukin 10
0
Immunoelectronmicroscopic analysis showed that QM/$T1$ and $T2$ are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.
Jif-1
PS1
0
Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for $T1$, suggesting these complexes contain two or three $T2$ molecules.
TNF-beta
TNF-R2
0
$T1$ encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, $T2$, and Cdk2 immunoprecipitates.
CIP1
cyclin E
0
$T1$ and its counter-receptor $T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$), $T2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
CD14
0
Association of $T1$ with both CDC37 and $T2$ may also imply a mechanistic link between the functions of CDC37 and HSP90.
CDK4
HSP90
1
$T1$ complexes in which an $T2$ chain occupies each receptor subunit.
SKR2
activin beta
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by $T1$$T2$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MIP-1beta
MCP-3
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
interleukin (IL) 1
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or $T1$$T2$, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).
Mcl-1
Bcl-X-L
0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant CBP and p300 (a $T1$$T2$ and p300 (a CBP-related protein).
CBP
CBP
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase ($T1$), and $T2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
AADC
GTP cyclohydrolase I
0
$T1$ expressed in an $T2$-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.
rIL-10R
IL-3
0
In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human $T1$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of $T2$ and site III of viral IL-6, which is necessary for receptor activation.
gp130
gp130
0
We found that in addition to MIP-1beta, $T1$, and $T2$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1alpha
RANTES
0
The binding of $T1$/Jif-1 to full-length $T2$ was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.
QM
PS1
1
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and $T1$ bind specifically and stably to $T2$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.
c-Jun
TBP
1
The SH2/SH3-containing protein $T1$ also contains a guanine nucleotide exchange factor domain, and $T2$ has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the TCR.
Vav
Vav
0
Studies of the $T1$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of $T2$.
IL-6
gp130
0
In the second of a series of experiments designed to identify $T1$-Src homology 3 (SH3)-binding molecules, we report the cloning of $T2$ (Src A box Nck-associated protein II) from an HL60 cDNA expression library.
p47nck
SAKAP II
0
The results show that $T1$ heterodimerizes with E12 and $T2$ in vivo, but it does not homodimerize to a measurable extent.
myogenin
E47
1
The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the $T1$($T2$)-like domain gives rise to two isoforms (alpha and beta).
epidermal growth factor
EGF
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein ($T1$), human TAFII250, $T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
dTBP
dTAFII60
0
In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the $T1$/$T2$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
Grb2
c-Cbl
1
Associations of $T1$ with $T2$, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.
UBE2I
RAD52
1
By using the growth factor dependent M-07e cell line, we found that both $T1$ and $T2$ ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.
c-Mpl
c-Kit
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$ (IFN-gamma SC1) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma
interferon-gamma
0
Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and $T1$$T2$, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.
Ht 31
microtubule-associated protein 2
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable $T1$$T2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
TBP
0
Electrophoretic mobility shift assays showed that PU.1 and $T1$$T2$ and NF-IL6 beta can simultaneously bind to adjacent DNA binding sites, but apparently do not influence the kinetics or affinity of each other's DNA binding.
NF-IL6 beta
PU.1
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early $T1$ complexes containing hsp70 and Hip ($T2$).
PR
p48
0
We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating $T1$$T2$ was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.
CD45
CD26
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$$T2$ bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
MDM2
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
tumour necrosis factors (TNF) alpha
0
Interleukin-13 (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with $T1$$T2$ (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.
IL-4
Interleukin-13
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$$T2$, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
elastin
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature $T1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T2$ and Hip (p48).
PR
hsp70
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and $T2$ (FasL/CD95L).
HVEM
Fas ligand
0
Here we show that a complex of $T1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural $T2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).
gp120
CCR-5
0
BACKGROUND: To elucidate the relationship between the expression of epidermal growth factor receptor family members (ErbB-1, neu/ErbB-2, ErbB-3, and $T1$$T2$, and ErbB-4) and tumor recurrence.
ErbB-4
ErbB-3
0
The ability of c-Fos and c-Jun proteins to interact directly with the $T1$ ($T2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
TATA box-binding protein
TBP
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.
IR
p85
0
The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with $T1$$T2$ beta.
IR beta
IR
0
In vitro experiments showed that the stable Grb2/c-Cbl complex interacts, through the Grb2 SH2 domain, with the $T1$$T2$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.
SCF
c-Cbl
0
Bcl-2 also interacted with $T1$ and $T2$ and with the dominant inhibitors Bax and Bcl-X-S. Bcl-X-L displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-X-L
Mcl-1
0
Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of $T1$$T2$ to promote subsequent events necessary for full activation of Raf-1.
Raf-1
Raf-1
0
Cotransfection experiments indicate that CIP1 and $T1$$T2$ and SV40 T antigen function in a mutually antagonistic manner to control cell cycle progression.
SV40 T antigen
CIP1
0
Cross-family dimerization of transcription factors Fos/Jun and $T1$$T2$ and ATF/CREB alters DNA binding specificity.
ATF
Jun
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in $T2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO
0
The switch II region of $T1$ is stabilized by GAP-334, thus allowing glutamine-61 of $T2$, mutation of which activates the oncogenic potential, to participate in catalysis.
Ras
Ras
0
$T1$ interacts with the "effector domain" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known $T2$ effector.
RIN1
RAS
0
$T1$ is also present in immunoaffinity-purified $T2$ complexes along with hsp70 and another protein, p60.
p23
hsp90
0
The gamma chain of the $T1$$T2$ (IL-2) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
interleukin-2 (IL-2) receptor
interleukin-2
0
These analyses showed that the ability of PBMC to proliferate to $T1$ correlated with expression of the $T2$ IL-7R, and not with expression of the p90 IL-7R.
IL-7
p76
0
ICE was also shown to cleave the precursor of $T1$$T2$ (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.
interferon-gamma
interferon-gamma inducing factor
0
However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with $T1$ and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or $T2$ receptors.
ErbB3
ErbB4
0
Thus, TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.
LIGHT
TR6
0
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein ($T1$) to transthyretin ($T2$) to determine vitamin A (VA) status during infection.
RBP
TTR
0
These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the $T1$ $T2$, and not with expression of the p90 IL-7R.
p76
IL-7R
0
The $T1$ oncoprotein is a cellular inhibitor of the $T2$ tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.
MDM2
p53
1
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$$T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
creatine kinase
ITF-2b
0
We found that ADA was associated with CD26 on T cell lines lacking either ADA or $T1$ enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
dipeptidyl peptidase IV
dipeptidyl peptidase IV
0
$T1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hPRL
hGH
0
Crosslinking of iodinated $T1$ (aFGF) and basic FGF ($T2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.
acidic FGF
bFGF
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either $T1$ or $T2$ in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.
pRB
p107
0
$T1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 ($T2$) and FLT-1.
VEGF
Flk-1
0
This activation with $T1$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T2$ (delta C-43).
p85
IGF-1R beta
1
Delineation of the binding regions of these three proteins revealed that $T1$, $T2$, and TFIIB each has two binding regions for the other two proteins.
HBx
RPB5
1
Based on the structure of the closely related lymphotoxin alpha-$T1$ complex, a molecular model of the $T2$ homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.
tumor necrosis factor receptor I
FasL
0
By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that $T1$/$T2$ and Grb2/c-Cbl are present in different complexes.
Grb2
Sos1
0
In addition, $T1$ associates with three different CDKs: $T2$, CDK4, and CDK6.
p27
CDK2
1
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ and hTFIID beta respectively), and is the homologue of Drosophila (d)$T2$.
hTFIID alpha
TAFII30 beta
0
In the present study, we demonstrate that $T1$ binds directly to the isolated $T2$.
14-3-3 zeta
Raf-CRD
1
alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both $T1$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and $T2$ from rat brain.
NR1
PSD-95
0
The correlation of SRF-RAP74 binding with transcriptional activation suggests that $T1$ is a critical target for $T2$-activated transcription.
RAP74
SRF
1
The $T1$ family currently consists of two agonists, IL-1alpha and $T2$, and one antagonist, IL-1ra.
IL-1
IL-1beta
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ($T1$$T2$ is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p47-phox
NADPH oxidase
0
Repression of $T1$-directed transcription may be accomplished through direct physical interaction between $T2$ and this activator.
CTF-1
YY1
0
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and $T2$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.
CD26
ADA
0
As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and $T1$ or $T2$ were detected.
hTAFII28
hTAFII30
0
$T1$, the soluble homologue of calnexin, was also shown to interact with $T2$ only when the protein bore a correctly modified oligosaccharide group.
Calreticulin
GT155
1
Specifically, substitution of proline for Ala-498 significantly diminished $T1$$T2$ binding, and similar mutation of Ile-502 or Ile-507 abolished interaction.
RII
RII alpha
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as $T1$$T2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
protein phosphatase 1
serine-threonine phosphatase 2A catalytic subunit
0
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, $T1$$T2$, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
cd44
hyaluronidase
0
$T1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor $T2$ (also known as the MIP-1 alpha/RANTES receptor).
CC CKR3
CC CKR1
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 $T1$$T2$ IL-7R but not T-cell clones that express predominantly the p76 IL-7R.
IL-7R
p90
0
The use of glutathione S-transferase-Lck fusion proteins in precipitation analysis showed that the SH2 domain of $T1$ could recognize $T2$ as expressed in the baculovirus expression system.
p56lck
CD5
1
Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for $T1$$T2$-mimetic peptide (EMP1), suggesting that Phe93 is also important for EMP1 binding.
EMP1
EPO
0
The structure provides evidence that the $T1$-p53 complex forms in vivo and may have a critical role in the $T2$ pathway of tumor suppression.
53BP2
p53
0
Induction of cell migration by $T1$ cleavage of $T2$.
matrix metalloprotease-2
laminin-5
1
IL-2, $T1$, IL-7 (whose receptors are known to contain gamma c), and $T2$ (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3.
IL-4
IL-9
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking $T1$$T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TAFII40
dTAFII60
0
TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including $T1$, $T2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.
Sp1
YY1
0
Cytokines IL-1alpha, IL-1beta, IL-6, $T1$, $T2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-8
IL-10
0
Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each $T1$ and three on each $T2$ in the oligomers.
C9
C8
0
These data show that $T1$ and $T2$ physically and functionally interact demonstrating that cross-talk occurs between factors of distantly related transcription families.
USF
Fra1
1
Here, a direct interaction between the activation domain of p53 and two subunits of the TFIID complex, $T1$ and $T2$, is reported.
TAFII40
TAFII60
0
The $T1$ ($T2$) is a target of viral oncoproteins.
retinoblastoma protein
Rb
0
$T1$ and $T2$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.
Syk
Lyn
1
Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an $T1$$T2$-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.
Abeta
LexA
0
Thus, during myogenic differentiation, formation of $T1$ and $T2$/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
E2F4
pRb2
1
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-$T1$ complex may contribute to the activation of the $T2$ pathway by gastrin.
Sos
mitogen-activated protein kinase
0
$T1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, $T2$ (KDR)/fetal liver kinase 1 (Flk-1) and FLT-1.
VEGF
kinase insert domain-containing receptor
0
$T1$ ($T2$) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.
Interleukin-13
IL-13
0
Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the TPO receptor and five anti-$T1$$T2$ receptor and five anti-TPO1-153 monoclonal antibodies.
TPO1
TPO
0
Using the human RAD52 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast UBC9, designated $T1$, that interacts with $T2$, RAD51, p53, and a ubiquitin-like protein UBL1.
UBE2I
RAD52
1
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T1$$T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
NGF
trkA
0
Expression of $T1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T2$ IIIb-expressing cells responded only to FGF-1.
FGFR3 IIIc
FGFR3
0
RIN1 interacts with the "effector domain" of $T1$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known $T2$ effector.
RAS
RAS
0
We find that p53, p21(CIP1) and $T1$$T2$(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
p15
p21
0
A mutant form of human interferon-gamma (IFN-gamma SC1) that binds one $T1$$T2$) that binds one IFN-gamma receptor alpha chain (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma receptor
IFN-gamma SC1
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature $T1$$T2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
PR
0
$T1$, a human G1 and S phase protein phosphatase that associates with $T2$.
Cdi1
Cdk2
1
The data thus demonstrate specific binding of platelet $T1$ to $T2$ and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.
FXIII
HSP27
1
Studies with monoclonal antibodies specific for the $T1$ receptor gamma chain showed that the gamma chain participates in the functional high-affinity receptor complexes for $T2$ that are involved in the differentiation of T and B cells.
IL-2
IL-7
0
In the present study, we examined the presence of glucocorticoid receptors (GRs) and cyclooxygenase-2 ($T1$$T2$ (COX-2) in the nasal polyps of nonallergic patients as compared with normal controls.
COX-2
cyclooxygenase-2
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$ complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF-receptor
trk
0
Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase $T1$$T2$ (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
SKR2
activin type II receptor kinase
0
The objective of this study was to measure the concentrations of $T1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether $T2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
TNFalpha
0
Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-$T1$$T2$ is the central organizing component of an hsp90-p60-hsp70 complex.
p60
p60
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
HVEM
LIGHT
0
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and $T1$$T2$ (EPO) receptor are important for binding EPO and EPO mimetic peptide.
EPO mimetic peptide
erythropoietin
0
We propose that c-Fos and $T1$$T2$ and c-Jun proteins function as transcriptional activators, in part by recruiting TBP to form complexes to initiate RNA synthesis.
c-Jun
c-Fos
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and $T1$) and three cytosol proteins (p47-phox, p67-phox, and $T2$) that translocate to membrane and bind to cytochrome b558.
gp91-phox
p21rac
0
Coassociation of $T1$ (dipeptidyl peptidase IV) with $T2$ on the surface of human T lymphocytes.
CD26
CD45
1
RANTES interacts with $T1$ and SDF-1 with $T2$ receptors.
CCR5
CXCR4
0
The interactions between cyclin E and $T1$, or $T2$, may be important at the G1 to S transition in human cells.
CDC2
CDK2
0
This protein, designated $T1$$T2$ (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
VEGF
VEGF-related protein
0
Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which $T1$ promotes $T2$ activation is complex and remains poorly understood.
Ras
Raf-1
0
Isolation of human $T1$ and its binding specificity with $T2$.
delta-catenin
presenilin 1
1
These results demonstrate that IL-11 and IL-6 utilize different ligand binding proteins, but share common signal transducer, $T1$$T2$ utilize different ligand binding proteins, but share common signal transducer, gp130, in TF-1 cells.
gp130
IL-6
0
The products of the $T1$ and RBP2 genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for $T2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP1
RBP2
0
Whereas $T1$ serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for $T2$ signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.
IL-13Ralpha
IL-4
1
These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and $T1$ $T2$ have different extracellular domains.
p76
IL-7R
0
The binding of $T1$/$T2$ to full-length PS1 was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.
QM
Jif-1
0
$T1$ suppresses the function of c-Jun homodimers via interaction with $T2$/Jif-1.
Presenilin 1
QM
1
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
p21CIP1
cyclin D1
0
The findings suggest a model whereby Bax and Bcl-X-S differentially regulate $T1$$T2$ differentially regulate Bcl-2 function, and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization.
Bcl-2
Bcl-X-S
0
$T1$ does not bind to the hGH receptor, but hGH binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGHR
0
LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-$T1$$T2$ fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
Abeta
B42
0
We sought to characterize how $T1$ binds and activates its receptor, $T2$.
TPO
myeloproliferative leukemia virus receptor
1
The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, $T1$ and $T2$, and is thought to regulate signalling by many cell surface receptors.
Crk
PI3 kinase
0
$T1$-driven proliferation is mediated via high affinity $T2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7
IL-7R
0
In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in $T1$:$T2$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548).
RBP
TTR
0
Discrete protein interactions with the $T1$/$T2$ complex in SCF- and TPO-mediated myeloid cell proliferation.
Grb2
c-Cbl
1
The first cDNA from the E2F family to be cloned was designated $T1$, and multiple $T2$ family members have now been identified.
E2F-1
E2F
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for $T1$$T2$ beta (delta C-43).
IGF-1R beta
IGF-1R
0
The structure of the complex shows that the $T1$ binding site on the $T2$ core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding.
53BP2
p53
1
Here we use simian virus 40 DNA replication in vitro to show than $T1$ directly inhibits $T2$-dependent DNA replication in the absence of a cyclin/CDK.
p21
PCNA
1
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
LTbetaR
1
A 51-residue region from the conserved C-terminal region of $T1$, previously shown to be the binding site for the viral activator protein $T2$, interacts with c-Fos and c-Jun proteins.
TBP
E1A
1
Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including $T1$, -2, -4, and -6, while $T2$ IIIb-expressing cells responded only to FGF-1.
FGF-1
FGFR3
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/$T2$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, cyclin E-Cdk2, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
cyclin A
Cdk4
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts ($T1$$T2$/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
E2F
cyclinA
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, $T1$, that interacts with the transcriptional inhibitor Id3/$T2$.
ITF-2b
HLH462
1
The MAP kinase enzymes $T1$ and $T2$/44 are regulated by tyrosine as well as serine/threonine phosphorylation.
pp54
pp42
0
$T1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTAFII28
hTFIID
0
The growth-promoting effects of $T1$ on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin/$T2$, which belongs to the family of G protein-coupled receptors.
gastrin
CCKB receptor
0
Monomeric ($T1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular ("soluble") portions of the $T2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6M
IL-6
0
XPG protein interacts with multiple subunits of TFIIH and with $T1$$T2$ and with CSB protein.
CSB
TFIIH
0
The general transcription factor $T1$ nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in $T2$-promoter complexes.
TFIID
TFIID
0
Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and $T1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with $T2$.
c-Jun
TBP
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/$T1$$T2$ (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cdk2
p130
0
In addition, JAK2 phosphorylated $T1$ at sites different from those phosphorylated by $T2$.
Raf-1
pp60v-src
1
$T1$, cyclin D, p19(INK4d) and p27($T2$) decrease in both cell types.
pRB
KIP1
0
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and $T1$ IIIc, that result from alternative splicing of exon III of the $T2$ gene encoding the ligand binding domain.
FGFR3
FGFR3
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
transforming growth factors (TGF) beta1
0
These data demonstrate that $T1$ but not Stat1 or Stat5 is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat3
IL-10 receptor
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/$T2$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by $T1$-Cdk2, cyclin E-Cdk2, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
cyclin A
cyclin D1
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor $T1$ ($T2$) in vitro.
UBF
upstream binding factor
0
Endothelin-1 (ET-1) and $T1$$T2$ (ET-1) and ET-3 had a strong positive inotropic effect in all trabeculae.
ET-3
Endothelin-1
0
This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with $T1$$T2$ from an immature B-cell line did not reassociate with Lyn in vitro.
Lyn
Syk
0
Interactions of the $T1$ protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and $T2$, were explored with a yeast two-hybrid system.
Bcl-2
Bax
1
Under these conditions, a ternary complex of p21ras, $T1$, and $T2$ was observed.
JAK2
Raf-1
0
We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell $T1$$T2$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18.
TFIID
TATA-binding protein
0
Interaction of p85 and N+C-SH2 with IR beta ($T1$$T2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
IR beta
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for $T1$ signaling, it could not replace the function of $T2$ in allowing enhanced IL-2 binding activity.
IL-4
gammac
0
Using a yeast interaction assay, we find that SRF binds the RAP74 subunit of $T1$ and that $T2$'s transcriptional activation domain is the region involved in this binding.
TFIIF
SRF
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$$T2$) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
p67-phox
gp91-phox
0
Deletion of this domain impairs $T1$'s ability to support $T2$-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support SP1-activated transcription.
RAP74
SRF
0
In yeast, Cdi1 interacts with cyclin-dependent kinases, including human Cdc2, $T1$, and $T2$, but not with Cdk4.
Cdk2
Cdk3
0
Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to $T1$$T2$ and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and PDGF receptor-alpha/beta heterodimers.
PDGF receptor-alpha
PDGF alpha
0
CONCLUSIONS: In this population of malnourished hospitalised children, molar $T1$:$T2$ ratio does not appear to be useful to assess VA status during infection.
RBP
TTR
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing $T1$$T2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
Crosslinking of iodinated acidic FGF (aFGF) and basic FGF ($T1$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both $T2$ and bFGF.
bFGF
aFGF
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, $T1$, and p21rac) that translocate to membrane and bind to $T2$.
p67-phox
cytochrome b558
1
Like mIL-10R, hIL-10R is structurally related to $T1$$T2$ is structurally related to IFNR.
IFNR
hIL-10R
0
pRB, $T1$, p19($T2$) and p27(KIP1) decrease in both cell types.
cyclin D
INK4d
0
The three-dimensional structure of the complex between human $T1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP ($T2$) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
H-Ras
GAP-334
1
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 (MPIF-2)/$T1$$T2$ (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
eotaxin-2
myeloid progenitor inhibitory factor 2
0
Mutagenesis of the $T1$$T2$ (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.
erythropoietin
erythropoietin receptor
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$$T2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.
KGFR
FGFR2 IIIb
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the $T1$$T2$ with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
p85
IRS-1
0
Raf-1 is a serine/threonine protein kinase positioned downstream of $T1$ in the $T2$ cascade.
Ras
mitogen-activated protein kinase
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of $T1$$T2$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.
IRS-1
gastrin
0
Further investigation indicated that the $T1$/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T2$/HLH462.
ITF-2b
Id3
0
Expression of $T1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while $T2$ IIIb-expressing cells responded only to FGF-1.
FGFR3
FGFR3
0
Analysis of p53, $T1$(CIP1), p15(INK4b), p16(INK4a), and p57($T2$) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p21
KIP2
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: $T1$, $T2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-2
MCP-3
0
CONCLUSION: The triple transduction of $T1$, $T2$ and GCH genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.
TH
AADC
0
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D ($T1$$T2$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.
sIL-6R
IL-6
0
The $T1$ associates with the $T2$ catalytic subunit.
retinoblastoma protein
protein phosphatase type 1
1
Thus, Phe93 and Phe205 are important binding determinants for both $T1$ and EMP1, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the $T2$ for productive ligand binding.
EPO
EPOR
1
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
trkA
0
Interestingly, the $T1$ binding site overlaps the largest continuous hydrophobic patch on $T2$.
ifnar2
IFNalpha2
1
This transcriptional activity is inhibited by association with the $T1$ (pRB) or its relatives $T2$ and p103.
retinoblastoma tumor suppressor protein
p107
0
In the present study, we examined both the binding of $T1$ and $T2$ and the functional consequences of this interaction.
ADA
CD26
1
Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, $T1$$T2$, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns.
hyaluronic acid synthase 2
procollagen I
0
We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the phosphoCREB:$T1$ interaction and report here that $T2$ can activate transcription through a region in its carboxy terminus.
CBP
CBP
0
Cytokines IL-1alpha, $T1$, IL-6, IL-8, IL-10 (Immunotech, France), $T2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).
IL-1beta
endothelin-1
0
Furthermore, this mutational analysis implicates KDR, but not FLT-1, in $T1$$T2$, but not FLT-1, in VEGF induction of endothelial cell proliferation.
VEGF
KDR
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
NGF-receptor
0
We found that in addition to $T1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, $T2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MIP-1beta
MCP-4
0
In addition, activation of $T1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate $T2$.
PI 3-kinase
PI 3-kinase
0
USF specifically interacts with Fra1 but not with other closely related family members, $T1$$T2$ but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun.
c-Fos
Fra1
0
Human spleen tyrosine kinase $T1$ associates with the Src-family kinase $T2$/56Lyn and a 120-kDa phosphoprotein.
p72Syk
p53
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ib
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/$T1$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of $T1$$T2$, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.
CREB
p300
0
The protein product of c-cbl proto-oncogene is known to interact with several proteins, including $T1$, $T2$ and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.
Grb2
Crk
0
CREB is activated through phosphorylation by protein kinase A ($T1$$T2$ (PKA), but precisely how phosphorylation stimulates CREB function is unknown.
PKA
protein kinase A
0
In order to characterize the signaling pathway through which $T1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the $T2$ gene encoding the ligand binding domain.
FGFR3
FGFR3
0
METHODS: The genes for dopamine synthetic enzymes, $T1$ (TH), $T2$ (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
tyrosine hydroxylase
aromatic L-amino acid decarboxylase
0
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
ADA
ADA
0
However, the various $T1$/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the $T2$ subunit.
E2F
E2F
0
Analysis of p53, $T1$(CIP1), p15(INK4b), p16(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p21
p57
0
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T1$ to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
1
In vitro, purified $T1$ subunits specifically bound to a GST fusion protein encoding amino acids 1-330 of Raf-1 ($T2$).
G beta gamma
Raf/330
1
Analysis of p53, p21(CIP1), $T1$(INK4b), p16(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p15
p57
0
Peptide growth factors, as well as the immediate early gene products c-Jun, v-Fos, and $T1$, inhibit the activity of myogenin through a mechanism independent of its association with $T2$ products.
c-Myc
E2A
0
Collectively, the novel function of PS1 via QM/Jif-1 influences $T1$$T2$ influences c-jun-mediated transcription and apoptosis.
c-jun
Jif-1
0
Interferon-gamma and several other cytokines that are known to activate $T1$ kinase were also found to stimulate $T2$ activity toward MEK-1 in mammalian cells.
JAK2
Raf-1 kinase
0
In the second of a series of experiments designed to identify p47nck-Src homology 3 (SH3)-binding molecules, we report the cloning of $T1$ ($T2$) from an HL60 cDNA expression library.
SAKAP II
Src A box Nck-associated protein II
0
Overexpression of wild-type $T1$ delays progression through the cell cycle in yeast and HeLa cells; delay is dependent on $T2$ phosphatase activity.
Cdi1
Cdi1
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
0
We have shown previously that Phe93 in the extracellular domain of the $T1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or $T2$) and no detectable binding to full-length mutant receptor expressed in COS cells.
erythropoietin
EBP
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
Cdk2
Cdk4
0
The bZIP domains of Fos and $T1$ mediate a physical association with the $T2$.
Jun
TATA box-binding protein
1
Withdrawal from the cell cycle of differentiating myocytes is regulated by the $T1$ (bHLH) protein MyoD and the pocket proteins $T2$, p107 and pRb2/p130.
myogenic basic helix-loop-helix
pRb
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$ suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
Jif-1
PS1
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 $T1$ but not T-cell clones that express predominantly the $T2$ IL-7R.
IL-7R
p76
0
$T1$ activation of $T2$ may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.
MAP kinase
c-jun
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-$T1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-$T2$.
FD5
FD8
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable $T1$$T2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
The interactions between $T1$ and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and $T2$.
GRB2
Shc
0
More importantly, adenosine in the absence of cell surface ADA inhibited T cell proliferation and $T1$$T2$ inhibited T cell proliferation and IL-2 production induced by various stimuli.
IL-2
ADA
0
Interactions between $T1$ and the $T2$.
brain-derived neurotrophic factor
TRKB receptor
1
Interferon-gamma and several other cytokines that are known to activate $T1$$T2$ were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.
JAK2
JAK2 kinase
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with $T1$, consistent with the previous report of a $T2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.
PTF
PTF
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a $T1$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the $T2$ gamma reported here.
PTF
PTF
0
Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for $T1$$T2$, but only 30% for MIP-1beta.
MIP-1beta
MCP-2
0
Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by $T1$ or $T2$.
TNF-alpha
TNF-beta
0
An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/$T1$$T2$-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).
cdk2
E2F
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), $T1$ (AADC), and $T2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
aromatic L-amino acid decarboxylase
GTP cyclohydrolase I
0
Crosslinking of iodinated acidic FGF ($T1$) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both $T2$ and bFGF.
aFGF
aFGF
0
Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing $T1$$T2$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.
Bcl-2
Bcl-2
0
In addition, hsp90 in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with $T1$$T2$ in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.
hsp90
hsp90
0
Although multimeric complexes of $T1$ and $T2$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
p75
0
Mouse IL-10 does not bind to $T1$, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of $T2$.
hIL-10R
IL-10
0
Furthermore, we have identified a short sequence motif (YV/IN) present in IRS-1, EGFR and $T1$$T2$ and Shc, which specifically binds the SH2 domain of GRB2 with high affinity.
Shc
EGFR
0
The $T1$ family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, $T2$.
IL-1
IL-1ra
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of $T1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and $T2$-FD8.
Fas
Fas
0
These data are consistent with a model wherein cyclin D/CDK complexes sequester the $T1$-dependent kinase inhibitory activity of $T2$.
CDK2
p27
0
Two lines of evidence support the notion that RbAP46 and simian virus 40 T antigen have homologous $T1$-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with $T2$ for binding to Rb.
Rb
RbAP46
0
The products of the RBP1 and $T1$ genes are ubiquitously expressed, large (200 kDa for $T2$ and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.
RBP2
RBP1
0
Interaction of $T1$ and gamma c chains with Jak1 and $T2$: implications for XSCID and XCID.
IL-2R beta
Jak3
1
Here we report the crystal structure of the $T1$ ectodomain in a dimeric form that is induced by simultaneous binding to $T2$ and a heparin decasaccharide.
FGFR2
FGF1
1
Cross-linking of 125I-$T1$ and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for $T2$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.
TNF-alpha
TNF-alpha
0
Preincubation with the $T1$ antagonist FR139317 (1 microM) decreased significantly (P < 0.005) the potency of $T2$ in both atrial and ventricular trabeculae, without any significant changes in Emax (maximum effect obtained with an agonist).
ET(A) receptor
ET- I
0
We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as $T1$ ($T2$) in mammalian cells.
protein phosphatase 1
PP1C
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional $T1$ pocket; and (4) $T2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
Rb
Rb
0
We observed that the protein $T1$ interacted with protein $T2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.
HOX11
serine-threonine phosphatase 2A catalytic subunit
1
hTAFII28 is a core hTAFII present in both of the previously described $T1$ species which either lack or contain hTAFII30 (hTFIID alpha and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID
0
We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor ($T1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR ($T2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.
EPOR
EPO
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$$T2$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.
CCKB
IRS-1
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-$T1$$T2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
TBP
PTF
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/$T1$$T2$ but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
Jif-1
c-Jun
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat3
Stat3
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/$T2$ related protein, and the Torpedo 87K protein.
dystrophin
dystrophin
0
We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, RBP1 and $T1$, cloned originally by their interaction with $T2$.
RBP2
pRB
1
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of $T1$ coimmunoprecipitated with $T2$ in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.
Raf-1
JAK2
1
OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein ($T1$$T2$ (RBP) to transthyretin (TTR) to determine vitamin A (VA) status during infection.
RBP
retinol-binding protein
0
Alanine-scanning mutagenesis was used to identify a positively charged surface in $T1$ that mediates binding to $T2$/Flk-1.
VEGF
KDR
0
When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to IL-1, $T1$ rapidly associated with the $T2$ complex and was phosphorylated.
IRAK
IL-1RI
1
COS-7 cells transfected with the $T1$ cDNA bind $T2$ with high affinity but do not bind IL-4.
IL-13R
IL-13
1
The objective of this study was to measure the concentrations of $T1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, $T2$ (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
alpha-1-antitrypsin
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and $T2$ (FasL/CD95L).
herpes virus entry mediator (HVEM)-L
Fas ligand
0
Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein $T1$, regulated on activation, normal T expressed and secreted ($T2$), and monocyte chemoattractant protein-3 (MCP-3), but the receptors involved have not been defined.
(MIP)-1 alpha
RANTES
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta receptor
LIGHT
0
We show that the physical interaction between YY1 and p300, a coactivator for $T1$, is not sufficient for repression of $T2$-mediated transcription.
CREB
CREB
0
Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human $T1$ and the extracellular ("soluble") portions of the $T2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.
IL-6
IL-6
0
These proteins, 14-3-3 zeta ($T1$) and 14-3-3 beta ($T2$), are members of the 14-3-3 family of proteins.
PLA2
HS1
0
Although the individual amino acids in $T1$ involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
neurotrophin-3
0
FGF-7 recognizes one FGFR isoform known as the $T1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
FGFR2 IIIb
KGFR
0
Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, $T1$$T2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.
MCP-3
CCR5
0
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ and $T2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID alpha
hTFIID beta
0
Two lines of evidence support the notion that $T1$ and $T2$ have homologous Rb-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
RbAP46
simian virus 40 T antigen
0
Here we show that beta:$T1$ binds to the activin type II receptor kinase ($T2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.
beta activin
ActRII
1
Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D ($T1$)2 complex to couple with the soluble portion of $T2$.
sIL-6R
gp130
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30L
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and $T1$-$T2$ complexes.
cyclin D2
Cdk4
1
Cloning and characterization of $T1$, hTAFII20 and $T2$: three subunits of the human transcription factor TFIID.
hTAFII18
hTAFII28
1
We also show that $T1$ is a serine-threonine kinase that is recruited by $T2$ to TNFR1 in a TNF-dependent process.
RIP
TRADD
0
A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of $T1$ with $T2$.
C8
C9
1
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing ($T2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
TAP
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/$T1$ and BR-II/$T2$) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-Ia
BR-Ib
0
In the present study we evaluated tyrosine phosphorylation of $T1$ and the interaction of the $T2$/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.
c-Cbl
Grb2
0
The interactions of $T1$ and hsp90 in intermediate $T2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
PR
0
Our results demonstrate that the SH3 domain of $T1$ interacts with a DPAPNPPHFP motif (residues 1,373-1,382) of $T2$.
c-Abl
ATM
1
Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring $T1$$T2$) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.
RII beta
RII beta
0
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
delta C-4
p85
0
RIP also interacts weakly with the $T1$ tumor necrosis factor receptor (TNFR1) intracellular domain, but not with a mutant version of $T2$ corresponding to the murine lprcg mutation.
p55
Fas
0
This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or $T1$ but not those containing Bcl-X-S (an alternatively spliced form of $T2$ that lacks a well-conserved 63-amino acid region).
Mcl-1
Bcl-X
0
pRB, cyclin D, p19(INK4d) and $T1$($T2$) decrease in both cell types.
p27
KIP1
0
We demonstrate here that both the site 2 and site 3 $T1$ variants complexed with $T2$ bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130.
IL-6
IL-6R alpha
1
Mechanism of CDK activation revealed by the structure of a $T1$-$T2$ complex.
cyclinA
CDK2
1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-$T1$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of $T2$/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.
MyoD
cyclinA
0
Site-specific mutants were expressed in Escherichia coli as soluble $T1$ and analyzed for $T2$ binding in several different assay formats.
EBP
EPO
0
p23 is also present in immunoaffinity-purified hsp90 complexes along with $T1$ and another protein, $T2$.
hsp70
p60
0
Analysis of p53, $T1$$T2$, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
p21
p53
0
$T1$$T2$: a ligand and specific activator of the tyrosine kinase receptor Flt4.
Vascular endothelial growth factor
Vascular endothelial growth factor-related protein
0
Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and $T1$$T2$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.
PTF
PTF
0
The gamma chain of the $T1$ (IL-2) receptor is shared with the functional $T2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.
interleukin-2
IL-4 receptor
0
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a $T1$$T2$ in a p21ras-dependent manner.
p21ras
Raf-1
0
$T1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/$T2$ (Flk-1) and FLT-1.
VEGF
fetal liver kinase 1
0
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing $T1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing $T2$ and Hip (p48).
heat shock protein 90
hsp70
0
Our analyses demonstrate that the $T1$, $T2$, p44, and p62 proteins interact with each other.
XPB
XPD
1
Functional studies in Jurkat T lymphocytic cells point to the importance of both the E2F and NF-kappaB binding sites in $T1$$T2$ binding sites in E2F-1 mediated repression of HIV-1 promoter, in vivo.
E2F-1
NF-kappaB
0
$T1$: a ligand and specific activator of the tyrosine kinase receptor $T2$.
Vascular endothelial growth factor-related protein
Flt4
1
The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/$T1$$T2$ gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.
Snf
CSB
0
The $T1$ and hPRL receptors ($T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hGHR
1
In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), $T1$, and immunophilins and, on the other, enhance recovery of early $T2$ complexes containing hsp70 and Hip (p48).
p23
PR
0
We demonstrate that $T1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of $T2$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.
HLA-E
HLA-E
0
A mutant form of human interferon-gamma ($T1$) that binds one $T2$ (IFN-gamma R alpha) has been designed and characterized.
IFN-gamma SC1
IFN-gamma receptor alpha chain
1
Moreover, a partial recombinant TFIID complex containing $T1$ was capable of mediating in vitro transcriptional activation by the $T2$ activation domain.
hTAFII32
VP16
0
$T1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and $T2$-Cdk4 complexes.
p21CIP1
cyclin D2
0
$T1$ protein fused to the Drosophila protein $T2$ (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
bicoid
0
The genes for MPIF-2/$T1$ (SCYA24) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
eotaxin-2
SCYA26
0
Taken together, our results suggest that $T1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T2$.
IRS-1
insulin receptor
0
IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 $T1$$T2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.
IL-7R
p76
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-$T1$, cyclin D1-$T2$, and cyclin D2-Cdk4 complexes.
Cdk2
Cdk4
0
In addition, hsp90 in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, $T1$, which has never been recovered in cytosol in the form of a native multiprotein complex with $T2$.
pp60c-src
hsp90
0
Affinity chromatography and co-immunoprecipitation assays provide evidence for direct interaction of $T1$ and $T2$ in the absence of their DNA target sequences.
E2F-1
p50
1
Although Fos/Jun and $T1$$T2$/Jun and ATF/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.
ATF
Fos
0
The 2.8 A crystal structure of a complex between the extracellular portions of $T1$ and $T2$ shows two HFE molecules which grasp each side of a twofold symmetric TfR dimer.
HFE
TfR
1
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, $T1$, that interacts with the transcriptional inhibitor $T2$/HLH462.
ITF-2b
Id3
1
This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta ($T1$$T2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).
delta C-4
IR beta
0
LexA protein fused to the Drosophila protein $T1$ ($T2$-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
LexA
0
SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for $T1$$T2$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.
SF3a
SF3a
0
Two lines of evidence support the notion that RbAP46 and $T1$ have homologous $T2$-binding properties: first, several mutated Rb proteins that failed to bind to T also did not associate with RbAP46; and second, both T antigen and T peptide (amino acids 101-118) were able to compete with RbAP46 for binding to Rb.
simian virus 40 T antigen
Rb
1
The induced expression of $T1$, similar to $T2$, produces a senescent-like phenotype.
p57
p16
0
$T1$ inhibited $T2$-induced cytotoxicity in HT29 cells .
TR6
LIGHT
0
The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of $T1$$T2$ and is dependent on tyrosine phosphorylation of c-Cbl.
c-Cbl
Vav
0
The cell surface form of $T1$ is assembled during biosynthesis as a heteromeric complex with $T2$ (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.
LT-alpha
lymphotoxin-beta
1
LexA protein fused to the Drosophila protein $T1$ (LexA-bicoid) failed to interact with the $T2$ fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
bicoid
B42
0
We have therefore investigated whether the octamer binding proteins might physically interact with $T1$, the $T2$ component of the TFIID factor.
TBP
TATA box binding protein
0
BMP-2 binding significantly increased hetero- and homo-oligomerization (except for the BR-II homo-oligomer, which binds ligand poorly in the absence of $T1$$T2$ binding significantly increased hetero- and homo-oligomerization (except for the BR-II homo-oligomer, which binds ligand poorly in the absence of BR-I).
BR-I
BMP-2
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by $T2$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.
Rb
cyclin A
0
Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and $T1$ ($T2$) genes under the control of LexA-dependent operators.
LEU2
leucine utilization
0
LexA protein fused to the Drosophila protein bicoid ($T1$-bicoid) failed to interact with the $T2$ fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific.
LexA
B42
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-$T1$, cyclin E-Cdk2, $T2$-Cdk4, and cyclin D2-Cdk4 complexes.
Cdk2
cyclin D1
0
$T1$ is activated through phosphorylation by protein kinase A ($T2$), but precisely how phosphorylation stimulates CREB function is unknown.
CREB
PKA
1
A $T1$ fragment retaining the CD4-binding site and overlapping epitopes was able to interact with $T2$ only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
gp120
CCR-5
1
In yeast, $T1$ interacts with cyclin-dependent kinases, including human Cdc2, $T2$, and Cdk3, but not with Cdk4.
Cdi1
Cdk2
1
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with $T1$$T2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Grb2
insulin receptor
0
We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between GRB2 and the two targets IRS-1 and $T1$$T2$ and Shc.
Shc
IRS-1
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-$T1$, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
Cdk2
Cdk4
0
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T1$/ BR-Ib, and also $T2$/ BR-Ib) oligomers in the absence of ligand.
BR-Ib
BR-Ia
0
$T1$ is a T-cell-specific antigen which binds to the B-cell antigen $T2$ and acts as a coreceptor in the stimulation of T-cell growth.
CD5
CD72
1
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
HVEM
lymphotoxin beta
0
Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both $T1$$T2$ or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
RPB5
TFIIB
0
Cotransfection of hGITRL and $T1$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 ($T2$) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITR
TRAF2
0
A second region of $T1$ that includes residues from the carboxyl terminus of the D-helix and A-B loop also had a weak influence on $T2$ binding.
hLIF
hLIF-R
1
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of $T1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-$T2$ complexes.
Rb
Cdk4
0
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p140trk (trkA) tyrosine kinase receptor
1
Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with $T1$$T2$ with RII-anchoring proteins occurs through an amphipathic helix binding motif.
RII
cAMP-dependent protein kinase
0
Transcriptional synergy with NF-IL6 beta (C/$T1$, $T2$).
EBP delta
CRP3
0
Here we show that $T1$ directly interacts with TRAF2 and $T2$, signal transducers that activate NF-kappa B and induce apoptosis, respectively.
TRADD
FADD
1
The extracellular domain of the human $T1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor ($T2$).
neurotrophin TRKB receptor
BDNF
1
In yeast, $T1$ interacts with cyclin-dependent kinases, including human Cdc2, Cdk2, and $T2$, but not with Cdk4.
Cdi1
Cdk3
1
Two potentially oncogenic cyclins, cyclin A and $T1$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein .Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor ($T2$) as well as a candidate proto-oncogene.
cyclin D1
SPF
0
As expected, overexpression of either $T1$/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T2$.
Id3
MyoD
0
A protein, $T1$ ($T2$), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.
sorting nexin-1
SNX1
0
pRB, cyclin D, $T1$($T2$) and p27(KIP1) decrease in both cell types.
p19
INK4d
0
We found that deletion of the carboxyl-terminal 28 amino acids of $T1$ disrupted PU.1-$T2$ physical interaction.
PU.1
NF-IL6 beta
0
We found that the human TR subtype beta 1 ($T1$) physically interacted with $T2$ via its DNA binding domain.
h-TR beta 1
p53
1
We find that p53, p21(CIP1) and p15($T1$$T2$, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.
INK4b
p53
0
The objective of this study was to measure the concentrations of $T1$ ($T2$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.
tumor necrosis factor-alpha
TNFalpha
0
Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the $T1$$T2$ uses components of the IL-2 receptor.
IL-2
IL-15
0
PI 3-kinase activity and the regulatory $T1$ subunit of $T2$ associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.
p85
PI 3-kinase
0
DESIGN: We took advantage of previously collected data during a randomised double-blind, placebo-controlled clinical trial to conduct a secondary analysis of the RBP/$T1$$T2$/TTR ratio and its relationship to infection and VA status.
TTR
RBP
0
The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to $T1$$T2$ (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.
cytochrome b558
cytochrome b558
0
Characterization of the $T1$ binding proteins $T2$ and RBP2.
retinoblastoma
RBP1
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ($T1$/BR-Ia and BR-II/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, BR-Ib/ $T2$, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature $T1$$T2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
PR
hsp90
0
The apparent affinity of the interaction between $T1$ and $T2$ was dramatically lower in the absence of soluble CD4.
gp120
CCR-5
1
hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ($T1$ alpha and $T2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta.
hTFIID
hTFIID
0
The stimulation of Sp1-mediated transcription by $T1$ in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human $T2$.
RB
TAFII250
0
These interactions are $T1$-specific, since another DNA repair-related ubiquitin-conjugating enzyme, $T2$ (UBC2), does not interact with these proteins.
UBE2I
RAD6
0
Using co-immunoprecipitation and protein-protein association assays, we show that both $T1$ and c-Jun bind specifically and stably to $T2$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.
c-Fos
TBP
1
COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and $T1$$T2$ cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.
IL-13
IL-4R
0
MMP2 cleaved the Ln-5 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on $T1$$T2$ subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.
Ln-5
Ln-5 gamma2
0
The bZIP domains of $T1$ and $T2$ mediate a physical association with the TATA box-binding protein.
Fos
Jun
0
Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by $T1$$T2$/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.
c-Jun
c-Jun
0
The IL-1 family currently consists of two agonists, $T1$ and $T2$, and one antagonist, IL-1ra.
IL-1alpha
IL-1beta
0
Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect $T1$$T2$ binding, and mutants deficient in FLT-1 binding did not affect KDR binding.
KDR
FLT-1
0
Using immunoprecipitation techniques, we have determined the rates at which $T1$ and $T2$ (GS) are released from groEL in a form committed to refold to active enzyme.
rhodanese
glutamine synthetase
0
RESULTS: TH, AADC and GCH were effectively coexpressed in transduced cells with three separate AAV vectors, AAV-$T1$, AAV-AADC and AAV-$T2$.
TH
GCH
0
The HFE-TfR complex suggests a binding site for transferrin on $T1$$T2$ complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.
TfR
TfR
0
The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, $T1$, and $T2$, which interact with guanine nucleotide exchange factors specific for the Ras family.
Crk
Crk-L
0
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-$T1$, and cyclin D2-$T2$ complexes.
Cdk4
Cdk4
0
Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta($T1$$T2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.
delta C-43
IR beta
0
A protein ligand for the ECK receptor protein-tyrosine kinase has been isolated by using the extracellular domain ($T1$$T2$ receptor protein-tyrosine kinase has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.
ECK
ECK
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of $T1$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate $T2$.
IRS-1
PI 3-kinase
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T1$-LPR and Fas-$T2$.
Fas
FD8
0
RANTES interacts with CCR5 and $T1$ with $T2$ receptors.
SDF-1
CXCR4
1
Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by $T1$$T2$ and granulysin expression by CD3(-) CD16(+) cells in healthy controls.
CD3
perforin
0
The screen identified interactions involving $T1$ and two 14-3-3 isoforms, cytokeratin 18, human unconventional myosin IC, and a recently identified SH3 domain containing protein, $T2$.
c-Cbl
SH3 P17
1
Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two $T1$, two $T2$ and two gp130 molecules.
IL-6
IL-6R alpha
1
$T1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S. $T2$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as Bcl-2.
Bcl-2
Bcl-X-L
0
The genes for MPIF-2/$T1$ ($T2$) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
eotaxin-2
SCYA24
0
We screened for proteins that bind to PS1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the $T1$/$T2$ gene.
QM
Jif-1
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
HVEM
TR6
0
Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, $T1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants $T2$-LPR and Fas-FD8.
FADD
Fas
0
We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, $T1$, MCP-1, and $T2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.
MCP-4
eotaxin
0
In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator $T1$ ($T2$) as well as with the general transcription factor TFIIB.
viral protein 16
VP16
0
The genes for MPIF-2/eotaxin-2 ($T1$) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
SCYA24
eotaxin-3
0
However, the various E2F/DP complexes display strong differences in the ability to bind to either $T1$ or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the $T2$ subunit.
pRB
E2F
0
Collectively, the novel function of PS1 via $T1$/Jif-1 influences $T2$-mediated transcription and apoptosis.
QM
c-jun
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin related protein
1
In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, $T1$ IIIb and $T2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.
FGFR3
FGFR3 IIIc
0
Jak1 and Jak3 associated with $T1$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased $T2$-gamma c associations.
IL-2R beta
Jak3
0
Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas $T1$$T2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.
TBP
dTAFII60
0
Some $T1$ substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or $T2$ in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.
HBx
RPB5
1
Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human $T1$ (IL-6) that activates human $T2$.
interleukin-6
gp130
1
We have identified an 18-amino acid residue stretch in the $T1$ head that is conserved only among type II epidermal keratins and that appears to play some role in $T2$ tail binding.
K5
DPI
1
Furthermore, $T1$ blocks the ability of $T2$ to activate DNA polymerase delta, the principal replicative DNA polymerase.
p21
PCNA
1
The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether $T1$ shares common signal transduction mechanisms with $T2$.
IL-11
IL-6
0
METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I ($T1$$T2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.
GCH
GTP cyclohydrolase I
0
$T1$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and $T2$-chain (23%).
PDGF-C
PDGF A
0
Furthermore, $T1$ blocks the ability of PCNA to activate $T2$, the principal replicative DNA polymerase.
p21
DNA polymerase delta
0
It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, erythropoietin and $T1$$T2$, erythropoietin and interleukin-2 (beta-chain) and also to the prolactin receptor.
interleukin-2
interleukin-6
0
From these results, it appears that $T1$ is a key mediator in the chaperoned assembly and functional maturation of $T2$ complexes.
p60
PR
0
In addition, we show that in extracts depleted of $T1$ and TBP-associated factors, transcription from the U1 promoter is restored by recombinant $T2$ but not by TFIID or TFIIIB, indicating that transcription of class II snRNA genes requires a TBP complex different from the one used for mRNA-encoding genes.
TBP
TBP
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$ receptor ($T2$) and HVEM/TR2 receptors.
lymphotoxin beta
LTbetaR
1
Reconstitution of the multiprotein complex of $T1$, $T2$, and p50 in a cell-free system.
pp60src
hsp90
1
CIP1 encodes a novel 21 kd protein that is found in $T1$, $T2$, cyclin E, and Cdk2 immunoprecipitates.
cyclin A
cyclin D1
0
Thus, during myogenic differentiation, formation of $T1$ and pRb2/$T2$ containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
E2F4
p130
1
CD5 associates with the $T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
T-cell receptor zeta chain (TcR zeta)/CD3
CD3
0
$T1$ interacts with the "effector domain" of RAS and employs some $T2$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.
RIN1
RAS
0
In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 $T1$$T2$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the p76 IL-7R.
IL-7R
IL-7R
0
The ability of $T1$ and $T2$ proteins to interact directly with the TATA box-binding protein (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.
c-Fos
c-Jun
0
$T1$ and RPB5 specifically bound to $T2$ (TFIIB) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
HBx
transcription factor IIB
0
Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex ($T1$) containing substoichiometric levels of TBP and a component ($T2$) identical in sequence to the PTF gamma reported here.
SNAPc
SNAPc43
0
Scatchard analysis of in vitro binding between Raf/330 and G beta gamma revealed an affinity of interaction (Kd = 163 +/- 36 nM), similar to that seen between $T1$ and $T2$ (Kd = 87 +/- 24 nM).
G beta gamma
beta ARK
1
The $T1$ (IL-1beta) converting enzyme (ICE) processes the inactive $T2$ precursor to the proinflammatory cytokine.
interleukin-1beta
IL-1beta
0
One clone encodes a novel $T1$ catalytic subunit ($T2$), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.
type 1 protein phosphatase
PP-1 alpha 2
0
The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ($T1$$T2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).
hsp70
hsp90
0
Cotransfection of hGITRL and $T1$ in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve $T2$ (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8].
hGITR
TNFR-associated factor 2
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/eotaxin-2 ($T2$) and have identified a novel CC chemokine termed eotaxin-3.
MPIF-2
SCYA24
0
The binding of QM/$T1$ to full-length $T2$ was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.
Jif-1
PS1
1
The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the $T1$$T2$.
epidermal growth factor
epidermal growth factor receptor
0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD/MORT, RIP, FLICE/MACH, and TRAFs) associated with both of the $T1$$T2$, FLICE/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.
p60
RIP
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules $T1$ and beta, $T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
tumour necrosis factors (TNF) alpha
transforming growth factors (TGF) beta1
0
Analysis of p53, p21($T1$), p15(INK4b), p16(INK4a), and $T2$(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.
CIP1
p57
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$), whereas FGF-2 binds well to $T2$, FGFR2, and FGFR4 but interacts poorly with KGFR.
KGFR
FGFR1
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$ and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
TR2
LIGHT
0
$T1$ produced in E. coli bound and activated the CDC2 protein in extracts from human G1 cells, and antibodies against $T2$ immunoprecipitated a histone H1 kinase from HeLa cells.
Cyclin E
cyclin E
0
Isothermal titration calorimetry shows that $T1$ forms a 1:1 complex with its high-affinity receptor ($T2$ R alpha) with an affinity of 27(+/- 9) nM.
IFN-gamma SC1
IFN-gamma
0
We show that the physical interaction between YY1 and $T1$, a coactivator for $T2$, is not sufficient for repression of CREB-mediated transcription.
p300
CREB
1
Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II/BR-Ia and $T1$/BR-Ib) and homomeric (BR-II/BR-II, BR-Ia/ BR-Ia, $T2$/ BR-Ib, and also BR-Ia/ BR-Ib) oligomers in the absence of ligand.
BR-II
BR-Ib
0
The substrate specificity, the expression pattern of this kinase, and the ability to deplete 50% of this kinase activity with a CDK6-specific antibody suggest that the CDK6 protein mediates, in part, the p27-associated $T1$$T2$ protein mediates, in part, the p27-associated Rb-kinase activity.
Rb
CDK6
0
Thus, during p53-mediated suppression of cell proliferation, p21 and $T1$$T2$ and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
PCNA
p21
0
FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor ($T1$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with $T2$.
KGFR
KGFR
0
In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased $T1$$T2$ (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.
CD4
CD26
0
Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF ($T1$$T2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.
upstream binding factor
Rb
0
Here , we demonstrate that TR6 specifically binds two cellular ligands , LIGHT ( $T1$ ) and Fas ligand ( $T2$ / CD95L ) .
herpes virus entry mediator ( HVEM ) - L
FasL
0
Many of the same signaling molecules, including protein kinase C (PKC), $T1$$T2$), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.
tyrosine kinase, phosphatidylinositol 3-kinase
PKC
0
p53 transcriptional activation mediated by coactivators TAFII40 and $T1$$T2$ and TAFII60.
TAFII60
TAFII40
0
We now show that full-length $T1$ interacts with activated $T2$ in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding.
RIN1
RAS
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T1$ (FasL/$T2$).
Fas ligand
CD95L
0
Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to $T1$, but fails to form the $T2$.
ActRII
ActRII
0
